TW201204254A - Pesticidal 3-(aryloxy)azacycloalkanes - Google Patents

Pesticidal 3-(aryloxy)azacycloalkanes Download PDF

Info

Publication number
TW201204254A
TW201204254A TW100122670A TW100122670A TW201204254A TW 201204254 A TW201204254 A TW 201204254A TW 100122670 A TW100122670 A TW 100122670A TW 100122670 A TW100122670 A TW 100122670A TW 201204254 A TW201204254 A TW 201204254A
Authority
TW
Taiwan
Prior art keywords
compound
group
independently
formula
alkyl
Prior art date
Application number
TW100122670A
Other languages
Chinese (zh)
Inventor
David Alan Clark
George Philip Lahm
Original Assignee
Du Pont
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont filed Critical Du Pont
Publication of TW201204254A publication Critical patent/TW201204254A/en

Links

Landscapes

  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

Disclosed are compounds of Formula 1, including all stereoisomers, N-oxides, and salts thereof, wherein A1 is N or CR7; A2 is N or CR8; A3 is N or CR9; A4 is N or CR10; provided that not more than two of A1, A2, A3 and A4 are N; T is O, S(O)k or NR36; L is -C(R11)=C(R12)-, wherein the carbon atom bonded to R11 is also bonded to CR4R5 and the carbon atom bonded to R12 is also bonded to R6; or 1, 4-diphenylene optionally substituted with up to 4 substituents independently selected from R13; or -C(R34)(R35)-Z-, wherein the carbon atom bonded to R34 and R35 is also bonded to CR4R5 and Z is bonded to R6; Z is O, S(O)m, NR37 or CR38R39; R1 is a phenyl or 5- or 6-membered heteroaromatic ring optionally substituted with up to 5 substituents independently selected from R14; R6 is a phenyl or 5- or 6-membered heteroaromatic ring optionally substituted with up to 5 substituents independently selected from R22; s is 1, 2 or 3; t is 1 or 2; provided that the sum of s and t is 2, 3 or 4; and R2, R3, R4, R5, R7, R8, R9, R10, R11, R12, R13, R14, R22, R34, R35, R36, R37, R38, R39, W, k, m and n are as defined in the disclosure. Also disclosed are compositions containing the compounds of Formula 1 and methods for controlling an invertebrate pest comprising contacting the invertebrate pest or its environment with a biologically effective amount of a compound or a composition of the invention.

Description

201204254 六、發明說明 【發明所屬之技術領域】 本發明關於某些3_^签 動物之無脊椎動物害蟲的;法'農藝環境中防治如節肢 為達成農作物生產之高效益 10 15 =重要=椎動物害蟲對於;長與儲 的危害,可引起產量的顯著下降且因而導致消費 增加。在森林、溫室農魏、㈣W找f者成本 藏食物及纖維產品、牲畜Λ '健 r多針對此目的之市售產品,:仍:續為有重 效、成本較少、毒性較低、對環境較為安全或具有2 作用位點之新穎化合物的需求。 、不冋 二CT專利公開第wo 2G_5146 A1號揭 殺蟲的、«的、殺軟體動物的及殺線蟲的化合物= 包含-直接鍵結至-芳香環或雜芳環的派【口+井、。 本發明之該3·(芳氧基)氮雜觀類未於本公開文件^揭 露。 【發明内容】 20 201204254 本發明係關於式1化合物(包括所有立體異構 物)、其N.氧化物及其㈣’以及含有彼等之組合物及 其用於防治無脊椎動物害蟲之用途:201204254 VI. Description of the Invention [Technical Fields of the Invention] The present invention relates to invertebrate pests of certain 3_^ animals; in the 'agronomic environment', prevention and control such as arthropods for achieving high yield of crop production 10 15 = important = vertebrate animals The pest's harm to the long-term storage can cause a significant drop in yield and thus an increase in consumption. In the forest, greenhouse agriculture, (four) W to find the cost of food and fiber products, livestock Λ 'Jian r more for this purpose of the commercial products, still: continue to be more efficient, less cost, less toxic, The need for a safer or novel compound with 2 sites of action. , the second CT patent publication No. 2G_5146 A1, the insecticide, the mollusk and the nematicidal compound = contains - directly bonded to the - aromatic ring or hetero-aromatic ring [mouth + well, . The 3((aryloxy)azepines of the present invention are not disclosed in the present disclosure. SUMMARY OF THE INVENTION 20 201204254 The present invention relates to compounds of formula 1 (including all stereoisomers), their N. oxides and (iv)' and compositions containing the same and their use for controlling invertebrate pests:

其中 A1 係 N 或 CR7 ; A2 係 N 或 CR8 ; 10 A3 係 N 或 CR9 ; A4 係 N 或 CR10 ; 其限制條件為A1、A2、A3及A4之中不多於兩個係 N ; T 係 Ο、s(0)k 或 NR36 ; 15 L lc(RU)=c(Rl2)-,其中與R11鍵結之破原子亦與 CR4R5鍵結,且與R12鍵結之碳原子亦與R6 鍵結;或選擇性地以至多4個獨立選自之 取代基所取代的1,4-二伸笨義.戈 -c(r34)(r35)-z-,其中與R34及R35鍵結之碳^ 20 子亦與CR4R5鍵結’且Z係與R6鍵結;反’、 Z 係 Ο、s(0)m、NR37 或 CR38R39 ; ° ’ v v 201204254Wherein A1 is N or CR7; A2 is N or CR8; 10 A3 is N or CR9; A4 is N or CR10; and the restriction condition is not more than two of N1, A2, A3 and A4; T system , s(0)k or NR36; 15 L lc(RU)=c(Rl2)-, wherein the breaking atom bonded to R11 is also bonded to CR4R5, and the carbon atom bonded to R12 is also bonded to R6; Or optionally substituted with up to 4 independently selected substituents, 1,4-diexene. Go-c(r34)(r35)-z-, wherein the carbon bonded to R34 and R35 is 20 The subunit is also bonded to CR4R5' and the Z system is bonded to R6; anti', Z system Ο, s(0)m, NR37 or CR38R39; ° ' vv 201204254

Ri係一選擇性地以至多5個獨立選自R14之取代基 所取代的苯基或5員或6員雜芳香環; R2係Η、經基、Cl—C6院基、Cl—C6鹵烧基、C2-C6 稀基、C2-C6 1¾稀基、C2-C6快基、C3-C6函快 基、C3-C7環院基、C4-C8環炫基炫•基、C5-C7 環烯基、Ci-Q烷氧基、C2-C6烷氧基烷基、 -CHO、C^WbR15、c(0)OR16、C(0)NR17R18、 S(0)pR19 或 S(O)2NR20R21 ; 各R3係獨立為i素、氰基、CH:4烷基或Ci-C:4 烷氧基; R4係Η或Ci_C4炫基; r5係Η或C1-C4炫•基; R6係一選擇性地以至多5個獨立選自R22之取代基 所取代的苯基或5員或6員雜芳香環; r7、R8、R9及R1G係獨立為Η、鹵素、氰基、硝基、 OR23、NR24R25、C厂C6 烷基、CH:6 鹵烷基、 C2-C6 烯基、C2-C6 |g 烯基、C2-C6 炔基、C3-C6 鹵炔基、C3-C7環烷基、C4-C8環烷基烷基、 C5-C7 環烯基、-CHO、C(W2)R26、C(〇)〇R27、 C(0)NR28R29、S(0)qR3°、S(0)2NR28R29 或 0C(0)R31;或一選擇性地以至多5個獨立選自 R40之取代基所取代的苯基或5或6員雜芳香 環;或一 R7及R8、或R8及R9、或R9及R10 之鄰偶(vicinal pair) ’與彼等偶對所連接之 碳原子一起形成一稠合5員或6員芳香族或非Ri is a phenyl or 5- or 6-membered heteroaromatic ring optionally substituted with up to 5 substituents independently selected from R14; R2 hydrazine, thiol, Cl-C6, and Cl-C6 Base, C2-C6 dilute group, C2-C6 13⁄4 base, C2-C6 fast group, C3-C6 function fast group, C3-C7 ring base group, C4-C8 cyclodendyl group, C5-C7 cycloolefin a group, a Ci-Q alkoxy group, a C2-C6 alkoxyalkyl group, -CHO, C^WbR15, c(0)OR16, C(0)NR17R18, S(0)pR19 or S(O)2NR20R21; R3 is independently i, cyano, CH:4 alkyl or Ci-C:4 alkoxy; R4 is hydrazine or Ci_C4 ray; r5 is hydrazine or C1-C4 ray; R6 is selectively a phenyl or a 5- or 6-membered heteroaromatic ring substituted with up to 5 substituents independently selected from R22; r7, R8, R9 and R1G are independently oxime, halogen, cyano, nitro, OR23, NR24R25, C plant C6 alkyl, CH: 6 haloalkyl, C2-C6 alkenyl, C2-C6 | g alkenyl, C2-C6 alkynyl, C3-C6 haloalkynyl, C3-C7 cycloalkyl, C4-C8 Cycloalkylalkyl, C5-C7 cycloalkenyl, -CHO, C(W2)R26, C(〇)〇R27, C(0)NR28R29, S(0)qR3°, S(0)2NR28R29 or 0C ( 0) R31; or a selectively up to 5 independent choices a phenyl substituted with a substituent of R40 or a 5- or 6-membered heteroaromatic ring; or a R7 and R8, or R8 and R9, or a vicinal pair of R9 and R10 and a carbon to which they are coupled The atoms together form a fused 5 or 6 member aromatic or non

S 8 芳香族環’其包含選自碳原子及至多3個獨立 選自N、〇及S之雜原子的環員; R及R12係獨立為Η、鹵素、Ci—Q烷基或Ci—C2 烷氧基; 各R13、R14、R22及R4G係獨立為_素、氰基、硝基、 ◦R23、NR24R25、c「c6 燒基、Q-c6 函院基、 c2-c6 烯基、c2-C6 齒烯基、c2-c6 炔基、c3—c6 鹵炔基' Cs-C:7環烷基、c4-c8環烷基烷基、 C5-C7 環稀基、_CHO、c(w2)r26、c(o)or27、 C(0)NR28R29、s(0)qR30、S(0)2NR28R29 或 〇C(0)R31 ; R及R係獨立為Q-C6烧基、Ci-C6鹵垸基、 C2-C6 烯基、C2-C6 鹵烯基、C2-C6 炔基、c3-c6 鹵炔基、C^C7環烷基、C4-Cs環烷基烷基或 C5—C7環烯基;或選擇性地以至多3個獨立選 自鹵素、氰基、硝基、〇R23、NR24R25、Ci_C4 炫•基、(VC4烯基、q-C4炔基、Ci-C4鹵烷基、 C2—C26燒氧基烷基、c2-C4鹵烯基、-CHO、 C(W2)R26 > C(〇)〇R27. C(0)NR28R29' S(0)qR30 . S(〇)2NR28r29及0C(0)R31之取代基所取代的 苯基; 各R及R20係獨立為H、c广Q烧基、Ci_C6由燒 基、C2—〇6稀基' c2-c6 _烯基、c2-c6炔基、 3 6 _块基、C3-C7環烧基、Q-Q環燒基垸 土或C5 i衣稀基;或選擇性地以至多3個獨 立選自4素、氰基、硝基、OR23、NR24R25、 201204254 Q-C4 烷基、c2-c4 烯基、c2-C4 炔基、Ci-C4 鹵烷基、Cz-C:6烷氧基烷基、C2_C4鹵烯基、 •CHO、C(W2)R26、C(〇)〇R27、C(0)NR28R29、 S(0)qR3Q、S(0)2NR28R29 及 〇c(〇)R3i 之取代基 所取代的苯基; 各R18、R2i、r24及r-係獨立為H、c广Q烷基、 c2-c6烯基或c2-c6炔基; 各R 9、R26、R2W〇係獨立為c广c6烧基或c「c6 鹵烷基; 各R及R31係獨立為H、c广C6烧基或C「C6函烧 基; 各R、R及R37係獨立為H、c广c6烷基、c(〇)R32 或 C(〇)〇R33 ; 15 各R及尺32係獨立為H'CrC6烧基、Q-C6姐 基、c2-c6稀基、c2—c6鹵烯基、c2_c6炔基、 =—C6自炔基、C3~~c7環烷基、c4-c8環烷基烷 基或Cs-C:7環烯基; 各R係獨立為Cr_C6燒基、祕基、c2—C6 、基、C2—c6 _歸基、c2_c6炔基、c3_c6齒炔 i、C3—C7環炫1基、c4-c8環烷基烷基或c5-c7 環烯基; r34係 H、C广Cm p 4況基、Cr~C2S烷基、C2-C4烯基、 R35係2以1: Cl'C4烷氧基或氰基; R38係h、〇h、鹵音p 圆素、(Vc2烷基或Ci-c2烷氧基;An S 8 aromatic ring which comprises a ring member selected from carbon atoms and up to 3 heteroatoms independently selected from N, fluorene and S; R and R 12 are independently hydrazine, halogen, Ci-Q alkyl or Ci-C2 Alkoxy; each of R13, R14, R22 and R4G is independently _, cyano, nitro, hydrazine R23, NR24R25, c "c6 alkyl, Q-c6 functional, c2-c6 alkenyl, c2- C6 alkenyl, c2-c6 alkynyl, c3—c6 haloalkynyl “Cs-C: 7 cycloalkyl, c4-c8 cycloalkylalkyl, C5-C7 cycloaliphatic, _CHO, c(w2)r26 , c(o)or27, C(0)NR28R29, s(0)qR30, S(0)2NR28R29 or 〇C(0)R31; R and R are independently Q-C6 alkyl, Ci-C6 halogen fluorenyl , C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, c3-c6 haloalkynyl, C^C7 cycloalkyl, C4-Cs cycloalkylalkyl or C5-C7 cycloalkenyl; Or optionally up to 3 independently selected from the group consisting of halogen, cyano, nitro, hydrazine R23, NR24R25, Ci_C4 hexyl, (VC4 alkenyl, q-C4 alkynyl, Ci-C4 haloalkyl, C2-C26 Alkoxyalkyl, c2-C4 haloalkenyl, -CHO, C(W2)R26 > C(〇)〇R27. C(0)NR28R29' S(0)qR30 . S(〇)2NR28r29 and 0C( 0) a phenyl group substituted with a substituent of R31; each R and R20 Is independently H, c broad Q alkyl, Ci_C6 from alkyl, C2 - 〇6 dilute 'c2-c6 _ alkenyl, c2-c6 alkynyl, 3 6 _ block, C3-C7 cycloalkyl, QQ Ring-activated alumina or C5 i-based; or optionally up to 3 independently selected from 4, cyano, nitro, OR23, NR24R25, 201204254 Q-C4 alkyl, c2-c4 alkenyl, c2 -C4 alkynyl, Ci-C4 haloalkyl, Cz-C: 6 alkoxyalkyl, C2_C4 haloalkenyl, • CHO, C(W2)R26, C(〇)〇R27, C(0)NR28R29, a phenyl group substituted with a substituent of S(0)qR3Q, S(0)2NR28R29 and 〇c(〇)R3i; each R18, R2i, r24 and r- is independently H, c-wide Q-alkyl, c2-c6 Alkenyl or c2-c6 alkynyl; each R 9 , R 26 , R 2 W 〇 is independently c c6 alkyl or c "c 6 haloalkyl; each R and R 31 are independently H, c widely C6 alkyl or C" C6 functional base; each R, R and R37 is independently H, c wide c6 alkyl, c (〇) R32 or C (〇) 〇 R33; 15 each R and 尺 32 are independently H'CrC6 alkyl, Q-C6 sister group, c2-c6 base, c2-c6 haloalkenyl, c2_c6 alkynyl, =—C6 alkynyl, C3~~c7 cycloalkyl, c4-c8 cycloalkylalkyl or Cs-C :7 cycloalkenyl; each R is independently a Cr_C6 alkyl group, a secret group c2-C6, group, C2-C6 _ group, c2_c6 alkynyl, c3_c6 tooth alkyne i, C3—C7 cyclodextyl, c4-c8 cycloalkylalkyl or c5-c7 cycloalkenyl; r34 H C wide Cm p 4 condition base, Cr~C2S alkyl group, C2-C4 alkenyl group, R35 system 2 with 1: Cl'C4 alkoxy group or cyano group; R38 system h, 〇h, halogen tone p-circle, ( Vc2 alkyl or Ci-c2 alkoxy;

S 10 25 201204254S 10 25 201204254

r39係選自Η、氰基及Cl_C2烷基,且當R38係鹵素 時’則R係額外選自鹵素;或者 R及R與上述R38及R39所連接之碳原子一起代 表一羰基部分; w係〇或S ; wl係〇或s; 各W2係獨立為〇或s ; k係0、1或2 ; 10 m係〇、1或2 ; n為0至5之整數; Ρ係0、1或2 ; 各q係獨立為〇、1或2 ; s係1、2或3 ;且 t係1或2 ; 15 其限制條件為s及t之總和係2、3或4。 更特定言之,本發明關於一選自式丨化合物、其 N-氧化物或其鹽類之化合物。 八 20 本發明亦提供-種組合物,其包含式i化合物、其 N-氧化物或其鹽類(意即具有生物有效量)以及至少j 選自由界面活性劑、固體稀釋劑及液體稀釋劑所組成群 、‘且之其他組&。在—實施例中,本發明亦提供—種防治 無脊椎動物害紅組合物,其包含式丨之化合物、宜 N-氧化物或其鹽類,及至少一種選自由界面活性劑、固 體稀釋劑及賴__組成之群_其域分,該組 合物選擇性地進-步包含至少—種具生物活性之其他 化合物或樂劑。 25 201204254R39 is selected from the group consisting of hydrazine, cyano and Cl_C2 alkyl, and when R38 is halogen, then R is additionally selected from halogen; or R and R together with the carbon atom to which R38 and R39 are attached represent a carbonyl moiety; 〇 or S; wl is 〇 or s; each W2 is independently 〇 or s; k is 0, 1 or 2; 10 m is 〇, 1 or 2; n is an integer from 0 to 5; Ρ is 0, 1 or 2; each q series is independently 〇, 1 or 2; s is 1, 2 or 3; and t is 1 or 2; 15 The limiting condition is the sum of s and t, 2, 3 or 4. More specifically, the present invention relates to a compound selected from the group consisting of hydrazine compounds, N-oxides thereof or salts thereof.八20 The present invention also provides a composition comprising a compound of formula i, an N-oxide thereof or a salt thereof (ie, having a biologically effective amount) and at least a surfactant selected from the group consisting of a surfactant, a solid diluent, and a liquid diluent The group, 'and other groups & In an embodiment, the present invention also provides a composition for controlling invertebrate harmful red, comprising a compound of the formula, preferably an N-oxide or a salt thereof, and at least one selected from the group consisting of a surfactant, a solid diluent And the group of __ _ its domain, the composition selectively further comprises at least one other biologically active compound or agent. 25 201204254

本發明進-步提供-種用於防治 之喷灑組成合物,其包含式1之化合物 。蟲 _+、 U、+、 物、其N-氧化物 或其鹽類’或—上奴組合物及-麵劑。本 5 供-種狀防絲錄動物㈣之誘_合物其包含 式1之化合物、其N-氧化物或其鹽類,或一上述具體 實施例中之組合物、一種或多種食物材料、視情況之一 種引誘劑及視情況之一種保濕劑。 本發明進-步提供-種用於防治無脊椎動物害蟲 之捕捉裝置’其包含_娜合物及—適合㈣該誘飼 組合物之外殼,其中該外殼具有至少一開口,該開口之 尺寸訂定為允許該無脊椎動物害蟲通過該開口,因此該 無脊椎動物害蟲可自外殼外部之位置接近該誘餌組合 物,且其中該外殼進一步適合置放在無脊椎動物害蟲之 潛在或已知活動地點或其附近。 20 本發明提供一防治無脊椎動物害蟲之方法,其包含 將一生物有效劑量之一式丨化合物、其N_氧化物或其 鹽類(例如:本文所述之組合物)與該無脊椎動物害蟲 或其環境接觸。本發明亦關於一種方法,其中將一組合 物與該無脊椎動物害蟲或其環境接觸,該組合物包含式 ^化合物、其N_氧化物或其鹽類(意即具有生物有效 ’以及至少一種選自界面活性劑、固體稀釋劑及液 體稀釋劑所組成之群組的其他成分,該組合物選擇性地 進步包含至少一生物有效劑量之其他具生物活性化 合物或試劑。 本發明亦提供一種保護種子或自其所長出之植物 免文無脊椎動物害蟲侵害之方法 ’包含將該種子與一生The present invention further provides a spray composition for controlling a compound comprising Formula 1. Insect _+, U, +, substance, N-oxide or a salt thereof or a slave composition and a face agent. The present invention provides a compound of the formula 1, a N-oxide or a salt thereof, or a composition of the above specific embodiment, one or more food materials, An attractant and a humectant as appropriate. The present invention further provides a capture device for controlling invertebrate pests, which comprises a shell and a shell suitable for (4) the feeding composition, wherein the shell has at least one opening, the size of the opening The invertebrate pest is allowed to pass through the opening so that the invertebrate pest can approach the bait composition from a location external to the outer casing, and wherein the outer casing is further adapted to be placed at a potential or known activity site for the invertebrate pest Or nearby. 20 The present invention provides a method of controlling an invertebrate pest comprising comprising a biologically effective amount of a compound of the formula, an N-oxide thereof, or a salt thereof (e.g., a composition described herein) and the invertebrate pest Or contact with the environment. The invention also relates to a method wherein a composition is contacted with the invertebrate pest or an environment thereof, the composition comprising a compound of the formula, an N-oxide thereof or a salt thereof (ie, having biological effectiveness) and at least one Other ingredients selected from the group consisting of surfactants, solid diluents, and liquid diluents, which selectively advance other biologically active compounds or agents comprising at least one biologically effective amount. The invention also provides a protection The method of seed or the exemption of invertebrate pests from plants grown by them' contains the seed with a lifetime

S 12 25 201204254 =· 物有效劑量之式1化合物、其Ν-氧化物或其鹽類(例 • 如:本文所述之組合物)接觸。本發明亦關於經處理之 種子。本發明進一步提供一種保護動物免受無脊椎動物 寄生害蟲侵害之方法,包括投予一殺寄生蟲有效劑量之 5 式1化合物、其Ν-氧化物或其鹽類(例如:如本文所 述之組合物)至該動物。本發明亦提供式1化合物、其 Ν-氧化物或其鹽類(例如:如本文所述之組合物)用於 保護動物免受無脊椎動物害蟲侵害之用途。 貫施方式】 15 20 如本文中所使用,術語「包含」、「包括」、「具有」、 「含有」'「特徵為」或該術語任何其他的變化/係音指 在涵蓋非排他性的包含’並糾任何明確表示的限 ,如’包含-it件清單之組合物、混合物、程序 物品或設備JiH較祕所从件 仙 明確列出或該組合物、混合物、程序其他未 備本身即具備之元件。 斤以、物品或設 .會封财請專利制,使I 讀的用 =質之外’不包括那些在列舉以外二;會=關 *由..····組成」出現在-個請求項的字、ώ备連接詞 刻,言,則該連接詞只限定在;是立 r其他元件㈣除於崎整現體的 25 201204254 連接詞「主1 x 戈由··所組成」(consisting essentially of) #'用於疋義-包括文字所揭露者以外之材料、步驟、特 ,、組《或70件的組成物、方法或裝置,前提是該等額 ^包括之材料' 步驟、特徵、组分或元件實質上未影響 發明基本及新賴特徵。術語「主要由......組成」居於 包二」$「由·.··..組成」之間的中間地帶。 立八右申人以開放式用語如「包含」定義一發明或其 ^刀’則表不(除非另有說明)該敘述應解讀為亦以「主 要由……所組成」或「由_·...·所組成」描述該發明。 「此外’除非有相反的明確說明,「或」是指包含性 的「或」,而不是指排他性的「或」。例如,以下任何一 種情況均滿足條件A或B : A為真(或存在)且B為偽 (或不存在)、A為偽(或不存在)且B為真(或存在) 以及A與B皆為真(或存在)。 「此外/位於本發明之元素或成分之前的不定冠詞 一」及「一個」旨在非限制性地說明該元素或成分的 實例數目(即出現數)。因此「一」或「一個」應理解為 包括-個或至少-個’且該元素或成分的單數詞形也包 括複數,除非該數目顯然是指單數。 如本發明揭露之内容,該術語「無脊椎動物害蟲」 包括由於為害蟲故對經濟有其重要性之節肢動物、腹足 動物與線蟲。較而f ’「無脊椎動物害蟲」代表節肢 動物類及腹絲,且更料言之,「好軸物害蟲」 代表節肢動物類。術語「節肢動物」包括昆H咏 蛛壤影a馬陸球潮蟲與結間蟲(symphy丨ans)。 術S吾「腹足動物」包括螞牛、奶I與其他柄眼目。術語 201204254S 12 25 201204254 =· An effective amount of a compound of formula 1 or a bismuth-oxide or a salt thereof (e.g., a composition as described herein) is contacted. The invention also relates to treated seeds. The invention further provides a method of protecting an animal from parasitic pests of an invertebrate comprising administering a parasiticidally effective amount of a compound of formula 1 , a cerium-oxide or a salt thereof (eg, as described herein). Composition) to the animal. The invention also provides the use of a compound of formula 1, its bismuth-oxide or a salt thereof (e.g., a composition as described herein) for protecting an animal from invertebrate pests.实施方式方式 15 20 As used herein, the terms "including", "including", "having", "containing", "characterized" or any other variation/tune of the term are meant to encompass non-exclusive inclusions. 'And correct any restrictions expressed, such as 'inclusion-it parts list of compositions, mixtures, program items or equipment JiH secrets are clearly listed from the pieces or the composition, mixture, procedures, other provisions are available The components. If you want to use, or if you want to set up a patent, you will be asked to use the patent system, so that the reading of I will not include those other than the enumeration; the meeting will be made up of -. The word of the item, the word for the connection, the word, the word is limited to it; the other elements of the group r (4) in addition to the appearance of the 25th 201204254 conjunction "master 1 x Ge by · ·" (consisting Essentially)) used for materials, steps, specials, or groups other than those disclosed in the text, or 70 components, methods, or devices, provided that the equivalent materials include the steps and characteristics. The components, or components, do not substantially affect the basic and new features of the invention. The term "mainly composed of" resides in the middle ground between the package "$" and "..".立八右申人 defines an invention or its knives in an open-ended language such as "including" (unless otherwise stated). The statement should be interpreted as "mainly composed of" or "by _· "·Composed" describes the invention. "In addition," unless expressly stated to the contrary, "or" means an inclusive "or" rather than an exclusive "or". For example, any of the following cases satisfies condition A or B: A is true (or exists) and B is pseudo (or nonexistent), A is pseudo (or nonexistent) and B is true (or exists) and A and B All are true (or exist). "Additional articles" and "an" before and after the elements or components of the invention are intended to be non-limiting, the number of instances (i.e., the number of occurrences) of the element or component. Thus, the word "a" or "an" is intended to mean a singular or a singular singular singular singular singular. As the disclosure of the present invention, the term "invertebrate pest" includes arthropods, gastropods and nematodes that are of economic importance to pests. More than f' "invertebrate pests" represent arthropods and abdomen, and more specifically, "good axis pests" represent arthropods. The term "arthropod" includes Kun H. 蛛 壤 a a 马 马 马 马 马 马 马 。 。 。 。 。 。 。 。 。 。 。 。 。. S. "gastropods" include ox, milk I and other stalks. Terminology 201204254

10 15 20 「線蟲」及「線蟲類」包括線形動物門的成員,例如草 食性線蟲。 如本發明揭露之内容,「無脊椎動物害蟲之控制」 意指抑制無脊椎動物害蟲之發育(包括死亡、進食減 少、與/或擾亂交配),並且相關描述為類似的定義。 術語「農藝」意指田間作物如食物與纖維之生產, 並且包含下列作物之生長,如毂物、大豆與其他豆科植 物、稻米、穀類(如··小麥、燕麥、大麥、黑麥、稻米、 玉米)、葉菜類(如:萵苣、甘藍菜,及其他甘藍類作物)、 果菜類(如:番茄、胡椒、茄子、十字花科植物及瓜類)、 馬鈴薯、甘藷、葡萄、棉花、樹果類(如:梨果、石科 及柑橘)、小果實類(漿果、櫻桃)以及其他特別作物 (如:芥花、向曰葵、橄欖)。術語「非農藝」意指其 他非田間作物,如:園藝作物(例如,溫室、苗圃或非 生長於田地之裝飾性植物)、住宅的、農業的、商業的 及工業的結構物、草皮地(例如,草皮場、牧草地、高 爾夫球場、草坪、運動場等)、木材製品、存積產物, 農林,植被管理、公共衛生(意即•人)及動物健康(例 如,家畜,如寵物、家畜及家禽、非家畜動物,如野生 動物)應用。 π何諳烷化劑」意指一種化合4 其中含碳自由基係藉由碳原子鍵結到像是_化物或 I鹽的脫離基上’藉由將親核騎結騎述破原子上 可使其離開。除非特別強,w 「 η」M ’術逢院化」不限定含 自6由基為:基’烷化劑中的含碳自由基包括r4、r: R及L所指明知多種鍵結韻取代自由基。 25 201204254 上面的詳述中’術語「炫基」’無論是單獨使用或 在如「烷硫基」或「鹵烷基」的複合詞中使用,包括直 鏈或支鏈烧基’如甲基、乙基、正丙基、異丙基或各種 丁基、戊基或己基異構物。「烯基」包括直鏈或支鏈烯 5 類’如乙稀基、1-丙烯基、2-丙烯基和各種丁稀基、戊 烯基或己烯基異構物。「烯基」也包括如1,2-丙二婦基 和2,4-己二稀基的多稀。「快基」包括直鏈或支鏈炔類, 如乙炔基、1-丙炔基、2-丙炔基和各種丁炔基、戊炔基 或己炔基異構物。「炔基」也包括由多重參鍵組成的部 ίο 份,如2,5-己二炔基。 「烷氧基」包括例如甲氧基、乙氧基、正丙氧基、 異丙氧基和各種丁氧基、戊氧基和己氧基異構物。「烷 氧基烷基」意指烷基上被烷氧基取代。「烷氧基烷基」 的實例包括 ch3och2- 、 ch3och2ch2-、 CH3CH2OCH2- 、 CH3CH2CH2CH20CH2-及 CH3CH2OCH2CH2“ 「環烷基」包括例如環丙基、環丁基、環戊基和環 己基。術語「環烷基烷基」意指在烷基部分上經環烷基 取代。「環烧基烷基」的實例包括環丙甲基、環戊乙基 和其他鍵結到直鏈或支鏈烷基團的環烷基部分。「環烯 基」包括如環戊烯和環己烯之基團以及一個雙鍵以上之 基團,如1,3-及1,4_環己二烯基。 術語「鹵素」’無論是單獨使用或在像是「函烷基」 的複合詞中使用,或者在像是r經自素取代的烷基」的 敘述中使用時,包括氟、氣、溴或碘。此外,當在像是 「鹵烷基」的複合詞中使用時,或者在像是「經鹵素取 201204254 .代的烷基」的敘述中使用時,所述烷基可能經相同或不 .· 同的鹵素原子部份或全部取代。「鹵烷基」或「以鹵素 取代之烷基」包括 F3C-、C1CH2-、CF3CH2_及 CF3CC12-。 術語「ii烷氧基」、「鹵烷硫基」、「鹵烯基」、「函炔基」 5 等等,定義類似於術語「函烷基」。「鹵烷氧基」之實例 包括0戶3〇-、(:(:13(:出〇-、1^?2(^2(:出〇-及€卩3(:112〇-。 「鹵烷硫基」之實例包括CC13S-、CF3S-、CC13CH2S_ 及cich2ch2ch2s-。「鹵炔基」之實例包括 HC=CCHC1-、CF3CeC_、CCLCeC-及 FCH^CeCCH^· 〇 10 「烷羰基」意指一鍵結至c(=o)部分的直鏈或支鏈 烷基部分。「烷羰基」之實例包括ch3c(=o)-、 ch3ch2ch2c(=o)·及(ch3)2chc(=o)-。「烷氧羰基」之 實例包括 ch3oc(=o)- 、 ch3ch2oc(=o)-、 ch3ch2ch2oc(=o)-、(ch3)2choc(=o)·及各種丁氧基- 15 或戊氧羰基異構物。 取代基團中的碳原子總數以前綴詞「Ci-Cj」表示, 其中i和j為1到8的數字。例如,c2烷氧基烷基表示 CH3OCH2- ; C3烷氧基烷基表示例如CH3CH(OCH3)-、 CH3〇CH2CH2-或CH3CH2OCH2-;及c4烷氧基烷基則表 20 示各種不同的烧基團異構物,其係以總共包含四個碳原 子的烷氧基團取代,示例包括CH3CH2CH2OCH2-及 CH3CH2OCH2CH2-。 當化合物被取代基取代,且該取代基帶有表明所述 取代基數目可以超過1的下標符號,所述取代基(當它 25 們超過1時)係獨立選自被定義的取代基所組成之群 組,例如:(R3)n且η為1、2、3、4或5。當基團包含 17 201204254 ==時::、::、r8,r'則當 變基團顯示為可選擇性地連i到2:未2代。當可 的u娜V其中Γ可以為〇,二置二二列如’展示! 即使該可變基團的定義中並未提及置上, 個或多個位置為「沒有被取代 j述基團上的一 原子將連接其上⑽據任何自由價。代」時,則氫 除非另有說明,作為式丨組成的 (例如,取代基R丨或R0)係碳環 :长系」 代表兩個或更多_環。術語「稠環雜二表=環系」 另-環而形成1合雙環系。術語「 2合至 雙環系」表示由兩個稠環所組成的環系:,、时另= 明’其中任-環可為飽和、部分不飽 和 15 20 因此:除非另有說明否則各環可為芳香族或非 術H員」意指形成環或環系主鍵的原子或其=;分 (例如 c(=0)、c(=s)、s(o)或 s(0)2)。 術奴環」、「碳環化合物」或「碳環系」表示一 環或環系,其中形成環骨幹的原子僅選自碳。除非另有 說明,碳環可以為飽和、部分不飽和或完全不飽和環。 當-完全不飽和碳環滿足休克耳定則⑽ekel,請le), 則該環亦稱作「芳環」。 術語「雜環」或「雜環系」表示一環或環系,其中 至少一個形成環主鏈的原子不是碳,例如,氮、氧或硫。 一般而言,一雜環包含不多於3個氮原子、不多於2個 氧原子及不多於2個硫原子。除非另有說明,雜環可以 為飽和、部分不飽和或完全不飽和環.除非另有說明, 25 201204254 • · 香族。當-完全不飽和雜環 • 芳環」或「芳香雜^香族化合物,則該環亦稱作「雜 可透過任何可得的;^除=有說明’雜環和雜環系 5 連接。 Α或虱,猎由置換該碳或氮上的氫而 面t = 化合物」意指每個環原子基本上在同-平 r豆中:P軌道垂直於環平面,且(4η + 2)π電子 正整數)與該環聯結以遵守休克耳定則。術 Ϊ小方:ΐ」/示—個碳環系或雜環系,其中該環系的 10 至少一個環為芳族。 2本文巾所使用,刊定義應適用於本文中,除非 兒月術°吾Γ視情況取代」可與片語「經取代或未 、=代」或與術語「(未)經取代」互換使用。除非另 、况明’可轉地鋒代的基團可能在該基團每個可取 代的位置具有—個取代基’而且每個取代作用均彼此獨 立。 ^ ro^Rl>R6'R7'R8'R9^Rl0^- 5^6 芳,時,除非另有說明,其可透過任何可得的碳環原子 或7氮環原子連接至式1其餘部分。如上所述,R1、R6、 R、R、R9或R10可以是(除了別的之外)苯基,其選 擇性地以一個或多個選自如發明内容中所界定的取代 基群組中的取代基所取代。選擇性地經一到五個取代基 所取代的苯基實例係如展示i中uq所繪示的環,其中 '係R 4、R22或R40 ’如發明内容中所界定分別為Ri、 R、R7、R8、R9或Ri〇 ’且r係一從〇到5的整數。 19 201204254 如上所述,尺1、尺6、尺7、118、119或111()可以是(除 了別的之外)5貞或6員雜芳環,其選擇性地以至多可 付位置數目的取代基所取代,且該些取代基係獨立選自 由發明内容巾所界定之基團組成之群組(意即分別為 〇 14 ο 22 τ^40\ „ 或R )。選擇性地以一個或多個取代基所取代 的5員或6員雜芳環之實例包括該些展示1中υ_2至 U-61所繪示的環,其中RV係任何如發明内容中所界定 冗取代f ’為,、R6、R7、R8、R9或Rl° (意即分別為 R 、R或R40),且r係一從〇至4之整數,其被各^^ 群組上的可得位置數目所限制。由於U-29、U-30、 U-36、U-37、U-38、U-39、U-40、U-4卜 U-42 及 U-43 y、有個可得位置,這些U群組的r經限制為〇或1的 整數,且〇意指該ϋ群組未經取代且氫存在於表示 為(RV ) r的位置上。 展示110 15 20 "Nematodes" and "Nematodes" include members of the linear phylum, such as herbivorous nematodes. As disclosed herein, "control of invertebrate pests" means inhibiting the development of invertebrate pests (including death, reduced feeding, and/or disturbing mating), and the related description is a similar definition. The term "agronomy" means the production of field crops such as food and fiber, and includes the growth of the following crops, such as hubs, soybeans and other legumes, rice, cereals (eg wheat, oats, barley, rye, rice) , corn), leafy vegetables (eg lettuce, kale, and other cabbage crops), fruits and vegetables (eg, tomatoes, pepper, eggplant, cruciferous plants and melons), potatoes, sweet potatoes, grapes, cotton, trees Classes (eg, pear, stone and citrus), small fruits (berries, cherries) and other special crops (eg canola, hollyhock, olive). The term "non-agronomic" means other non-field crops such as horticultural crops (eg greenhouses, nurseries or decorative plants not grown in the field), residential, agricultural, commercial and industrial structures, turf ( For example, turf fields, pastures, golf courses, lawns, playgrounds, etc.), wood products, stored products, agriculture and forestry, vegetation management, public health (meaning), and animal health (eg, livestock, such as pets, livestock and Poultry, non-stock animals, such as wild animals) applications. "π" alkylating agent" means a compound 4 in which a carbon-containing radical is bonded to a cleavage group such as a _ compound or an I salt by a carbon atom by arranging a nucleophilic ride on a broken atom Let it go. Unless it is particularly strong, w η η M ' 逢 」 」 」 不 不 不 不 不 不 不 不 不 不 不 不 不 不 不 不 不 不 不 不 不 不 不 不 不 不 不 不 不 不 不 不 不 不 不 不 不 不 不 不Replace free radicals. 25 201204254 In the above detailed description, the term 'hind base' is used either alone or in a compound such as "alkylthio" or "haloalkyl", including straight-chain or branched alkyl groups such as methyl. Ethyl, n-propyl, isopropyl or various butyl, pentyl or hexyl isomers. "Alkenyl" includes straight-chain or branched olefins such as ethyl, 1-propenyl, 2-propenyl and various butyric, pentenyl or hexenyl isomers. "Alkenyl" also includes polythene such as 1,2-propanyl and 2,4-hexanediyl. "Quick" includes straight-chain or branched acetylenes such as ethynyl, 1-propynyl, 2-propynyl and various butynyl, pentynyl or hexynyl isomers. "Alkynyl" also includes a moiety consisting of multiple reference bonds, such as 2,5-hexadiynyl. "Alkoxy" includes, for example, methoxy, ethoxy, n-propoxy, isopropoxy and various butoxy, pentyloxy and hexyloxy isomers. "Alkoxyalkyl" means an alkyl group substituted with an alkoxy group. Examples of the "alkoxyalkyl group" include ch3och2-, ch3och2ch2-, CH3CH2OCH2-, CH3CH2CH2CH20CH2- and CH3CH2OCH2CH2 ""Cycloalkyl" includes, for example, cyclopropyl, cyclobutyl, cyclopentyl and cyclohexyl. The term "cycloalkylalkyl" means substituted by a cycloalkyl group on the alkyl moiety. Examples of "cycloalkylalkyl" include cyclopropylmethyl, cyclopentylethyl and other cycloalkyl moieties bonded to a straight or branched alkyl group. The "cycloalkenyl group" includes a group such as a cyclopentene and a cyclohexene group and a group having a double bond or more, such as a 1,3- and 1,4-cyclohexadienyl group. The term "halogen" is used either alone or in a compound such as "alkyl" or in the context of an alkyl group such as r substituted by itself, including fluorine, gas, bromine or iodine. . Further, when used in a compound such as "haloalkyl" or in the description of "alkyl substituted by halogen, 201204254.", the alkyl group may be the same or not. The halogen atom is partially or completely replaced. "Haloalkyl" or "alkyl substituted with halogen" includes F3C-, C1CH2-, CF3CH2_ and CF3CC12-. The terms "ii alkoxy", "haloalkylthio", "haloalkenyl", "alkynyl" 5 and the like are defined similarly to the term "functional alkyl". Examples of "haloalkoxy" include 0 households 3-〇-, (:(:13(:出〇-, 1^?2(^2(:出〇- and €卩3(:112〇-. "halogen Examples of the alkylthio group include CC13S-, CF3S-, CC13CH2S_, and cich2ch2ch2s-. Examples of "haloalkynyl" include HC=CCHC1-, CF3CeC_, CCLCeC-, and FCH^CeCCH^·〇10 "Alkylcarbonyl" means one A straight or branched alkyl moiety bonded to the c(=o) moiety. Examples of "alkylcarbonyl" include ch3c(=o)-, ch3ch2ch2c(=o)., and (ch3)2chc(=o)-. Examples of "alkoxycarbonyl" include ch3oc(=o)-, ch3ch2oc(=o)-, ch3ch2ch2oc(=o)-, (ch3)2choc(=o)·, and various butoxy-15 or pentyloxycarbonyl The total number of carbon atoms in the substituent group is represented by the prefix "Ci-Cj", where i and j are numbers from 1 to 8. For example, c2 alkoxyalkyl represents CH3OCH2-; C3 alkoxyalkyl Representing, for example, CH3CH(OCH3)-, CH3〇CH2CH2- or CH3CH2OCH2-; and c4 alkoxyalkyl group, Table 20 shows various different alkyl group isomers, which are alkoxy groups containing a total of four carbon atoms. Group substitution, examples include CH3CH2CH2OCH2- and CH3CH2OCH2CH2-. When the compound is taken Substituent, and the substituent bears a subscript symbol indicating that the number of substituents may exceed 1, and the substituent (when it exceeds 1) is independently selected from the group consisting of the defined substituents, For example: (R3)n and η is 1, 2, 3, 4 or 5. When the group contains 17 201204254 ==::, ::, r8, r' then when the variant group is shown as being selectively connectable i to 2: not 2 generations. When can be u Na V where Γ can be 〇, two sets of two or two columns such as 'show! Even if the definition of the variable group does not mention setting, one or more positions In the case where "one atom on a group that is not substituted" is to be attached (10) according to any free price, hydrogen is used as a formula (for example, a substituent R丨 or R0) unless otherwise stated. Carbocycle: long system" stands for two or more _ rings. The term "fused ring heterodiforms = ring system" and - ring forms a monocyclic ring system. The term "2 to bicyclic system" means two fused rings. The ring system consisting of:, and then = 'the ring-ring can be saturated, partially unsaturated 15 20 Therefore: unless otherwise stated, each ring can be aromatic or non-operative H" means The atom of the ring or ring primary bond or its =; (for example, c (=0), c (= s), s (o) or s (0) 2). The slave ring", "carbocyclic compound" or "Carbocyclic" means a ring or ring system in which the atoms forming the ring backbone are selected from carbon only. Unless otherwise stated, a carbocyclic ring can be a saturated, partially unsaturated or fully unsaturated ring. When the -completely unsaturated carbon ring satisfies the shock rule (10)ekel, please le), then the ring is also called "aromatic ring". The term "heterocycle" or "heterocycle" means a ring or ring system wherein at least one of the atoms forming the ring backbone is not carbon, for example, nitrogen, oxygen or sulfur. Generally, a heterocyclic ring contains no more than 3 nitrogen atoms, no more than 2 oxygen atoms, and no more than 2 sulfur atoms. Unless otherwise indicated, a heterocyclic ring can be a saturated, partially unsaturated or fully unsaturated ring. Unless otherwise stated, 25 201204254 • · Fragrance. When a - completely unsaturated heterocyclic ring or an aromatic heterocyclic compound, the ring is also referred to as "heterois permeable to any available; ^ except = indicated" heterocycle and heterocyclic ring 5 are attached. Α or 虱, hunting by replacing the hydrogen on the carbon or nitrogen with the surface t = compound means that each ring atom is substantially in the same-flat r bean: the P orbit is perpendicular to the plane of the ring, and (4η + 2) π An electronic positive integer is associated with the loop to comply with the Shock Rule. Ϊ Ϊ ΐ ΐ / / / / / / / 个 个 个 个 个 个 个 个 个 个 个 个 个 个 个 个 个 个 个 个 个 个2 The use of this article, the definition of the journal should apply to this article, unless the child's monthly treatment, I disregard the situation, can be used interchangeably with the phrase "replaced or not, = generation" or with the term "(un) replaced" . Unless otherwise stated, the radical group may have a substituent at each of the replaceable positions of the group and each substitution is independent of each other. ^ ro^Rl>R6'R7'R8'R9^Rl0^- 5^6 aryl, which, unless otherwise stated, may be attached to the remainder of Formula 1 via any available carbon ring atom or 7 nitrogen ring atom. As stated above, R1, R6, R, R, R9 or R10 may be, among other things, a phenyl group optionally selected from one or more substituent groups selected as defined in the Summary of the Invention. Substituted by a substituent. Examples of phenyl groups optionally substituted with one to five substituents are as shown by the formula iq in i, wherein 'system R 4, R22 or R40' are as defined in the Summary of the Invention, respectively, Ri, R, R7, R8, R9 or Ri〇' and r is an integer from 〇 to 5. 19 201204254 As noted above, Ruler 1, Ruler 6, Ruler 7, 118, 119 or 111() may be, among other things, a 5-inch or 6-membered heteroaryl ring, optionally with a maximum number of positions available. Substituted by a substituent, and the substituents are independently selected from the group consisting of groups defined by the disclosure of the invention (ie, 〇14 ο 22 τ^40\ „ or R respectively). Optionally one Examples of the 5- or 6-membered heteroaryl ring substituted with a plurality of substituents include the rings depicted in 1_2 to U-61 of the display 1, wherein RV is any of the redundant substitutions f' as defined in the Summary of the Invention. , R6, R7, R8, R9 or Rl° (meaning R, R or R40 respectively), and r is an integer from 〇 to 4, which is limited by the number of available positions on each ^^ group Since U-29, U-30, U-36, U-37, U-38, U-39, U-40, U-4, U-42 and U-43 y, there is a position available, these The r of the U group is limited to an integer of 〇 or 1, and 〇 means that the ϋ group is unsubstituted and hydrogen is present at a position denoted as (RV) r.

U]2 U-13 U-14 U-15U]2 U-13 U-14 U-15

S 20 201204254S 20 201204254

4 (Rv)r4 (Rv)r

N N-U-18N N-U-18

JJ (RV)rJJ (RV)r

4 (Rv)r Ο—N U-214 (Rv)r Ο—N U-21

5 (RV)r YV S——N U-24 U-23 4 (Rv)r 丫V N—N 3 (RV)r 4 (Rv)r n N—N 、t> (Rv)r U-26 U-27 U-28 U-29 (Rv)r w if, N—N if N—N (Rv)r N—N U-31 U-32 U-33 U-34 (Rv)r:r 5—0 U-20 (RV)r、0 U-25 (RV)r U-305 (RV)r YV S——N U-24 U-23 4 (Rv)r 丫VN—N 3 (RV)r 4 (Rv)rn N—N , t> (Rv)r U-26 U- 27 U-28 U-29 (Rv)rw if, N—N if N—N (Rv)r N—N U-31 U-32 U-33 U-34 (Rv)r:r 5—0 U- 20 (RV)r, 0 U-25 (RV)r U-30

U-36 U-37U-36 U-37

N (RV)r U-39N (RV)r U-39

(R )r (RV)r(R )r (RV)r

(RV)r 'SN N-N7(RV)r 'SN N-N7

(Rv)r(Rv)r

4 (RV)r4 (RV)r

N // (rV n U-40 (Rv)r O N=N U-45 (Rv)r 6 U-46 6 (RV)r U-51 (RV)r N I N—N U-47N // (rV n U-40 (Rv)r O N=N U-45 (Rv)r 6 U-46 6 (RV)r U-51 (RV)r N I N-N U-47

N=N U-48 (RV)r r^N 7 II U-53 人N」6N=N U-48 (RV)r r^N 7 II U-53 person N”6

2 U-492 U-49

U-50 6 (Rv)r 'NU-50 6 (Rv)r 'N

(RV)r 6 (R U-54 U-55 2 201204254(RV)r 6 (R U-54 U-55 2 201204254

U-61 雖在結構11·1至U-61中顯示有Rv基團,值得注意 要^由於該等基團是視情況取代基,該等基團不—定需 取^在。需要取代以填補其價的氮原子係被Η或rv所 值得注意的是當(RV) r及ϋ群組之間的連接點 不成浮動的,(RV)r可連接到該u群組上之任何可 :被原子。值得注意的是當U群組上的連接 的碳或氮^ U群組透過U群組上任何可得 值;r主音藉由置換氫原子可連接到式1之其餘部分。 Q的是一些1;群組可僅經少於4個rv*團取代 (例y叫到、及㈣到⑽)代 之鄰偶上二二述’二"以及R8、或r8及r9、或r9及Rl0 或6員芳;族二碳起形成-稠合5員 15 及R8、或…'t /及R。, A2、A3及八4之6員芳 ’係稠合至該包含A、 且可為全部不飽和:’一;=广部 -CH=CH-CH=CHn 偶的實例匕括 n > -CH=N-CH=CH- ' s 22 201204254 -CH=CH-N=CH-、-CH=CH-CH=N-、-N=N-CH=N-、 -N=CH-N=N-、-S-CH=CH-、-CH=CH-S-、-〇-CH=CH_、 -CH=CH-0-、-〇-CH=N-、-N=CH-0-、-〇养CH_、 -CH=N-0-、-S-CH=N_、-N=CH_S_、_s养CH、 •CH=N-S-、-(CH2)4-、-(CH2)3-、_ch=CH-CH2-、 -CIVCHCH- ' -OCH2CH2_、_CH2CH2〇 及 _OCH2CH2〇- ’其中左手連接鍵對應於尺7及R8、或R8 及R9、或R9及R1G之左員,且右手連接鍵對應於R7及 10 15 •20 R8、或R8及R9、或R9及f之右員。一值得特別注意 之鄰偶為·α·Ι=(:Η-(:Η=(:Η-。 在該技術領域中,有多種已知的可製備芳香雜環及 環系統的方法;廣泛的回顧參見第八冊comprehensiveAlthough U-61 shows an Rv group in the structures 11.1 to U-61, it is worth noting that since these groups are optionally substituted, the groups are not required to be taken. It is worth noting that the nitrogen atom that needs to be replaced to fill its price is Η or rv. When the connection point between (RV) r and the ϋ group is not floating, (RV)r can be connected to the u group. Anything can be: being atomized. It is worth noting that the connected carbon or nitrogen groups on the U group pass through any of the available values on the U group; the r mains can be connected to the remainder of Equation 1 by replacing the hydrogen atoms. Q is some 1; groups can be replaced by only less than 4 rv* groups (example y called, and (d) to (10)) instead of two pairs of two 'two' and R8, or r8 and r9, Or r9 and Rl0 or 6 member aryl; group two carbons formed - fused 5 members 15 and R8, or ... 't / and R. , A2, A3, and 8 of 6 members are fused to the inclusion of A, and may be all unsaturated: 'one; = wide part -CH=CH-CH=CHn even examples include n > CH=N-CH=CH- ' s 22 201204254 -CH=CH-N=CH-, -CH=CH-CH=N-, -N=N-CH=N-, -N=CH-N=N -, -S-CH=CH-, -CH=CH-S-, -〇-CH=CH_, -CH=CH-0-, -〇-CH=N-, -N=CH-0-,- CHCH_, -CH=N-0-, -S-CH=N_, -N=CH_S_, _s raise CH, •CH=NS-, -(CH2)4-, -(CH2)3-, _ch= CH-CH2-, -CIVCHCH- '-OCH2CH2_, _CH2CH2〇, and _OCH2CH2〇- 'where the left-hand connection key corresponds to the ruler 7 and R8, or the left member of R8 and R9, or R9 and R1G, and the right-hand connection key corresponds to R7 and 10 15 • 20 R8, or R8 and R9, or R9 and f to the right. A neighbor that deserves special attention is α·Ι=(:Η-(:Η=(:Η-. In this technical field, there are various known methods for preparing aromatic heterocyclic rings and ring systems; extensive For review, see the eighth volume of comprehensive

Heterocyclic Chemistry, A. R. Katritzky 及 C. W. Rees 主 編,Pergamon Press,Oxford, 1984 及第十二冊Heterocyclic Chemistry, A. R. Katritzky and C. W. Rees, ed., Pergamon Press, Oxford, 1984 and Twelfth

Comprehensive Heterocyclic Chemistry II, a. R Katritzky,C. W. Rees and E. F. V. Scriven 主編,pergamon Press,Oxford,1996)。 本發明的化合物可以存在有一個或多個立體異構 物。各種立體異構物包括鏡像異構物、非鏡像異構物、 阻轉異構物和幾何異構物。熟習該領域之技藝人士將明 瞭,一個立體異構物當相對於其他立體異構物經濃化或 當從其他立體異構物經分離出時,可能活性更高及/或 可能展示出有益的效果。此外,該熟習該領域之技藝人 士知道如何分離、濃化及/或選擇性地製備所述立體異 構物。本發明的化合物可以存在為立體異構物的混合 物、個別立體異構物或光學活性形式。 23 25 201204254 以存2式1中酿胺鍵的旋轉限制,本發明的化合物可 個衫個構形異構物。本發明包含構形異構 二Γ : 明包括富含-個構形異構物之 化口物’其富含係相較於其他構形異構物。 自式:l、其立體異構物、互變異構物、N_氧化物 j的化合物’通常存在不止—種形式,且式i因此 表不的化合物的所有晶形和非晶形。非晶形包 15 和膠的_實_’也包括像是溶液和炼體的 施例。結晶型包括必須呈現—單—結晶型態以及 …見了多形體之混合物的實施例。(即不同的結晶型)。 t乡形體」思指—可以結晶成不同晶形之化合物的 特疋晶形’這些形式的晶格内分子有不同的排列及/或 構形。雜多形體可以有同樣的化學組成,它們也可以 在組成上因為共結晶核其他分子的存在或不存在而 不同,該共結晶水或其他分子可以弱或強地結合在晶格 内。多形體相在辦、物理和生物雜有所不同 是晶體形狀、密度、硬度、顏色、化學穩定性、炼點、 吸濕性、懸浮率、溶解速率和生物利用度。熟習該領域 之技藝人士將瞭解到由< i所呈現的化合物多型性相 對於式1呈制同樣化合物之其他乡频或是多形體 的混合物可展現有益之效果(例如適合於製備有用^配 方以改善生物利用效果)製備或分離由式i所呈現的= 殊化合物多形體可藉由熟席此技術領域人士所通曉的 方法來達成,例如,利用特定的溶劑及溫度來進行結曰、 熟習該領域之技藝人士將明瞭,並非所有含氮=曰产 皆可形成氮氧化物,因為氮原子需要一個可利用的孤= 25 201204254 ' 電子對以氧化成氧化物;熟習該領域之技藝人士亦將明 , 瞭三級胺可形成氮氧化物。製備雜環及三級胺之N-氧 _ 化物的合成方法為熟悉該項技術之人士中眾所皆知,包 括以如過氧乙酸和3-氣過氧苯甲酸(MCPBA)的過氧 5 酸、過氧化氫、如第三丁基過氧化氳的烷基氫過氧化 物、過硼酸鈉及如二甲基雙環氧乙烷的雙環氧乙烷來氧 化雜環及三級胺。此些製備N-氧化物的方法已在文獻 中經廣泛地描述以及回顧,例如:T. L. Gilchrist in Comprehensive Organic Synthesis, vol. 7, pp 748-750, S. 10 v. Ley, Ed·, Pergamon Press ; M· Tisler 及 B. Stanovnik in Comprehensive Heterocyclic Chemistry, vol. 3, pp 18-20, A. J. Boulton 及 A. McKillop,Eds., Pergamon Press;M_ R. Grimmett 及 B. R. T. Keene in Advances in Heterocyclic Chemistry, vol. 43, pp 149-161, A. R. Katritzky, Ed., 15 Academic Press; M. Tisler 及 B. Stanovnik in Advances in Heterocyclic Chemistry, vol. 9, pp 285-291, A. R. Katritzky 及 A. J_ Boulton, Eds., Academic Press;及 G. W. H. Cheeseman 及 E. S. G. Werstiuk in Advances in Heterocyclic Chemistry, vol. 22, pp 390-392, A. R. 2〇 Katritzky 及 A. J. Boulton, Eds” Academic Press。當 R2 不為H時衍生自式1化合物的吖咀N—氧化物顯然為最 穩定者。 熟習該領域之技藝人士瞭解到,因為化合物的鹽類 與它們對應的非鹽形式在環境和生理條件下會處於平 25 衡狀態,所以鹽類會分享非鹽形式的生物效用。因此各 種式1化合物的鹽類可用來防治無脊椎動物害蟲。式i 25 201204254 化合物的鹽類包括含有機酸或無機酸的酸加成鹽類,酸 像是氫溴酸、鹽峻、硝酸、鱗酸、硫酸、乙酸、丁酸、 延胡索酸、乳=、順丁烯二酸、丙二酸、草酸、丙酸、 水楊酸、酒石4-甲苯磺酸或戊酸。當式丨化合物包 5 含㈣之酸性D時,鹽類亦包含那些與錢或無機鹼 形成之鹽類,驗如定、三乙胺或氨,或醯胺、或納、 鉀、鋰、妈、鎮或鋇之氫化物、氮氧化物或碳酸鹽。因 此、本發明包含選自式i之化合物、其N_氧化物 其生物上適用的鹽類。 1〇 在本發明的實施例中,包含以下所述,提及式j時 包含其N-氧化物及其鹽類’且提及「一種式i化人物 時’除非在實施例中特別定義,否則包含 」 強調的取代基定義。 円今中 實施例1. 一種式1化合物,其中Αι係N。 15 實施例2. —種式1化合物,其中Αι係cR7。 實施例3. -種式1或實施例i或2之化合物 A2 係 CR8。 、 合物 實施例5. 合物 實施例6. 實施例4. 一種式1化合物或實施例丨至3之任一化 其中A3係CR9。 -種式1化合物或實施例丨至4之任一化 ,其中A4係CR10。 ,…一種式1化合物或實施例〗至5之任一化 合物,其中R7、R8、R9及係獨立為H、齒素、 綠、石肖基、0R23、nr24r25、ca 燒基、Ci_C6 鹵院基、C2-c6烯基、c2_c6鹵稀基、炔其、 c3-c6 鹵炔基、c3-c7 環烷基、c4—c8Comprehensive Heterocyclic Chemistry II, a. R Katritzky, C. W. Rees and E. F. V. Scriven, ed., pergamon Press, Oxford, 1996). The compounds of the invention may be present in one or more stereoisomers. Various stereoisomers include mirror image isomers, non-image isomers, atropisomers, and geometric isomers. It will be apparent to those skilled in the art that a stereoisomer may be more active and/or may exhibit beneficial properties when concentrated relative to other stereoisomers or when isolated from other stereoisomers. effect. Moreover, those skilled in the art know how to separate, concentrate and/or selectively prepare the stereoisomers. The compounds of the invention may exist as a mixture of stereoisomers, individual stereoisomers or optically active forms. 23 25 201204254 The compound of the present invention can be a conformational isomer of the present invention by the rotation limitation of the amine bond in Formula 1. The present invention encompasses conformational isomerizations: the inclusion of a perfusate rich in a conformational ampoule, which is richer than the other conformational isomers. The compound of the formula: l, its stereoisomer, tautomer, N-oxide j' usually exists in more than one form, and all the crystal forms and amorphous forms of the compound thus represented by the formula i. The amorphous package 15 and the glue_real_' also include examples such as solutions and refining. Crystalline forms include those which must exhibit a single-crystalline form and ... a mixture of polymorphs. (ie different crystal forms). The t-shaped body is a metamorphic form of a compound that can be crystallized into different crystal forms. These forms of intramolecular molecules have different arrangements and/or configurations. Heteropolymorphs may have the same chemical composition, and they may also differ in composition due to the presence or absence of other molecules of the co-crystal nucleus, which may be weakly or strongly bound in the crystal lattice. Polymorphic phases differ in handling, physical, and biological properties. Crystal shape, density, hardness, color, chemical stability, refining point, hygroscopicity, suspensibility, dissolution rate, and bioavailability. Those skilled in the art will appreciate that the polymorphism of the compound presented by <i can exhibit beneficial effects in combination with other rural or polymorphic forms of the same compound of Formula 1 (e.g., suitable for preparation) Formulations to improve bioavailability) Preparation or isolation of the polymorphs represented by formula i can be achieved by methods well known to those skilled in the art, for example, by using specific solvents and temperatures for crusting, Those skilled in the art will appreciate that not all nitrogen-containing compounds can form nitrogen oxides because the nitrogen atoms require an available orphan = 25 201204254 'electron pair to oxidize to oxides; skilled artisans in the field It will also be apparent that tertiary amines can form nitrogen oxides. The synthesis of N-oxo compounds for the preparation of heterocyclic and tertiary amines is well known to those skilled in the art, including peroxygenation with, for example, peroxyacetic acid and 3-phenylperoxybenzoic acid (MCPBA). An acid, hydrogen peroxide, an alkyl hydroperoxide such as t-butyl peroxy ruthenium, sodium perborate, and a dioxirane such as dimethyl dioxirane are used to oxidize the heterocyclic ring and the tertiary amine. Such methods for preparing N-oxides have been extensively described and reviewed in the literature, for example: TL Gilchrist in Comprehensive Organic Synthesis, vol. 7, pp 748-750, S. 10 v. Ley, Ed., Pergamon Press M. Tisler and B. Stanovnik in Comprehensive Heterocyclic Chemistry, vol. 3, pp 18-20, AJ Boulton and A. McKillop, Eds., Pergamon Press; M_R. Grimmett and BRT Keene in Advances in Heterocyclic Chemistry, vol. 43, pp 149-161, AR Katritzky, Ed., 15 Academic Press; M. Tisler and B. Stanovnik in Advances in Heterocyclic Chemistry, vol. 9, pp 285-291, AR Katritzky and A. J_ Boulton, Eds., Academic Press; and GWH Cheeseman and ESG Werstiuk in Advances in Heterocyclic Chemistry, vol. 22, pp 390-392, AR 2〇Katritzky and AJ Boulton, Eds” Academic Press. Derivatives derived from compounds of formula 1 when R2 is not H N-oxides are clearly the most stable. Those skilled in the art understand that because the salts of the compounds and their corresponding non-salt forms will be under environmental and physiological conditions. Yu Ping 25 balances the state, so the salt will share the biological effects of the non-salt form. Therefore, the salts of various compounds of formula 1 can be used to control invertebrate pests. The salts of the compounds of formula i 25 201204254 include those containing organic or inorganic acids. Acid addition salts, acids like hydrobromic acid, salt, nitric acid, squaric acid, sulfuric acid, acetic acid, butyric acid, fumaric acid, milk =, maleic acid, malonic acid, oxalic acid, propionic acid, water Acid, tartar 4-toluenesulfonic acid or valeric acid. When the formula 5 compound contains 5 (4) of acid D, the salt also contains those salts formed with money or inorganic bases, such as triethylamine or ammonia. , or guanamine, or a hydride, nitrogen oxide or carbonate of sodium, potassium, lithium, mom, or strontium. Accordingly, the present invention comprises a compound selected from the group consisting of a compound of the formula i, and an N-oxide thereof, which is biologically applicable. In the examples of the present invention, the following is included, and when the formula j is referred to, the N-oxide and its salt are included, and the term "a formula" is used unless otherwise specified in the examples. Otherwise contains the emphasized substituent definition. Present Embodiment 1. A compound of formula 1 wherein Αι is N. 15 Example 2. A compound of formula 1 wherein Αι is cR7. Example 3. - Compound of Formula 1 or Example i or 2 A2 is CR8. Compound Example 5. Example 6. Example 4. A compound of formula 1 or any of the examples 丨 to 3 wherein A3 is CR9. a compound of the formula 1 or any of the examples 丨 to 4 wherein A4 is CR10. Or a compound of any one of the above formulas, wherein R7, R8, R9 and each independently are H, dentate, green, schlossyl, 0R23, nr24r25, ca alkyl, Ci_C6 halogen, C2 -c6 alkenyl, c2_c6 halo, alkyne, c3-c6 haloalkynyl, c3-c7 cycloalkyl, c4-c8

S 26 25 201204254 基 C5~C7 環烯基、_CH〇、c( 2 26 7 C(0)NR::R« . S(〇)qR30 .S 26 25 201204254 Basis C5~C7 cycloalkenyl, _CH〇, c( 2 26 7 C(0)NR::R« . S(〇)qR30 .

Rl0(〇)R,或-R7及 R8、或 R8 及 R9、或 R9及 之鄰偶’與彼等所連接之碳原子〜起形成一 5員或6員芳香族或非芳香族環,其包 子=^1多3_立選自N'^s之雜原 實施例7.—種實施例6之化合物,其中r7 H ,^係獨立為Η、齒素、Cr~C4院基、Cr_C4 Γ’ >元基、C2一Q烯基、CrC4鹵稀基、Cr_C4炔基、 7 _块基、c3—c6環烧基、Ci—C4燒氧基、 二^鹵燒氧基、CpCA硫基、Cl_c4 _炫硫基 或亂基’或—r7及R8、或R8及R9、或R9&Rl〇 15 25 之鄰偶,與彼等所連接之碳原子一起形成一稠合 或6員芳香族或非芳香族環,其包含選自碳 =及至多3個獨立選自N、〇AS之雜原子的 银員。 貝施例8.種式1之化合物或實施例1至7之任一 =合物’其中當r7、r8、r9或R1G係獨立地分 離時(意即未一起形成一環),則該R7、R8、R9 或Rl〇係獨立為Η、齒素、Cl-c4燒基、Ci—C4 4燒基、C2-c4稀基、c2-c4鹵烯基、c ” i块基、c3—c6繼、Cl一心氧基' 或氰c基函烷氧基、C1—C4烷硫基、C1—C4 *烷硫基 27 201204254 實施例9. 一種實施例8之化合物,其中當R7、R8、 R9或R1Q係獨立分離時,則該R7、R8、R9或R1G 係獨立為Η、鹵素或Q-C4鹵烷基。 實施例10. —種式1之化合物或實施例1至9之任一 5 化合物,其中當R7分離時,則R7係Η或鹵基。 實施例11. 一種實施例10之化合物,其中當R7分離 時,則R7係Η或F。 實施例12. —種實施例11之化合物,其中當R7分離 時,則R7係Η。 · ίο 實施例13. —種式1之化合物或實施例1至12之任 一化合物,其中當R8分離時,則R8係Η、鹵素 或鹵烷基。 實施例14. 一種實施例13之化合物,其中當R8分離 時,則R8係H、鹵素或C!氟烷基(意即氟曱基, 15 包括 CH2F、CHF2 及 CF3)。 實施例15. —種實施例14之化合物,其中當R8分離 時,則R8係Η、鹵素或CF3。 實施例16. —種實施例15之化合物,其中當R8分離 時,貝丨J R8係Η、F、C1或CF3。 2〇 實施例17. —種實施例15之化合物,其中當R8分離 時,則R8係鹵素或CF3。 實施例18. —種實施例17之化合物,其中當R8分離 時,則R8係F、C1或CF3。 實施例19. 一種式1之化合物或實施例1至18之任 25 一化合物,其中當R9分離時,則R9係Η、鹵素 或CrQ鹵烷基。Rl0(〇)R, or -R7 and R8, or R8 and R9, or R9 and the adjacent couples', and the carbon atoms to which they are attached, form a 5- or 6-membered aromatic or non-aromatic ring, Buns = ^1 more 3_ from the original of the N'^s. Example 7. The compound of Example 6, wherein r7 H , ^ is independent of Η, dentate, Cr~C4, and Cr_C4 Γ ' > elemental, C 2 -Q alkenyl, CrC 4 halo, Cr_C 4 alkynyl, 7 _ block, c 3 -c 6 cycloalkyl, Ci-C 4 alkoxy, dihalo alkoxy, CpCA thio , Cl_c4 _ thiol or chaotic group ' or -r7 and R8, or R8 and R9, or R9 & Rl 〇 15 25 ortho, together with the carbon atom to which they are attached form a fused or 6-membered aromatic Or a non-aromatic ring comprising a silver member selected from the group consisting of carbon = and up to 3 heteroatoms independently selected from N, 〇AS. Example 8. Compound of Formula 1 or any of Examples 1 to 7 = where R7, r8, r9 or R1G are independently separated (ie, a ring is not formed together), then R7, R8, R9 or Rl is independently ruthenium, dentate, Cl-c4 alkyl, Ci-C4 4 alkyl, C2-c4, c2-c4 haloal, c"i block, c3-c6 , a C-cardioxy' or a cyanyl-alkoxy group, a C1-C4 alkylthio group, a C1-C4*alkylthio group. 201204254 Example 9. A compound of embodiment 8, wherein R7, R8, R9 or When R1Q is isolated independently, the R7, R8, R9 or R1G is independently hydrazine, halogen or Q-C4 haloalkyl. Embodiment 10. The compound of the formula 1 or the compound of any of the examples 1 to 9 Wherein, when R7 is isolated, then R7 is a hydrazine or a halo group. Embodiment 11. A compound of embodiment 10, wherein when R7 is isolated, then R7 is hydrazine or F. Example 12. Compound of Example 11 Wherein, when R7 is isolated, then R7 is Η. ίο. Embodiment 13. The compound of Formula 1 or any one of Examples 1 to 12, wherein when R8 is separated, then R8 is hydrazine, halogen or halogen Example 14. One The compound of Embodiment 13 wherein, when R8 is isolated, R8 is H, halogen or C! fluoroalkyl (ie, fluoroindolyl, 15 includes CH2F, CHF2, and CF3). Example 15. Example 14 A compound wherein, when R8 is isolated, then R8 is hydrazine, halogen or CF3. Embodiment 16. The compound of embodiment 15, wherein when R8 is isolated, the beryllium J R8 is hydrazine, F, C1 or CF3. Embodiment 17. The compound of Embodiment 15, wherein when R8 is isolated, then R8 is halogen or CF3. Embodiment 18. The compound of Embodiment 17, wherein when R8 is isolated, then R8 is F, C1 or CF 3. Embodiment 19. A compound of Formula 1 or a compound of any one of Embodiments 1 to 18, wherein when R9 is isolated, R9 is a hydrazine, a halogen or a CrQ haloalkyl group.

S 28 201204254S 28 201204254

實施例20.—種實施例19之化合物,其中當R9分離 時’則R9係H、鹵素或q氟烷基(意即氟甲基)。 實施例21.—種實施例2〇之化合物,其中當R9分離 時,則R9係Η、鹵素或CF3。 實施例22.—種實施例21之化合物,其中當R9分離 時,則R9係Η、C1或CF3。 實施例23.—種式丨之化合物或實施例1至22之任 一化合物’其中當R10分離時,則r1〇係Η或鹵 基。 10 實施例24.—種實施例23之化合物,其中當Rl0分 離時,則R1G係Η或F。 實施例25. —種實施例24之化合物,其中當Rl0分 離時’則R1G係H。 15 貝施例26. 一種式1之化合物或實施例1至25之任 一化,物,其中當R7及R8、或R8及R9、或R9 f R之鄰偶’與彼等所連接之碳原子一起形成 二稠口 J衣時,該鄰偶係-CH=CH-CH=CH-(意即 該稠合環係苯并)。 20 貝施^ 27·種式1之化合物或實施例1至26之任 =匕ί物’其中-R7及R8'或R8及R9、或R9 之鄰偶如上述與彼等所連接之碳原子一起 形成一稠合環。 實施例28.種式1之化合物或實施例1至27之任 —化合物’其中-R7及R8之鄰偶如上述與彼等 所連接之碳原子一起形成一稠合環。 29 25 201204254 實施例29. —種式1之化合物或實施例1至27之任 一化合物,其中一 R8及R9之鄰偶如上述與彼等 所連接之碳原子一起形成一稠合環。 實施例30. —種式1之化合物或實施例1至27之任 一化合物,其中一 R9及R10之鄰偶如上述與彼 等所連接之碳原子一起形成一稠合環。 實施例31. —種式1之化合物或實施例1至25之任 一化合物,其中各R7、R8、r9及Rl〇係分離的 (意即未一起形成一稠合壞)。 實施例32. —種式1之化合物或實施例1至31之任 一化合物,其中L係-CXRUfQR12)- ’其中該鍵 結至R11之碳原子亦鍵結至CR4R5,且該鍵結至 Rl2之碳原子亦鍵結至R6 ;或視情況以至多4個 獨立選自R13之取代基所取代的丨,4_二伸苯基。 實施例33. 一種式!之化合物或實施例1至32之任 一化合物,其中L係。 實施例34· 一種式1之化合物或實施例1至33之任 化合物,其中R11及R12係獨立為Η、齒素或 甲基。 實施例35. 一種實施例34之化合物,其中R11及R12 係獨立為Η或甲基。 實施例36. 一種實施例35之化合物,其中R11及R12 係H 〇 實施例37. 一種式1之化合物或實施例1至32之任 一化合物,其中L係選擇性地以至多4個獨立選 自Rl3之取代基所取代的1,4-二伸苯基。Embodiment 20. The compound of Embodiment 19, wherein when R9 is isolated, then R9 is H, halogen or qfluoroalkyl (i.e., fluoromethyl). Embodiment 21. The compound of Embodiment 2 wherein, when R9 is separated, R9 is hydrazine, halogen or CF3. Embodiment 22. The compound of Embodiment 21, wherein when R9 is isolated, then R9 is hydrazine, C1 or CF3. Embodiment 23. A compound of the formula or a compound of any of Embodiments 1 to 22 wherein, when R10 is isolated, r1 is a hydrazine or a halide. 10. The compound of embodiment 23, wherein when R10 is separated, the R1G is Η or F. Embodiment 25. The compound of Embodiment 24, wherein when R10 is separated, then R1G is H. 15 Shell Example 26. A compound of formula 1 or any of embodiments 1 to 25, wherein the carbon of the R' and R8, or R8 and R9, or R9 f R's ortho' When the atoms together form a two-layered J coat, the ortho-couple is -CH=CH-CH=CH- (i.e., the fused ring system is benzo). 20 贝施^27· The compound of Formula 1 or the Examples 1 to 26=匕ί物' wherein -R7 and R8' or R8 and R9, or the adjacent couple of R9 are as described above with the carbon atom to which they are attached Together form a fused ring. Embodiment 28. The compound of the formula 1 or the compound of any of the examples 1 to 27 wherein the ortho to each of -R7 and R8, together with the carbon atom to which they are attached, form a fused ring. 29 25 201204254 Embodiment 29. A compound of the formula 1 or a compound of any one of the embodiments 1 to 27, wherein a argon of R8 and R9 together with the carbon atom to which they are attached forms a fused ring. Embodiment 30. A compound of Formula 1 or any one of Embodiments 1 to 27, wherein a argon of R9 and R10 together with the carbon atom to which they are attached forms a fused ring. Embodiment 31. A compound of Formula 1 or any one of Embodiments 1 to 25 wherein each R7, R8, r9 and R1 are separated (i.e., a fused defect is not formed together). Embodiment 32. A compound of Formula 1 or any one of Embodiments 1 to 31, wherein L is -CXRUfQR12)- 'wherein the carbon atom bonded to R11 is also bonded to CR4R5, and the bond is bonded to Rl2 The carbon atom is also bonded to R6; or, as the case may be, up to 4 oximes, independently substituted with a substituent selected from R13, 4-diphenyl. Example 33. One style! A compound or any one of embodiments 1 to 32 wherein L is a system. Embodiment 34. A compound of Formula 1 or a compound of any of Embodiments 1 to 33, wherein R11 and R12 are independently oxime, dentate or methyl. Embodiment 35. A compound of Embodiment 34 wherein R11 and R12 are independently hydrazine or methyl. Embodiment 36. A compound of Embodiment 35, wherein R11 and R12 are H 〇 Example 37. A compound of Formula 1 or any one of Examples 1 to 32 wherein L is optionally independently selected up to 4 independently. A 1,4-diphenyl group substituted with a substituent of Rl3.

S 30 201204254 實施例38. —種式1之化合物或實施例1至31之任 一化合物,其中L係-C(R34)(R35)-Z-,其中該鍵 結至R34及R35之碳原子亦鍵結至CR4R5,且Z 係鍵結至R6。 5 實施例39. —種式1之化合物或實施例1至31之化 合物或實施例38之化合物,其中R34係Η或 C】-C4烧基。 實施例40. —種實施例39之化合物,其中R34係Η 或CrQ烷基。 ίο 實施例41.實施例40之化合物,其中R34係Η或甲 基。 實施例42.實施例41之化合物,其中R34係Η。 實施例43. —種式1之化合物或實施例1至31之化 合物或實施例38至42之化合物,其中R35係Η。 15 實施例44. 一種式1之化合物或實施例1至31之化 合物或實施例38至43之化合物,其中Ζ係Ο、 S、NR37 或 CR38R39 (意即 m 係 0 )。 實施例45. —種實施例44之化合物,其中Z係0、S 或 NR37。 2〇 實施例46. —種實施例45之化合物,其中Z係Ο或 NR37。 實施例47. —種實施例46之化合物,其中Z係Ο。 實施例48. —種式1之化合物或實施例1至47之任 一化合物,其中R37係Η。 25 實施例49. 一種式1之化合物或實施例1至48之任 一化合物,其中R38及R39係Η。 31 201204254 實施例50. —種式1之化合物或實施例1至49之任 一化合物,其中當L包含1,4-聯伸苯基,則該 1,4-聯伸苯基係選擇性地以至多2個獨立選自 R13之取代基所取代。 5 實施例51. —種實施例50之化合物,其中當L包含 1,4-聯伸苯基,則該1,4-二伸苯基係未經取代(除 了其鍵結至C(R4)(R5)及R6)。 實施例52. —種式1之化合物或實施例1至51之任 一化合物,其中各R13係獨立為鹵素或Ci-C4烧 10 基。 實施例53. —種實施例52之化合物,其中各R13係 獨立為齒素或曱基。 實施例54. —種式1之化合物或實施例1至53之任 一化合物’其中R1係一選擇性地以至多4個獨 15 立選自R14之取代基所取代的苯環或5員或6員 雜芳環。 實施例55. —種實施例54之化合物,其中R1係一選 擇性地以至多4個獨立選自R14之取代基所取代 的苯環或吡啶環。 20 實施例56. —種實施例55之化合物’其中Rl係一選 擇性地以至多4個獨立選自R14之取代基所取代 的苯環。 實施例57. —種實施例55之化合物’其中Rl係一選 擇性地以至多4個獨立選自R14之取代基所取代 的°比咬環。S 30 201204254 Embodiment 38. A compound of Formula 1 or any one of Embodiments 1 to 31, wherein L is -C(R34)(R35)-Z-, wherein the carbon atom bonded to R34 and R35 It is also bonded to CR4R5, and the Z system is bonded to R6. 5. A compound of formula 1 or a compound of embodiments 1 to 31 or a compound of embodiment 38, wherein R34 is hydrazine or C]-C4 alkyl. Embodiment 40. The compound of Embodiment 39, wherein R34 is hydrazine or CrQ alkyl. </ RTI> The compound of embodiment 40, wherein R34 is hydrazine or methyl. Embodiment 42. The compound of Embodiment 41 wherein R34 is hydrazine. Embodiment 43. A compound of Formula 1 or a compound of Examples 1 to 31 or a compound of Examples 38 to 42 wherein R35 is hydrazine. 15 A compound of formula 1 or a compound of examples 1 to 31 or a compound of examples 38 to 43 wherein indole, S, NR37 or CR38R39 (i.e., m system 0). Embodiment 45. A compound of Embodiment 44 wherein Z is 0, S or NR37. The compound of Example 45, wherein Z is hydrazine or NR37. Embodiment 47. The compound of Embodiment 46, wherein Z is hydrazine. Embodiment 48. A compound of Formula 1 or any one of Embodiments 1 to 47, wherein R37 is hydrazine. A compound of formula 1 or a compound of any one of embodiments 1 to 48 wherein R38 and R39 are indole. 31. The compound of the formula 1 or the compound of any one of the embodiments 1 to 49, wherein when L contains a 1,4-linked phenyl group, the 1,4-linked phenyl group is selectively Substituted with up to 2 substituents independently selected from R13. 5. The compound of embodiment 50, wherein when L comprises a 1,4-linked phenyl group, the 1,4-diphenyl group is unsubstituted (except that it is bonded to C(R4) (R5) and R6). Embodiment 52. A compound of Formula 1 or any one of Embodiments 1 to 51, wherein each R13 is independently halogen or Ci-C4. Embodiment 53. The compound of Embodiment 52, wherein each R13 is independently dentate or sulfhydryl. Embodiment 54. A compound of Formula 1 or any one of Examples 1 to 53 wherein R1 is optionally substituted with up to 4 phenyl rings or 5 members independently substituted with a substituent selected from R14 or 6 members of the aromatic ring. Embodiment 55. The compound of Embodiment 54 wherein R1 is a phenyl or pyridine ring optionally substituted with up to 4 substituents independently selected from R14. 20 Embodiment 56. The compound of Embodiment 55 wherein R1 is a benzene ring optionally substituted with up to 4 substituents independently selected from R14. Embodiment 57. The compound of Embodiment 55 wherein R1 is optionally a bite ring substituted with up to 4 substituents independently selected from R14.

S 32 201204254 實施例58. —種實施例57之化合物,其中R1係一選 擇性地以至多4個獨立選自R14之取代基所取代 的4-吼啶環。 實施例59. —種實施例58之化合物’其中R1係一選 5 擇性地以1至3個獨立選自R14之取代基所取代 的4-吡啶環,其中該取代基之/係位於該4-吡 啶環之2-位(2-position)(意即相鄰於吡啶環的 氮原子並相間於將該吡啶環連結至式1其餘部 分的鍵結)。 10 實施例60· —種實施例59之化合物,其中R1係一選 擇性地以1個獨立選自R14之取代基所取代的4-吡啶環’其中該取代基係位於該4-吡啶環之2-位。 實施例61_ —種式1之化合物或實施例1至60之任 15 一化合物,其中各R14係獨立為鹵素、CH:4烷 基、Ci—C4 _烧基、氰基、C2—C4婦基、C2—C4 鹵婦基、C2—C4快基、C3_C4 _块基、C3-C6環炫1 基、CH:4烷氧基、Q-Q鹵烷氧基、Q-Q烷硫 基或Ci-c4鹵炫硫基。 20 實施例62. —種實施例61之化合物,其中各R14係 獨立為鹵素或Q-C4鹵烷基。 實施例63. —種實施例62之化合物,其中各R14係 獨立為F、Q、Br或CF3。 實施例64· —種實施例63之化合物,其中各R14係 25 C1。 33 201204254 實施例65. —種式1之化合物或實施例1至64之任 一化合物,其中R2係Η、Q-Q烷基、Q-Q烷 氧基、C2-C5烷氧基烷基、C2-C5烷氧羰基或 C2-C5烷羰基; 5 實施例66. —種實施例65之化合物,其中R2係Η、 曱基、甲氧基、C2-C5烷氧基烷基或C2-C5烷氧 幾基。 實施例67. —種實施例66之化合物,其中R2係Η、 甲基、C2-C5烷氧基烷基或C2-C5烷氧羰基。 ίο 實施例68. —種實施例67之化合物,其中R2係Η。 實施例69. —種式1之化合物或實施例1至68之任 一化合物,其中各R3係獨立為CrQ烷基。 實施例70. —種實施例69的化合物,其中各R3係曱 基。 15 實施例71. —種式1之化合物或實施例1至70任一 化合物,其中R4係Η或CrQ烷基。 實施例72. —種實施例71之化合物,其中R4係Η 或Q-C2烷基。 實施例73. —種實施例72之化合物,其中R4係Η 20 或甲基。 實施例74. —種實施例73之化合物,其中R4係Η。 實施例75. —種式1之化合物或實施例1至74任一 化合物,其中R5係Η。 實施例76. —種式1之化合物或實施例1至75 —化 25 合物,其中R6係一選擇性地以至多5個獨立選The compound of Embodiment 57, wherein R1 is a 4-acridine ring optionally substituted with up to 4 substituents independently selected from R14. Embodiment 59. The compound of Embodiment 58 wherein R1 is optionally 5-substituted with 1 to 3 4-pyridine rings independently selected from substituents of R14, wherein the substituent is located in the The 2-position of the 4-pyridine ring (ie, the nitrogen atom adjacent to the pyridine ring and interphased to the linkage of the pyridine ring to the remainder of Formula 1). The compound of Embodiment 59, wherein R1 is a 4-pyridine ring which is optionally substituted with a substituent independently selected from R14, wherein the substituent is located in the 4-pyridine ring. 2-bit. The compound of the formula 1 or the compound of any one of the embodiments 1 to 60, wherein each R14 is independently halogen, CH: 4 alkyl, Ci-C4-alkyl, cyano, C2-C4 , C2-C4 halo, C2-C4 fast radical, C3_C4 _blockyl, C3-C6 cyclodextyl, CH:4 alkoxy, QQ haloalkoxy, QQ alkylthio or Ci-c4 halogen Sulfur based. The compound of Embodiment 61, wherein each R14 is independently halogen or Q-C4 haloalkyl. Embodiment 63. The compound of Embodiment 62 wherein each R14 is independently F, Q, Br or CF3. Embodiment 64. The compound of Embodiment 63 wherein each R14 is 25 C1. 33201204254 Embodiment 65. A compound of Formula 1 or any one of Embodiments 1 to 64, wherein R2 is hydrazine, QQ alkyl, QQ alkoxy, C2-C5 alkoxyalkyl, C2-C5 alkane Oxycarbonyl or C2-C5 alkylcarbonyl; 5 Embodiment 66. The compound of Embodiment 65, wherein R2 is hydrazine, fluorenyl, methoxy, C2-C5 alkoxyalkyl or C2-C5 alkoxy . Embodiment 67. The compound of Embodiment 66, wherein R2 is hydrazine, methyl, C2-C5 alkoxyalkyl or C2-C5 alkoxycarbonyl. </ RTI> </ RTI> </ RTI> <RTIgt; </ RTI> <RTIgt; Embodiment 69. A compound of Formula 1 or any one of Embodiments 1 to 68 wherein each R3 is independently a CrQ alkyl group. Embodiment 70. The compound of Embodiment 69, wherein each R3 is decyl. The compound of the formula 1 or the compound of any one of embodiments 1 to 70, wherein R4 is a hydrazine or a CrQ alkyl group. Embodiment 72. The compound of Embodiment 71, wherein R4 is Η or Q-C2 alkyl. Embodiment 73. The compound of Embodiment 72, wherein R4 is Η20 or methyl. Embodiment 74. The compound of Embodiment 73, wherein R4 is hydrazine. Embodiment 75. A compound of Formula 1 or a compound of any one of Embodiments 1 to 74 wherein R5 is hydrazine. Embodiment 76. A compound of Formula 1 or Examples 1 to 75, wherein R6 is optionally independently selected up to 5 independently.

S 34 201204254 自R22之取代基所取代的苯環或一選擇性地以至 多4個獨立選自R22之取代基所取代的吡啶環。 實施例77. —種實施例76之化合物,其中R6係一以 1至3個獨立選自R22之取代基所取代的苯環或 5 吡啶環,其中一個取代基係位於對位(相對於將 該環連接至式1其餘部分的鍵結)。 實施例78. —種實施例77之化合物,其中R6係一以 1至2個獨立選自R22之取代基所取代的苯環或 吡啶環,其中一個取代基係位於對位。 ίο 實施例79. —種實施例78之化合物,其中R6係一在 對位以一獨立選自R22之取代基所取代且選擇性 地在鄰位以一獨立選自R22之取代基所取代的苯 環或σ比变環。 實施例80. —種實施例79之化合物,其中R6係一在 15 對位以一獨立選自R22之取代基所取代的苯環或 °比°定環。 實施例81. —種式1之化合物或實施例1至80之化 合物,其中當R6包含一吼啶環之時,該環係在 2-位(2-position)鍵結至式1其餘部分。 2〇 實施例82. —種式1之化合物或實施例1至80之化 合物,其中R6係一如所述而經取代的苯環。 實施例83. —種式1之化合物或實施例1至81之化 合物,其中R6係一如所述而經取代的吡啶環。 實施例84. —種實施例76之化合物,其中R6係一選 25 擇性地以至多5個獨立選自R22之取代基所取代 的苯環。 35 201204254 實施例85. —種實施例84之化合物,其中R6係一以 1至3個獨立選自R22之取代基所取代的苯環, 其中該取代基之一係位於該苯環之4-位。 實施例86. —種實施例85之化合物,其中R6係一以 5 1個選自R22之取代基所取代的苯環,其中該取 代基係位於該苯環之4-位。S 34 201204254 A benzene ring substituted with a substituent of R22 or a pyridine ring optionally substituted with up to 4 substituents independently selected from R22. Embodiment 77. The compound of Embodiment 76, wherein R6 is a phenyl ring or a 5 pyridine ring substituted with 1 to 3 substituents independently selected from R22, wherein one substituent is in the para position (relative to This ring is connected to the bond of the rest of Equation 1.) Embodiment 78. The compound of Embodiment 77, wherein R6 is a phenyl or pyridine ring substituted by 1 to 2 substituents independently selected from R22, wherein one substituent is in the para position. The compound of Embodiment 78, wherein R6 is substituted in the para position with a substituent independently selected from R22 and optionally substituted in the ortho position with a substituent independently selected from R22. A benzene ring or a σ ratio ring. Embodiment 80. The compound of Embodiment 79, wherein R6 is a ring of benzene or substituted at a 15 position with a substituent independently selected from R22. Embodiment 81. A compound of Formula 1 or a compound of Examples 1 to 80, wherein when R6 comprises an acridine ring, the ring is bonded to the remainder of Formula 1 at the 2-position. 2) Embodiment 82. A compound of Formula 1 or a compound of Embodiments 1 to 80, wherein R6 is a benzene ring substituted as described. Embodiment 83. A compound of Formula 1 or a compound of Examples 1 to 81 wherein R6 is a substituted pyridine ring as described. Embodiment 84. The compound of Embodiment 76, wherein R6 is a benzene ring which is optionally substituted with up to 5 substituents independently selected from R22. 35. The compound of Embodiment 84, wherein R6 is a benzene ring substituted with 1 to 3 substituents independently selected from R22, wherein one of the substituents is located in the benzene ring. Bit. Embodiment 86. The compound of Embodiment 85, wherein R6 is a phenyl ring substituted with 51 substituents selected from R22, wherein the substituent is at the 4-position of the phenyl ring.

實施例87. —種式1之化合物或實施例1至86之化 合物,其中各R22係獨立為鹵素、氰基、CrQ 烧基、Ci-C6鹵烧基、C3_C6環烧基、C2-C6稀基、 10 C2-C6鹵烯基、C2-C6炔基、CrQ烷氧基或CrQ 鹵烧氧基。 實施例88. —種實施例87之化合物,其中各R22係 獨立為F、C卜Br、氰基、CH3、CF3、環丙基、 HOC、CH30 或 CF30。 15 實施例89. —種實施例88之化合物,其中各R22係 獨立為 F、a、Br、CF3 或 CF30。 實施例90. —種實施例89之化合物,其中各R22係 獨立為F、Q、Br或CF3。 實施例91. 一種實施例90之化合物,其中各R22係 2〇 獨立為F、C1或CF3。 實施例92. —種實施例91之化合物,其中各R22係F 或α。 實施例93. —種式1之化合物或實施例1至92之任 一化合物,其中Τ係0、S或NR36(意即k係0)。 25 實施例94. 一種實施例93之化合物,其中T係0或 NR36。Embodiment 87. A compound of Formula 1 or a compound of Examples 1 to 86, wherein each R22 is independently halogen, cyano, CrQ alkyl, Ci-C6 halogen, C3_C6 cycloalkyl, C2-C6 Base, 10 C2-C6 haloalkenyl, C2-C6 alkynyl, CrQ alkoxy or CrQ halooxy. Embodiment 88. The compound of Embodiment 87, wherein each R22 is independently F, CBr, cyano, CH3, CF3, cyclopropyl, HOC, CH30 or CF30. The compound of Embodiment 88, wherein each R22 is independently F, a, Br, CF3 or CF30. Embodiment 90. The compound of Embodiment 89 wherein each R22 is independently F, Q, Br or CF3. Embodiment 91. A compound of Embodiment 90 wherein each R22 is independently F, C1 or CF3. Embodiment 92. The compound of Embodiment 91 wherein each R22 is F or a. Embodiment 93. A compound of Formula 1 or any one of Embodiments 1 to 92 wherein the oxime is 0, S or NR36 (i.e., k is 0). 25. A compound of embodiment 93 wherein T is 0 or NR36.

S 36 201204254 實施例95. —種實施例94之化合物,其中T係0。 實施例96. —種式1之化合物或實施例1至95之任 一化合物,其中R36係Η。 實施例97. —種式1之化合物或實施例1至96之任 5 一化合物,其中W係Ο。 實施例98_ —種式1之化合物或實施例1至97之任 一化合物,其中W1係Ο。 實施例99. 一種式1之化合物或實施例1至98之任 一化合物,其中各W2係Ο。 ίο 實施例100. —種式1之化合物或實施例1至99之任 一化合物,其中η係一從0到2的整數。 實施例101. —種實施例100之化合物,其中η係0 或1。 實施例102. —種實施例101之化合物,其中η係0。 15 實施例103. —種式1之化合物或實施例1至102之 任一化合物,其中ρ係0或2。 實施例104. —種實施例103之化合物,其中ρ係0。 實施例105. —種式1之化合物或實施例1至104之 任一化合物,其中s係1。 2〇 實施例106. —種式1之化合物或實施例1至105之 任一化合物,其中t係1。 實施例107. —種發明内容中所述之化合物或實施例 1至106之任一化合物,其不以N-氧化物形式存 在。 25 實施例108. —種實施例107之化合物,其不以N-氧 化物或鹽類形式存在。 37 201204254 實施例109. —種發明内容中所述之化合物或實施例 1至108之任一化合物,其中R7不為NH2。 實施例110. —種實施例109之化合物,其中R7不為 NR24R25。 5 本發明之實施例,包括以上的實施例1至110及任 何其它本文中所述之實施例,可以用任何方式組合,且 實施例中變數的描述不只與式1化合物有關,也與可用 於製備式1化合物的起始化合物及中間化合物有關。此 外’本發明之實施例,包括以上的實施例1至11()及任 0 何其它本文中所述之實施例,以及彼等之任何組合,與 本發明之組合物及方法有關。 實施例1至110之組合說明: 實施例A1. —種式1之化合物,其中 T係〇 ; 5 z 係 〇 ; R1係一以1至3個獨立選自R!4之取代基所取代 的4·^比啶環’其中上述取代基之一係位於該 4·0比啶環之 2-位(2-2position); R2係Η'甲基、C2_C5烷氧基烷基或c2_c4烷氧 ^ 羰基; R4係Η或C!-C4烷基; R5 係 Η ; R係一選擇性地以至多5個獨立選自R22之取代 5 基所取代之苯環或選擇性地以至多4個獨 立選自R22之取代基所取代之吡啶環;S 36 201204254 Embodiment 95. The compound of Embodiment 94, wherein T is 0. Embodiment 96. A compound of Formula 1 or any one of Embodiments 1 to 95 wherein R36 is hydrazine. Embodiment 97. A compound of Formula 1 or a compound of any one of Embodiments 1 to 96, wherein W is a hydrazine. Embodiment 98 - A compound of Formula 1 or a compound of any of Embodiments 1 to 97, wherein W1 is hydrazine. Embodiment 99. A compound of Formula 1 or any one of Examples 1 to 98, wherein each W2 is in the form of hydrazine. 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。 。. Embodiment 101. The compound of Embodiment 100, wherein η is 0 or 1. Embodiment 102. The compound of Embodiment 101 wherein η is 0. 15. The compound of formula 1 or any one of embodiments 1 to 102, wherein ρ is 0 or 2. Embodiment 104. The compound of Embodiment 103, wherein ρ is 0. Embodiment 105. A compound of Formula 1 or any one of Examples 1 to 104, wherein s is 1. 2) Embodiment 106. A compound of Formula 1 or any one of Examples 1 to 105, wherein t is 1 . Embodiment 107. A compound of the invention or any one of embodiments 1 to 106 which is not present in the form of an N-oxide. 25 Embodiment 108. A compound of Embodiment 107 which is not in the form of an N-oxide or a salt. 37. The compound of the invention or the compound of any one of embodiments 1 to 108, wherein R7 is not NH2. Embodiment 110. The compound of Embodiment 109, wherein R7 is other than NR24R25. 5 Embodiments of the invention, including the above Examples 1 to 110 and any other embodiments described herein, may be combined in any manner, and the description of the variables in the examples is not only related to the compound of Formula 1, but also to The starting compounds for the preparation of the compounds of formula 1 are related to intermediate compounds. Further, the embodiments of the present invention, including the above Examples 1 to 11 () and any other embodiments described herein, and any combinations thereof, relate to the compositions and methods of the present invention. Combination of Examples 1 to 110 Description: Example A1. The compound of Formula 1, wherein T is 〇; 5 z is 〇; R1 is substituted by 1 to 3 substituents independently selected from R! Wherein one of the above substituents is located at the 2-position (2-2position) of the 4·0-pyridine ring; R2 is Η'methyl, C2_C5 alkoxyalkyl or c2_c4 alkoxy^ a carbonyl group; an R4 system or a C!-C4 alkyl group; an R5 system; R is a benzene ring optionally substituted with up to 5 substituted 5 groups independently selected from R22 or optionally up to 4 independently selected a pyridine ring substituted with a substituent of R22;

S 38 201204254 R、R8、尺9及Rl〇係獨立為Η、鹵素、Cr_C4烷 f Cl c4 1¾ 燒基、c2_c4 稀基、齒烯 ς C2匚4块基、c3_c4 _快基、^環烷 土、Cr~C4烷氧基、c广c4 _烷氧基、Cl—^ 烧8硫基、Cl—c4鹵烷硫基或氰基,或R7及4 =、或R8及V、或R9ARH)之鄰偶,盘彼 等所連接之碳原子一起形成一5員或6員芳 香族或非芳香族環,其包含選自碳原子及至 以/^^立選自㈣及^雜原子的環員; 係獨立為Η、鹵素或甲基; 各R13係鹵素或甲基;S 38 201204254 R, R8, 尺9 and Rl〇 are independently Η, halogen, Cr_C4 alkane f Cl c4 13⁄4 alkyl, c2_c4 dilute, dentate ς C2匚4, c3_c4 _ fast, ^ naphthenic , Cr~C4 alkoxy, c-C4 alkoxy, Cl-^ 8 thio, Cl-c4 haloalkylthio or cyano, or R7 and 4 =, or R8 and V, or R9ARH) The carbon atoms to which the adjacent couple, the ring and the like are joined together form a 5- or 6-membered aromatic or non-aromatic ring comprising a ring member selected from the group consisting of carbon atoms and to (a) and (hetero) atoms; Is independently hydrazine, halogen or methyl; each R13 is halogen or methyl;

各R14係,立為i素、Ci_c4院基、Ci_C4函烧 基、氰基、C2-C4烯基、C2_C4鹵烯基、C2_C4 炔基、c3-c4 i 炔基、c3—Cpf 烷基、Ci—Q 院氧基、CVCt由院氧基、Ci—c4烷硫基或 Ci-c4 i烷硫基; 20 各R22係獨立為鹵素、氰基、Ci_c6烷基、Ci—C6 齒院基、C3—C6環炫基、c2_c6烯基、c2—c6 鹵稀基、C:2-C6炔基、C广c6烷氧基或CVQ 鹵烷氧基; R34係Η或CrC2烷基; R35 係 Η ; W係0 ; η係0 ; s係1 ;且 t係卜 39 25 201204254 實施例A2_ —種實施例A1之化合物,其中 A1 係 N 或 CR7 ; A2 係 N 或 CR8 ; A3 係 N 或 CR9 ; 5 A4 係 CR10; L 係-C(Ru)=c(R12)-、-C(R34)(R35)〇-或未經取代 之二伸苯基; R1係以1個選自R14之取代基所取代的4-吡啶 環’其中上述取代基係位於該4-吡啶環之 10 2-位(2-p〇sition ); R2 係 Η ; R4係Η或甲基; R係以1至3個獨立選自r22之取代基所取代的 苯環或》比啶環,其中一個取代基係位於對 15 位; R7、R8、R9及Ri〇係獨立為Η、鹵素或c广C4鹵 院基; R11 與 R11係 各R14係獨立為!I素或 c「c4鹵烷基; 20 各R22係獨立為F、C卜Br、氰基、CH3、CF3、 環丙基、HOC、CH30或CF30 ;以及 R34係H或曱基。 實施例6A3·—種實施例A2之化合物,其中 R係在對位以一獨立選自R22之取代基所取代, 且選擇性地在一鄰位以一獨立選自R22之取 代基所取代的苯環或吼啶環;Each R14 system, which is i, Ci_c4, Ci_C4, cyano, C2-C4 alkenyl, C2_C4 haloalkenyl, C2_C4 alkynyl, c3-c4 i alkynyl, c3-Cpf alkyl, Ci —Q alkoxy, CVCt consists of alkoxy, Ci—c4 alkylthio or Ci-c4 ialkylthio; 20 each R22 is independently halogen, cyano, Ci_c6 alkyl, Ci—C6 dentate, C3 —C6cyclohexyl, c 2 —c 6 alkenyl, c 2 —c 6 halo, C: 2—C 6 alkynyl, C-C6 alkoxy or CVQ haloalkoxy; R 34 hydrazine or CrC 2 alkyl; R 35 hydrazine ; W system 0; η system 0; s system 1; and t system 39 25 201204254 Example A2_ The compound of Example A1, wherein A1 is N or CR7; A2 is N or CR8; A3 is N or CR9; A4 is CR10; L is -C(Ru)=c(R12)-, -C(R34)(R35)〇- or unsubstituted diphenyl; R1 is one substituent selected from R14 Substituted 4-pyridine ring 'wherein the above substituent is located at the 10 2-position (2-p〇sition) of the 4-pyridine ring; R2 is Η; R4 is Η or methyl; R is 1 to 3 independent a benzene ring or a "pyridinium ring" substituted with a substituent selected from r22, wherein one substituent is in the 15 position; R7, R8, R9 and Ri The 〇 is independent of Η, halogen or c-C4 halogen base; R11 and R11 are independent of each R14! I or c "c4 haloalkyl; 20 each R22 is independently F, C, Br, cyano, CH3, CF3, cyclopropyl, HOC, CH30 or CF30; and R34 is H or fluorenyl. Example 6A3 a compound of embodiment A2 wherein R is substituted in the para position with a substituent independently selected from R22, and optionally substituted in the ortho position with a phenyl ring independently substituted with a substituent selected from R22 or Acridine ring

S 201204254 R7係Η或p ; R及R係獨立為H、鹵素或Ci_C4齒炫基; R係Η或ρ ; 各R22係獨立為F、C卜Br或CF3 ;以及 各11係獨立為F、C卜Br、CF3或CF30。 實施例6 Α4·實施例A3之化合物,其中 R係在鄰位以—選自r22之取代基所取代的苯 環; R7 係 Η ; R8係Η、鹵素或cf3 ; R9係Η、鹵素或cf3 ; R10 係 Η ; R14係Cl ;以及 R22 係 F、a、Br 或 CF3。 特定實施例包括由下列化合物所構成之群組中選 出之式1化合物: 2-氣·Ν-〇[[1·[(2Ε)-3-(4-氯苯基)-2-丙烯-1-基]-3-吖丁啶基]氧基]-6-(三氟曱基)-3-吼啶基]-4·-比啶羧 醯胺,及 2·氯-N-[4,5-二氣-2-[[1-[(2Ε)-3-(4-氣苯基)-2-丙烯 -1-基]-3-吖丁啶基基]氧基]苯基]-4-吼啶羧醯胺、 2-氯-N-[6-氯-2-[[1-[(2Ε)-3-(4-氣苯基)-2-丙烯-1-基]-3-吖丁啶基]氧基]-5-氟-3-。比啶基]-4-。比啶羧醯 胺、 201204254 2-氯-N-[5-氯-2-[[1-[(2Ε)-3-(4-氣苯基)-2-丙烯-l-基]-3-吖丁啶基]氧基氟-3-°比啶基]-4·吼啶羧醯 胺、 2-氯-N-[2-[[ 1-[(2Ε)-3-(4-氣苯基)-2丙烯-1-基)-2-甲基-3-0丫丁σ定基]氧基]_6-(三氟甲基)-3-〇比咬基]-4-〇比〇定叛酿胺,及 2-氯~^-[6-氣-2-[[1-[2-(4-氣苯氧基)丙基]-3·。丫丁咬 基]氧基]-5-氟-3-α比咬基]-4-ni;b咬叛酿胺。 值得注意的是,本發明化合物之特徵在於有利之代 謝及/或土壤殘留模式’且展示控制多種之農藝及非農 藝無脊椎動物害蟲之活性。 尤其值得注意的是,出於無脊椎動物害蟲控制範圍 及經濟價值之原因,藉由控制無脊椎動物害蟲來保護農 作物免遭無脊椎動物害蟲造成之損害或傷害為本發明 之實施例。本發明之化合物由於在植物中有良好的轉移 特性或系統性,因此也可保護並未直接接觸到式丨化合 物或包含該化合物之組合物的葉子或植物的其他部分。 本發明另外值得注意的實施例為組合物,其包含任 何先前實施例以及任何其他在此所述實施例中之一化 。物,及至少一選自由一界面活性劑、一固體稀釋劑及 ,一液體稀釋劑所組成之群組的額外成分,該組合物選擇 ί*生地進一步包含至少一額外生物活性化合物或藥劑。 、本發明更進一步值得注意的實施例為用於防治無 脊椎動物害蟲的組合物,其包含任何先前實施例以及任 何其他在此所述實施例以及其任意結合中之一化合 物,及至少一選自由一界面活性劑、一固體稀釋劑及一S 201204254 R7 is Η or p; R and R are independently H, halogen or Ci_C4 dentate; R is Η or ρ; each R22 is independently F, C, Br or CF3; and each 11 is independently F, C Br Br, CF3 or CF30. Embodiment 6 The compound of Embodiment A3 wherein R is a benzene ring substituted in the ortho position with a substituent selected from the group consisting of R22; R7 system; R8 system ruthenium, halogen or cf3; R9 system ruthenium, halogen or cf3 R10 system Η; R14 system Cl; and R22 system F, a, Br or CF3. Particular embodiments include a compound of formula 1 selected from the group consisting of 2-gas·Ν-〇[[1·[(2Ε)-3-(4-chlorophenyl)-2-propene-1 -yl]-3-azetidinyl]oxy]-6-(trifluoromethyl)-3-acridinyl]-4.-bipyridylcarboxamide, and 2·chloro-N-[4,5- Diqi-2-[[1-[(2Ε)-3-(4-carbophenyl)-2-propen-1-yl]-3-azetidinyl]oxy]phenyl]-4-acridine Carboxylamidine, 2-chloro-N-[6-chloro-2-[[1-[(2Ε)-3-(4-carbophenyl)-2-propen-1-yl]-3-azetidinyl] Oxy]-5-fluoro-3-. Bipyridyl]-4-. Bipyridine carboxamide, 201204254 2-chloro-N-[5-chloro-2-[[1-[(2Ε)-3-(4-phenylphenyl)-2-propenyl-l-yl]-3- Azetidinyloxyfluoro-3-pyrylpyridyl]-4·acridine carboxamide, 2-chloro-N-[2-[[1-[(2Ε)-3-(4-phenylphenyl)) -2 propen-1-yl)-2-methyl-3-0 丫 σ 定 ]] oxy]_6-(trifluoromethyl)-3-indole ratio bite base] -4- 〇 〇 叛 叛 叛Amine, and 2-chloro-^-[6-gas-2-[[1-[2-(4-cyclophenoxy)propyl]-3.丫丁基基]oxy]-5-fluoro-3-α than bite base]-4-ni; b bite the amine. Notably, the compounds of the invention are characterized by advantageous metabolism and/or soil residual patterns&apos; and exhibit control of the activity of a variety of agronomic and non-agronomic invertebrate pests. It is particularly noteworthy that the protection of crops from invertebrate pests by controlling invertebrate pests is an embodiment of the invention for reasons of invertebrate pest control and economic value. The compounds of the present invention also protect leaves or other parts of the plant which are not in direct contact with the compound of the formula or the composition comprising the compound, due to its good transfer characteristics or systemic properties in the plant. Further notable embodiments of the invention are compositions comprising any of the prior embodiments and any other embodiments described herein. And an additional component selected from the group consisting of a surfactant, a solid diluent, and a liquid diluent, the composition optionally further comprising at least one additional biologically active compound or agent. Further noteworthy embodiments of the invention are compositions for controlling invertebrate pests comprising any of the prior embodiments and any other of the compounds described herein and any combination thereof, and at least one selected Free-surfactant, a solid diluent and a

S 201204254 液體稀釋劑所組成之群組的額外成分,該組合物選擇性 地進-步包含至少-額外生物活性化合物或試劑。 明實施例進-步包括防治騎椎祕害蟲之方法^ 含使無脊椎動物害麵其環境與生物有效量之任何^ 述實施例之單-化合物或其組合(例如,呈述 組合物之形式)接觸。 迎 本發明之實施例也包括一形式為土壤 方的組合物,包含任何先前實施例中的一單一化人物七 其組合。本發明實施例進—步包括防治無脊椎動 =法,其包含使场㈣土錢 。$ 物接觸,該《組合物包含絲有效之f體組合 例之單一化合物或其組合。 里之任何别述實施 15 20 本發明之實施例也包括—用 害蟲的喷霧組合物,包含任何先會方、①―無脊椎動物 量的單獨化合物或其組合以及貫^列中一生物有效 例進一步包括-用於防治-無脊椎動„明之實施 合物,包含任何先前實施例中— 物。蟲的誘餌組 物或其組合、—或多個食物材料、效量的單-化合 劑及一選擇性地選用保濕劑。本發明^擇性地選用引誘 用於控制無脊椎動財蟲U 實施例亦包括-種 及一適合組合物μ該雜組合物 少一開口,該開口之尺寸訂定其中該外殼具有至 通過該開口,因此該無脊椎動物脊椎動物害義 置接近該_組合物,且其中該;卜=自外殼外部之位 無脊椎動物Μ之潛在或已置放在 43 25 201204254 本t明實施例亦包括保護種子免遭無脊椎動物害 蟲侵害之方法,其包含使該種子與生物有效量之任何前 述實施例之化合物(單-化合物或其組合)接觸。 本發明實施例亦包括保護動物免遭無脊椎動物寄 5 生害敲害之方法’其包含向該動物投予殺寄生蟲有效 量之任何前述實施例之化合物(單-化合物或其組合)。 本發明實施例亦包括防治無脊椎動物害蟲之方 法’其包含使該無歸動物害蟲或其環境触物有效量 之式1化合物、其N-氧化物或其鹽類(例如,呈本文 10 巾所述組合物之形式)接觸’其限制條件為該方法並非 藉由療法在醫學上治療人類或動物身體之方法。 本發明亦關於该專方法,其中使該無脊椎動物害蟲 或其環境與一組合物接觸,該組合物包含生物有效量之 式1化合物、其N-氧化物或其鹽類,及至少一種選自 15 由界面活性劑、固體稀釋劑及液體稀釋劑所組成之群組 之其他組伤,该組合物選擇性地進一步包含生物有效量 之至少一種其他生物活性化合物或試劑,其限制條件為 該等方法並非藉由療法在醫學上治療人類或動物身體 之方法。 20 本發明之實施例亦包括任何前述實施例(單一或其 組合)’其中該無脊椎動物害蟲係一種節肢動物。本發 明之實施例亦包括任何前述實施例,其中該節肢動物係 選自由昆蟲、蜗、4知蛛、蠍子、娱讼、馬陸、球潮蟲(p⑴ bugs)及千足蟲(Symphylans)組成之群組。本發明之 25 實施例亦包括任何前述實施例,其中該節肢動物係一種 昆蟲。S 201204254 An additional component of the group consisting of liquid diluents, which composition optionally further comprises at least - additional biologically active compound or agent. DETAILED DESCRIPTION OF THE INVENTION The present invention includes a method of controlling occipital pests, a mono-compound or a combination thereof (for example, in the form of a composition) of any of the embodiments of the invertebrate lesions in an environmentally and biologically effective amount thereof. )contact. Embodiments of the invention also include a composition in the form of a soil comprising a combination of a singular character of any of the previous embodiments. The embodiment of the present invention further comprises a method for controlling invertebral motion, which comprises making a field (four) earth money. In the case of physical contact, the composition comprises a single compound or a combination thereof in which the silk is effective. Any of the embodiments of the present invention 15 20 embodiments of the present invention also include a spray composition for pests, a single compound comprising a first meeting, a 1-invertebrate, or a combination thereof, and a biologically effective Examples further include - a control composition for use in a control-invertebrate movement, comprising any of the previous embodiments - a bait group of a pest or a combination thereof, or a plurality of food materials, a single amount of a single agent, and A selective use of a humectant. The present invention selectively employs an inducer for controlling an invertebrate worm. U. The embodiment also includes a species and a suitable composition. The hybrid composition has one opening, and the size of the opening is set. Wherein the outer shell has access to the opening, such that the invertebrate vertebrate is placed close to the composition, and wherein; the potential of the invertebrate is outside the outer shell or has been placed at 43 25 201204254 The present invention also includes a method of protecting a seed from invertebrate pests comprising a compound (single-compound or combination thereof) of any of the foregoing embodiments in an amount effective to the seed with a biologically effective amount. Embodiments of the invention also include a method of protecting an animal from insults, which comprises administering to the animal a parasiticidally effective amount of a compound of any of the foregoing examples (single-compound or combination thereof). An embodiment of the present invention also includes a method of controlling an invertebrate pest comprising 'a compound of formula 1 or an N-oxide thereof or a salt thereof effective to render the non-organized animal pest or an environmentally acceptable substance thereof (for example, 10 The form of the composition in the form of a contact is a method in which the method is not medically treating a human or animal body by therapy. The present invention also relates to the method in which the invertebrate pest or its environment is made Contacting the composition, the composition comprising a biologically effective amount of a compound of formula 1, an N-oxide or a salt thereof, and at least one group selected from the group consisting of a surfactant, a solid diluent, and a liquid diluent The other group of the group, the composition optionally further comprising a biologically effective amount of at least one other biologically active compound or agent, with the limitation that the methods are not A method of medically treating a human or animal body by therapy. 20 Embodiments of the invention also include any of the foregoing embodiments (single or a combination thereof) wherein the invertebrate pest is an arthropod. Embodiments of the invention are also Included in any of the preceding embodiments, wherein the arthropod is selected from the group consisting of an insect, a worm, a spider, a scorpion, an entertainment, a horse, a stag beetle (p(1) bugs), and a phylum (Symphylans). Embodiments also include any of the foregoing embodiments, wherein the arthropod is an insect.

S 44 201204254 本發明之實施例亦包括任何前述實施例(單一或其 組合),其中該無脊椎動物害蟲係一種腹足動物。本發 明之實施例亦包括任何前述實施例,其中該腹足動物係 選自由螺類、蛞蝓及其它柄眼目動物組成之群組。 如方案1至27中所述的一或多個以下方法及變化 可用於製備式1化合物。除非另有說明,八1、A2、A3、 A4、L、T、R1、R2、R3、r4、R5、r6、R36、w、k、η、 10 15 20 s及t在下式1至34化合物中的定義如上面發明内容中 所界定。式 la 至 Id、1U、1%至 17d、2〇a、22a、24a、 26a 至 26c、30a 及 31&amp;分別係式 i、u、17、2〇、22、 24、26、30及31的各種子集。除非另有說明,式u 至Id的任何取代基如上述為式丨所定義。 如方案1中所示’在—方法中—種式1&amp;之化合物 (意即式h其中R5係H)係藉由-式2之十旦與一式 3之酸·或酮以及一適當還κ态丨r u田通原劑(例如:NaHB(OAc)3或 腿3腳)在-適當溶劑(例如:四氫料((刪或 f二乳巾反應而•。該反應—㈣在接近環 之沸點可有助於反應進行。方if旦加熱至該溶劑 例4之步驟D、合成實例由合成實 驟E及合成實例8之步驟0而:、合成實例7之步 方案1 45 201204254S 44 201204254 Embodiments of the invention also include any of the preceding embodiments (single or a combination thereof), wherein the invertebrate pest is a gastropod. Embodiments of the invention also include any of the foregoing embodiments, wherein the gastropod is selected from the group consisting of snails, scorpions, and other stalks. One or more of the following methods and variations as described in Schemes 1 through 27 can be used to prepare compounds of Formula 1. Unless otherwise stated, 8.1, A2, A3, A4, L, T, R1, R2, R3, r4, R5, r6, R36, w, k, η, 10 15 20 s and t are compounds of the following formulas 1 to 34 The definitions are as defined in the above summary. Equations la to Id, 1U, 1% to 17d, 2〇a, 22a, 24a, 26a to 26c, 30a, and 31&amp; are respectively of the formulas i, u, 17, 2, 22, 24, 26, 30, and 31 Various subsets. Unless otherwise stated, any substituent of the formula u to Id is as defined above for the formula. As shown in Scheme 1, in the method - the compound of the formula 1 &amp; (meaning that the formula h wherein R5 is H) is by the acid or ketone of the formula 2 and the formula 3 and a suitable κ State 丨 ru Tiantong original agent (for example: NaHB (OAc) 3 or leg 3 feet) in - appropriate solvent (for example: tetrahydrogen ((deleted or f two nipples reacted. • the reaction - (d) in the vicinity of the ring The boiling point can contribute to the reaction. The step of heating to the solvent of Example 4, step D, the synthesis example from the synthesis of the reaction E and the synthesis of the example 8 step 0: Synthesis of the step 7 of the scheme 1 45 201204254

R6〆R6〆

L 3L 3

R4 還原劑R4 reducing agent

溶削Solution cutting

式2之。丫:二另一方法中式1化合物係藉由 即離枝體)ί ΐ之燒化劑(其中&amp;係-脫離基 :離,?,例如*化物(例如:Br、或一磺酸鹽(例 一%酸鹽、二氟曱確酸鹽))在—適當驗存在下於 適冨〉谷劑中反應而製備,該驗係例如三乙胺、Ν Ν, 一異丙基乙胺或碳酸钟,該溶劑係例如乙腈、Ν,ν·二曱 基曱酿胺(DMF)或THF。該反應一般係在接近環境溫 10 度進行,但冷卻至-20°C或加熱至低於120°C或溶劑之 沸點可利於反應。方案2之方法係藉由合成實例5之步 驟D說明。 方案2Equation 2丫: In another method, the compound of formula 1 is a burn-in agent by means of a detached ( ( (wherein &amp; -- cleavage group: 脱,?, for example, * hydride (for example: Br, or monosulfonate ( Example 1 % acid salt, difluoro sulfonium acid salt)) is prepared by reacting in a suitable assay in the presence of a suitable colostant such as triethylamine, anthraquinone, monoisopropylethylamine or carbonic acid. The solvent is, for example, acetonitrile, hydrazine, ν·dimercaptoamine (DMF) or THF. The reaction is generally carried out at a temperature close to 10 ° C, but cooled to -20 ° C or heated to below 120 °. The boiling point of C or solvent may be advantageous for the reaction. The method of Scheme 2 is illustrated by the step D of Synthesis Example 5. Scheme 2

S 46 201204254 10 15 如方案3中所示,在另一方法中式la化合物係藉 由式2之吖咀與式5之醛(或R4係Η時為三聚甲路)曰 及硼酸(式6,γ係〇Η)或其衍生物例如硼酸酯(例 如:式6,其中或氟硼酸鹽(式 7,其中Μφ係相對離子)於一適當溶劑中反應而製備, 選擇性地有—路易斯酸催化劑(例如:BF;3 · 〇段2或丁$4) 存在,該溶劑係例如甲苯、L2-二氣乙烷、丨,‘二噁^ 或乙醇。該反應一般係在環境溫度及該溶劑之沸點之間 進行’且該反應混合物可利用微波輻射加熱。該條件之 實例可於數個參考文獻中找到,例如Tetrahedr〇n Uu 2004, 3471-3474 ; Tetrahedron Lett. 2005, 8027-8031 ; 以及 Chemtracts 2001,14(14),796-801 及該文中所引述 之參考文獻。方案3之方法係藉由合成實例1之步驟ρ 說明。 方案3S 46 201204254 10 15 As shown in Scheme 3, in another method, the compound of formula la is obtained by the oxime of formula 2 and the aldehyde of formula 5 (or trimeric road of R4 system) and boric acid (formula 6). , γ 〇Η) or a derivative thereof such as a boronic ester (for example, Formula 6, wherein fluoroborate (Formula 7, wherein Μ φ is a relative ion) is prepared by reacting in a suitable solvent, optionally having - Lewis An acid catalyst (for example: BF; 3 · hydrazine 2 or butyl $4) is present, the solvent is, for example, toluene, L2-diethane, hydrazine, 'dioxin^ or ethanol. The reaction is generally at ambient temperature and the solvent The boiling point is between 'and the reaction mixture can be heated by microwave radiation. Examples of such conditions can be found in several references, such as Tetrahedr〇n Uu 2004, 3471-3474; Tetrahedron Lett. 2005, 8027-8031; Chemtracts 2001, 14(14), 796-801 and the references cited therein. The method of Scheme 3 is illustrated by the step ρ of Synthesis Example 1. Scheme 3

r6’V 6 2 + R4CHO + 或者 ---ia 方案4之方法中,式1化合物(其中R2不為η) 2〇 係藉由式1 b化合物(意即式1其中r2係η )與一適當 的鹼(例如:氫化鈉或六甲基二矽胺基鋰(UH]VIE)S)) 及一式9化合物(其中X2係一脫離基例如一鹵化物(例 47 201204254 如:Cl、Br)或一續酸鹽(例如:曱石黃酸鹽、三氟曱續 酸鹽))於一適當溶劑(例如:THF或DMF )中反應而 製備。該反應一般係在接近環境溫度進行,但冷卻至-20 °C或加熱至低於120°C或溶劑之沸點可利於反應。R6'V 6 2 + R4CHO + or --- ia In the method of Scheme 4, the compound of formula 1 (wherein R 2 is not η) 2 is a compound of formula 1 b (that is, formula 1 wherein r 2 is η ) and a suitable base (for example: sodium hydride or lithium hexamethyldiamine lithium (UH) VIE) S)) and a compound of formula 9 (wherein X 2 is a cleavage group such as a halide (Example 47 201204254 eg Cl, Br) Or a continuous acid salt (for example: fluorite, trifluorosulfonate)) is prepared by reaction in a suitable solvent (for example: THF or DMF). The reaction is generally carried out at near ambient temperature, but cooling to -20 ° C or heating to below 120 ° C or the boiling point of the solvent may be beneficial.

S 48 201204254 方案4S 48 201204254 Scheme 4

二方案5之方法中,式2之吖咀中間物係自—受適當 保濩之式10衍生物(其中,pg係一保護基,例如:三 級丁氧基、二苯甲基或(特別當丁係 NH時)二氟乙醯基)藉由在技術領域中具有通常知識 者所熟習之條件下去保護而製備,該條件在T w Green 及 P. G. Wuts,Protecting Groups in Organic SynthesisIn the method of the second scheme, the intermediate of the formula 2 is derived from a suitably protected derivative of the formula 10 (wherein the pg is a protecting group, for example, a tertiary butoxy group, a diphenylmethyl group or (particularly) When dibutyl NH) difluoroacetamido) is prepared by the protection of the conditions well known to those skilled in the art, in Tw Green and PG Wuts, Protecting Groups in Organic Synthesis

Wiley, 1991, pages 327-329 及 364-365 中回顧。方案 5 之方法(其中Pg係B〇C )係藉由合成實例i之步驟e、 合成實例4之步驟D、合成實例5之步驟c、合成實例 6之步驟C、合成實例7之步驟D及合成實例8之步驟 c而說明。 49 201204254 方案5Review by Wiley, 1991, pages 327-329 and 364-365. The method of Scheme 5 (wherein Pg is B〇C) is by the step e of the synthesis example i, the step D of the synthesis example 4, the step c of the synthesis example 5, the step C of the synthesis example 6, the step D of the synthesis example 7, and The step c of Example 8 is synthesized. 49 201204254 Scheme 5

5 如方案6中所說明,式10之化合物係藉由式11之 胺基化合物(其中Pg係如方案5中所定義)與式12之 酸或衍生物(其中,例如X3係OH或C1)在該技術領 域中具有通常知識者所習知之條件下反應而製備,且該 些條件描述於數本教科書中,例如:J. March,Advanced ίο Organic Chemistry,Wiley,1992, pages 417-421。例示性 的條件包括以RtOCl (如式12)在一適當鹼(例如: 三乙胺)存在下於一適當溶劑(例如:THF或CH2C12) 中處理式11之胺基化合物,或藉由以RtC^H (如式 12)及活化劑(例如:(苯并三唑-1-基氧基)三(二曱胺 15 基)六氟磷化鱗(CAS # 56602-33-6,B0P試劑))在一 適當驗(例如:4-甲基嗎&gt;#)存在下於一適當溶劑(例 如:DMF)中處理式11之胺基化合物。該反應一般係 在0°C及環境溫度之間進行,雖然冷卻至-20°C或加熱 至低於80°C或該溶劑之沸點可利於反應。方案6之方 2〇 法(其中X3係C1)係藉由合成實例1之步驟D、合成5 As illustrated in Scheme 6, the compound of formula 10 is an amine compound of formula 11 (wherein Pg is as defined in Scheme 5) and an acid or derivative of formula 12 (wherein, for example, X3 is OH or C1) It is prepared in the art by reaction under the conditions conventional to those skilled in the art, and these conditions are described in several textbooks, for example: J. March, Advanced ίο Organic Chemistry, Wiley, 1992, pages 417-421. Illustrative conditions include treatment of an amine compound of formula 11 in the presence of RtOCl (e.g., formula 12) in the presence of a suitable base (e.g., triethylamine) in a suitable solvent (e.g., THF or CH2C12), or by RtC ^H (as in Formula 12) and an activator (for example: (benzotriazol-1-yloxy)tris(diamineamine 15yl)hexafluorophosphorus scale (CAS # 56602-33-6, B0P reagent) The amine compound of formula 11 is treated in the presence of a suitable assay (e.g., 4-methyl® &gt;#) in a suitable solvent (e.g., DMF). The reaction is generally carried out between 0 ° C and ambient temperature, although cooling to -20 ° C or heating to below 80 ° C or the boiling point of the solvent may be beneficial. The method of Scheme 6 2〇 method (where X3 is C1) is synthesized by the step D of Synthesis Example 1.

S 50 201204254 :. 實例4之步驟C、合成實例5之步驟B、合成實例6之 步驟B及合成實例8之步驟B而說明。 方案6S 50 201204254: Step B of Example 4, Step B of Synthesis Example 5, Step B of Synthesis Example 6, and Step B of Synthesis Example 8 are illustrated. Option 6

式10化合物(其中Pg係一氧化上穩定的保護基(例 如BOC ) ’ T係s(0)k ’且k係1或2)可自相對應的式 10化合物(其中k係一低整數)藉由以適當的氧化劑 10 15 (例如:2_氯過氧苯曱酸(MCPBA)或過氧單硫酸氫 鉀複合鹽(OXONE®))在一適當溶劑(例如:分別為 二氯甲烷或水醇混合物)中經氧化作用而製備。可 能的氧化程度係由相對的氧化劑量而決定。如碳酸氫鈉 的驗可包括於該反應混合物中。該氧化作用一般係在環 境溫度製備’雖然如_2(TC的低溫或如8〇。⑽高溫可利 於反應。 方案7之方法中,R2不為Η之式n化合物(其中 Pg係如方案5中所定義)係藉由將式Ua化合物(意即 $ 11 ’其中R2係H)與式13化合物(其中χ4係一適 田脫離基)一般利用驗在一適當溶劑中反應而製備。具 有脫離基χ4之式13化合物及適用於附著R2之反應條 20 201204254 件係衍生胺基之技術領域中所習知。一般的脫離基包括 鹵化物(例如:Cl、Br、I)及續酸鹽類(例如:曱續 酸鹽、三氟甲磺酸鹽)。當R2係一烷基時,碘基係特別 有用的。可利用多種驗,其視式13之選擇及該驗是否 用於將式11 a胺基去質子或僅作為自該反應之酸副產物 的吸附劑而定。強鹼(例如:氫化鈉)可用於去質子化, 而三級胺鹼類(例如:三乙胺)可用於作為反應中的酸 吸附劑,其中R2係一醯基。有用的溶劑包括極性非質 子溶劑,例如:THF及DMF。當R2係醯基且該鹼係三 級胺時,二氯甲烷特別有用。該反應一般係在環境溫度 進行’雖然冷卻至-20°C或加熱至低於120°C或溶劑之 彿點可利於反應。 方案7A compound of formula 10 wherein Pg is an oxidatively stable protecting group (e.g., BOC) 'T system s(0)k' and k is 1 or 2) can be from a corresponding compound of formula 10 (where k is a low integer) By using a suitable oxidizing agent 10 15 (for example: 2_chloroperoxybenzoic acid (MCPBA) or potassium peroxymonosulfate complex salt (OXONE®)) in a suitable solvent (for example: methylene chloride or water respectively) Prepared by oxidation in an alcohol mixture). The degree of possible oxidation is determined by the relative amount of oxidant. A test such as sodium bicarbonate can be included in the reaction mixture. The oxidation is generally prepared at ambient temperature 'although, such as _2 (TC low temperature or as high as 8 〇. (10) high temperature can be favorable for the reaction. In the method of Scheme 7, R2 is not a compound of formula n (wherein Pg is as in Scheme 5) (Defined as defined herein) by preparing a compound of formula Ua (ie, $11' wherein R2 is H) and a compound of formula 13 (wherein χ4 is an ex situ), generally prepared by reaction in a suitable solvent. Compounds of formula 13 based on formula 4 and reaction strips 20 suitable for attachment to R2 are known in the art of derivatizing amine groups. The general deionization groups include halides (e.g., Cl, Br, I) and the hydrochlorides. (e.g., a citrate salt, a triflate). When R2 is a monoalkyl group, the iodine group is particularly useful. A variety of tests can be utilized, and the choice of the mode of view 13 and whether the test is used for the formula 11 a amine deprotonated or only as an adsorbent from the acid by-product of the reaction. Strong bases (eg sodium hydride) can be used for deprotonation, while tertiary amine bases (eg triethylamine) are available As an acid adsorbent in the reaction, wherein R2 is a mercapto group. Useful solvent Including polar aprotic solvents such as THF and DMF. Methylene chloride is particularly useful when R2 is a mercapto group and the base is a tertiary amine. The reaction is generally carried out at ambient temperature 'although cooling to -20 ° C or heating To the point below 120 ° C or the solvent of the Buddha can be favorable for the reaction.

方案8說明式Ua胺基化合物(其中Pg係如方案5 中所定義)之製備’其係藉由將相對應的式14硝基化 合物還原而製得;當取代基r7、r8、r9及rig 一致時係 藉由觸媒氫化作用,或藉由溶解金屬還原。觸媒還原之 實例牽涉氫源(例如:分子氫(較佳為在常壓至35〇kpaScheme 8 illustrates the preparation of a compound of the formula Ua (wherein the Pg is as defined in Scheme 5), which is prepared by reduction of the corresponding nitro compound of formula 14; when the substituents r7, r8, r9 and rig Consistent by hydrogenation of the catalyst or by dissolution of the metal. Examples of catalyst reduction involve hydrogen sources (eg, molecular hydrogen (preferably at atmospheric pressure to 35 〇 kpa)

S 52 201204254 之壓力範圍,雖然可用更高的壓力)或1,4-環己二烯或 甲酸銨)之利用,及金屬催化劑(例如:鈀(較佳為支 托於碳或其它基質例如碳酸鈣)或鉑(選擇性地支托於 碳或氧化銘))以其元素形式或其氧化物形式之利用。 該反應一般係在乙醇、甲醇或乙酸乙酯中且在環境溫度 進行,雖然可提升溫度至高達該溶液之彿點。仔細的選 10 15 擇條件(意即低壓、短反應時間)對Pg係节基或二苯 甲基的情況而言是必須的。溶解金屬還原之實例包括在 醋酸中或在包含催化劑(例如:氣化銨)的含水乙醇中 使用細緻鐵粉(例如:粒子大小為10 μιη)。該反廊、係 在升高的溫度進行,較佳的範圍為自7(rc至該、、容 彿點。當其它可還原的官能性物質(例如:烯 族鹵化物)存在於該化合物中時,該些條件係ς = 方案8之該溶解金屬還原方法係藉由合成實例牛趣 C、合成實例4之步驟Β及合成實例6之步驟Β‘明驟 方案8S 52 201204254 pressure range, although higher pressures can be used or 1,4-cyclohexadiene or ammonium formate), and metal catalysts (eg palladium (preferably supported by carbon or other substrates such as carbonic acid) Calcium) or platinum (optionally supported by carbon or oxidized)) is utilized in its elemental form or in its oxide form. The reaction is typically carried out in ethanol, methanol or ethyl acetate at ambient temperature, although the temperature can be raised up to the point of the solution. Careful selection of conditions (meaning low pressure, short reaction time) is necessary for the case of Pg-based or diphenylmethyl groups. Examples of the dissolved metal reduction include the use of fine iron powder (e.g., a particle size of 10 μηη) in acetic acid or in aqueous ethanol containing a catalyst (e.g., ammonium sulfide). The anti-corridor is carried out at an elevated temperature, preferably in the range of from 7 (rc to 、, 容佛点. When other reducible functional substances (e.g., olefinic halides) are present in the compound When the conditions are ς = the dissolved metal reduction method of the scheme 8 is a step of synthesizing the example Niu C, the step of synthesizing the example 4, and the step of synthesizing the example 6

lla lla之胺基化合物(其 T不為NH)係藉由庫 或者,在方案9之方法中,式 中Pg係如方案5中所定義,且 53 20 201204254 爾提斯重排反應原位形成的醯基疊氮化合物而製備,例 如藉由以疊氮磷酸二苯酿處理式15的羧酸,或藉由將 式15的酸轉化成酸氣化物(例如:#由以草酿氣處理) 然後與疊氮化合物源(例如疊氮化納)在驗(例如三乙 胺)存在時反應而製備。在例如甲苯之溶劑中,該重排 反應較佳為在自阶至高達該溶液之沸點的升高的溫 度中進行。接著水解該混合物以釋放式lla之胺基化合 物。或者,該重排反應可在醇溶劑(例如以三級丁醇做 為溶劑)中進行,其提供受B0C保護形式的苯胺。接 著藉由以強酸(例如三氟乙酸或氣化氫)在醚溶劑中處 理而釋放式lla之胺基化合物。對此方案9方法的修飾 而吕,Pg —般係選自一耐酸基團例如苄基,以避免在 以強酸處理的過程中流失。該庫爾提斯重排反應概述於 J. March, Advanced Organic Chemistry, Wiley, 1992 pages 1091-1092 中;亦參見 〇rg. synth., Coll. Vol. 6: 910-913 。 方案9The amine compound of lla lla (whose T is not NH) is formed by a library or, in the method of Scheme 9, wherein the Pg system is as defined in Scheme 5, and the 53 20 201204254 Ertis rearrangement reaction is formed in situ. Prepared by a mercapto azide compound, for example, by treating a carboxylic acid of formula 15 with azide diphenyl phosphate or by converting an acid of formula 15 to an acid vapor (eg: #processed with grass brewing gas) It is then prepared by reaction with an azide source such as sodium azide in the presence of a test such as triethylamine. In a solvent such as toluene, the rearrangement reaction is preferably carried out in an elevated temperature from the order to the boiling point of the solution. The mixture is then hydrolyzed to release the amine compound of formula 11a. Alternatively, the rearrangement reaction can be carried out in an alcohol solvent (e.g., using tertiary butanol as a solvent) which provides the aniline in a protected form of BOC. The amine compound of formula 11a is then released by treatment with a strong acid such as trifluoroacetic acid or hydrogen sulfide in an ether solvent. Modifications to this Scheme 9 method, and Pg is generally selected from an acid-resistant group such as a benzyl group to avoid loss during treatment with a strong acid. The Kurtis rearrangement reaction is outlined in J. March, Advanced Organic Chemistry, Wiley, 1992 pages 1091-1092; see also 〇rg. synth., Coll. Vol. 6: 910-913. Option 9

·· (PhO)2(〇)N3 或者 (C0C1)2,接著4氣化合物源/鹼 2.水解作用或去保護作用· · (PhO) 2 (〇) N3 or (C0C1) 2, followed by 4 gas compound source / base 2. Hydrolysis or deprotection

lla 20 15 201204254 在方案10的方法中,其中T係0、S或NR36,一 種式14化合物係藉由將式16化合物(其中X5係一適 當的脫離基例如鹵化物)與式17之受保護吖祖醇(其 中Pg係如方案5所定義)在一適當鹼(例如:氫化鈉、 5 氫氧化鈉或碳酸鉀)存在下並在一適當溶劑(例如: DMF、乙腈、THF或甲苯)中反應而製備。當A1係CR7 時,X5較佳為F,且當A1係N時,係C1之X5 —般亦 很有效。該反應一般係在環境溫度進行,雖然冷卻至-20 °C或加熱至低於80°C或溶劑之沸點可利於反應。方案 ίο 10之方法係藉由合成實例1之步驟B、合成實例6之步 驟A及合成實例7之步驟B而說明。 方案10 PgLla 20 15 201204254 In the method of Scheme 10, wherein the T system is 0, S or NR36, a compound of formula 14 is protected by the compound of formula 16 wherein X5 is a suitable cleavage group such as a halide The proterenol (wherein Pg is as defined in Scheme 5) in the presence of a suitable base (eg sodium hydride, 5 sodium hydroxide or potassium carbonate) and in a suitable solvent (eg DMF, acetonitrile, THF or toluene) Prepared by reaction. When A1 is CR7, X5 is preferably F, and when A1 is N, X5 of C1 is also generally effective. The reaction is generally carried out at ambient temperature, although cooling to -20 ° C or heating to below 80 ° C or the boiling point of the solvent may be beneficial. The method of Scheme ί 10 is illustrated by the synthesis of Step B of Example 1, Step A of Synthesis Example 6, and Step B of Synthesis Example 7. Option 10 Pg

16 17 14 15 式14化合物(其中Pg係一氧化上安定的保護基(例 如BOC),T係3(0^且k係1或2)可自相對應的式 14化合物(其中k係一低整數)藉由以適當的氧化劑 氧化而製備。適當的氧化作用條件係與該些已經在方案 2〇 6下描述之用於從相對應的式10化合物(其中k係一 55 201204254 低整數)製備式10化合物(其中T係S(0)kX k係1 或2)的條件一樣。 在方案11之方法中(其中T係〇、s或NR36),式 19醋(其中Ra係低碳燒基,例如甲基、乙基、三級丁 基)係藉由將式18化合物(其中X5係一適當脫離基例 如鹵化物)與式1 7之受保護α丫。旦醇(其中Pg係如方案 5所定義)在驗及溶劑存在且在如用於方案10之方法 所描述的反應條件下反應而製備。當A1係CR7時,X5 較佳為F,且當A1係N時’係X5係ci者一般亦很有 效。然後,式19酯係藉由利用水性驗(例如:Na〇H) 皂化,接著,若為曱酯及乙酯則藉由酸化,或者為三級 丁酯則藉由以強酸(例如:三氟乙酸或對乙醇或二噁烷 中的氯化氫溶液)處理而轉化成式15羧酸。可加入共 溶劑例如二氣甲烷以提高溶解度。在水性皂化混合物 中,乙醇及二噁院做為共溶劑特別有用於提高式19酯 類的溶解度。式19酯至式15羧酸的轉化一般係在環境 溫度進行,然而冷卻至-20°C或加熱至低於⑺❶芄或該 溶劑的沸點可利於反應。許多其他條件亦會影響此轉 變,且多種除Ra低碳烧基羧酸之外的保護基可用於方 案11的方法中。有關的參考文獻可見τ w Greeneand P. G. Wuts, Protecting Groups in Organic Synthesis, Wiley, 1991,pages 229-263。 s 56 201204254 方案11 Pg16 17 14 15 a compound of formula 14 (wherein Pg is a oxidatively stable protecting group (eg BOC), T system 3 (0^ and k is 1 or 2) can be derived from the corresponding compound of formula 14 (where k is a low Integer) is prepared by oxidation with a suitable oxidizing agent. Suitable oxidation conditions are prepared as described in Scheme 2〇6 for the corresponding compound of formula 10 (where k is a 55 201204254 low integer) The compound of formula 10 (wherein the T system S(0)kX k is 1 or 2) has the same conditions. In the method of Scheme 11 (wherein T is 〇, s or NR36), the vinegar of formula 19 (wherein the Ra-based low-carbon alkyl group) , for example, methyl, ethyl, tert-butyl) by the compound of formula 18 (wherein X5 is suitably decoupled from a group such as a halide) and the protected alpha oxime of formula 17. (wherein Pg is as defined 5) is prepared by examining the presence of a solvent and reacting under the reaction conditions as described for the method of Scheme 10. When A1 is CR7, X5 is preferably F, and when A1 is N, 'X5 is The ci is also generally effective. Then, the ester of the formula 19 is saponified by using an aqueous test (for example, Na〇H), and then, if it is an oxime ester and a Then, by acidification, or as a tertiary butyl ester, it is converted into a carboxylic acid of the formula 15 by treatment with a strong acid (for example, trifluoroacetic acid or a solution of hydrogen chloride in ethanol or dioxane). A cosolvent such as two gases may be added. Methane to increase solubility. In aqueous saponification mixtures, ethanol and dioxins are used as cosolvents to increase the solubility of esters of formula 19. The conversion of esters of formula 19 to formula 15 is generally carried out at ambient temperature, however cooling Up to -20 ° C or heating to below (7) ❶芄 or the boiling point of the solvent may be beneficial to the reaction. Many other conditions may also affect this conversion, and a variety of protecting groups other than Ra low carbon carboxylic acid can be used in Scheme 11 In the method, the relevant references can be found in τ w Greeneand PG Wuts, Protecting Groups in Organic Synthesis, Wiley, 1991, pages 229-263. s 56 201204254 Scheme 11 Pg

15 Ra係低碳烷基(例如:甲基、乙基、三級丁基) 式15化合物(其中Pg係一氧化上穩定的保護基(例 如B〇C)’T係S(0)i^k係i或2,可自相對應的式 化合物(其中k係一低級整數)藉由以適當的氧化 劑氧化而製備。適t的氧化作用條件係與該些已經在方 案6描述之用於從相對應的式1〇化合物(其中k係一 低級整數)製備式10化合物(其中T係s(0)k且k係1 或2)的條件一樣。 b在方案10及11的方法中,一在鄰位的硝基或烷基15 Ra-based lower alkyl (for example: methyl, ethyl, tert-butyl) compound of formula 15 (wherein Pg is an oxidatively stable protecting group (eg B〇C) 'T-system S(0)i^ The k-system i or 2 can be prepared from the corresponding compound of the formula (wherein k is a lower-order integer) by oxidation with a suitable oxidizing agent. The oxidation conditions suitable for the t are as described in the scheme 6 The corresponding compound of the formula 1 (wherein k is a lower integer) is prepared under the same conditions as the compound of the formula 10 (wherein the T system is s(0)k and the k is 1 or 2). b In the methods of the schemes 10 and 11, one Nitro or alkyl in the ortho position

隨(C〇2Ra)取代基活化脫離基X5的置換。當A1係N 時如合成實例8的步驟A所述,可能不需要活化取代 基的存在。 如方案12中所述,其中T係〇、s或NR36,式22 化合物(其中E及G的組合有關式1、1〇、14、19及 25)亦藉由將式20羥基芳香族化合物與具有恰當脫離 基(X6)例如甲績酸鹽或溴化物的式21吖咀在適當驗 (例如ICCb、NaH或LiHMDS )存在下反應而製備。 201204254 該反應一般係在環境溫度進行,雖然冷卻至-20°C或加 熱至低於120°C或溶劑之沸點可利於反應。 方案12The substitution of the (X〇2Ra) substituent activates the cleavage group X5. When A1 is N, as described in Step A of Synthesis Example 8, the presence of an activating substituent may not be required. As described in Scheme 12, wherein the T system is 〇, s or NR36, the compound of formula 22 (wherein the combination of E and G is related to formulas 1, 1, 、, 14, 19 and 25) is also obtained by reacting a hydroxyaromatic compound of formula 20 with Formulations of the formula 21 having a suitable cleavage group (X6) such as a methyl ester or a bromide are prepared by reaction in the presence of a suitable assay (e.g., ICCb, NaH or LiHMDS). 201204254 The reaction is generally carried out at ambient temperature, although cooling to -20 ° C or heating to below 120 ° C or the boiling point of the solvent may be beneficial. Option 12

E係N02、C〇2Ra或NI^CWR1 ’ R&quot;係羧酸保護基,例如低碳烷基 G係如方案6所定義之保護基Pg或CRf-L-Re · 10 15 式20化合物可藉由許多種有機化學合成技術領域 中習知的方法製備。值得注意的是,藉由利用 Newman-Kwart重排作用自相對應的式20化合物(其中 T係0)製備式20化合物(其中T係S)(見Dirk Kusch,E system N02, C〇2Ra or NI^CWR1 'R&quot; is a carboxylic acid protecting group, for example, a lower alkyl group G is a protecting group Pg or CRf-L-Re 10 15 as defined in Scheme 6. It is prepared by a variety of methods known in the art of organic chemical synthesis. It is worth noting that the compound of formula 20 (where T is S) is prepared from the corresponding compound of formula 20 (where T is 0) by Newman-Kwart rearrangement (see Dirk Kusch,

Specialty Chemicals Magazine 2003, 23(9),41 )。 如方案13中所示,式22a化合物(即式22,其中 T係Ο )亦係自式20a中間物(即式20,其中T係Ο ) 及式23 (即式17或26,其中T係〇)在如所述之 Mitsunobu條件下而製備,例如,在Bioorg. Med. Chem. Lett. 2008, 18, 5581-5585中。™F係特別有用的溶劑, 且該反應一般係在-20°C及環境溫度之間進行,雖然加 熱至60°C可利於反應。方案13的方法係藉由合成實例 4之步驟A說明。 s 58 201204254 方案13Specialty Chemicals Magazine 2003, 23(9), 41). As shown in Scheme 13, the compound of formula 22a (ie, formula 22, wherein T is Ο) is also from the intermediate of formula 20a (ie, formula 20, wherein T is Ο) and formula 23 (ie, formula 17 or 26, wherein the T is 〇) Prepared under the Mitsunobu conditions as described, for example, in Bioorg. Med. Chem. Lett. 2008, 18, 5581-5585. TMF is a particularly useful solvent, and the reaction is generally carried out between -20 ° C and ambient temperature, although heating to 60 ° C may be beneficial. The method of Scheme 13 is illustrated by the step A of Synthesis Example 4. s 58 201204254 Scheme 13

GG

20a 23 G Rb0C(O)N=NC(O)ORb PPh3 -- 溶劑20a 23 G Rb0C(O)N=NC(O)ORb PPh3 -- Solvent

22a E係N〇2、Cc^Ra或NR2C(W)Ri,炉係羧酸保護基’例如低碳烷基。 G係如方案6所定義之保護基?8或〇^七把。 驴較佳為Et或i-Pr · 如方案14中所說明,式1化合物或者藉由以適當 的式12酸衍生物(其中X3係例如〇H或α )由相似於 上述方案6之化學醯化式24苯胺而製備。提供方案6 方法的揭露文件提供方案14之方法。方案14之方法係 藉由合成實例2之步驟D說明。 10 方案1422a E is N〇2, Cc^Ra or NR2C(W)Ri, a furnace carboxylic acid protecting group such as a lower alkyl group. G is a protecting group as defined in Scheme 6, 8 or 〇^. Preferably, 驴 or i-Pr · as illustrated in Scheme 14, a compound of formula 1 or by an acid derivative of the formula 12 wherein X3 is, for example, 〇H or α, is similar to that of Scheme 6 above. Prepared by formula 24 aniline. The disclosure document providing the method of Scheme 6 provides the method of Scheme 14. The method of Scheme 14 is illustrated by the step D of Synthesis Example 2. 10 Scheme 14

方案15之方法中,式24化合物(其中R2不為η) 係藉由將式24a化合物(意即式24,其中R2係Η)與 式13化合物(其中X4係一適當脫離基)反應而製備, 59 15 201204254 一般利用在恰當溶劑中的鹼,相似於上述方案7之方 法。提供方案7方法的揭露文件提供方案15之方法。 方案15In the method of Scheme 15, the compound of formula 24 (wherein R 2 is not η) is prepared by reacting a compound of formula 24a (ie, formula 24, wherein R 2 is a hydrazone) with a compound of formula 13 wherein X 4 is a suitably delocalized group. , 59 15 201204254 Generally using a base in a suitable solvent, similar to the method of Scheme 7 above. The disclosure document providing the method of Scheme 7 provides the method of Scheme 15. Option 15

案16的方法中,式⑽胺基化合物係藉由還 8之古、;Γ的ί 25硝基化合物而製備,相似於上述方案 方沐。*祕方案8方法的揭露文件提供方案16之 L係16的方法中,溶解金屬還原作用當 作用右關)·時較佳為過氫化。與溶解金屬還原 明。 ’、16方法係藉由合成實例2之步驟D說 方案16In the method of item 16, the amine compound of the formula (10) is prepared by the glutamic acid compound of the ruthenium, which is similar to the above scheme. * The disclosure of the method of the method of claim 8 provides the L system 16 of the method of claim 16, wherein the dissolution of the dissolved metal is preferably a hydrogenation when it is applied to the right. Reducing with dissolved metals. ', 16 methods are described by the step D of the synthesis example 2

S 201204254 在方案17的方法中(其中τ係〇、s或^^36), 25硝基化合物係藉由將式16化合物(其中χ5係—適^ 的脫離基,例如*化物)以式26 α丫轉在適當驗及二 劑存在下反應而製備,相似於上述方案1〇之方法。= 供方案10方法的揭露文件包括方案17之方法。然而, 方案Π之方法巾’在高達12G。⑶溫度或該溶劑的沸 點進行該反應可能係有利的。方案17之方法係藉由合 成實例2之步驟B說明。 α 方案17S 201204254 In the method of Scheme 17, wherein the τ system is 〇, s or ^^36, the 25 nitro compound is obtained by the compound of the formula 16 (wherein the χ5 system is suitable for the cleavage group, for example, the * compound) The α-oxime is prepared by reacting in the presence of a suitable two-agent, similar to the method of the above scheme. = The disclosure document for the method of Scheme 10 includes the method of Scheme 17. However, the method of the method is as high as 12G. (3) The temperature or the boiling point of the solvent may be advantageous for carrying out the reaction. The method of Scheme 17 is illustrated by the step B of Synthesis Example 2. α Scheme 17

式16、18及20芳香族化合物可藉由許多種有機化 學合成領域中習知之方法製備。式26化合物亦可藉由 多種方法製備。下列方案18之方法特別有用於製備式 26化合物’其中γ係〇,且s及t各係1。 如方案18中所示’式26a吖咀醇(即式26,其中 Y係Ο,且s及t:各係1 )可藉由將式28胺與式27表 i代醇(其中X6係,且最一般為α)或其 衍生物反應,選擇性地存在有添加劑(例如三乙胺或溴 61 201204254 化鎂),根據已公開之步驟(例如J. Het. Chem. 1971,8, 1059-1062; J. Org. Chem. 1967, 32, 2972-2976; Tetrahedron Lett. 1997,6059-6062)製備。方案 18 之方 法係藉由合成實例2之步驟A說明《式28胺可藉由領 域中習知之方法製成;例如:桂皮胺可根據J_ Org. Chem. 1982, 47, 5395-5397中所述之一般方法製備。 方案18The aromatic compounds of the formulae 16, 18 and 20 can be prepared by a variety of methods known in the art of organic chemical synthesis. Compounds of formula 26 can also be prepared by a variety of methods. The method of the following Scheme 18 is particularly useful for the preparation of the compound of the formula 26 wherein γ is 〇, and s and t are each 1. As shown in Scheme 18, 'Formula 26a oxime (i.e., Formula 26, wherein Y is Ο, and s and t: each 1) can be obtained by substituting an amine of formula 28 with an alcohol of formula 27 (wherein X6, And most typically alpha) or a derivative thereof, optionally in the presence of an additive (e.g., triethylamine or bromine 61 201204254 magnesium), according to the disclosed procedures (e.g., J. Het. Chem. 1971, 8, 1059- 1062; J. Org. Chem. 1967, 32, 2972-2976; Tetrahedron Lett. 1997, 6059-6062). The method of Scheme 18 is illustrated by the synthesis of Example 2, Step A. The amine of Formula 28 can be prepared by methods well known in the art; for example, cinnamamine can be as described in J_ Org. Chem. 1982, 47, 5395-5397. The general method of preparation. Option 18

用於製備經羥基及胺基取代的受保護式17 旦、 吼咯啶及哌啶(其中Τ係Ο或NR36)之方法係有機化 學合成領域中所習知的’且多種該些化合物可於商業上 購得。 方案19說明一種方法,其相似於方案18之方法, 用於製備經羥基取代的受保護式17a (即式17,其中τ 係0)吖。旦(即受保護吖°旦醇),其中Pg例如係二苯甲 基或苄基。在此方法中’ 一受保護之式17a 〇丫哩醇係藉 由將受保護之式29胺與式27之表鹵代醇利用該些相似 於方案18所述之流程反應而製備。再者,利用領域中 習知之一般方法(例如’ T. W. Green及p g別办Processes for the preparation of protected 17-denier, pyrrolidine and piperidine (wherein lanthanum or NR36) substituted with hydroxy and amine groups are customary in the field of organic chemical synthesis and a plurality of such compounds are Commercially available. Scheme 19 illustrates a method similar to that of Scheme 18 for the preparation of a hydroxy substituted protected formula 17a (i.e., Formula 17, wherein τ is 0) oxime. Once (i.e., protected 吖), wherein Pg is, for example, a diphenylmethyl or benzyl group. In this process, a protected formula 17a sterol is prepared by reacting a protected amine of formula 29 with an epihalohydrin of formula 27 using such procedures as described in Scheme 18. Furthermore, use the general methods known in the field (eg ' T. W. Green and p g do not do

Protecting Groups in Organic Synthesis,Wiley,1991 第 327-329及364-365頁)’該保護基可自該式na 〇丫〇旦醇Protecting Groups in Organic Synthesis, Wiley, 1991, pp. 327-329 and 364-365) The protective group can be derived from the formula na

S 201204254 (其中Pg例如係二苯甲基或苄基)移除,且接著可接 . 附另一保護基以形成一受保護式17a。丫哩醇(其中pg 例如係BOC)。該式17a化合物(其中Pg係B〇c且n 係〇)可自商業上購得。 方案19S 201204254 (wherein Pg is, for example, a diphenylmethyl or benzyl group) is removed and then attached. Another protecting group is attached to form a protected form 17a. Sterol (where pg is for example BOC). The compound of the formula 17a wherein Pg is B〇c and n is 〇 is commercially available. Option 19

3如方案20中所示,式26b吖呕醇(即式26,其中 1〇 R3未接附至吖咀環之3-位)(其中η,係一自0至4的整 數)亦可藉由以還原劑(例如:在曱醇或乙醇中的硼氮 化鈉)將式30十且酮利用與美國專利第36681%號中 所述相似的流程還原而製備。 方案203, as shown in Scheme 20, formula 26b oxime (ie, formula 26, wherein 1 〇 R3 is not attached to the 3-position of the oxime ring) (where η is an integer from 0 to 4) The ketone of the formula 30 is prepared by reduction with a reducing agent (for example, sodium borohydride in decyl alcohol or ethanol) using a procedure similar to that described in U.S. Patent No. 36,681%. Option 20

15 =時’如方案21中所示,受保護之式17b吖哩醇 f17/中T係〇’且R3未接附至°丫°旦環之3-位) 、η係一自0至4的整數,且Pg係-方案5中所 63 20 201204254 界定的保護基)可藉由以還原劑將式31吖η旦酮還原而 製備,類似於方案20之方法。 方案2115 = hour 'as shown in Scheme 21, protected formula 17b sterol f17 / medium T system 〇 ' and R3 is not attached to the ° 丫 ° ring 3 position), η system from 0 to 4 An integer of the formula, and the protecting group defined by 63 20 201204254 in Pg-Scheme 5 can be prepared by reducing the hydrazine of the formula 31 with a reducing agent, similar to the method of Scheme 20. Option 21

在方案22的方法中,式26c吖咀醇(即式26,其 中R3 (如R3a)係接附至吖哩環之3-位)(其中η’係一 自0至4的整數,且R3a係烷基)係藉由將式32有機 ίο 金屬試劑(例如,有機裡或格任亞試劑)加入至在驗溶 劑(例如:二乙基醚或THF)中的式30吖咀酮而製備, 上述係在環境溫度或較佳為冷卻至如-78°C之低溫,並 利用領域中習知之流程(例如:Tetrahedron Lett. 1972, 5063-5064 ;美國專利第 3668196 號)。 15 方案22In the method of Scheme 22, the formula 26c is a thiol alcohol (i.e., Formula 26, wherein R3 (e.g., R3a) is attached to the 3-position of the anthracene ring) (where η' is an integer from 0 to 4, and R3a The alkyl group is prepared by adding an organic reagent of the formula 32 (for example, an organic or genomic reagent) to the formula 30 oxime in a test solvent (for example, diethyl ether or THF). The above is at ambient temperature or preferably cooled to a low temperature such as -78 ° C, and utilizes the well-known procedures in the art (for example: Tetrahedron Lett. 1972, 5063-5064; U.S. Patent No. 3,668,196). 15 Scheme 22

M2例如係Li、MgCl、MgBr。 相似的,如方案23中所示,受保護之式17c吖咀 2〇 醇(即式17,其中T係0,且R3 (如R3a)係接附至吖M2 is, for example, Li, MgCl, or MgBr. Similarly, as shown in Scheme 23, the protected formula 17c is a 2-mer alcohol (i.e., Formula 17, wherein T is 0, and R3 (e.g., R3a) is attached to 吖

S 64 201204254 咀%之3·位)(其中n,係一自〇至4的整數,Rh係烷基, 且Pg係一方案5中所界定的保護基)係藉由將式32有 機金屬化合物加入至在醚溶劑中的受保護式31吖咀酮 而製備,類似於方案22之方法。 方案23S 64 201204254 5% of the mouth) (where n is an integer from 〇 to 4, Rh is an alkyl group, and Pg is a protecting group as defined in Scheme 5) by using an organometallic compound of formula 32 Prepared by addition to the protected formula 31 in the ether solvent, analogous to the method of Scheme 22. Option 23

1^係烷基; OH J7c Μ2例如係Li、MgCl、MgBr。 式30及31吖咀酮可藉由領域中習知的一般方法製 備。例如,如方案24中所示,經成對雙取代的式3〇a 吖咀酮(即式30,其中吖咀環之2_位係以兩個R3所取 代)可藉由以鹼(例如:碳酸氫鈉)在一溶劑(例如·· DMF或含水甲醇)中處理相對應的式33之丨-溴_2_丁酮 而製備,其係利用相似於美國專利第3668196號中所描 述之流程。 方案241^ is an alkyl group; OH J7c Μ2 is, for example, Li, MgCl, MgBr. Formulas 30 and 31 can be prepared by conventional methods well known in the art. For example, as shown in Scheme 24, a pair of disubstituted formula 3〇a oxime ketones (i.e., Formula 30 in which the 2 _ position of the oxime ring is substituted with two R 3 ) can be used as a base (eg, : Sodium bicarbonate) is prepared by treating a corresponding oxime-bromo-2-butanone of the formula 33 in a solvent (for example, DMF or aqueous methanol), which is similar to that described in U.S. Patent No. 3,668,196. Process. Option 24

驗 溶劑Solvent

护及俨係獨立為烷基。 65 201204254 5 相似地,如方案25中所示’受保護經成對雙取代 的式31a吖咀酮(即式31,其中吖旦環之2-位係以兩 個R3所取代)(其中Pg係一適當的保護基,例如:二 苯曱基或苄基)可藉由利用相似於方案24之方法中所 述之反應條件處理相對應的式34之1-溴-2·丁酮而製 備0 方案25The care and tether are independently alkyl. 65 201204254 5 Similarly, as shown in Scheme 25, a protected pair of disubstituted formula 31a oxime ketones (ie, formula 31 wherein the 2-position of the oxime ring is replaced by two R3) (where Pg Preparing a suitable protecting group, for example, a diphenyl fluorenyl or benzyl group, can be prepared by treating a corresponding 1-bromo-2-butanone of formula 34 using a reaction condition similar to that described in the method of Scheme 24. 0 Scheme 25

尺31&gt;及俨係獨立為烷基。 10 如方案26中所示,式nd硫醇化合物(即式17, ' 糸S)可藉由以硫醇親核劑Na〗S處理相對庳的 15 题田鹼(例如:NaH)存在睥可心 / 中!㈣-適當保護基,例如gSH(其 硫醇親核劑,— 土( Bn))形式之適當Ruler 31&gt; and the oxime are independently alkyl groups. 10 As shown in Scheme 26, the formula nd thiol compound (i.e., formula 17, '糸S) can be treated by the thiol nucleophile Na s S relative to the presence of ruthenium (e.g., NaH). Heart / in! (iv) - Appropriate protecting groups, such as gSH (the thiol nucleophile, - soil (Bn)) form appropriate

對於此與硫醇覩例如液氨中的鈉去保護。DMF 加熱(例如=有關的置換反應係良溶劑,且緩和 王80 C )利於反應。For this, deprotection with sodium in thiol hydrazines such as liquid ammonia. DMF heating (for example = the relevant displacement reaction is a good solvent and mildening of King 80 C) facilitates the reaction.

S 66 201204254 方案26S 66 201204254 Scheme 26

21twenty one

Na2S/DMF 或者Na2S/DMF or

1. BnSH, NaH/DMF 2. Na/液體NH;i 5 式21化合物可藉由多種有機化學合成技術領域中 習知之方法製備,包括自相對應的式17化合物(其中 T係0)製備。具有本文件中各數值之s及t的式21化 合物(其中Pg係BOC,η係0,且X6係I或OMs )可 自商業上購得。某些其他式21化合物(其中Pg係其他 ίο 保護基,例如三氟乙醯基、羧苄基(CBz)或二苯甲基) 亦可自商業上購得。 如方案27中所示,式lc化合物(即式1,其中W 係S)可藉由硫化相對應的式Id化合物(即式1,其中 W係0)而製備。硫化作用牵涉以硫化劑處理,例如: 15 五硫化二磷或2,4-雙(4-曱氧苯基)-1,3,2,4-二硫二磷、 2,4-二硫化物(勞森試劑(Lawesson’s Reagent)),或 2,4-雙(4-苯氧基苯基)-1,3,2,4-二硫二磷、2,4-二硫化物(貝 盧試劑(Belleau’s Reagent))。該反應較佳為在如甲苯、 二曱苯或二噁烷的溶劑中,並在自80°C至該溶劑沸點 20 的升高的溫度中進行。 67 201204254 方案271. BnSH, NaH/DMF 2. Na/Liquid NH; i 5 The compound of formula 21 can be prepared by a variety of methods known in the art of organic chemical synthesis, including the preparation of a corresponding compound of formula 17 wherein T is 0. A compound of the formula 21 having a s and t of each value in the present document (wherein Pg is BOC, η is 0, and X6 is I or OMs) is commercially available. Certain other compounds of formula 21 wherein Pg is a further protecting group, such as trifluoroethyl, carboxybenzyl (CBz) or diphenylmethyl, are also commercially available. As shown in Scheme 27, a compound of formula lc (i.e., Formula 1, wherein W is S) can be prepared by vulcanizing a corresponding compound of formula Id (i.e., Formula 1, wherein W is 0). Vulcanization involves treatment with a vulcanizing agent, for example: 15 phosphorus pentasulfide or 2,4-bis(4-indolylphenyl)-1,3,2,4-dithiophos, 2,4-disulfide (lawson Lawesson's Reagent), or 2,4-bis(4-phenoxyphenyl)-1,3,2,4-dithiophosphorus, 2,4-disulfide (Belleau's Reagent) )). The reaction is preferably carried out in a solvent such as toluene, dinonylbenzene or dioxane, and at an elevated temperature from 80 ° C to the boiling point of the solvent of 20. 67 201204254 Scheme 27

5 應認可,上述用於製備式1化合物的一些試劑及反 應條件’可此無法與某些存在於中間物中的官能性相 容。在這些實例中,併入保護/去保護次序或官能基相 互轉換至該合成中’將有助於獲得所欲產物。保護基的 使用和選擇對熟習化學合成之技藝人士而言是顯而易 10 知的(例如,可參照 T. W. Greene, P. G. M. Wuts;5 It should be recognized that some of the reagents and reaction conditions described above for the preparation of the compound of Formula 1 may not be compatible with certain functionalities present in the intermediate. In these examples, incorporation of a protection/deprotection sequence or mutual conversion of functional groups into the synthesis will help to obtain the desired product. The use and selection of protecting groups is readily apparent to those skilled in the art of chemical synthesis (for example, see T. W. Greene, P. G. M. Wuts;

Protective Groups in Organic Synthesis, 2nd ed.; Wiley: New York,1991)。技術領域中具有通常知識者將認可, 在一些狀況中’在引入個別方案中所述之試劑之後,可 能需要未詳述的額外例行合成步驟以完成式1化合物 15 的合成。技術領域中具有通常知識者亦將認可,需要以 不同於本文中呈現之順序組合執行上述方案中說明的 步驟以製備式1化合物。 熟習該領域之技藝人士也將能認可,本文中所述的 式1化合物及中間物可以接受各種親電子反應、親核反 ⑴ 應、自由基反應、有機金屬反應、氧化反應及還原反應Protective Groups in Organic Synthesis, 2nd ed.; Wiley: New York, 1991). Those of ordinary skill in the art will recognize that, in some cases, after introduction of the reagents described in the individual schemes, additional routine synthetic steps not detailed may be required to complete the synthesis of Compound 15 of Formula 1. It will also be recognized by those of ordinary skill in the art that the steps described in the above schemes need to be performed in a combination other than that presented herein to produce a compound of formula 1. Those skilled in the art will also recognize that the compounds and intermediates of Formula 1 described herein can accept various electrophilic reactions, nucleophilic reactions (1), free radical reactions, organometallic reactions, oxidation reactions, and reduction reactions.

S 68 201204254 、+力取代基或修飾存在的取代基。例如,合成實例5 .的步『A說明中間物的,化作用。 P使沒有進一步的闡述,相信使用上述說明的本領 域具有通常知識者仍能夠最大程度地利用本發明。因 5 此,下面的合成實例應理解為僅僅是說明性的,且不以 2方式作為對本文揭露内容的限制。下列合成實例中 、Y驟’說明在整個合成變化中每一步驟的製程,且每 2步驟的起始原料不—定非得由在其他實例或步驟中 1。 4述的特別製備方案之製程來製備。百分率為按重量 °除了層析溶劑混合物或另有指明者。除非特別指 女,、則層f溶航合物係體積份及體積百分比。除非另 說明’ HNMR光譜記述為ppm,並以CDC13之四τ 土「石夕院往低磁場位移;「s」代表單峰,「d」代表雙峰, dd」代表雙雙峰,「dt」代表雙三♦,「m」代表多,「br 表寬單峰’「brd」代表寬雙峰,及「d之AB對」 對雙峰,其中化學位移差異不大於耦合常數。質 = MS)描述藉由增加H+ (分子量為n至該分子而 ^的最㈣位素豐度正電親體離子(M+1)之分子量 2〇 S. ^ 失去Η (刀子望:為1)而形成的最高同位素豐度 施電離子(M-ι) ’其係藉由質譜測定法利用電喷灑游 法(ESI)而觀察,其中「挪以」代表原子質量單位。 合成實例1 — 土»比啶基H-吡啶羧醯胺(化合物1)的S 68 201204254 , + Force substituent or modification of the substituent present. For example, the step "A of the synthesis example 5" illustrates the chemistry of the intermediate. Without further elaboration, it is believed that those of ordinary skill in the art using the foregoing description will still be able to utilize the invention. The following synthesis examples are to be construed as illustrative only and not as a limitation of the disclosure herein. In the following synthesis examples, the Y step 'describes the process of each step in the entire synthesis change, and the starting materials per 2 steps are not determined to be in other examples or steps. Prepared by the process of the special preparation scheme described in 4. The percentages are by weight in addition to the chromatographic solvent mixture or otherwise indicated. Unless otherwise specified, the layer f is a volume fraction and a volume percent. Unless otherwise stated, 'H NMR spectrum is described as ppm, and the tetragonite of CDC13 is "Shi Xiyuan to low magnetic field displacement; "s" represents a single peak, "d" represents a double peak, dd" represents a doublet, and "dt" represents a double peak. Double three ♦, "m" stands for more, "br table width single peak" "brd" stands for wide double peak, and "b pair of d" pairs of double peaks, where the chemical shift difference is not greater than the coupling constant. Mass = MS) Describes the molecular weight of the positive electrophilic ion (M+1) by increasing the H+ (molecular weight n to the molecule) and the abundance of the positive electrophilic ion (M+1). 2 〇S. ^ Loss Η (Knife look: 1) The highest isotope abundance of the applied ion (M-ι) is formed by mass spectrometry using an electrospray ionization (ESI) method, where "Nove" represents the atomic mass unit. Synthesis Example 1 - Soil »pyridyl H-pyridine carboxamide (Compound 1)

69 25 201204254 步驟A : 2-氣-3-硝基-6_(三氟甲基)础咬的製備 、在濃硫酸(?5mL)及過氧化氫水溶液(40%,37mL) 的混一合^中於〇°C逐滴加入在硫酸(93 mL)中的2·氣 冬(三說f基)-3-胺基B比咬(7〇〇g,35 6 _〇1)溶液、。 10 15 20 然後將錢m物於錢溫度麟2Q小時。批分 析(20: EtOAc /石油醚)顯示反應完成。將混合物倒 入冰水中並藉由加入漢氨水中和至PH 8至9,接著以 乙酸乙S旨(3χ)萃取。乾燥(Na2S〇4)該合併的有機層 f濃縮以得到呈黃色固體(3.72g)的標題產物。 HNMR5 8_4(d,lH),7.8(d,lH)。 步驟B · 3_[[3-硝基_6_(三氟甲基)2_吼咬基]氧基]小 σ丫0旦繞酸1,1_二甲基乙基酯的製備 對Ν,Ν_二曱基甲醯胺(35mL)中的3-羥基-1-吖咀 叛酸1,1-二甲基乙基酯(2.61 g,15.1 mmol)溶液,在 f中加入碳酸鉀(4 g,28_9 mm〇1)及2_氣_3-硝基_6_(三 氟曱基)吡啶(即步驟A的產物K 3 27 g,14 4 mm〇1)。 接著在環境溫度授拌該混合物5小時。過慮該反應混合 物,並將濾液倒至冰水中並以乙酸乙酯萃取。將該有機 ,以鹽水洗滌並乾燥(Na2S〇4)。將溶劑蒸發,並藉由 管柱層析術(60至12〇篩目的矽膠,2〇%在石油醚中的 乙酸乙酯)純化殘餘物以得到呈灰白色固體、在96-98 C炼化的標題產物(id g)。 4 NMR δ 8.43 (d,1H), 7.5 (d,1H),5·5 (m,1H),4.4 (m, 2H), 4.1 (m, 2H), 1.5 (s, 9H) 〇 MS $SI) 364 amu (M+1)。 25 201204254 步驟C . 3-[[3-胺基-6-(三氟甲基)-2-0比咬基]氧基]-1· 吖咀羧酸1,1-二曱基乙基酯的製備 對乙醇(20 mL)及水(2 mL)混合物中的3-[[3-硝基-6-(三氟曱基)-2-吡啶基]氧基]-1-吖哩羧酸ι,ι_二 曱基乙基醋(即步驟B的產物)(1.5 g,4.1 mmol)溶 液,在其中加入鐵粉(300篩目(約50 μηι),692 mg, 12.3 mmol)及氯化銨(lio mg,2.1 mmol)並將該混合 物回流加熱4小時。將該反應混合物冷卻、經celite® 矽藻土助濾劑過濾並濃縮。將殘餘物以二氣甲烷稀釋並 以水洗滌。將該有機相乾燥(Na2S04)並濃縮以得到呈 白色固體(1.2 g)、在132-134。(:熔化的標題產物。 ^NMR δ 7.18 (d3 1 Η), 6.9 (d, 1Η), 5.4 (m, 1H)5 4.38 (m, 2 H),4.1 (br s, 2 H),3.97 (m,2H), 1.45 (s, 9H)。 MS (ESI) 334 amu (M+l)。 步驟D : 3-[[3-[[(2_氯-4-«比啶基)羰基]胺基]-6-(三氟 甲基)-2-吡啶基]氧基]-i_吖哩羧酸ι,ι·二甲 基乙基酯的製備 對二氯甲烷(15 mL)中的2-氣-4-吡啶羰基氯化物 (640mg ’ 3.63 mmol)溶液,於 〇。(:在其中加入 3-[[3- 胺基·6-(三氟曱基)-2-°比咬基]氧基]小吖哩幾酸1,1-二 甲基乙基醋(即步驟C的產物)(1·1 g,3·3 mmol)及 三乙胺(1.1 mL,8.25 mmol)且將該反應混合物在環 境溫度攪拌3小時。然後將該反應混合物以二氣甲烷稀 釋、以水洗滌並乾燥(Na2S04)。將溶劑蒸發,並藉由 201204254 管柱層析術純化殘餘物以得到呈灰白色固體(95〇 . · mg)、在85-87°C熔化的標題產物。 · NMR δ 8.85 (d, 1H), 8.65 (d, 1H), 8.38 (s5 1H), 7.79 (s, · 1H),7.62 (d,1H),7.41 (d,1H),5.5 (m,1H), 4.43 (m,2H), 5 1.43 (s,9H)。 ’ ’ MS (ESI) 471 amu (M-l)。 步驟E : N-[2-(3- °丫 α旦氧基)_6_(三氟甲基)_3· 0比啶 基]-2-氯-4-吡啶羧醯胺的製備 1〇 對曱醇(145 mL)中的3-[[3-[[(2·氣-4-吡啶基)羰基] 胺基]-6-(三氟甲基)-2-°比咬基]氧基]_i&lt;D旦叛酸丄卜二 甲基乙基酯(即步驟D的產物)(50〇 mg,35.0 mmol) 溶液’於0°C在其中逐滴加入乙醯氯(5 mL)。將該反 應混合物在0C攪拌超過2小時,加熱至環境溫度,並 15 接者額外授摔4小時。將该反應混合物在減壓下濃縮, 溶解在二氯曱烧中’以10%碳酸氫納水溶液洗務並乾燥 (Na2S〇4)。將濃縮後的殘餘物以乙喊研磨,以得到呈 黃色固體(275 mg)的標題化合物。 !H NMR (DMSO-d6) δ 8.63 (d5 1H), 8.42 (d, 1H)S 7.98 (s, 20 1H),7.83 (d, 1H), 7.59 (d,1H),5.4 (m, 1H),3.78 (m,2H), 3.6 (m5 2H), (N-H共振在3.36與寬水峰合併)。 MS (ESI) 373 amu (M+l)。 步驟 F : 2-氯-N_[2-[[H(2E)-3-(4-氣苯基)-2-丙烯-1- 25 基]-3_吖丁啶基]氧基]-6_(三氟曱基)_3-吡啶 基]_4_吡啶羧醯胺的製備69 25 201204254 Step A: Preparation of 2-gas-3-nitro-6_(trifluoromethyl) base bite, mixed in concentrated sulfuric acid (?5mL) and aqueous hydrogen peroxide solution (40%, 37mL)^ A solution of 2·glyconsin (tris-f-)-3-amino-based B in a sulfuric acid (93 mL) was added dropwise at 〇 °C to a bite (7 〇〇g, 35 6 〇 1) solution. 10 15 20 Then put the money in the money temperature for 2Q hours. Batch analysis (20: EtOAc / petroleum ether) showed the reaction was completed. The mixture was poured into ice water and neutralized to pH 8 to 9 by addition of aqueous ammonia, followed by extraction with ethyl acetate (3 χ). The combined organic layer f was dried (Na2EtOAc) elute HNMR 5 8_4 (d, lH), 7.8 (d, lH). Step B · Preparation of 3_[[3-nitro-6-(trifluoromethyl) 2 吼 基 methoxy] oxy] small σ 丫 0 tarar acid 1,1 dimethyl ethyl ester Ν, Ν a solution of 3-hydroxy-1-indole acid 1,1-dimethylethyl ester (2.61 g, 15.1 mmol) in dimercaptocaramine (35 mL) with potassium carbonate (4 g) , 28_9 mm〇1) and 2_gas_3-nitro-6-(trifluoromethyl)pyridine (ie product of step A, K 3 27 g, 14 4 mm 〇 1). The mixture was then stirred at ambient temperature for 5 hours. The reaction mixture was taken care of, and the filtrate was poured into ice water and extracted with ethyl acetate. The organic layer was washed with brine and dried (Na.sub.2). The solvent was evaporated and the residue was purified by column chromatography (EtOAc EtOAc EtOAc EtOAc EtOAc Title product (id g). 4 NMR δ 8.43 (d,1H), 7.5 (d,1H),5·5 (m,1H),4.4 (m, 2H), 4.1 (m, 2H), 1.5 (s, 9H) 〇MS $SI ) 364 amu (M+1). 25 201204254 Step C. 3-[[3-Amino-6-(trifluoromethyl)-2-0 butyl]oxy]-1· 1,1-didecylethyl carboxylic acid Preparation of 3-[[3-nitro-6-(trifluoromethyl)-2-pyridyl]oxy]-1-indolecarboxylic acid in a mixture of ethanol (20 mL) and water (2 mL) Ip,ι_dimercaptoethyl vinegar (ie the product of Step B) (1.5 g, 4.1 mmol) solution, to which iron powder (300 mesh (about 50 μηι), 692 mg, 12.3 mmol) and chlorinated Ammonium (lio mg, 2.1 mmol) and the mixture was heated under reflux for 4 hours. The reaction mixture was cooled, filtered through celite® celite filter and concentrated. The residue was diluted with di-methane and washed with water. The organic phase was dried (Na.sub.2SO.sub.4) and concentrated to afford a white solid (1.2 g). (: melted title product. ^NMR δ 7.18 (d3 1 Η), 6.9 (d, 1 Η), 5.4 (m, 1H)5 4.38 (m, 2 H), 4.1 (br s, 2 H), 3.97 ( m, 2H), 1.45 (s, 9H) MS (ESI) 334 amu (M+l). Step D: 3-[[3-[[(2-chloro-4-)-pyridyl)carbonyl]amine Preparation of yl,-6-(trifluoromethyl)-2-pyridyl]oxy]-i-indolecarboxylic acid ι,ι·dimethylethyl ester in dichloromethane (15 mL) - a solution of 4-pyridylcarbonyl chloride (640 mg ' 3.63 mmol) in hydrazine. (:3-[3-amino-6-(trifluoromethyl)-2-° ratio bite base added thereto] Oxyl] succinic acid 1,1-dimethylethyl vinegar (ie the product of step C) (1.1 g, 3.3 mmol) and triethylamine (1.1 mL, 8.25 mmol) and The reaction mixture was stirred at ambient temperature for 3 hr. then the mixture was diluted with methylene chloride, washed with water and dried (Na2SO4). (95 〇· · mg), the title product melted at 85-87 ° C. · NMR δ 8.85 (d, 1H), 8.65 (d, 1H), 8.38 (s5 1H), 7.79 (s, · 1H), 7.62 (d, 1H), 7.41 (d, 1 H), 5.5 (m, 1H), 4.43 (m, 2H), 5 1.43 (s, 9H). ' MS (ESI) 471 amu (Ml) Step E: N-[2-(3- °丫Preparation of α-danooxy)_6_(trifluoromethyl)_3·0-pyridyl]-2-chloro-4-pyridinecarboxamide A 3-[3-[[in the sterol (145 mL)) [(2·Ga-4-pyridyl)carbonyl]amino]-6-(trifluoromethyl)-2-° ratio methoxy]_i&lt;D-denidic acid dimethyl dimethyl ester (i.e., the product of Step D) (50 〇 mg, 35.0 mmol) of solution 'Ethyl chloride (5 mL) was added dropwise at 0 ° C. The reaction mixture was stirred at 0 C for more than 2 hours and heated to ambient temperature. And the recipient was additionally given a drop of 4 hours. The reaction mixture was concentrated under reduced pressure, dissolved in dichlorohydrazine and washed with 10% aqueous sodium hydrogencarbonate solution and dried (Na2S〇4). The title compound was obtained as a yellow solid ( 275 mg). NMR (DMSO-d6) δ 8.63 (d5 1H), 8.42 (d, 1H)S 7.98 (s, 20 1H), 7.83 (d, 1H), 7.59 (d, 1H), 5.4 (m, 1H), 3.78 (m, 2H), 3.6 (m5 2H), (NH resonance is combined with a broad water peak at 3.36). MS (ESI) 373 amu (M+l). Step F: 2-Chloro-N_[2-[[H(2E)-3-(4-carbophenyl)-2-propen-1-yl]]]-]]- Preparation of fluoromethyl)_3-pyridyl]_4_pyridinecarboxamide

S 72 201204254 對二噁烷(5mL)中的Ν-[2·(3-吖η旦氧基)_6·(三氟 甲基)-3-吡啶基]-2-氣-4-吡啶羧醯胺(即步驟Ε的產物) (200 mg,0.53 mmol)溶液,在其中加入三聚曱酸(25 mg,0·8 mmol),並將該混合物一邊攪拌一邊在90°C加 5 熱1小時。然後加入Β-[(1Ε)-2-(4-氯苯基)乙烯基㈣酸 (196 mg,1.07 mmol),並將該反應混合物在90°C攪拌 4小時。將該混合物冷卻,以乙酸乙酯稀釋並以氫氧化 鈉水溶液(1 N)洗滌。將有機相乾燥(Na2S04),並將 殘餘物於濃縮後利用管柱層析術(100至200筛目的石夕 10 膠,2%在CHCb中的MeOH)純化以得到呈灰白色固 體(90mg)、在l〇〇-l〇2°C熔化的標題化合物(本發明 之化合物)。 'H NMR δ 8.87 (d, 1H), 8.61 (d, 1H), 8.48 (s, 1H), 7.83 (s, 1H), 7.7(d,1H),7.4 (d, 1H), 7.3 (s,4H), 6.5 (d, 1H), 15 6.2-6.12 (m, 1H), 5.42 (m, 1H), 3.84 (m, 2H), 3.4-3.32 (m,4H)。 MS (ESI) 523 amu (M+l)。 合成實例2 20 2_ 氣-N_[4,5·二氯 氣苯基)-2-丙烯-1-基]-3- 0丫丁咬基]氧基]苯基]比咬缓酿胺(化合物2)的製備 步驟A : P W(2E)-3 -(4·氣苯基)_2·丙烯_丨_基]_3_吖口旦 醇的製備 將對2_丙醇(10mL)中的表氯醇(2.12mL,27.0 25 mm〇l)溶液於環境溫度加入對2-丙醇(1〇〇 mU中的 (2E)-3-(4-氯苯基)_2_ 丙烯 胺(】〇rg Chem 1982, 73 201204254 =5::·Γ:27_υ溶液,並將該混合物攪拌隔夜。 濃縮歧應混合物,並將殘餘物溶解在乙猜(250 mL) 中^入三乙胺(7.5mL,54mm〇1),並將該混合物在 ^力:熱2.5小時’接著冷卻並濃縮。將殘餘物以飽和 妷馱虱鈉水溶液處理並以二氯甲烷(2χ)萃取。將a併 的萃取物乾燥(MgS〇4)及濃縮’並藉由層析術(石夕^ , 梯度為EtOAe — 1G%二乙胺/Et〇Ae)純化以得到呈白 色固體(2.44 g)的標題化合物。 NMR δ 7.27 (AB pair of d5 4H)5 6.46 (d, 1H)3 6.12 (dt, 1H), 4.48 (quintet, 1H), 3.69 (m, 2H), 3.23 (dd5 2H), 2 95 (m, 2H) ° 5 10 步驟B : l-[(2E)-3-(4-氣苯基)_2_丙烯 氣-2-硝苯氧基)吖吸的製備 將虱化納(60%在油中’ 59 mg,1.49 mmol)於環 境溫度加至在N,N-二甲基甲醯胺(5 mL)中的 1 [(2E)-3-(4-氣苯基)_2·丙稀 基] -3-吖11旦醇(即步驟a 的產物)(301 mg,1 35 mmol)溶液中。攪拌5分鐘之 後’加入 1,2-二氣_4_氟-5-硝基苯(213 μί,1.62mmol) 並將該混合物於環境溫度攪拌隔夜。將該混合物以乙酸 乙酯稀釋並以水(3x)洗滌.,且將有機相乾燥(MgS04) 並濃縮。將殘餘物藉由層析術(矽膠,梯度為50% EtOAc/己燒—100% Et0Ac )純化以得到呈黃色油狀 (0.23 g)的標題化合物。 74 201204254 !H NMR δ 8.01 (s, 1H), 7.28 (AB pair of d, 4H), 6.90 (s, 1H), 6.50 (d, 1H), 6.13 (dt, 1H)? 4.88 (quintet, 1H), 3.89 (m,2H), 3.32 (dd,2H),3.24 (m, 2H)。 5 步驟 C : 4,5-二氯-2-[[1-[(2丑)-3-(4-氯苯基)-2-丙烯-1- 基]-3-吖丁啶基]氧基]苯胺的製備 對乙醇-水(體積比9: 1,10mL)中的1-[(2Ε)-3-(4-氯苯基)-2-丙稀-1 -基]-3-(4,5-二氯-2-硝基苯氧基)σ丫0旦 (即步驟Β的產物)(0.13 g,0.31 mmol)溶液,在其 ίο 中加入氯化銨(10 mg,0.19 mmol)及鐵粉(10 μιη ;S 72 201204254 Ν-[2·(3-吖ηdyloxy)_6·(trifluoromethyl)-3-pyridyl]-2-a-4-pyridiniumcarboxylate in dioxane (5 mL) a solution of the amine (ie the product of the step oxime) (200 mg, 0.53 mmol), to which was added tris-decanoic acid (25 mg, 0·8 mmol), and the mixture was stirred at 90 ° C for 5 hours while stirring. . Then Β-[(1Ε)-2-(4-chlorophenyl)vinyl (tetra) acid (196 mg, 1.07 mmol) was added, and the reaction mixture was stirred at 90 ° C for 4 hr. The mixture was cooled, diluted with ethyl acetate and washed with aqueous sodium sulfate (1 N). The organic phase was dried (Na.sub.2SO.sub.4). The title compound (compound of the invention) which was melted at 1 〇〇 2 °C. 'H NMR δ 8.87 (d, 1H), 8.61 (d, 1H), 8.48 (s, 1H), 7.83 (s, 1H), 7.7 (d, 1H), 7.4 (d, 1H), 7.3 (s, 4H), 6.5 (d, 1H), 15 6.2-6.12 (m, 1H), 5.42 (m, 1H), 3.84 (m, 2H), 3.4-3.32 (m, 4H). MS (ESI) 523 amu (M+l). Synthesis Example 2 20 2_gas-N_[4,5·dichlorophenyl)-2-propen-1-yl]-3-oxindole]oxy]phenyl] is more than a chiral amine (compound 2) Preparation Step A: Preparation of PW(2E)-3 -(4·Phenylphenyl)_2·Propylene_丨_yl]_3_Loutanol Ethyl Chlorohydrin in 2-propanol (10 mL) (2.12 mL, 27.0 25 mm 〇l) solution was added to 2-propanol (2E)-3-(4-chlorophenyl)_2-propenamine (1 〇rg Chem 1982 in 1 〇〇mU) at ambient temperature. 73 201204254 =5::·Γ:27_υ solution, and the mixture was stirred overnight. Concentrate the mixture and dissolve the residue in B guess (250 mL) into triethylamine (7.5 mL, 54 mm〇1) And the mixture was cooled and concentrated. The residue was treated with saturated aqueous sodium sulphate and extracted with dichloromethane (2 EtOAc). And </ RTI> <RTIgt; </ RTI> <RTIgt; </ RTI> <RTIgt; </ RTI> </ RTI> </ RTI> </ RTI> </ RTI> </ RTI> </ RTI> D5 4H)5 6.46 (d, 1H)3 6.12 (dt, 1H), 4.48 (quintet, 1H), 3.69 (m, 2H), 3. 23 (dd5 2H), 2 95 (m, 2H) ° 5 10 Step B: l-[(2E)-3-(4-Phenylphenyl)_2_propylene-2-nitrophenoxy) Preparation of sodium hydride (60% in oil '59 mg, 1.49 mmol) at ambient temperature to 1 [(2E)-3-(4) in N,N-dimethylformamide (5 mL) - gas phenyl) 2 · propyl] -3- 吖 11 danyl alcohol (ie the product of step a) (301 mg, 1 35 mmol) solution. After stirring for 5 minutes 'add 1, 2 - 2 _ 4 _Fluoro-5-nitrobenzene (213 μί, 1.62 mmol) and the mixture was stirred at ambient temperature overnight. The mixture was diluted with ethyl acetate and washed with water (3x) and organic phase dried (MgS04) The residue was purified by EtOAc EtOAc EtOAc (EtOAc) s, 1H), 7.28 (AB pair of d, 4H), 6.90 (s, 1H), 6.50 (d, 1H), 6.13 (dt, 1H)? 4.88 (quintet, 1H), 3.89 (m, 2H), 3.32 (dd, 2H), 3.24 (m, 2H). 5 Step C: 4,5-Dichloro-2-[[1-[(2 ugly)-3-(4-chlorophenyl)-2-propen-1-yl]-3-azetidinyl]oxy] Preparation of aniline 1-[(2Ε)-3-(4-chlorophenyl)-2-propan-1-yl]-3-(4, in ethanol-water (9:1,10 mL by volume) a solution of 5-dichloro-2-nitrophenoxy) σ丫0 denier (ie the product of the step oxime) (0.13 g, 0.31 mmol), with ammonium chloride (10 mg, 0.19 mmol) and iron Powder (10 μιη ;

176 mg,3.1 mmol)並將混合物在回流加熱30分鐘後 冷卻,及經由Celite®石夕躁土助渡劑過滤。將該Celite® 以二氯甲烷潤洗,並以水洗蘇濾液。將水相以二氯甲烷 萃取,並將合併的有機萃取物乾燥(MgS04)並濃縮。 is 將殘餘物藉由層析術(矽膠,梯度為40%含有l%Et2NH 的EtOAc/己烷—70%含有l%Et2NH的EtOAc/己烷)純 化以得到呈黃色油狀的標題產物(0.09 g)。 NMR δ 7.28 (m, 4Η), 6.77 (d, 1H), 6.54 (d5 1H), 6.50 (m, 1H), 6.14 (m, 1H), 4.78 (m, 1H), 3.90-3.81 (m, 4H), 2〇 3.31 (m,2H), 3_22 (m, 2H)。 步驟 D : 2-氯-N-[4,5-二氯-2-[[l-[(2E)-3-(4-氯苯 基)-2-丙稀-1-基]-3-σ丫丁咬基]氧基]苯基]-4· 吡啶羧醯胺的製備 25 4,5-二氣-2-[[1-[(2£)-3-(4-氣苯基)-2-丙烯-1-基]-3· 吖丁啶基]氧基]苯胺(即步驟C的產物)(101 mg,0.26 75 201204254176 mg, 3.1 mmol) and the mixture was heated at reflux for 30 minutes, cooled and filtered through a Celite®. The Celite® was rinsed with dichloromethane and the threshed filtrate was washed with water. The aqueous phase was extracted with dichloromethane and the combined organic extracts were dried (MgSO4) and concentrated. The residue was purified by EtOAc (EtOAc:EtOAc:EtOAc g). NMR δ 7.28 (m, 4Η), 6.77 (d, 1H), 6.54 (d5 1H), 6.50 (m, 1H), 6.14 (m, 1H), 4.78 (m, 1H), 3.90-3.81 (m, 4H) ), 2〇3.31 (m, 2H), 3_22 (m, 2H). Step D: 2-Chloro-N-[4,5-dichloro-2-[[l-[(2E)-3-(4-chlorophenyl)-2-propan-1-yl]-3- Preparation of σ丫丁基基]oxy]phenyl]-4·pyridine carboxamide 25 4,5-diqi-2-[[1-[(2£)-3-(4-phenylene) -2-propen-1-yl]-3·azetidyl]oxy]phenylamine (ie the product of Step C) (101 mg, 0.26 75 201204254

日稀釋,以水(3χ)洗滌, 將殘餘物藉由層析術(石夕膠, 1度為4〇%含有1〇/〇 Et2NH的EtOAc/己燒4100%含有 1% Ε_Η的EtOAc)純化以得到呈橘色固體的標題產 物(97 mg)(本發明之化合物)。 夜。將該反應混合物以 乾燥(MgS〇4)並濃縮 4 &gt;iMR δ 8.65 (s,1H), 8.59 (d,1H),8.47 (br s,1H), 7.78 (s, 1H), 7.63 (d, 1H), 7.27 (s, 4H), 6.75 (s, 1H), 6.49 (d, 1H),6.12 (m,1H),4.87 (m,1H),3.80 (m,2H), 3.35-3.29 (m,ffi)。 合成實例3 2-氣-N-[4,5-二氣-2-[[l-[(2E)-3-(4-氯苯基)-2-丙烯-l-基]_3_ 吖丁啶基]氧基]笨基]-4-吡啶羧醯胺(化合物3)草酸鹽的製 備 20 對二氣甲烷(3 mL )中的2-氣-N-[4,5-二氣 -2-[[1-[(2Ε)-3·(4-氯苯基)-2-丙烯-1-基]-3-吖丁啶基]氧 基]苯基]-4-吡啶羧醯胺(即實例2的產物)(56 mg,0.11 mmol)溶液’將其以對乙醇(100叫)中的草酸(4 8mg, 53 μηιοί)溶液處理’接著濃縮並以乙鍵研磨以得到呈 25 淺棕色固體的標題草酸鹽產物(29 mg )(本發明化合Diluted daily, washed with water (3 Torr), and the residue was purified by chromatography (EtOAc, 1% EtOAc / EtOAc EtOAc / EtOAc EtOAc The title product (97 mg) (compound of the invention) was obtained as an orange solid. night. The reaction mixture was dried (MgS 〇 4) and concentrated 4 &gt; iMR δ 8.65 (s, 1H), 8.59 (d, 1H), 8.47 (br s, 1H), 7.78 (s, 1H), 7.63 (d , 1H), 7.27 (s, 4H), 6.75 (s, 1H), 6.49 (d, 1H), 6.12 (m, 1H), 4.87 (m, 1H), 3.80 (m, 2H), 3.35-3.29 ( m, ffi). Synthesis Example 3 2-Gas-N-[4,5-dioxa-2-[[l-[(2E)-3-(4-chlorophenyl)-2-propenyl-l-yl]_3_azetidinyl] Preparation of oxalate]-4-pyridylcarboxamide (Compound 3) Oxalate 20 2-Gas-N-[4,5-di-gas-2-[2- in methane (3 mL) [1-[(2Ε)-3·(4-chlorophenyl)-2-propen-1-yl]-3-azetidinyl]oxy]phenyl]-4-pyridinecarboxamide (ie Example 2 The product (56 mg, 0.11 mmol) solution was treated with a solution of oxalic acid (4 8 mg, 53 μηιοί) in ethanol (100 s), followed by concentration and trituration with an ethyl bond to give the title of 25 light brown solids. Acid product (29 mg) (combination of the invention)

S 76 201204254 lU NMR (DMSO-d6) δ 10.23 (br s, 1H), 8.63 (d, 1H), 8.06 (s, 1H), 7.97 (s, 1H), 7.87 (d, 1H), 7.47 (d, 2H), 7.40 (d, 2H), 7.24 (s, 1H), 6.71 (d5 1H), 6.28 (m, 1H)? 5.12 (br s, 1H), 4.31 (br s, 2H),3_82 (br s,2H), 3.73 (br d,2H)。 5 合成實例4 2·氣-N_[5-氯-2·[[Η(2Ε)-3-(4-氣苯基)-2-丙烯-1-基]-3-。丫丁 啶基]氧基]-3-吡啶基]-4·•吡啶羧醯胺(化合物16)的製備 步驟A : 3·[(5-氣-3-硝基-2-吡啶基)氧基]-1-吖哩羧酸 ίο 1,1_二甲基乙基酯的製備 對THF中(100 mL)的5-氯-3-硝基-2(1Η)-吡啶酮 (3.51 g,20·1 mmol)、3-羥基-1-吖咀羧酸 1,1-二曱基 乙基酯(3.48 g,20.1 mmol)及三苯基膦(5.27 g,24.1 mmol)溶液,於0°C加入1,2-偶氮二羧酸l,2-雙(1-甲基 15 乙基)酯(4.67 mL,24_1 mmol),並使混合物隔夜緩慢 加熱至環境溫度。然後在減壓下濃縮該混合物,並藉由 層析術(矽膠’ 5%至20%在己烷中的乙酸乙酯)純化 以得到呈白色固體的標題產物(4.78g)。 'H NMR δ 8.32 (m5 2Η), 5.42 (m, 1H), 4.35 (dd, 2H), 4.06 2〇 (dd, 2H),1.45 (s, 9H)。 步驟B : 3-[(3-胺基-5-氯-2-吡啶基)氧基]-i-吖^旦羧酸 U-二甲基乙基酯的製備 對乙醇(45 mL)及水(5 mL)中的3_[(5_氣·3-石肖 25 基_2_吡啶基)氧基]-1-吖0旦羧酸1,1-二曱基乙基酯(即步 驟Α的產物)(4.78 g ’ 14.5 mmol)溶液,在其中加入 77 201204254 氯化銨(46611^,8_7 111111〇1)及鐵粉末(4〇叫,812§, 145 mmol),然後在回流加熱混合物〖小時。將冷卻後 的混合物以一氣甲烧稀釋,並經Celite®;5夕藤土助滤劑 墊過濾,以二氣甲烷沖提。將濾液以水洗滌、乾燥 5 ( MgS〇4)並濃縮。將殘餘物經&gt;5夕膠墊過濾、以3〇%在 己烷中的乙酸乙酯沖提,並將濾液濃縮以得到呈黃色泡 沫狀(4.48 g)的標題產物。 lU NMR δ 7.43 (d5 1H), 6.89 (d, 1H), 5.31 (m, 1H), 4.33 (dd, 2H), 3.98 (dd, 2H), 3.89 (br s, 2H), 1.45 (s, 9H) ° 10 步驟C · 3·[[5-氣_3_[[(2_氣_4_。比啶基)羰基]胺基]_2_吡 咬基]氧基]-1-吖咀叛酸1,丨_二甲基乙基酯的 製備 對一氣曱燒(2〇mL)中的3-[(3-胺基-5-氣-2-吡啶 15 基)氧基]·1_%π旦綾酸1,1-二曱基乙基酯(即步驟B的產 物)(1.80 g,6 0 _〇1)及三乙胺(1.25 mL,9.0 mmol) 溶液’在其中加入2-氣-4-吡啶羰基氣化物(0.79 mL, 6.6 mm^l) ’並在環境溫度將反應隔夜攪拌。加入飽和 的碳酸氮=水溶液’並以二氯曱烷(2χ)萃取混合物。 2〇 將合併的萃取物乾燥(MgS〇4),並將濃縮後的殘餘物 以乙醚磨碎’然後從乙醇(6G mL)再結晶以得到 黃色固體的標題產物(18〇g)。 彳、 lH NMR δ 8 80 (d,1H),8·64 (d,1H),8.22 (br s,1H), 7.85 (d,1H),7 77 (d,出),7.60 (dd,1Η),5.39 (m, 1H), 4 39 25 (dd,2H),4 01 (dd,2H),1.45 (s,9H)。S 76 201204254 lU NMR (DMSO-d6) δ 10.23 (br s, 1H), 8.63 (d, 1H), 8.06 (s, 1H), 7.97 (s, 1H), 7.87 (d, 1H), 7.47 (d , 2H), 7.40 (d, 2H), 7.24 (s, 1H), 6.71 (d5 1H), 6.28 (m, 1H)? 5.12 (br s, 1H), 4.31 (br s, 2H), 3_82 (br s, 2H), 3.73 (br d, 2H). 5 Synthesis Example 4 2. Gas-N_[5-chloro-2·[[Η(2Ε)-3-(4-carbophenyl)-2-propen-1-yl]-3-. Preparation of azetidinyloxy]-3-pyridyl]-4·•pyridine carboxamide (Compound 16) Step A: 3·[(5-Ga-3-nitro-2-pyridyl)oxy] Preparation of -1-indolecarboxylic acid ίο 1,1-dimethylethyl ester in THF (100 mL) of 5-chloro-3-nitro-2(1Η)-pyridone (3.51 g, 20·) 1 mmol), 1,1-dimercaptoethyl 3-hydroxy-1-indolecarboxylate (3.48 g, 20.1 mmol) and triphenylphosphine (5.27 g, 24.1 mmol), added at 0 °C 1,2-bis(1-methyl15-ethyl) azodicarboxylate (4.67 mL, 24_1 mmol), and the mixture was slowly warmed to ambient temperature overnight. The mixture was then concentrated under reduced pressure and purified with EtOAc EtOAcjjjjjjj 'H NMR δ 8.32 (m5 2Η), 5.42 (m, 1H), 4.35 (dd, 2H), 4.06 2 〇 (dd, 2H), 1.45 (s, 9H). Step B: Preparation of 3-[(3-amino-5-chloro-2-pyridyl)oxy]-i-indolecarboxylic acid U-dimethylethyl ester for ethanol (45 mL) and water 3_[(5_Gas-3-Synthocyl25-yl-2-pyridyl)oxy]-1-indenyl carboxylic acid 1,1-didecylethyl ester in (5 mL) (ie step Α (4.78 g ' 14.5 mmol) solution, to which 77 201204254 ammonium chloride (46611^, 8_7 111111〇1) and iron powder (4 〇, 812§, 145 mmol) were added, and then the mixture was heated under reflux. hour. The cooled mixture was diluted with a gas-fired product and filtered through a pad of Celite® 5 vine soil filter pad, and extracted with di-methane. The filtrate was washed with water, dried (MgSO.sub.4) and concentrated. The residue was filtered through EtOAc EtOAc (EtOAc)EtOAc. lU NMR δ 7.43 (d5 1H), 6.89 (d, 1H), 5.31 (m, 1H), 4.33 (dd, 2H), 3.98 (dd, 2H), 3.89 (br s, 2H), 1.45 (s, 9H ° 10 Step C · 3·[[5-gas_3_[[(2_气_4_.pyridyl)carbonyl]amino]_2_pyridyl]oxy]-1-吖 叛 叛 1 1 , 丨_Dimethylethyl ester preparation of 3-[(3-amino-5-a-2-pyridyl15-yl)oxy]·1_% 绫 绫 in 1-gas 曱(2〇mL) 1,1-Dimercaptoethyl ester (ie product of Step B) (1.80 g, 60 〇1) and triethylamine (1.25 mL, 9.0 mmol) solution in which 2-gas-4- Pyridine carbonyl vapor (0.79 mL, 6.6 mm^l)' and the reaction was stirred overnight at ambient temperature. Saturated carbonated water = aqueous solution was added and the mixture was extracted with dichloromethane (2 Torr). The combined extracts were dried (MgSO.sub.4) and EtOAc (EtOAc)彳, lH NMR δ 8 80 (d, 1H), 8·64 (d, 1H), 8.22 (br s, 1H), 7.85 (d, 1H), 7 77 (d, out), 7.60 (dd, 1Η) ), 5.39 (m, 1H), 4 39 25 (dd, 2H), 4 01 (dd, 2H), 1.45 (s, 9H).

78 201204254 步驟 D : 2-氯-N-[5-氣-2-[[1-[(2Ε)-3-(4-氣苯基)-2-丙 烯-1-基]-3-吖丁啶基]氧基]-3-。比啶基]-4-吡 啶羧醯胺的製備 以氣化氫(5-6N在異丙醇中,10mL)處理3-[[5-5 氣-3-[[(2-氯-4-吼啶基)羰基]胺基]-2-咬啶基]氧基]小吖 咀羧酸U-二甲基乙基酯(即步驟C的產物)(0.45 g), 並劇烈地攪拌混合物1小時。加入二氣甲烷(10 mL), 並將混合物在環境溫度攪拌隔夜。在真空中濃縮該反應 混合物,以飽和碳酸氫鈉水溶液處理並以二氣甲烷(3 X ) ίο 萃取。將合併的有機相乾燥(MgS04)並在真空中濃縮 以得到含有N-[2-(3-吖《旦氧基)-5-氯-3-吼啶基]-2-氣-4-吡啶羧醯胺的白色固體狀產物(0.18 g,大約50%純 度),將其直接使用而不再進一步純化。在此物質的樣 本中(85 11^)加入(2£)-3-(4-氣苯基)-2-丙烯醛(5〇1^, 15 0·30 mmol)、三乙醯氧基石朋氫化納(64 mg,0_30 mmol)、 THF (3 mL)及醋酸(17 μί),並在環境溫度將該混合 物攪拌隔夜。將混合物以飽和碳酸氳鈉水溶液處理並以 二氯甲烷(2χ)萃取。將合併的有機相乾燥(MgS04), 並將濃縮後的殘餘物藉由層析術(矽膠,30%在己烷中 2〇 的乙酸乙酯(含有1% Et2NH) —1%在乙酸乙酯中的78 201204254 Step D: 2-Chloro-N-[5-Gas-2-[[1-[(2Ε)-3-(4-Phenylphenyl)-2-propen-1-yl]-3-indolyl) ]oxy]-3-. Preparation of pyridyl]-4-pyridinecarboxamide The treatment of 3-[[5-5 gas-3-[[(2-chloro-4-)) with hydrogenated hydrogen (5-6N in isopropanol, 10 mL) Acridine)carbonyl]amino]-2-oxaridinyloxy] U-dimethylethyl sulfonate (product of step C) (0.45 g), and vigorously stirred mixture 1 hour. Di-hydrogen methane (10 mL) was added and the mixture was stirred at ambient temperature overnight. The reaction mixture was concentrated in vacuo,qqqqq eluted The combined organic phases were dried (MgSO4) and concentrated in vacuo to give N-[2-(3-[&quot;&quot;&quot;&quot;&gt; The product of the carboxamide as a white solid (0.18 g, ca. 50% purity) was used directly without further purification. In the sample of this material (85 11^), add (2£)-3-(4-carbophenyl)-2-propenal (5〇1^, 15 0.30 mmol), triethylenesulfonate Sodium hydride (64 mg, 0-30 mmol), THF (3 mL) and EtOAc (EtOAc) The mixture was treated with saturated aqueous sodium bicarbonate and extracted with dichloromethane (2 EtOAc). The combined organic phases were dried (MgS04) and the residue was purified by chromatography (EtOAc, EtOAc (EtOAc: EtOAc middle

Et2NH)純化以得到標題產物(一種本發明之化合物, 29 mg)。 lU NMR δ 8.77 (d, 1H), 8.62 (d, 1H), 8.37 (br s, 1H)5 7.84 (d, 1H), 7.78 (s, 1H), 7.63 (dd, 1H), 7.28 (s, 4H), 6.50 (d, 25 1H), 6.14 (dt, 1H), 5.34 (m, 1H), 3.83 (m, 2H), 3.35-3.30 (m, 4H)。 79 201204254 合成實例5 N-[2-[[l-[2-(4-溴苯氧基)乙基]-3-吖丁啶基]氧基]_56 一氣 -3-吡啶基]-2-氣-4-吡啶羧醯胺(化合物8〇)的製備 步驟A : Η(3·胺基·5,6·二氣_2_0比咬基)氧基h个旦 叛酸1,1-一曱基乙基醋的製備 對DMF (20 mL)中的H(3_胺基·5_氣&gt;比咬 氧基]-1-十旦誠1,1-二甲基乙基酉旨(即實例4,步驟土B 的產物)(1.3 g,4_34 mmol)溶液,在其中加入n_氣號 珀醯亞胺( 608 mg,4.56 mmol),並將反應混合物在環 境溫度攪拌隔夜。將混合物以乙喊稀釋、以水〇)、先 滌並乾燥(MgS〇4) ’並將濃縮後的殘餘物藉由層析術 (矽膠,10%至30%在己烷中的乙酸乙酯)純化以得^ 呈橙色泡沫狀的標題產物(0.85 g)。 15 'H NMR δ 6.99 (s5 1Η)5 5.32 (m, 1Η), 4.35 (dd5 2H), 3.98 (dd,2H), 3.88 (br s,2H), 1.45 (s,9H)。 步驟B : 3-[[5,6-二氣-3-[[(2-氯-4· 比咬基)幾基]胺 基]-2-。比咬基]氧基]-1-σγα旦敌酸ι,ι·二甲基 2〇 乙基酯的製備 對‘一氣曱烧(20 mL)中的3-[(3-胺基-5,6-二氣_2_Purification of Et2NH) gave the title product (a compound of the invention, 29 mg). lU NMR δ 8.77 (d, 1H), 8.62 (d, 1H), 8.37 (br s, 1H)5 7.84 (d, 1H), 7.78 (s, 1H), 7.63 (dd, 1H), 7.28 (s, 4H), 6.50 (d, 25 1H), 6.14 (dt, 1H), 5.34 (m, 1H), 3.83 (m, 2H), 3.35-3.30 (m, 4H). 79 201204254 Synthesis Example 5 N-[2-[[l-[2-(4-Bromophenoxy)ethyl]-3-azetidinyl]oxy]_56-mono-3-pyridyl]-2- gas- Preparation of 4-pyridinecarboxamide (Compound 8〇) Step A: Η(3·Amino·5,6·二气_2_0 咬 咬) Oxygen h-denidic acid 1,1- fluorenyl B Preparation of base vinegar for H (3_Amine·5_gas&gt; than methoxyl group) in DMF (20 mL) (1, dimethylidene) , a solution of the product of Step B) (1.3 g, 4_34 mmol), to which was added n- s y ytamine ( 608 mg, 4.56 mmol), and the mixture was stirred overnight at ambient temperature. Dilute, dilute with water, first wash and dry (MgS〇4) 'and the concentrated residue is purified by chromatography (gelatin, 10% to 30% ethyl acetate in hexane) to obtain ^ The title product (0.85 g) was obtained as an orange foam. 15 'H NMR δ 6.99 (s5 1Η) 5 5.32 (m, 1Η), 4.35 (dd5 2H), 3.98 (dd, 2H), 3.88 (br s, 2H), 1.45 (s, 9H). Step B: 3-[[5,6-Dimethyl-3-[[(2-chloro-4.)-yl)]amino]-2-. Preparation of methoxy,-1-σγα-denidic acid ι,ι·dimethyl 2-indenyl ester of 3-[(3-amino-5,] in a gas-fired (20 mL) 6-two gas_2_

0比。定基)氧基]-1-。丫π旦叛酸1,1-二曱基乙基醋(即步驟A 的產物)(〇·85 g,2.54 mmol)及三乙胺(531 μΐ^,3.81 mmol)溶液,在其中加入2-氯-4-吡啶羰基氣化物(0.36 25 mL,2_54 mmol),並將反應混合物在環境溫度攪拌隔 夜。加入水,並以二氣甲烷(2χ)萃取混合物。乾燥合0 ratio. Alkyl)oxy]-1-.丫 旦 旦 叛 叛 1 1,1-dimercaptoethyl vinegar (ie the product of step A) (〇 · 85 g, 2.54 mmol) and triethylamine (531 μΐ ^, 3.81 mmol) solution, adding 2- Chloro-4-pyridinecarbonyl vapor (0.36 25 mL, 2 - 54 mmol), and the mixture was stirred at ambient temperature overnight. Water was added and the mixture was extracted with di-methane (2 Torr). Drying

S 80 201204254 併萃取物(MgS04),並藉由層析術(矽膠,10%至40% 在己炫中的乙酸乙酯)純化濃縮後的殘餘物以得到黃色 泡洙。以乙醚磨碎以得到呈淺棕色固體的標題產物(0_9 g)。 5 ^NMR δ 8.91 (s, 1H)5 8.64 (d, 1H), 8.14 (s, 1H), 7.76 (d, 1H), 7.60 (dd5 1H), 5.41 (m5 1H), 4.42 (dd, 2H), 4.03 (dd, 2H), 1.46 (s,9H)。 步驟C : N-[2-(3-n丫咀氧基)_5,6_二氣_3_吡啶基]_2-氯 10 -4-吡啶羧醯胺的製備 對二氣甲烷(36mL)中的 3_[[5,6_二氣-3-[[(2-氣-4-吡啶基)羰基]胺基]-2-吡啶基]氧基]-1-吖哩羧酸l,l-二 甲基乙基酯(即步驟B的產物)(〇·85 g)溶液,在其中 加入氫溴酸(48°/❶水溶液,1.8 mL),並將混合物劇烈地 15 攪拌15分鐘。將上清液傾析,並將殘餘物小心地以飽 和碳酸氫鈉水溶液中合。過濾混合物,並在真空中乾燥 固體以得到呈黃色固體的標題產物(〇4g)。 4 NMR (丙酮-d6) δ 8·76 (s, 1H), 8.61 (d, 1H), 7.91 (br s, 1H), 7.87 (br s5 1H), 5.18 (br s), 3.66 (br s, 2H), 3.34 (br s, 2〇 2H)。 步驟D : N-[2-[[l-[2-(4-漠苯氧基)乙基]_3_吖丁啶基] 氧基]-5,6-一氣-3-°比咬基]-2-氣-4-°比α定叛酿 胺的製備 將 1 /臭-4-(2-&gt;臭乙氣基)苯(95 mg5 0.34 mmol)加 入N [2 (3-。丫 π旦氣基二氣各吼。定基]·2·氯比咬 201204254 羧醯胺(即步驟C的產物)(100 mg,0.28 mmol)及 Ν,Ν·二異丙基乙胺(76 mL,0.42 mmol)在乙腈(3 mL ) 中的混合物,並將反應混合物在60°C加熱隔夜。以飽 和碳酸氫鈉水溶液(2 mL)及水(2 mL)處理冷卻的 5 溶液,然後以二氯甲烷稀釋,接著經由含有Celite⑧矽 藻土助濾劑的管柱過濾、以二氣甲烷沖提。藉由層析術 (矽膠,乙酸乙酯至5%在乙酸乙酯中的曱醇)純化濃 縮後的殘餘物,以得到呈淡黃色油體的標題產物(本發 明之化合物)(84 mg)。 ίο !H NMR δ 8.88 (s5 1H), 8.62 (d, 1H), 8.28 (br s, 1H), 7.77 (d, 1H),7.62 (d,1H),7.37 (d,2H),6_78 (d,2H),5.35 (m, 1H), 3.99 (t, 2H), 3.92 (t, 2H), 3.42 (br s, 2H), 2.95 (t, 2H)。 15 合成實例6 2-氣-N-[6-氣-2-[[l_[(2E)-3_(4-氣苯基)-1甲基-2-丙烯-1- 基]-3-吖丁啶基]氧基]-3·-比啶基]-4-吼啶羧醯胺(化合物17) 的製備 步驟A . 3·[(6-氣-3-石肖基-2-α比〇定基)乳基]_1-〇丫 α旦魏酸 20 1,1_二甲基乙基酯的製備 對甲苯(20mL)中的3-羥基-1-吖咀羧酸1,1-二甲 基乙基酯(1.0 g,5.78 mmol)及2,6-二氣-3-硝基吼唆 (1.12 g’ 5.78 mmol)溶液,在其中加入固體氫氧化鈉, 並將混合物在環境溫度攪拌隔夜。以乙醚稀釋混合物、 25 以水洗務並乾燥(MgS〇4 )。藉由層析術(石夕膠,5%至S 80 201204254 and the extract (MgS04), and the concentrated residue was purified by chromatography (gelatin, 10% to 40% ethyl acetate in hexane) to give a yellow foam. The title product (0-9 g) was obtained as a light brown solid. 5 ^ NMR δ 8.91 (s, 1H) 5 8.64 (d, 1H), 8.14 (s, 1H), 7.76 (d, 1H), 7.60 (dd5 1H), 5.41 (m5 1H), 4.42 (dd, 2H) , 4.03 (dd, 2H), 1.46 (s, 9H). Step C: Preparation of N-[2-(3-n丫-thoxyoxy)_5,6-diox_3-pyridyl]_2-chloro 10 -4-pyridinecarboxamide in di-methane (36 mL) 3_[[5,6_Digas-3-[[(2-)-4-pyridyl)carbonyl]amino]-2-pyridyl]oxy]-1-indolecarboxylic acid l,l- A solution of dimethylethyl ester (i.e., the product of Step B) (〇·85 g), to which was added hydrobromic acid (48° / hydrazine aqueous solution, 1.8 mL), and the mixture was vigorously stirred for 15 minutes. The supernatant was decanted and the residue was carefully taken up in saturated aqueous sodium bicarbonate. The mixture was filtered, and the title compound was obtainedjjjjjjjj 4 NMR (acetone-d6) δ 8·76 (s, 1H), 8.61 (d, 1H), 7.91 (br s, 1H), 7.87 (br s5 1H), 5.18 (br s), 3.66 (br s, 2H), 3.34 (br s, 2〇2H). Step D: N-[2-[[l-[2-(4-oxaphenoxy)ethyl]_3_azetidinyl]oxy]-5,6-one gas-3-° ratio bite base-2 - Gas -4-° ratio α 定 叛 酿 的 的 的 将 将 将 ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( Base two gas. 定基]·2· 氯比 bite 201204254 Carboxyguanidamine (ie the product of step C) (100 mg, 0.28 mmol) and hydrazine, hydrazine diisopropylethylamine (76 mL, 0.42 mmol) The mixture was heated in EtOAc (3 mL). It was then filtered through a column containing Celite 8 diatomaceous earth filter aid and extracted with di-methane. The residue after purification was purified by chromatography (gelatin, ethyl acetate to 5% decyl alcohol in ethyl acetate). The title product (the compound of the invention) (84 mg) was obtained as a pale yellow oil. ίο !H NMR δ 8.88 (s5 1H), 8.62 (d, 1H), 8.28 (br s, 1H), 7.77 (d, 1H), 7.62 (d, 1H), 7.37 (d, 2H), 6_78 (d, 2H), 5.35 (m, 1H), 3.99 (t, 2H), 3 .92 (t, 2H), 3.42 (br s, 2H), 2.95 (t, 2H). 15 Synthesis Example 6 2-Gas-N-[6-Gas-2-[[l_[(2E)-3_( Preparation of 4-oxophenyl)-1methyl-2-propen-1-yl]-3-azetidinyl]oxy]-3--pyridinyl]-4-acridinecarboxamide (Compound 17) Step A. 3·[(6-Gas-3-Gentocyl-2-α is hydrazinyl))]]- 〇丫α-D-Weric acid Preparation of 1,1,1-dimethylethyl ester p-toluene (20 mL) 1,1-Dimethylethyl 3-hydroxy-1-indolecarboxylic acid (1.0 g, 5.78 mmol) and 2,6-dioxa-3-nitroindole (1.12 g' 5.78 mmol) The solution, to which solid sodium hydroxide was added, and the mixture was stirred overnight at ambient temperature. The mixture was diluted with diethyl ether, washed with water and dried (MgS 〇 4). by chromatography (Shixi gum, 5% to

S 82 201204254 20%在己烷中的乙酸乙酯)純化濃縮後的殘餘物,以得 到呈淡黃色固體的標題化合物(1.21 g)。 [H NMR δ 8.32 (d, 1Η), 7.10 (d, 1H), 5.46 (m, 1H), 4.38 (dd, 2H),4.08 (dd, 2H), 1.46 (s, 9H)。 5 步驟B : 3-[[6-氯-3-[[(2-氯-4』比啶基)羰基]胺基]-2_。比 啶基]氧基]_1_吖咀羧酸1,1-二甲基乙基酯的 製備 對乙醇及水(體積比為9 : 1,25 mL)混合物中的 ίο 3-[(6-氮-3-硝基-2-。比咬基)氧基]-1-α丫 α旦竣酸1,1 -二曱基 乙基醋(即步驟Α的產物)(1.21 g,3.67 mmol)溶液, 在其中加入氯化敍(118 mg,2.20 mmol)及鐵粉(40 μιη,2.06 g,36.7 mmol),並將混合物在回流加熱1.5 小時。將冷卻後的混合物以二氯甲烷稀釋,並經Celite® 15 矽藻土助濾劑墊過濾,以二氯甲烷沖提。將濾液以水洗 滌、乾燥(MgS04)並濃縮。加入甲苯,並在真空中再 次濃縮生成的溶液。將含有3-[(3-胺基-6-氣-2-10比咬基) 氧基]-1-吖哩羧酸1,1-二曱基乙基酯的殘餘物溶解在二 氣甲烷(35 mL)中,並依序加入三乙胺(0.77 mL,5.50 2〇 mmol )及2-氯-4·0比咬叛基氯化物(0.48 mL,4.04 mmol)。將該反應於環境溫度下攪拌整夜。加入水並以 二氯甲烷(2χ )萃取混合物。將合併的萃取物乾燥 (MgS04),並藉由層析術(矽膠,10%至40%在己烷 中的乙酸乙酯)純化濃縮後的殘餘物以得到標題產物 25 ( 1.52 g)。 83 201204254 1HNMR5 8.70(d,1H),8.63 (d, 1H),8.17 (s,1H),7.77 (d, 1H), 7.60 (dd, 1H), 7.04 (d, 1H), 5.43 (m, 1H), 4.42 (dd5 2H),4.03 (dd, 2H),1·46 (s,9H)。 5 步驟C . N-[2-(3-口丫 σ旦氧基)-6-氣-3_α比0定基]-2_氯-4-α比 啶羧醯胺的製備 對二氣曱烷(50 mL)中的3-[[6-氯-3-[[(2_氣-4-吼 啶基)羰基]胺基]-2-吡啶基]氧基]-1-吖咀羧酸1,1-二甲 基乙基酯(即步驟B的產物)(1.95g)溶液,在其中加 ίο 入氫溴酸(48%水溶液,4.45 mL),並將混合物劇烈地 攪拌15分鐘。將上清液傾析,並將殘餘物小心地以飽 和碳酸氫鈉水溶液中和。依序以在二氣甲烷中的10體 積百分比甲醇及二氯甲烷(4χ)萃取水相將合併萃取物 乾燥(MgS04)並濃縮以得到標題產物(1.08 g,大約 is 90%純度),將其直接用於下一步驟中而不再進一步純 化。 lU NMR δ 8.68 (d, 1H), 8.61 (d, 1H), 8.30 (s, 1H), 7.78 (d, 1H), 7.63 (dd, 1H), 7.00 (d, 1H), 5.59 (m, 1H), 4.10 (dd, 2H),3.78 (dd,2H)。 20 步驟 D : 2-氣-N-[6-氯-2_[[l-[(2E)-3-(4-氯苯基)·1·曱 基_2_丙婦-1-基]-3 -α丫丁 σ定基]氧基]-3-π比咬 基]_4·吡啶羧醢胺的製備 對Ν-[2-(3·σΥ σ旦氧基)·6·氯-3-°比σ定基]·2·氯比咬 25 羧醯胺(即步驟C的產物)(79 mg,0.23 mmol)的溶 液,在其中加入(3E)-4-(4-氯苯基)-3-丁烯-2-酮(48mg,The title compound (1.21 g) was obtained. [H NMR δ 8.32 (d, 1 Η), 7.10 (d, 1H), 5.46 (m, 1H), 4.38 (dd, 2H), 4.08 (dd, 2H), 1.46 (s, 9H). 5 Step B: 3-[[6-Chloro-3-[[(2-chloro-4"pyridinyl)carbonyl]amino]-2_. Preparation of 1,1-dimethylethyl ester of pyridyl]oxy]_1_ oxime carboxylic acid ίο 3-[(6-) in a mixture of ethanol and water (9: 1,25 mL by volume) Nitro-3--3--2-pyrene.1,1-dimercaptoethyl vinegar (ie the product of the step oxime) (1.21 g, 3.67 mmol) To the solution, chlorinated (118 mg, 2.20 mmol) and iron powder (40 μm, 2.06 g, 36.7 mmol) were added, and the mixture was heated under reflux for 1.5 hours. The cooled mixture was diluted with dichloromethane and filtered over a pad of Celite® 15 EtOAc. The filtrate was washed with water, dried (MgSO4) and concentrated. Toluene was added and the resulting solution was concentrated again in vacuo. Dissolving the residue containing 1,1-dimercaptoethyl 3-((3-amino-6-gas-2-10 octyl)oxy]-1-indolecarboxylate in di-methane (35 mL) was added triethylamine (0.77 mL, 5.50 2 mmol) and 2-chloro-4·0 ratio (0.48 mL, 4.04 mmol). The reaction was stirred overnight at ambient temperature. Water was added and the mixture was extracted with dichloromethane (2 Torr). The combined extracts were dried (M.sub.4). EtOAc (EtOAc) 83 201204254 1HNMR5 8.70(d,1H), 8.63 (d, 1H), 8.17 (s,1H), 7.77 (d, 1H), 7.60 (dd, 1H), 7.04 (d, 1H), 5.43 (m, 1H) ), 4.42 (dd5 2H), 4.03 (dd, 2H), 1·46 (s, 9H). 5 Step C. Preparation of N-[2-(3-indolyl sigma-oxy)-6-gas-3_α ratio 0-butyl]-2_chloro-4-α-pyridinium carboxamide bis-dioxane ( 3-[[6-Chloro-3-[[(2)--4-indolyl)carbonyl]amino]-2-pyridyl]oxy]-1-indolecarboxylic acid 1 in 50 mL) A solution of 1-dimethylethyl ester (i.e., the product of Step B) (1.95 g), which was then added to hydrobromic acid (48% aqueous solution, 4.45 mL), and the mixture was stirred vigorously for 15 minutes. The supernatant was decanted and the residue was carefully neutralized with saturated aqueous sodium bicarbonate. The combined aqueous extracts were dried (MgS04) and concentrated to give the title product (1.08 g, approximately is 90% purity), which was obtained by sequentially extracting the aqueous phase with 10% by volume of methanol and dichloromethane (4 χ) in di-methane. Used directly in the next step without further purification. lU NMR δ 8.68 (d, 1H), 8.61 (d, 1H), 8.30 (s, 1H), 7.78 (d, 1H), 7.63 (dd, 1H), 7.00 (d, 1H), 5.59 (m, 1H) ), 4.10 (dd, 2H), 3.78 (dd, 2H). 20 Step D: 2-Gas-N-[6-Chloro-2_[[l-[(2E)-3-(4-chlorophenyl)·1·decyl_2_propyl-1-yl]- Preparation of 3 -α 丫 σ 定 ] ] 氧基 氧基 氧基 氧基 ] ] ] ] ] ] [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ [ a solution of carboxyguanamine (ie, the product of Step C) (79 mg, 0.23 mmol), to which (3E)-4-(4-chlorophenyl)-3- Buten-2-one (48 mg,

S 84 201204254 0.28 mmol )、三乙酿氧基蝴氫化納(59 mg’ 0.28 mmol)、 THF (3 mL)及醋酸(16 pL),並在環境溫度將該混合 物攪拌隔夜。將混合物以飽和碳酸氫鈉水溶液處理並以 二氯甲烷(2χ)萃取。將合併有機相乾燥(MgS04), 5 並將濃縮後的殘餘物藉由層析術(矽膠,30%在己烷中 的乙酸乙酯(含有1% Et2NH)至1%在乙酸乙酯中的 Et2NH)純化以得到標題產物(本發明之化合物)(21 mg)。 [H NMR δ 8.66 (d, 1H), 8.61 (d, 1H), 8.31 (br s, 1H)5 7.78 ίο (d, 1H), 7.63 (dd, 1H), 7.28 (s, 4H), 7.00 (d5 1H), 6.48 (d, 1H), 6.01 (dd, 1H), 5.31 (m, 1H), 3.78 (m, 2H), 3.31 (m5 2H), 3.01 (m,1H), 1.16 (d, 3H)。 合成實例7 15 N-[6-胺基-5 -氣-2-[[l -[(2E)-3-(4 -氣苯基)-2 -丙稀-1 -基]-3-°丫 丁啶基]氧基]-3-°比啶基]-2-氯-4-。比啶羧醯胺(化合物92)的 製備 步驟A · 3-氣-2,6-二氣-5-瑣基α比α定製備 對發煙硝酸(密度為1.5 g/mL,40 mL)中的3-氯 2〇 -2,6-二氟。比咬(4.94 g,33.0 mmol)溶液,在其中逐滴 加入硫酸(30 mL)。反應混合物的溫度上升至38°C。 然後在冷卻前將該混合物在60°C加熱1.5小時、在冰上 傾注並以己烷(2χ)萃取。濃縮己烷萃取物以得到呈黃 色晶體的標題化合物(3.7 g)。以二氣甲烷萃取水層, 25 接著乾燥(MgS04)並濃縮萃取物以提供額外的產物 (2.45 g)。 85 201204254 ,HNMR5”Ut,m)。 步驟B : 〇 r '[(5-氣-6-氟肖基-2-°比咬基)氧基]_1_0丫 σ旦 幾酸1,1-二甲基乙基g旨的製備_ 將3'氛m靖基吡啶(即步驟a的產物) 蔣生上g,1.5當量)合併在甲苯(5°mL)中,並 兮浥合物在環境溫度攪拌隔夜。然後以乙醚稀釋 =口:、以水洗條(3x)並乾燥(Mgs〇4)。藉由層 :膠’5%至15%在己烷中的乙酸乙醋)純化濃 縮後%餘物以得到標題產物(G.68g,8〇%純度),其 1 可不經進—步純化即用於下一步驟中。 咕 δ 8.56 (d,1H),5 39 (m,1H),4 % ⑼,2H),4 〇8 (m, 2H),1.45 (s,9H)。 15 v驟C H[6_胺基-5-氣-3-[[(2-氯-4·。比咬基)魏基]胺 基]_2_〇比啶基]氧基]_1_吖°旦羧酸1,1-二曱基 乙基酯的製備 ’ 6氣IT其丁醇(18mL)及水(Μ)中的3-[(5_氯 =_3·吨基&gt;比咬基)氧基]小十旦峡仏二甲基乙 Π步驟B)(〇.68g)混合物,將其以鐵粉(4〇叩, ^及氯化錄(63%,118随。。處 、’生成之混合物在回流加熱5〇分鐘。將;^細夕 =物以二氣曱㈣釋並經由Cel_㈣土助滤= 過〜以一虱甲燒沖提。將洗提液 (執)並濃縮。將殘餘物溶解在心:再t 25 201204254 縮。將殘餘物再溶解在二氣曱烷(20 mL)中,並加入 4-(二甲基胺基)吼咬(24 mg ’ 0.20 mmol )、三乙胺(0.68 mL ’ 4.9 mmol)及2-氣-4-吡啶羰基氣化物(500 mg)。 將混合物在環境溫度攪拌3天,接著以1N氫氧化鈉水 5 溶液處理。再15分鐘後,將混合物分離,並乾燥(MgS04 ) 及濃縮有機相。將殘餘物中的化合物藉由層析術(矽 膠’梯度為10%至40%在己烷中的乙酸乙酯)分離以提 供3-[[5-氯-3-[[(2·氣-4-吡啶基)羰基]胺基]_6-氟-2-吡啶 基]氧基]-1-吖。旦羧酸1,卜二甲基乙基酯(〇37 g)及標 ίο 題產物(0_16 g)。 lH NMR δ 8.59 (d5 1H), 8.56 (s, 1H), 7.92 (br s, 1H), 7.74 (s,1H),7.59 (dd,1H),5.29 (m,1H), 4.67 (br s, 2H), 4.34 (dd, 2H), 4.00 (dd5 2H), 1.45 (s, 9H) 〇 15 步驟D : N-[6-胺基-2-(1-吖咀氧基)_5_氯_3-吡啶基]-2- 氣-4-吡啶羧醯胺的製備 對二氣甲烷(7 mL)中的3-[[6-胺基-5-氯-3-[[(2-氯-4 - °比啶基)幾基]胺基]_ 2 _ α比咬基]氣基]小。丫 σ旦羧酸 u-二曱基乙基酯(即步驟c的產物)(〇 16g)溶液, 20 在其中加入氫溴酸(48%水溶液,0.35 mL),並將生成 之混合物在環境溫度攪拌15分鐘。將有機相傾析,並 ,飽和碳酸氫鈉水溶液處理殘餘物。將水相以10%在二 氣甲燒中的甲醇萃取(2x)。將合併萃取物乾燥(MgS〇4) 並濃縮以提供呈黃色固體的標題產物(0.06g)。 87 201204254 NMR (DMSO-d6) δ 9·97 (br s,1H),8_61 (d, 1Η),7·94 (s,1H),7.84 (dd5 1H), 7.69 (s,1H),6.26 (br s,2¾ 5.22 (m,1H), 3.74 (t, 2H), 3·52 (t,2H)。 5 步驟 E : N-[6-胺基-5-氯-2-[[1-[(2e)_3_(4_氣苯基)_2_ 丙烯-1·基]-3-吖丁啶基]氧基]_3_。比啶基]_2_ 氯_4_吡啶羧醯胺的製備 對THF (3mL)中的N-[6-胺基_2-(卜吖咀氧基)_5_ 氣-3-吼咬基]-2-氣·4-π比咬敌醯胺(即步驟〇的產物)(57 10 mg,0·16 mmol)溶液,將其以3-(4-氣苯基)_2-丙烯醛 (32 mg ’ 1.2當里)、二乙醯氧基石朋氫化納(41 mg,1 2 當量)及醋酸(11 μί,1.2當量)處理,並將生成之混 合物在環境溫度攪拌隔夜。將該混合物以1Ν氫氧化鈉 水溶液處理,然後以二氣甲烷(2χ)萃取。將有機相乾 15 燥(Mgs〇4) ’並藉由層析術(石夕膠,EtOAc至5%在S 84 201204254 0.28 mmol ), triethyl ethoxylate (57 mg' 0.28 mmol), THF (3 mL) and acetic acid (16 pL), and the mixture was stirred overnight at ambient temperature. The mixture was treated with saturated aqueous sodium bicarbonate and extracted with dichloromethane (2 EtOAc). The combined organic phases were dried (MgS04), 5 and the concentrated residue was purified by chromatography (EtOAc, 30% ethyl acetate in hexanes (1% Et2NH) to 1% in ethyl acetate Purification of Et2NH) gave the title product (the compound of the invention) (21 mg). [H NMR δ 8.66 (d, 1H), 8.61 (d, 1H), 8.31 (br s, 1H)5 7.78 ίο (d, 1H), 7.63 (dd, 1H), 7.28 (s, 4H), 7.00 ( D5 1H), 6.48 (d, 1H), 6.01 (dd, 1H), 5.31 (m, 1H), 3.78 (m, 2H), 3.31 (m5 2H), 3.01 (m, 1H), 1.16 (d, 3H ). Synthesis Example 7 15 N-[6-Amino-5-gas-2-[[l-[(2E)-3-(4-)-phenylphenyl)-2-propan-1-yl]-3-° Azetidinyloxy]-3-ylpyridinyl]-2-chloro-4-. Preparation of Bipyridyl Carboxamide (Compound 92) Step A · 3-Gas-2,6-Diox-5-Tridentyl α Ratio α Prepared for fuming nitric acid (density 1.5 g/mL, 40 mL) 3-Chloro-2-indole-2,6-difluoro. More than a bite (4.94 g, 33.0 mmol) solution, to which sulfuric acid (30 mL) was added dropwise. The temperature of the reaction mixture rose to 38 °C. The mixture was then heated at 60 ° C for 1.5 hours, cooled on ice and extracted with hexane (2 Torr). The hexane extract was concentrated to give the title compound (3.7 g). The aqueous layer was extracted with di-methane, then dried (MgSO.sub.4) and concentrated to afford additional product (2.45 g). 85 201204254 , HNMR 5"Ut,m). Step B: 〇r '[(5-Ga-6-fluoroshawyl-2-° ratio octyl)oxy]_1_0丫σdonic acid 1,1-dimethyl Preparation of the base ethyl group _ 3's meryl pyridine (ie the product of step a) jiangsheng g, 1.5 equivalents) was combined in toluene (5 ° mL), and the mixture was stirred overnight at ambient temperature Then dilute with ether = mouth: wash the strip with water (3x) and dry (Mgs 〇 4). Purify the concentrated residue by layer: gel 5% to 15% ethyl acetate in hexane The title product (G.68 g, 8 % purity) was obtained, which can be used in the next step without further purification. 咕 δ 8.56 (d, 1H), 5 39 (m, 1H), 4 % (9) , 2H), 4 〇8 (m, 2H), 1.45 (s, 9H). 15 v-CH [6-amino-5-gas-3-[[(2-chloro-4.) than bite) Preparation of 1,1-dimercaptoethyl ester of carbyl]amino]_2_〇pyridinyl]oxy]_1_吖~d carboxylic acid '6 gas IT butanol (18 mL) and water (Μ) 3-[(5_氯=_3·吨基和比咬基)oxy]小十旦峡仏二乙乙Π Step B) (〇.68g) mixture, which is iron powder (4 〇叩, ^ and chlorination record (63%, 118 with. 'The resulting mixture is heated under reflux for 5 。 minutes. Will be fined = 细 物 物 物 物 物 物 物 释 释 释 释 C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C C Dissolve the residue in the heart: re-t 25 201204254. Re-dissolve the residue in dioxane (20 mL) and add 4-(dimethylamino) bite (24 mg '0.20 mmol), Triethylamine (0.68 mL '4.9 mmol) and 2-gas-4-pyridinecarbonyl vapor (500 mg). The mixture was stirred at ambient temperature for 3 days, then treated with 1N aqueous sodium hydroxide solution. The mixture is separated, dried (MgS04) and the organic phase is concentrated. The compound in the residue is separated by chromatography (EtOAc EtOAc (EtOAc: EtOAc) [[5-Chloro-3-[[(2.sup.4-pyridyl)carbonyl]amino]]6-fluoro-2-pyridyl]oxy]-1-indole. Ethyl ethyl ester (〇37 g) and the title product (0_16 g). lH NMR δ 8.59 (d5 1H), 8.56 (s, 1H), 7.92 (br s, 1H), 7.74 (s, 1H), 7.59 (dd,1H), 5.29 (m,1H), 4.67 (br s, 2H), 4.34 (dd, 2H), 4.0 0 (dd5 2H), 1.45 (s, 9H) 〇15 Step D: N-[6-Amino-2-(1-indoleoxy)_5_chloro-3-pyridyl]-2- gas-4 -Preparation of pyridine carboxamide to 3-[[6-amino-5-chloro-3-[[(2-chloro-4 - °)pyridyl)]amine in di-methane (7 mL) The base]_ 2 _ α is smaller than the bite base] gas base].丫 旦 羧酸 carboxylic acid u-dimercaptoethyl ester (ie product of step c) (〇 16g) solution, 20 added hydrobromic acid (48% aqueous solution, 0.35 mL), and the resulting mixture at ambient temperature Stir for 15 minutes. The organic phase was decanted and the residue was treated with saturated aqueous sodium bicarbonate. The aqueous phase was extracted with 10% methanol in a methane (2x). The combined extracts were dried (MgSO4) elute 87 201204254 NMR (DMSO-d6) δ 9·97 (br s,1H),8_61 (d, 1Η),7·94 (s,1H), 7.84 (dd5 1H), 7.69 (s,1H),6.26 ( Br s,23⁄4 5.22 (m,1H), 3.74 (t, 2H), 3·52 (t,2H). 5 Step E: N-[6-Amino-5-chloro-2-[[1-[ (2e)_3_(4_Phenylphenyl)_2_ propylene-1·yl]-3-azetidinyl]oxy]_3_.pyridinyl]_2_chloro-4-pyridiniumcarboxamide Preparation in THF (3mL) N-[6-Amino-2-(Busoximeoxy)_5_Ga-3-indole]-2-gas·4-π ratio bitten amide (ie the product of the step )) (57 10 Mg, 0·16 mmol) solution, 3-(4-phenylphenyl)_2-acrolein (32 mg '1.2 ali), diethyl ethoxy sulfonate (41 mg, 12 equivalents) Treated with acetic acid (11 μί, 1.2 eq.), and the resulting mixture was stirred overnight at ambient temperature. The mixture was treated with 1N aqueous sodium hydroxide and then extracted with di-methane (2 EtOAc). Mgs〇4) 'and by chromatography (Shixi gum, EtOAc to 5% at

EtOAc中的MeOH)純化濃縮後的殘餘物以得到標題產 物(本發明之化合物)(17 mg)。 NMR δ 8.58 (d, 1Η), 8.55 (s, 1H), 7.98 (br s5 1H), 7.74 (s,1H), 7.60 (d,1H),7.28 (s,4H),6.49 (dt, 1H),6.14 (dt, 20 1H), 5.23 (m, 1H), 4.63 (br s, 2H), 3.82 (m, 2H), 3.31 (d, 2H),3.25 (m, 2H)。 合成實例8 2-氣-N-[6-氯-3-[[1-[(2Ε)·3-(4-氣苯基)-2-丙烯-1-基]_3·吖丁 25啶基]氧基]-4-嗒【口 +井】基]-4-吡啶羧醯胺(化合物96)的 製備The concentrated residue was purified to give the title compound (the compound of the invention) (17 mg). NMR δ 8.58 (d, 1 Η), 8.55 (s, 1H), 7.98 (br s5 1H), 7.74 (s, 1H), 7.60 (d, 1H), 7.28 (s, 4H), 6.49 (dt, 1H) , 6.14 (dt, 20 1H), 5.23 (m, 1H), 4.63 (br s, 2H), 3.82 (m, 2H), 3.31 (d, 2H), 3.25 (m, 2H). Synthesis Example 8 2-Gas-N-[6-chloro-3-[[1-[(2Ε)·3-(4-Phenylphenyl)-2-propen-1-yl]_3·吖丁25 pyridine Preparation of oxy]-4-oxime [mouth + well] group]-4-pyridine carboxamide (Compound 96)

S 88 201204254 步驟A: 3-[(4-胺基-6-氯-3-σ荅【口 +井】基)氣基] • 吖咀羧酸U-二甲基乙基酯的製備 對DMF ( 100 mL)中的1,1-二甲基乙基3-輕基 吖咀羧酸酯(3·8 g,22.0 mmol)溶液,將其以氫化納 5 ( 60°/〇在油中’ 805 mg,18.3 mmol)處理,並將生成之 混合物在環境溫度攪拌10分鐘。加入3,6-二氯-4-塔【D +井】胺(3.0 g,18.3 mmol),並將混合物在9〇°c授掉 隔夜。以乙酸乙酯稀釋冷卻的混合物並以水(3x)、_ 水洗務及乾燥(MgS〇4)。藉由層析術(♦膠,梯度為 ίο 20%至50%在己烷中的EtOAc )純化濃縮後的殘餘物, 接著藉由以乙醚研磨以得到呈白色固體的標題化合物 (1.6 g)。 咕 NMR (丙酮-d6) δ 6.71 (s, 1H),6.18 (br s,2H), 5.46 (m 1H), 4.32 (br m, 2H), 3.95 (m, 2H), 1.42 (s, 9H) 〇 15 步驟B : 3-[[6-氣-4-[[(2-氣-4-吡啶基)羰基]胺基嗒 【口+井】基]氧基]-1-吖咀羧酸1,1_二甲基乙 基酯的製備 河一乳T玩、叫, RV 1、十胺丞+氣_3_嗒【口 20 +井】基)氧基]-1-十旦羧酸U-二甲基乙基酿(即步驟A 的產物)(1.55 g ’ 5.16 mmol):;容液,將其以4_二甲胺 基吼咬(63mg,〇·1當量)、三乙胺(2 15虹,3當量) 及2_氣_4_吼錢基氣化物(g)處理,並將之 混合物在環境溫度攪拌隔夜丨N氫氧化納水溶 液’並將混。合物賤拌1〇分鐘,接著以二氣甲院萃取 (2x)。乾燥(MgS〇4)合併的有機相,並藉由層析術 89 25 201204254 (矽膠,梯度為30%至60%在己烷中的乙酴 G酉旨)李出 濃縮後的殘餘物以得到呈黃色固體的標題化人 '、化 ° 物(1.4, 1H),7.77 2H)5 4.07 5 10 15 20 iH NMR δ 8.67 (d,1H),8.56 (s,1H),8.43 (br s (m, 1H), 7.61 (dd,1H),5.59 (m,1H), 4.46 (dd (m,2H),1.45 (s,9H)。 ’ 步驟C : N-[3-(3-。丫咀氧基H-氣_4_嗒【D + 氯-4-吡啶羧醯胺的製備 基] 對二氣甲烷(60 mL)中的3·[[6-氣 啶基德基]胺基Η-塔【口+井】基]氧基]小0丫。日=^°比 二甲基乙基酯(即步驟B的產物)(1 36g,酸U-溶液,將其以氳溴酸(48%水溶液,3丨miy mm〇l) 將生成之混合物在環境溫度攪拌15分鐘。處理’並 析,並以飽和碳酸氩鈉水溶液處理殘餘物。、有機相傾 固體,以水洗滌並在真空中乾燥以得到標題所得之 巾 NMR (DMSO_d6) δ 8.51 (s, 1H),8.38 k im, 、,1H),7.96 (s 1H),7.91 (s, 1H),5.43 (m,1H),4.28 (t,2H) 4 〇2 2H) ° 5 步驟 D : 2-氯-N-[6-氯-3-[[l-[(2E)-3_(4_氣苯基)_2_丙 稀-1-基]-3-e丫丁 α定基]氧基]_4_塔【口 +井】 基]-4-吡啶羧醯胺的製備 25 在THF ( 3 mL)中的N-[3-(3-吖η旦氧基)_6_氯_4_口荅 【口 +井】基]-2-氣-4-吡啶羧醯胺(即步驟c的產物Χ110 90S 88 201204254 Step A: 3-[(4-Amino-6-chloro-3-σ荅[口+井]基) gas base] • Preparation of U-dimethylethyl carboxylic acid ester to DMF a solution of 1,1-dimethylethyl 3-light oxime carboxylic acid ester (3·8 g, 22.0 mmol) in (100 mL) with sodium hydride 5 (60 ° / 〇 in oil' Treated with 805 mg, 18.3 mmol) and the resulting mixture was stirred at ambient temperature for 10 min. 3,6-Dichloro-4-tower [D + well]amine (3.0 g, 18.3 mmol) was added and the mixture was taken at 9 ° C overnight. The cooled mixture was diluted with ethyl acetate and washed with water (3x), water, and dried (MgS?). The title compound (1.6 g) was obtained from mjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjjj咕NMR (acetone-d6) δ 6.71 (s, 1H), 6.18 (br s, 2H), 5.46 (m 1H), 4.32 (br m, 2H), 3.95 (m, 2H), 1.42 (s, 9H) 〇15 Step B: 3-[[6-Gas-4-[[(2-)-4-pyridyl)carbonyl]amino][]]]]]]]]]]]]]] ,1_Dimethylethyl ester preparation River Yi milk T play, called, RV 1, decaamine oxime + gas _3_ 嗒 [mouth 20 + well] based) oxy]-1-decyl carboxylic acid U - Dimethylethyl (i.e., the product of Step A) (1.55 g ' 5.16 mmol): a liquid, which was bitten with 4-dimethylamine (63 mg, 〇·1 equivalent), triethylamine ( 2 15 rainbow, 3 equivalents) and 2_gas_4_吼 money base gas (g) were treated, and the mixture was stirred overnight at ambient temperature, 丨N aqueous sodium hydroxide solution 'and mixed. The mixture was mixed for 1 minute and then extracted with 2 gas (2x). The combined organic phases were dried (MgS〇4) and the concentrated residue was obtained by chromatography 89 25 201204254 (gelatin, gradient 30% to 60% acetonitrile in hexane). Titled person's yellow solid, 1.4 (1H), 7.77 2H) 5 4.07 5 10 15 20 iH NMR δ 8.67 (d, 1H), 8.56 (s, 1H), 8.43 (br s (m) , 1H), 7.61 (dd, 1H), 5.59 (m, 1H), 4.46 (dd (m, 2H), 1.45 (s, 9H). ' Step C: N-[3-(3-. Base H-gas _4_嗒 [Preparation of D + chloro-4-pyridinecarboxamide] 3·[[6-acridine-based] amidino-pyrene in di-methane (60 mL) [mouth + well] base] oxy] small 0 丫. day = ^ ° than dimethyl ethyl ester (ie the product of step B) (1 36g, acid U-solution, which is 氲 bromic acid (48% Aqueous solution, 3 丨miy mm〇l) The resulting mixture was stirred at ambient temperature for 15 minutes. Treatment was carried out and the residue was treated with saturated aqueous sodium bicarbonate. The organic phase was poured, washed with water and dried in vacuo. To obtain the title of the towel NMR (DMSO_d6) δ 8.51 (s, 1H), 8.38 k im, ,, 1H), 7.96 (s 1H), 7.91 (s, 1H ), 5.43 (m, 1H), 4.28 (t, 2H) 4 〇 2 2H) ° 5 Step D: 2-Chloro-N-[6-chloro-3-[[l-[(2E)-3_(4 _ gas phenyl) 2 - propylene-1-yl]-3-e 丫 α 定 ] ] 氧基 氧基 氧基 氧基 氧基 井 井 井 井 井 井 井 井 在 在 在 在 在 在 在 在N-[3-(3-吖ηdyloxy)_6_chloro_4_ 荅 [mouth + well] group] in the mL)] 2- gas-4-pyridine carboxamide (ie the product of step c) Χ110 90

S 201204254 mg,0.32 mmol),將其以3-(4-氣苯基)-2-丙浠趨·(65 mg,1.2當量)、三乙醯氧基硼氫化鈉(82 mg,1.2當 量)及醋酸(22 μί,1.2當量)處理,並將生成之混合 物在環境溫度攪拌隔夜。將該混合物以1Ν氫氧化鈉水 5 溶液處理,然後以二氯曱烷(2χ)萃取。將有機相乾燥 (MgS04),並藉由層析術(矽膠,梯度為EtOAc至5% 在EtOAc中的MeOH)純化濃縮後的殘餘物以得到呈白 色固體的標題產物(一種本發明之化合物)(44 mg)。 lU NMR δ 8.65 (d, 1Η), 8.53 (br s, 2H), 7.78 (s, 1H), 7.63 i〇 (dd, 1H), 7.28 (s, 4H), 6.50 (d, 1H), 6.13 (dt, 1H), 5.55 (m, 1H), 3.85 (m, 2H),3.43 (dd, 2H), 3.34 (d, 2H)。 藉由本文中所述製程以及該領域中習知方法,可製 備出下面表1到表118的化合物。下述為下面表中所使 用的簡稱:Me代表甲基,且Et代表乙基。用於說明取 15 代基之破折號(「-」)(例如:(R3)n或氓13)。)代表取代 基不存在。 表1S 201204254 mg, 0.32 mmol), 3-(4-phenylphenyl)-2-propanthene (65 mg, 1.2 eq.), sodium triethyloxy borohydride (82 mg, 1.2 eq.) Treatment with acetic acid (22 μί, 1.2 eq.) and the resulting mixture was stirred at ambient temperature overnight. The mixture was treated with a 1 NaOH solution of sodium hydroxide and then extracted with dichloromethane (2 EtOAc). The organic phase was dried (M.sub.3) and the title compound was purified eluting eluting (44 mg). lU NMR δ 8.65 (d, 1Η), 8.53 (br s, 2H), 7.78 (s, 1H), 7.63 i〇(dd, 1H), 7.28 (s, 4H), 6.50 (d, 1H), 6.13 ( Dt, 1H), 5.55 (m, 1H), 3.85 (m, 2H), 3.43 (dd, 2H), 3.34 (d, 2H). The compounds of Tables 1 to 118 below can be prepared by the processes described herein and by conventional methods in the art. The following are abbreviations used in the following tables: Me represents a methyl group, and Et represents an ethyl group. Used to describe the dash ("-") of the 15th generation base (for example: (R3)n or 氓13). ) represents a substituent that does not exist. Table 1

3 20 2 201204254 A1 係 CH ; R2 係 Η ; R1C 係 H ; (R14)a 係 2-C1 ; s 係 1 ;且t係 1 ° R8 R9 R22 R8 R9 R22 R8 R9 R22 F F Cl F F Br F F H F H Cl F H Br F H H H F Cl H F Br H F H H Cl Cl H Cl Br H Cl H H Br Cl H Br Br H Br H Cl H Cl Cl H Br Cl H H Cl Cl Cl Cl Cl Br Cl Cl H Cl cf3 Cl Cl cf3 Br Cl cf3 H F cf3 Cl F cf3 Br F cf3 H Br cf3 Cl Br cf3 Br Br cf3 H H cf3 Cl H cf3 Br H cf3 H Cl F Cl Cl F Br Cl F H cf3 H Cl cf3 H Br cf3 H H Br F Cl Br F Br Br F H Br Cl Cl Br Cl Br Br Cl H cf3 Cl Cl cf3 Cl Br cf3 Cl H cf3 F Cl cf3 F Br cf3 F H Cl Br Cl Cl Br Br Cl Br H F F F F F cf3 F F cf3o F H F F H cf3 F H cf3o H F F H F cf3 H F cf3o H Cl F H Cl cf3 H Cl cf3o H Br F H Br cf3 H Br cf3o Cl H F Cl H cf3 Cl H cf3o Cl Cl F Cl Cl cf3 Cl Cl cf3o Cl cf3 F Cl cf3 cf3 Cl cf3 cf3o F cf3 F F cf3 cf3 F cf3 cf3o Br cf3 F Br cf3 cf3 Br cf3 cf3o H cf3 F H cf3 cf3 H cf3 cf3o Cl F F Cl F cf3 Cl F cf3o 92 2012042543 20 2 201204254 A1 is CH; R2 is Η; R1C is H; (R14)a is 2-C1; s is 1; and t is 1 ° R8 R9 R22 R8 R9 R22 R8 R9 R22 FF Cl FF Br FFHFH Cl FH Br FHHHF Cl HF Br HFHH Cl Cl H Cl Br H Cl HH Br Cl H Br Br H Br H Cl H Cl Cl H Br Cl HH Cl Cl Cl Cl Cl Cl Cl Cl H Cl cf3 Cl Cl cf3 Br Cl cf3 HF cf3 Cl F cf3 Br F cf3 H Br cf3 Cl Br cf3 Br Br cf3 HH cf3 Cl H cf3 Br H cf3 H Cl F Cl Cl F Br Cl FH cf3 H Cl cf3 H Br cf3 HH Br F Cl Br F Br Br FH Br Cl Cl Br Cl Br Br Cl H cf3 Cl Cl cf3 Cl Br cf3 Cl H cf3 F Cl cf3 F Br cf3 FH Cl Br Cl Cl Br Br Cl Br HFFFFF cf3 FF cf3o FHFFH cf3 FH cf3o HFFHF cf3 HF cf3o H Cl FH Cl cf3 H Cl Cf3o H Br FH Br cf3 H Br cf3o Cl HF Cl H cf3 Cl H cf3o Cl Cl F Cl Cl cf3 Cl Cl cf3o Cl cf3 F Cl cf3 cf3 Cl cf3 cf3o F cf3 FF cf3 cf3 F cf3 cf3o Br cf3 F Br cf3 cf3 Br Cf3 cf3o H cf3 FH cf3 cf3 H cf3 cf3o Cl FF Cl F cf3 Cl F cf3o 92 201204254

A1 係 CH ; R2係H R8 R9 — R22 cf3 H --—^ F Br F F Br Cl F cf3 Cl F cf3 F F Cl Br F R10 係 H;(Ri4)a 係 2_C1;H :且 R8 R9 R22 r8 ’、 cf3 hA1 is CH; R2 is H R8 R9 — R22 cf3 H --—^ F Br FF Br Cl F cf3 Cl F cf3 FF Cl Br F R10 is H; (Ri4)a is 2_C1; H: and R8 R9 R22 r8 ' Cf3 h

Br Br CF3 cf3 Cl F Cl Cl F Br cf3 cf3 cf3 cf3 cf3Br Br CF3 cf3 Cl F Cl Cl F Br cf3 cf3 cf3 cf3 cf3

R22 CF3〇 cf3〇 cf3〇 cf3〇 cf3〇 cf3〇 t明揭露内容也包括表2flj3G,絲 將表1的列標題(即「A1係CH;r2 承了 iR14、從,ο, κ 係 H,R 係 Η ; a '、-Cl,S係1 ;且t係1」)替換成下面顯示的 列標題外,均與上面表i的建構方式相同。例如,在 表2中列標題係「A1係CH ; R2係H ; &amp;10係H ; (R、 係2,5-二-Cl ; S係1且t係1」,且R8、R9及r22係如上 面表1所界定。因此,表2中第一個項目明確地揭露 2,5-二氣-Ν-|&gt;[[1-[(2Ε)-3-(4·氯苯基)-2-丙烯小基]_3_。丫 丁啶基]氧基]-4,5-二氟苯基]-4_吡啶羧醯胺。表3至30 係類似架構。 10 表 2 3 4 5 6 9 10 ______列標題__ A1 係 R10 係 H; (R14)a 係 2,5-di-Cl; Γ^ΐ ;且 t 係 1二 A1 係 CH; R2 係 H; R1G 係 H; (R14)a 係 2,6-di-Cl; s 係丨;且 t 係 1。 A1 係 CH; R2 係 H; R1。係 H; (R14)a 係 2-C1,5-F; s 係!;且 t 係卜 A1 係 CH; R2 係 h; R1。係 H; (R14)a 係 2-C1,6-F; s 係!;且 t 係 1。 A1 係 CH; R2 係 H; R1Q 係 H; (R14)a 係 2-F; s 係 1 ;且 t 係 1 » A1 係 CH; R2 係 h; R1Q 係 H; (R14)a 係 2-F,5-C1; s 係!;且 t 係卜 A1 係 CH; R2 係 H; R1G 係 H; (R14)a 係 2,5-di-F; s 係丨;且 t 係 1。 A1 係 CH; R2 係 H; R1Q 係 H; (R14)a 係 2,6-di-F; s 係 1 ;且 t 係 1。 A1 係 CH; R2 係 H; R1Q 係 Cl; (R14)a 係 2-C1; s 係 1 ;且 t 係卜 A1 係 CH; R2 係 Me; R1G 係 H; (R14)a 係 2-C1; s 係 1 ;且 t 係 1。 93 11 201204254 表 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 _列標題_ A1 係 CH; R2 係 MeOC(O)-; R1G 係 H; (R14)a 係 2-C1; s 係 1;且 t 係 1。 A1 係 CH; R2 係 EtOCH2-; R1Q 係 H; (R14)a 係 2-C1; s 係 1 ;且 t 係卜 A1 係 CF; R2 係 H; R1G 係 H; (R14)a 係 2-C1; s 係 1 ;且 t 係 1。 A1 係 CH; R2 係 H; R1Q 係 F; (R14)a 係 2-C1; s 係 1 ;且 t 係 1。 A1 係 CH; R2 係 H; R1G 係 H; (R14)a 係 2-CF3; s 係 1 ;且 t 係 1。 A1 係 N; R2 係 H; R1Q 係 H; (R14)a 係 2-C1; s 係 1 ;且 t 係 1。 A1 係 N; R2 係 H; R10 係 H; (R14)a 係 2,5-di-Cl; s 係 1 ;且 t 係 1。 A1 係 N; R2 係 H; R1G 係 H; (R14)a 係 2,6-di-Cl; s 係 1 ;且 t 係 1。 A1 係 N; R2 係 H; R1G 係 H; (R14)a 係 2-C1,5-F; s 係 1 ;且 t 係 1。 A1 係 N; R2 係 H; R1Q 係 H; (R14)a 係 2-C1,6-F; s 係 I ;且 t 係 1。. A1 係 N; R2 係 H; R1G 係 H; (R14)a 係 2-F; s 係 1 ;且 t 係 1。 A1 係 N; R2 係 H; R1Q 係 H; (R14)a 係 2-F,5-C1; s 係 1 ;且 t 係 1。 A1 係 N; R2 係 H; R10 係 H; (R14)a 係 2,5-di-F; s 係 1 ;且 t 係 1。 A1 係 N; R2 係 H; R10 係 H; (R14)a 係 2,6-di-F; s 係 1 ;且 t 係 1。 A1 係 N; R2 係 H; R1Q 係 Cl; (RI4)a 係 2-C1; s 係 1 ;且 t 係 1。 A1 係 N; R2 係 Me; R1Q 係 H; (R14)a 係 2-C1; s 係 1 ;且 t 係 1。 A1 係 N; R2 係 MeOC(O)-; R1G 係 H; (R14)a 係 2-C1; s 係 1 ;且 t 係 1。 A1 係 N; R2 係 EtOCH2-; R1Q 係 H; (R14)a 係 2-C1; s 係 1 ;且 t 係 1。 A1 係 N; R2 係 H; R1Q 係 H; (R14)a 係 2-CF3; s 係 1 ;且 t 係 1。 A1 係 CH; R2 係 H; R1G 係 H; (R14)a 係 2-C1; s 係 2 ;且 t 係 2。 A1 係 CH; R2 係 H; R1Q 係 H; (R14)a 係 2-F; s 係 2 ;且 t 係 2。 A1 係 CH; R2 係 H; R1G 係 H; (R14)a 係 2-CF3; s 係 2 ;且 t 係 2。 A1 係 N; R2 係 H; R1Q 係 H; (R14)a 係 2-C1; s 係 2 ;且 t 係 2。 A1 係 N; R2 係 H; R1G 係 H; (R14)a 係 2-F; s 係 2 ;且 t 係 2。 A1 係 N; R2 係 H; R1G 係 H; (R14)a 係 2-CF3; s 係 2 ;且 t 係 2。 A1 係 CH; R2 係 H; R1Q 係 H; (R14)a 係 2-C1; s 係 2 ;且 t 係 1。 A1 係 N; R2 係 H; R1G 係 H; (R14)a 係 2-C1; s 係 2 ;且 t 係 1。 A1 係 CH; R2 係 H; R1G 係 H; (R14)a 係 2-C1; s 係 3 ;且 t 係 1。 A1 係 N; R2 係 H; R1G 係 H; (R14)a 係 2-C1; s 係 3 ;且 t 係 1。 表41R22 CF3〇cf3〇cf3〇cf3〇cf3〇cf3〇t The contents of the disclosure also include Table 2flj3G, which will list the column headings of Table 1 (ie “A1 is CH; r2 is under iR14, from, ο, κ H, R The system Η; a ', -Cl, S system 1; and t system 1") are replaced by the column headings shown below, and are constructed in the same manner as in the above table i. For example, in Table 2, the column headings are "A1 series CH; R2 series H; &amp; 10 series H; (R, system 2, 5-di-Cl; S system 1 and t system 1), and R8, R9 and R22 is as defined in Table 1 above. Therefore, the first item in Table 2 explicitly discloses 2,5-digas-Ν-|&gt;[[1-[(2Ε)-3-(4·chlorophenyl) )-2-propenyl small group]_3_. azetidinyl]oxy]-4,5-difluorophenyl]-4_pyridinecarboxamide. Tables 3 to 30 are similar structures. 10 Table 2 3 4 5 6 9 10 ______ column heading __ A1 is R10 H; (R14)a is 2,5-di-Cl; Γ^ΐ; and t is 1 2 A1 is CH; R2 is H; R1G is H; (R14) a is 2,6-di-Cl; s is 丨; and t is 1. A1 is CH; R2 is H; R1 is H; (R14)a is 2-C1,5-F; s system!; t) A1 is CH; R2 is h; R1 is H; (R14)a is 2-C1,6-F; s is!; and t is 1. A1 is CH; R2 is H; R1Q is H; (R14)a is 2-F; s is 1; and t is 1 » A1 is CH; R2 is h; R1Q is H; (R14)a is 2-F, 5-C1; s is!; and t is A1 is CH; R2 is H; R1G is H; (R14)a is 2,5-di-F; s is 丨; and t is 1. A1 is CH; R2 is H; R1Q is H; (R14) a is 2,6-di-F; s is 1; and t Line 1. A1 is CH; R2 is H; R1Q is Cl; (R14)a is 2-C1; s is 1; and t is A1 is CH; R2 is Me; R1G is H; (R14)a is 2 -C1; s is 1; and t is 1. 93 11 201204254 Table 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 37 37 38 39 40 _ column heading _ A1 Line CH; R2 is MeOC(O)-; R1G is H; (R14)a is 2-C1; s is 1; and t is 1. A1 is CH; R2 is EtOCH2-; R1Q is H; (R14)a 2-C1; s is 1; and t is A1 is CF; R2 is H; R1G is H; (R14)a is 2-C1; s is 1; and t is 1. A1 is CH; R2 is H; R1Q is F; (R14)a is 2-C1; s is 1; and t is 1. A1 is CH; R2 is H; R1G is H; (R14)a is 2-CF3; s is 1; and t is 1. A1 is N; R2 is H; R1Q is H; (R14)a is 2-C1; s is 1; and t is 1. A1 is N; R2 is H; R10 is H; (R14)a is 2,5-di-Cl; s is 1; and t is 1. A1 is N; R2 is H; R1G is H; (R14)a is 2,6-di-Cl; s is 1; and t is 1. A1 is N; R2 is H; R1G is H; (R14)a is 2-C1,5-F; s is 1; and t is 1. A1 is N; R2 is H; R1Q is H; (R14)a is 2-C1,6-F; s is I; and t is 1. A1 is N; R2 is H; R1G is H; (R14)a is 2-F; s is 1; and t is 1. A1 is N; R2 is H; R1Q is H; (R14)a is 2-F, 5-C1; s is 1; and t is 1. A1 is N; R2 is H; R10 is H; (R14)a is 2,5-di-F; s is 1; and t is 1. A1 is N; R2 is H; R10 is H; (R14)a is 2,6-di-F; s is 1; and t is 1. A1 is N; R2 is H; R1Q is Cl; (RI4)a is 2-C1; s is 1; and t is 1. A1 is N; R2 is Me; R1Q is H; (R14)a is 2-C1; s is 1; and t is 1. A1 is N; R2 is MeOC(O)-; R1G is H; (R14)a is 2-C1; s is 1; and t is 1. A1 is N; R2 is EtOCH2-; R1Q is H; (R14)a is 2-C1; s is 1; and t is 1. A1 is N; R2 is H; R1Q is H; (R14)a is 2-CF3; s is 1; and t is 1. A1 is CH; R2 is H; R1G is H; (R14)a is 2-C1; s is 2; and t is 2. A1 is CH; R2 is H; R1Q is H; (R14)a is 2-F; s is 2; and t is 2. A1 is CH; R2 is H; R1G is H; (R14)a is 2-CF3; s is 2; and t is 2. A1 is N; R2 is H; R1Q is H; (R14)a is 2-C1; s is 2; and t is 2. A1 is N; R2 is H; R1G is H; (R14)a is 2-F; s is 2; and t is 2. A1 is N; R2 is H; R1G is H; (R14)a is 2-CF3; s is 2; and t is 2. A1 is CH; R2 is H; R1Q is H; (R14)a is 2-C1; s is 2; and t is 1. A1 is N; R2 is H; R1G is H; (R14)a is 2-C1; s is 2; and t is 1. A1 is CH; R2 is H; R1G is H; (R14)a is 2-C1; s is 3; and t is 1. A1 is N; R2 is H; R1G is H; (R14)a is 2-C1; s is 3; and t is 1. Table 41

S 94 201204254S 94 201204254

A1 係 CH ; R2 係 Η ; R1G 係 Η ;且(R14)a 係 2-C1。 R8 R9 R22 R8 R9 R22 R8 R9 R22 F F Cl F F Br F F H F H Cl F H Br F H H H Cl Cl H Cl Br H Cl H Cl H Cl Cl H Br Cl H H Cl Cl Cl Cl Cl Br Cl Cl H Cl cf3 Cl Cl cf3 Br Cl cf3 H F cf3 Cl F cf3 Br F cf3 H Br cf3 Cl Br cf3 Br Br cf3 H H cf3 Cl H cf3 Br H cf3 H Cl F Cl Cl F Br Cl F H cf3 H Cl cf3 H Br cf3 H H Br F Cl Br F Br Br F H Br Cl Cl Br Cl Br Br Cl H cf3 Cl Cl cf3 Cl Br cf3 Cl H cf3 F Cl cf3 F Br cf3 F H Cl Br Cl Cl Br Br Cl Br H F F F F F cf3 F F CF30 F H F F H cf3 F H CF30 H Cl F H Cl cf3 H Cl CF30 Cl H F Cl H cf3 Cl H CF30 Cl Cl F Cl Cl cf3 Cl Cl CF30 Cl cf3 F Cl cf3 cf3 Cl cf3 CF30 F cf3 F F cf3 cf3 F cf3 CF30 95 201204254A1 is CH; R2 is Η; R1G is Η; and (R14)a is 2-C1. R8 R9 R22 R8 R9 R22 R8 R9 R22 FF Cl FF Br FFHFH Cl FH Br FHHH Cl Cl H Cl Br H Cl H Cl H Cl Cl H Br Cl HH Cl Cl Cl Cl Cl Cl Cl Cl H Cl cf3 Cl Cl cf3 Br Cl Cf3 HF cf3 Cl F cf3 Br F cf3 H Br cf3 Cl Br cf3 Br Br cf3 HH cf3 Cl H cf3 Br H cf3 H Cl F Cl Cl F Br Cl FH cf3 H Cl cf3 H Br cf3 HH Br F Cl Br F Br Br FH Br Cl Cl Br Cl Br Br Cl H cf3 Cl Cl cf3 Cl Br cf3 Cl H cf3 F Cl cf3 F Br cf3 FH Cl Br Cl Cl Br Br Cl Br HFFFFF cf3 FF CF30 FHFFH cf3 FH CF30 H Cl FH Cl cf3 H Cl CF30 Cl HF Cl H cf3 Cl H CF30 Cl Cl F Cl Cl cf3 Cl Cl CF30 Cl cf3 F Cl cf3 cf3 Cl cf3 CF30 F cf3 FF cf3 cf3 F cf3 CF30 95 201204254

A 係 CH,R2 係 Η ; R1。係 fj ;且(rm) R8 R9 R22 Rs JA system CH, R2 system Η; R1. Department fj ; and (rm) R8 R9 R22 Rs J

Br H Cl CF3 Br Br CF3 cf3Br H Cl CF3 Br Br CF3 cf3

Cl CF3 cf3 F H F Cl Cl F BrCl CF3 cf3 F H F Cl Cl F Br

F F F F F F F F FF F F F F F F F F F

Br H Cl CF3 Br Br cf3 cf3 Cl CF3 cf3 F H F Cl Cl F Br 2-C1 cf3 cf3 cf3 cf3 cf3 cf3 cf3 cf3 CF, R8 R9Br H Cl CF3 Br Br cf3 cf3 Cl CF3 cf3 F H F Cl Cl F Br 2-C1 cf3 cf3 cf3 cf3 cf3 cf3 cf3 cf3 CF, R8 R9

R 22R 22

Br H Cl CF3 Br Br CF3 cf3 Cl cf3 cf3 F H F Cl Cl F Br CF30 CF30 CF3〇 CF3〇 CF3〇 CF3O CF3〇 CF3〇 cf3o 本發明揭露内容也包括表42到70, 將表41的列標題(即「Ai係CH ; R Η 1() 且(Rl4w」)替換成下面顯示的各自列桿 均與t面表41的建構方式相同。例如,在表4〇中歹= 題係「Α係CH;R2係係Η;且(R14)係25仏 -G。」,且心Μ、如上面表41所界二、因此: 表40中第一個項目明確地揭露2 5_二氣_Ν 氯[1,1'_聯苯Η-基)甲基]_3H定基]氧基]_45_二氣笨 基]-4-吡啶羧醯胺。表43至70係類似架構。 表 42 43 44 45 46 47 48 49 A1 係 CH; A1 係 CH; A1 係 CH; A1 係 CH; A1 係 CH; A1 係 CH; A1 係 CH; A1 係 CH; R2 係 H; R1Q 係 η R2 係 H; R1(&gt; 係 η R2 係 H; R1Q 係 η R2 係 Η; R1Q 係 η R2 係 Η; R1G 係 η R2 係 Η; Rlc 係 η R2 係 Η; R1Q 係 η R2 係 Η; R1G 係 η 列標題 i(R14)a 係 2,5^ϊΐΓ^Γ 且(R14MS 2,6-di-Cl 且(R14)a 係 2-C1,5-F 且(R14)a 係 2-C1,6-F 且(R14)a 係 2-F。 且(R14)a 係 2-F, 5-α 且(R14)a 係 2,5-di-F。 •,且(R14)a 係 2,6-di-F 〇Br H Cl CF3 Br Br CF3 cf3 Cl cf3 cf3 FHF Cl Cl F Br CF30 CF30 CF3 CF3〇CF3〇CF3O CF3〇CF3〇cf3o The present disclosure also includes Tables 42 to 70, which will be the column headings of Table 41 (ie, The Ai series CH; R Η 1() and (Rl4w") are replaced by the same columns as shown in the following table. For example, in Table 4〇, the title line is "Α系CH; R2" The system is Η; and (R14) is 25仏-G.", and the heart is as defined in Table 41 above. Therefore: The first item in Table 40 explicitly exposes 2 5_二气_Ν chlorine [1 , 1'-biphenylfluorenyl-yl)methyl]_3H-decyl]oxy]_45_dioxaphenyl]-4-pyridinecarboxamide. Tables 43 through 70 are similar architectures. Table 42 43 44 45 46 47 48 49 A1 system CH; A1 system CH; A1 system CH; A1 system CH; A1 system CH; A1 system CH; A1 system CH; A1 system CH; R2 system H; R1Q system η R2 system H; R1(&gt; is η R2 H; R1Q is η R2 system; R1Q is η R2 system; R1G is η R2 system; Rlc is η R2 system; R1Q is η R2 system; R1G is η The column heading i(R14)a is 2,5^ϊΐΓ^Γ and (R14MS 2,6-di-Cl and (R14)a are 2-C1,5-F and (R14)a is 2-C1,6- F and (R14)a are 2-F. And (R14)a is 2-F, 5-α and (R14)a is 2,5-di-F. •, and (R14)a is 2,6- di-F 〇

Cv 96 201204254 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 列標題 A1 係 CH; R2 係 H; R1()係 Cl ;且(R14)a 係 2-C1。 A1 係 CH; R2 係 Me; R1G 係 Η ;且(R14)a 係 2-C1。 A1 係 CH; R2 係 MeOC(O)-; R1G 係 Η ;且(R14)a 係 2-α。 Α1 係 CH; R2 係 EtOCH2-; R1G 係 Η ;且(R14)a 係 2-C1。 A1 係 CF; R2 係 H; R1G 係 Η ;且(R14)a 係 2-C1。 A1 係 CH; R2 係 H; R1G 係 F ;且(R14)a 係 2-C1。 A1 係 CH; R2 係 H; R1Q 係 Η ;且(R14)a 係 2-CF3。 A1 係 N; R2 係 H; R1G 係 Η ;且(R14)a 係 2-C1。 A1 係 N; R2 係 H; R1()係 Η ;且(R14)a 係 2,5-di-Cl。 A1 係 N; R2 係 H; R10 係 Η ;且(R14)a 係 2,6-di-Q。 A1 係 N; R2 係 H; R1G 係 Η ;且(R14)a 係 2-C1, 5-F。 A1 係 N; R2 係 H; R1G 係 Η ;且(R14)a 係 2-C1,6-F。 A1 係 N; R2 係 H; R1G 係 Η ;且(R14)a 係 2-F。 A1 係 N; R2 係 H; R1G 係 Η ;且(R14)a 係 2-F,5-α。 Α1 係 Ν; R2 係 Η; R10 係 Η ;且(R14)a 係 2,5-di-F。 A1 係 N; R2 係 H; R1Q 係 Η ;且(R14)a 係 2,6-di-F。 A1 係 N; R2 係 H; R1G 係 Cl ;且(R14)a 係 2-C1。 A1 係 N; R2 係 Me; R1Q 係 Η ;且(R14)a 係 2-C1。 A1 係 N; R2 係 MeOC(O)-; R1G 係 Η ;且(R14)a 係 2-C1。 A1 係 N; R2 係 EtOCH2-; R1G 係 Η ;且(R14)a 係 2-α。 Α1 係 Ν; R2 係 Η; R1G 係 Η ;且(R14)a 係 2-CF3。 表71Cv 96 201204254 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 Column headings A1 is CH; R2 is H; R1() is Cl; and (R14)a is 2-C1. A1 is CH; R2 is Me; R1G is Η; and (R14)a is 2-C1. A1 is CH; R2 is MeOC(O)-; R1G is Η; and (R14)a is 2-α. Α1 is CH; R2 is EtOCH2-; R1G is Η; and (R14)a is 2-C1. A1 is CF; R2 is H; R1G is Η; and (R14)a is 2-C1. A1 is CH; R2 is H; R1G is F; and (R14)a is 2-C1. A1 is CH; R2 is H; R1Q is Η; and (R14)a is 2-CF3. A1 is N; R2 is H; R1G is Η; and (R14)a is 2-C1. A1 is N; R2 is H; R1() is Η; and (R14)a is 2,5-di-Cl. A1 is N; R2 is H; R10 is Η; and (R14)a is 2,6-di-Q. A1 is N; R2 is H; R1G is Η; and (R14)a is 2-C1, 5-F. A1 is N; R2 is H; R1G is Η; and (R14)a is 2-C1,6-F. A1 is N; R2 is H; R1G is Η; and (R14)a is 2-F. A1 is N; R2 is H; R1G is Η; and (R14)a is 2-F, 5-α. Α1 is Ν; R2 is Η; R10 is Η; and (R14)a is 2,5-di-F. A1 is N; R2 is H; R1Q is Η; and (R14)a is 2,6-di-F. A1 is N; R2 is H; R1G is Cl; and (R14)a is 2-C1. A1 is N; R2 is Me; R1Q is Η; and (R14)a is 2-C1. A1 is N; R2 is MeOC(O)-; R1G is Η; and (R14)a is 2-C1. A1 is N; R2 is EtOCH2-; R1G is Η; and (R14)a is 2-α. Α1 is Ν; R2 is Η; R1G is Η; and (R14)a is 2-CF3. Table 71

97 201204254 A1 (R22)b (R13)c A1 (R22)b (R13)〇 A1 (R22)b (R13)〇 CH 4-Cl 2-F CH 2,6-di-F, 4-Cl 2-F N 2-F, 4-Cl 2-F CH 4-C1 3-F CH 2,6-di-F, 4-Cl 3-F N 2-F, 4-Cl 3-F CH 2-F, 4-Cl — CH 4-Cl 2-Me N 2,6-di-F, 4-Cl — CH 2-F, 4-Cl 2-F N 4-Cl 2-F N 2,6-di-F, 4-Cl 2-F CH 2-F, 4-Cl 3-F N 4-Cl 3-F N 2,6-di-F, 4-Cl 3-F CH 2,6-di-F, 4-Cl — N 2-F, 4-Cl — N 4-Cl 2-Me 表72 Ί97 201204254 A1 (R22)b (R13)c A1 (R22)b (R13)〇A1 (R22)b (R13)〇CH 4-Cl 2-F CH 2,6-di-F, 4-Cl 2- FN 2-F, 4-Cl 2-F CH 4-C1 3-F CH 2,6-di-F, 4-Cl 3-FN 2-F, 4-Cl 3-F CH 2-F, 4- Cl — CH 4-Cl 2-Me N 2,6-di-F, 4-Cl — CH 2-F, 4-Cl 2-FN 4-Cl 2-FN 2,6-di-F, 4-Cl 2-F CH 2-F, 4-Cl 3-FN 4-Cl 3-FN 2,6-di-F, 4-Cl 3-F CH 2,6-di-F, 4-Cl — N 2- F, 4-Cl — N 4-Cl 2-Me Table 72 Ί

Α1 係 CH ; (R3)n 係 2-Me ;且 R4、R11 及 R12 係 Η。Α1 is CH; (R3)n is 2-Me; and R4, R11 and R12 are Η.

R8 R9 R8 R9 R8 R9 R8 R9 F F F cf3 Br Cl H F F H Br cf3 cf3 Cl H Br H Cl H cf3 cf3 F H cf3 Cl H Cl F Cl Br I H Cl Cl cf3 H H H ch3 H Cl cf3 Br F Br H cf2ho H 98 201204254R8 R9 R8 R9 R8 R9 R8 R9 F F F cf3 Br Cl H F F H Br cf3 cf3 Cl H Br H Cl H cf3 cf3 F H cf3 Cl H Cl F Cl Br I H Cl Cl cf3 H H H ch3 H Cl cf3 Br F Br H cf2ho H 98 201204254

本發明揭露内容也包括表73到85,且每個 ^ 72^ ( Γ Al ^ CH ; 2_^ - T 及R係Η。」)替換成下面顯示的各自列標題外, 均與上面表72的建構方式相同。例如,在表73中列標 題係/ Α係CH ; (R3)n係3-Me ;且R11及R12係η。」, 且R及R9係如上面表72所界定。因此,表73中第一 個項目明確地揭露2-氯-Ν·[2-[[1-[(2Ε)-3-(4-氣苯基)_2_ 丙烯-1-基]-3-甲基-3-吖丁啶基]氧基]_45_二氟苯基]Μη 比啶羧醯胺 。表 74 至 85 係類似 架構。 兔 73 74 75 76 77 78 80 81 82 83 84 85 ______列標題 Α1 係 CH; (R3)n 係 3-Me ;且 r4, ru 且 r12 係 η。 Α 係 CH,(R )η 係(η 係 〇); 係 Me ;且 Rii 且 ri2 係 η。 Α 係 CH,(R )η 係(η 係 〇); R4 且 r12 係 η ;且 Rii 係 ρ。 A1 係 CH; (R3)n 係(n 係 〇); R4 且 Rii 係 η ;且 R12 係 ρ。 A 係 CH; (R )n 係 (n 係 〇); R4 且 ri2 係 η ;且 Rii 係 Me。 A1 係 CH; (R )n 係 (n 係 〇); R4 且 Ri 1 係 η ;且 ri2 係 Me。 A1 係 N; (R3)n 係 2-Me ;且 r4, ru 且 r12 係 η。 Α1 係 N; (R3)n 係 3-Me ;且 r4, r11 且 r12 係 η。 Α1 係 N; (R )η 係‘ (η 係 〇); r4 係 Me ;且 R11 且 R12 係 η。 Α1 係 N; (R )η 係-’(η 係 〇); r4 且 r12 係 η ;且 Rii 係 f。 A1 係 N; (R3)n 係“-’’(n 係 〇); R4 且 Rii 係 η ;且 Ri2 係 ρ。 A1 係 N; (R3)n 係“-’’(n 係 0); R4 且 r〗2 係 η ;且 Rii 係 Me。 A1 係 N; (R3)n 係“-”(n 係 0); R4 且 Rii 係 η ;且 ri2 係 Me。 表86 99 201204254The disclosure of the present invention also includes Tables 73 to 85, and each of the ^72^(Γ Al ^ CH ; 2_^ - T and R system Η.") is replaced by the respective column headings shown below, and is the same as Table 72 above. The construction method is the same. For example, in Table 73, the column system is / Α CH; (R3) n is 3-Me; and R11 and R12 are η. And R and R9 are as defined in Table 72 above. Therefore, the first item in Table 73 explicitly discloses 2-chloro-indole [2-[[1-[(2Ε)-3-(4-carbophenyl))-2-propen-1-yl]-3-) Alkyl-3-azetidinyl]oxy]_45_difluorophenyl]Μη is a pyridinium carboxamide. Tables 74 through 85 are similar architectures. Rabbit 73 74 75 76 77 78 80 81 82 83 84 85 ______ Column heading Α1 is CH; (R3)n is 3-Me; and r4, ru and r12 are η. Α is CH, (R) η (η system ;); Me is; and Rii and ri2 are η. Α is CH, (R) η (η system ;); R4 and r12 are η; and Rii is ρ. A1 is CH; (R3)n is (n system 〇); R4 and Rii are η; and R12 is ρ. A system CH; (R) n system (n system 〇); R4 and ri2 are η; and Rii is Me. A1 is CH; (R)n is (n-system); R4 and Ri 1 are η; and ri2 is Me. A1 is N; (R3)n is 2-Me; and r4, ru and r12 are η. Α1 is N; (R3)n is 3-Me; and r4, r11 and r12 are η. Α1 is N; (R) η is '(η system 〇); r4 is Me; and R11 and R12 are η. Α1 is N; (R) η-'(η system ;); r4 and r12 are η; and Rii is f. A1 is N; (R3)n is "-'' (n system); R4 and Rii are η; and Ri2 is ρ. A1 is N; (R3)n is "-'' (n is 0); R4 And r is 2 is η; and Rii is Me. A1 is N; (R3)n is "-" (n is 0); R4 is and Rii is η; and ri2 is Me. Table 86 99 201204254

A1 係 CH ; (R3)n 係 2-Me ;以及 R4 係 Η。 R8 R9 R8 R9 R8 R9 R8 R9 F F F cf3 Br Cl H F F H Br cf3 cf3 Cl H Br Η Cl H cf3 cf3 F H cf3 Cl H Cl F Cl Br I H Cl Cl cf3 H H H ch3 H Cl cf3 Br F Br H cf2ho H 本發明揭露内容也包括表87到91,且每個表除了 5 將表86的列標題(即「Α1係CH ; (R3)n係2-Me ;且 R4係Η。」)替換成下面顯示的各自列標題外,均與上 面表86的建構方式相同。例如,在表87中列標題係「Α1 係CH ; (R3)n係3-Me ;且R4係Η。」,且R8及R9係如 上面表86所界定。因此,在表87中第一個項目明確地 ίο 揭露 2-氯-Ν-[4,5-二氟-2-[[1·[(4'-氟[Ι,Γ-聯苯]-4-基)曱 基]-3-甲基-3-吖丁啶基]氧基]苯基]-4-吼啶羧醯胺。表 88至91係類似架構。 表 87 88 _列標題 Α1 係 CH; (R3)n 係 3-Me ;且 R4 係 Η。 Α1 係 CH; (R3)n 係“-”(η 係 0);且 R4 係 Me。 201204254 表 89 90 91 _列標題 A1 係 N; (R3)n 係 2-Me ;且 R4 係 Η。 Α1 係 N; (R3)n 係 3-Me ;且 R4 係 Η。 Α1 係 N; (R3)n 係“-”(η 係 0);且 R4 係 Me。 表92A1 is CH; (R3)n is 2-Me; and R4 is Η. R8 R9 R8 R9 R8 R9 R8 R9 FFF cf3 Br Cl HFFH Br cf3 cf3 Cl H Br Η Cl H cf3 cf3 FH cf3 Cl H Cl F Cl Br IH Cl Cl cf3 HHH ch3 H Cl cf3 Br F Br H cf2ho H The contents also include Tables 87 to 91, and each table except Table 5 replaces the column headings of Table 86 (ie, "Α1 is CH; (R3)n-series 2-Me; and R4 is Η.") with the respective columns shown below. Except for the title, it is the same as the construction of Table 86 above. For example, in Table 87, the column headings are "Α1 is CH; (R3)n is 3-Me; and R4 is Η.", and R8 and R9 are as defined in Table 86 above. Therefore, the first item in Table 87 clearly discloses that 2-chloro-indole-[4,5-difluoro-2-[[1·[(4'-fluoro[Ι,Γ-biphenyl]-4) -yl)mercapto]-3-methyl-3-azetidinyl]oxy]phenyl]-4-acridinium carboxamide. Tables 88 through 91 are similar architectures. Table 87 88 _ column heading Α1 is CH; (R3)n is 3-Me; and R4 is Η. Α1 is CH; (R3)n is "-" (η system 0); and R4 is Me. 201204254 Table 89 90 91 _ column headings A1 is N; (R3)n is 2-Me; and R4 is Η. Α1 is N; (R3)n is 3-Me; and R4 is Η. Α1 is N; (R3)n is "-" (η system 0); and R4 is Me. Table 92

A1 係 CH ; R34 係 Η ; Z 係 CH ; s 係 1 ;且 t 係 1。A1 is CH; R34 is Η; Z is CH; s is 1; and t is 1.

R8 R9 R22 R8 R9 R22 R8 R9 R22 F F Cl F F Br F F H F H Cl F H Br F H H Η F Cl H F Br H F H Η Cl Cl H Cl Br H Cl H Η Br Cl H Br Br H Br H Cl H Cl Cl H Br Cl H H Cl Cl Cl Cl Cl Br Cl Cl H Cl cf3 Cl Cl cf3 Br Cl cf3 H F cf3 Cl F cf3 Br F cf3 H Br cf3 Cl Br cf3 Br Br cf3 H H cf3 Cl H cf3 Br H cf3 H Cl F Cl Cl F Br Cl F H cf3 H Cl cf3 H Br cf3 H H Br F Cl Br F Br Br F H Br Cl Cl Br Cl Br Br Cl H cf3 Cl Cl cf3 Cl Br cf3 Cl H 101 201204254 A1 係 CH ; R34 係 Η ; Z 係 CH ; s 係 1 ;且 t 係 1。 R8 R9 R22 R8 R9 R22 R8 R9 R22 cf3 F Cl cf3 F Br cf3 F H Cl Br Cl Cl Br Br Cl Br H F F F F F cf3 F F cf3o F H F F H cf3 F H cf3o Η F F H F cf3 H F cf3o Η Cl F H Cl cf3 H Cl cf3o Η Br F H Br cf3 H Br cf3o Cl H F Cl H cf3 Cl H cf3o Cl Cl F Cl Cl cf3 Cl Cl cf3o Cl cf3 F Cl cf3 cf3 Cl cf3 cf3o F cf3 F F cf3 cf3 F cf3 cf3o Br cf3 F Br cf3 cf3 Br cf3 cf3o H cf3 F H cf3 cf3 H cf3 cf3o Cl F F Cl F cf3 Cl F cf3o cf3 H F cf3 H cf3 cf3 H cf3o Br F F Br F cf3 Br F cf3o Br Cl F Br Cl cf3 Br Cl cf3o cf3 Cl F cf3 Cl cf3 cf3 Cl cf3o cf3 F F cf3 F cf3 cf3 F cf3o Cl Br F Cl Br cf3 Cl Br cf3o 本發明揭露内容也包括表93到110,且每個表除了 將表92的列標題(即「A1係CH ; R34係Η ; Z係CH ; s係1 ;且t係1。」)替換成下面顯示的各自列標題外, 均與上面表92的建構方式相同。例如,在表93中列標 題係「A1係N ; R34係Η ; Z係CH ; s係1 ;且t係1。」, 且R8、R9及R22係如上面表92所界定。因此,表93 的第一個項目明確揭露2-氣-N-[2-[[l-[2-(4-氯苯氧基) 201204254 乙基]-3 -σ丫丁咬基]氧基]_5,6-二氣_3-°比咬基]-4_atb咬叛 醯胺。表94至110係類似架構。 表 列標題 93 A1 係 N; R34 係 Η; Z 係 CH; s 係1 ; 且t係1。 94 A1 係 CH; R34 係 Me; Z 係 CH “ s係 1 ;且t係1。 95 A1 係 N; R34 係 Me; Z 係 CH; s係1 ;且t係1。 96 A1 係 CH; R34 係 Η; Z 係 N; s 係1 ; 且t係1。 97 A1 係 N; R34 係 Η; Z 係 N; s 係 1 ;且 t 係 1。 98 A1 係 CH; R34 係 Me; Z 係 N; s係1 :且t係1。 99 A1 係 N; R34 係 Me; Z 係 N; s 係1 ; 且t係1。 100 A1 係 CH; R34 係 Η; Z 係 CH; s係2 ;且t係2。 101 A1 係 N; R34 係 Η; Z 係 CH; s 係2 ; 且t係2。 102 A1 係 CH; R34 係 Me; Z 係 CH; s 係 2 ;且t係2。 103 A1 係 N; R34 係 Me; Z 係 CH; s係2 :且t係2。 104 A1 係 CH; R34 係 Η; Z 係 CH; s係2 :且t係1 ° 105 A1 係 N; R34 係 Η; Z 係 CH; s 係2 ; 且t係1。 107 A1 係 CH; R34 係 Me; Z 係 CH [;s係 2 ;且t係1。 108 A1 係 N; R34 係 Me; Z 係 CH; s係2 :且t係1。 109 A1 係 CH; R34 係 Η; Z 係 CH; s係3 :且t係1 ° 110 A1 係 N; R34 係 Me; Z 係 CH; s係3 :且t係1。 表 111R8 R9 R22 R8 R9 R22 R8 R9 R22 FF Cl FF Br FFHFH Cl FH Br FHH Η F Cl HF Br HFH Η Cl Cl H Cl Br H Cl H Η Br Cl H Br Br H Br H Cl H Cl Cl H Br Cl HH Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl Cl FH cf3 H Cl cf3 H Br cf3 HH Br F Cl Br F Br Br FH Br Cl Cl Br Cl Br Br Cl H cf3 Cl Cl cf3 Cl Br cf3 Cl H 101 201204254 A1 system CH ; R34 system Η ; Z system CH ; s Line 1; and t is 1. R8 R9 R22 R8 R9 R22 R8 R9 R22 cf3 F Cl cf3 F Br cf3 FH Cl Br Cl Cl Br Br Cl Br HFFFFF cf3 FF cf3o FHFFH cf3 FH cf3o Η FFHF cf3 HF cf3o Η Cl FH Cl cf3 H Cl cf3o Η Br FH Br Cf3 H Br cf3o Cl HF Cl H cf3 Cl H cf3o Cl Cl F Cl Cl cf3 Cl Cl cf3o Cl cf3 F Cl cf3 cf3 Cl cf3 cf3o F cf3 FF cf3 cf3 F cf3 cf3o Br cf3 F Br cf3 cf3 Br cf3 cf3o H cf3 FH Cf3 cf3 H cf3 cf3o Cl FF Cl F cf3 Cl F cf3o cf3 HF cf3 H cf3 cf3 H cf3o Br FF Br F cf3 Br F cf3o Br Cl F Br Cl cf3 Br Cl cf3o cf3 Cl F cf3 Cl cf3 cf3 Cl cf3o cf3 FF cf3 F cf3 cf3 F cf3o Cl Br F Cl Br cf3 Cl Br cf3o The present disclosure also includes Tables 93 to 110, and each table except the column heading of Table 92 (ie, "A1 system CH; R34 system Η; Z system CH ; s is 1; and t is 1. ") is replaced with the respective column headings shown below, and is constructed in the same manner as in Table 92 above. For example, in Table 93, the headings are "A1 series N; R34 system Η; Z system CH; s system 1; and t system 1", and R8, R9 and R22 are as defined in Table 92 above. Therefore, the first item in Table 93 clearly reveals 2-oxo-N-[2-[[l-[2-(4-chlorophenoxy) 201204254 ethyl]-3 -σ丫丁丁基]oxy ]_5,6-two gas _3-° than bite base] -4_atb bite retinoic acid. Tables 94 through 110 are similar architectures. Table headings 93 A1 is N; R34 is Η; Z is CH; s is 1; and t is 1. 94 A1 is CH; R34 is Me; Z is CH "s system 1; and t is 1. 95 A1 is N; R34 is Me; Z is CH; s is 1; and t is 1. 96 A1 is CH; System Η; Z system N; s system 1; and t system 1. 97 A1 system N; R34 system Z; Z system N; s system 1; and t system 1. 98 A1 system CH; R34 system Me; Z system N s is 1 and t is 1. 99 A1 is N; R34 is Me; Z is N; s is 1; and t is 1. 100 A1 is CH; R34 is Z; Z is CH; s is 2; t is 2. 101 A1 is N; R34 is Η; Z is CH; s is 2; and t is 2. 102 A1 is CH; R34 is Me; Z is CH; s is 2; and t is 2. 103 A1 Line N; R34 is Me; Z is CH; s is 2: and t is 2. 104 A1 is CH; R34 is Η; Z is CH; s is 2: and t is 1 ° 105 A1 is N; R34 is Z system CH; s system 2; and t system 1. 107 A1 system CH; R34 system Me; Z system CH [; s system 2; and t system 1. 108 A1 system N; R34 system Me; Z system CH; s system 2: and t system 1. 109 A1 system CH; R34 system Z; Z system CH; s system 3: and t system 1 ° 110 A1 system N; R34 system Me; Z system CH; s system 3: and t Department 1. Table 111

103 201204254 R22b 係 2-F ;以及 R34 係 Η。 R8 R9 R22a R8 R9 R22a R8 R9 R22a F F Cl F F Br F F H F H Cl F H Br F H H H F Cl H F Br H F H H Cl Cl H Cl Br H Cl H H Br Cl H Br Br H Br H Cl H Cl Cl H Br Cl H H Cl Cl Cl Cl Cl Br Cl Cl H Cl cf3 Cl Cl cf3 Br Cl cf3 H F cf3 Cl F cf3 Br F cf3 H Br cf3 Cl Br cf3 Br Br cf3 H H cf3 Cl H cf3 Br H cf3 H Cl F Cl Cl F Br Cl F H cf3 H Cl cf3 H Br cf3 H H Br F Cl Br F Br Br F H Br Cl Cl Br Cl Br Br Cl H cf3 Cl Cl cf3 Cl Br cf3 Cl H cf3 F Cl cf3 F Br cf3 F H Cl Br Cl Cl Br Br Cl Br H F F F F F cf3 F F CF30 F H F F H cf3 F H CF30 H F F H F cf3 H F CF30 H Cl F H Cl cf3 H Cl CF30 H Br F H Br cf3 H Br CF30 Cl H F Cl H cf3 Cl H CF30 Cl Cl F Cl Cl cf3 Cl Cl CF30 Cl cf3 F Cl cf3 cf3 Cl cf3 CF30 F cf3 F F cf3 cf3 F cf3 CF30 Br cf3 F Br cf3 cf3 Br cf3 CF30 H cf3 F H cf3 cf3 H cf3 CF30 Cl F F Cl F cf3 Cl F CF30103 201204254 R22b is a 2-F; and R34 is a Η. R8 R9 R22a R8 R9 R22a R8 R9 R22a FF Cl FF Br FFHFH Cl FH Br FHHHF Cl HF Br HFHH Cl Cl H Cl Br H Cl HH Br Cl H Br Br H Br H Cl H Cl Cl H Br Cl HH Cl Cl Cl Cl Cl Br Cl Cl H Cl cf3 Cl Cl cf3 Br Cl cf3 HF cf3 Cl F cf3 Br F cf3 H Br cf3 Cl Br cf3 Br Br cf3 HH cf3 Cl H cf3 Br H cf3 H Cl F Cl Cl F Br Cl FH cf3 H Cl Cf3 H Br cf3 HH Br F Cl Br F Br Br FH Br Cl Cl Br Cl Br Br Cl H cf3 Cl Cl cf3 Cl Br cf3 Cl H cf3 F Cl cf3 F Br cf3 FH Cl Br Cl Cl Br Br Cl Br HFFFFF cf3 FF CF30 FHFFH cf3 FH CF30 HFFHF cf3 HF CF30 H Cl FH Cl cf3 H Cl CF30 H Br FH Br cf3 H Br CF30 Cl HF Cl H cf3 Cl H CF30 Cl Cl F Cl Cl cf3 Cl Cl CF30 Cl cf3 F Cl cf3 cf3 Cl cf3 CF30 F cf3 FF cf3 cf3 F cf3 CF30 Br cf3 F Br cf3 cf3 Br cf3 CF30 H cf3 FH cf3 cf3 H cf3 CF30 Cl FF Cl F cf3 Cl F CF30

S 104 201204254S 104 201204254

R22b 係 2-F ; 以及R R8 R9 R22a cf3 ~ — H 一---- F Br F F Br Cl F cf3 Cl F cf3 F F Cl Br F Η。 R8 _ R9 R22a cf3 H cf3 Br F cf3 Br Cl cf3 cf3 Cl cf3 cf3 F cf3 Cl Br cf3 R8 R9 R22a cf3 H cf3o Br F cf3o Br Cl cf3o cf3 Cl cf3o cf3 F cf3o Cl Br cf3o 本發明揭露内容也包括表112到ιΐ4,且每個表除 了將表111的列標題(即「Rm係2_F;及尺34係Η。」) 替換成下面顯示的各自列標題外,均與上面表111的建 5 構方式相同。例如,表112中的列標題係「R22b係3_F ; ^ R34係Η。」’且R8、尺9及尺瓜係如上面表U1所界 定。因此,表112的第一個項目明確揭露2_氯 -N-[2-[[l-[2-(4-氣-3-氟苯氧基)乙基]-3·吖丁啶基;|氧 基]二氟_3-°比啶基H-吡啶羧醯胺。表113至114係 1〇 類似架構。 兔 112 113 114 -Γ77~~-_____列標題 ------- R22b 係 3-F ;且 R34 係 η. R22b 係 2-F ;且 R34 係 Me R22b 係 3-F ;且 1134係 Me 表115 201204254R22b is 2-F; and R R8 R9 R22a cf3 ~ - H----F Br F F Br Cl F cf3 Cl F cf3 F F Cl Br F Η. R8 _ R9 R22a cf3 H cf3 Br F cf3 Br Cl cf3 cf3 Cl cf3 cf3 F cf3 Cl Br cf3 R8 R9 R22a cf3 H cf3o Br F cf3o Br Cl cf3o cf3 Cl cf3o cf3 F cf3o Cl Br cf3o The present disclosure also includes a table 112 to ιΐ4, and each table is replaced with the column heading of Table 111 (ie, "Rm system 2_F; and ruler 34 system 」."), and is replaced with the respective column headings shown below, and is constructed in the same manner as Table 111 above. the same. For example, the column headings in Table 112 are "R22b is 3_F; ^ R34 is Η."' and R8, Ruler 9, and Ruler are defined as Table U1 above. Therefore, the first item in Table 112 clearly discloses 2_chloro-N-[2-[[l-[2-(4-gas-3-fluorophenoxy)ethyl]-3·azetidinyl; Difluoro] 3-fluoropyridyl H-pyridine carboxamide. Tables 113 through 114 are similar architectures. Rabbit 112 113 114 -Γ77~~-_____ column heading ------- R22b is 3-F; and R34 is η. R22b is 2-F; and R34 is Me R22b is 3-F; and 1134 is Me Table 115 201204254

s係1 ;且t係 1 〇 R9 ~~ _ R14 R22 C1 Cl F C1 Cl Cl C1 Cl Br Br Cl F Br Cl Cl Br Cl Br cf3 Cl F cf3 Cl Cl cf3 Cl Br R9 R14 r22 Cl cf3 F Cl cf3 Cl Cl cf3 Br Br cf3 F Br cf3 Cl Br cf3 Br cf3 cf3 F cf3 cf3 Cl cf3 cf3 Br R9 R14 R22 Cl Br 〜----- F Cl Br Cl Cl Br Br Br Br F Br Br Cl Br Br Br cf3 Br F cf3 Br Cl cf3 Br Br 本發明揭露内容也包括表116至118,且每個 I將表115的列標題(即「S係1;且t係卜」),替換 =下面顯示的各自列標題外,均與上面表115的建構方 式相$同。例如,在表116中列標題係rs係2;且£係2。」, 且R9、R14及R22係如上面表115所界定。因此,表116 中第一個項目明確地揭露2_氣_N-[6_氣 '3'[[1-[(2Ε)-3-(4-氟苯基)_2_丙烯_卜基]_4_旅啶基]氣 基]-4-嗒【口 +井】基]-4-吡啶羧醯胺。表in至118係 類似架構。 列標題 201204254 表 116 117 118 列標題 s係2 ;且t係2。 s係2 ;且t係1。 s係3 ;且t係1 〇 製劑/效用 本發明之化合物將通常用來作為組合物(即配方) 中之控制無脊椎動物害蟲的活性成分,並伴隨有至少一 選自由表面活性劑、固體稀釋劑及液體稀釋劑所組成之 群組的額外成分以作為載體之用。此製劑或組合物成分 係經選擇,以配合活性成分之物理性質、施用型態與土 壌種類、濕度和溫度等環境因素。 可用的配方包括液體及固體組合物。液體組合物包 括溶液(包括乳劑)、懸浮液、乳液(包括微乳液和/或 懸浮乳液(suspoemulsions))等等,並可選擇地將其增 濃成凝膠。含水液體組合物的一般類型為可溶劑 (soluble concentrate )、水懸劑(suspensi〇n concentrate)、膠囊懸著劑(capsule suspension)、濃縮 乳液、微乳液和懸浮乳液。非水液體組合物的一般類型 為乳劑、微乳劑、水分散性乳劑(dispersible concentrate ) 及水分散性油懸劑(oil dispersion)。 固體組合物的一般類型為塵粉(dusts)、粉劑、粒 劑、丸劑(pellets)、珠劑(prills)、錠劑(pastilles)、 片劑、包膜(filled films)(包括種子塗覆物)等等,其 可為水分散性(「可濕性」)或水溶性。從成膜溶液劑或 可流動懸浮劑形成的薄膜和塗層在種子處理上特別有 201204254 用。活性成分可以經( -懸浮體或固體配方;$囊包裹者以及進-步形成 膠囊包裹著(或「保$活性物f的配方可以經 或減緩活性成分的釋玫:裹者」)。膠囊包裹可以防治 t:(通常是水)中。喷_量二=釋物 15 20 =槽中與水或其他適合的介質混合,:由= 面施用而運用於葉治療,或施胁植物的生^中或地 體配方和乾配方可在_時,直接計量=。液 統或犁溝。液體和固體配方可以施用於 ^灌概系 欲植物的種子,作為播種前種子處理之用,他所 ;收以保護發育中的根及其它地下的植物部 忒配;5Tif巾含㈣效量在下%近 =:稀釋劑和界面活性劑,其重量加起來會二 水分散性粒劑及水溶性粒劑,片 劑及粉劑 水分散性油懸劑、懸浮液、乳 液、溶液(包括乳劑) 重量百分比 成分 0 001-90 1-50s is 1; and t is 1 〇R9 ~~ _ R14 R22 C1 Cl F C1 Cl Cl C1 Cl Br Br Cl F Br Cl Cl Br Cl Br cf3 Cl F cf3 Cl Cl cf3 Cl Br R9 R14 r22 Cl cf3 F Cl cf3 Cl Cl cf3 Br Br cf3 F Br cf3 Cl Br cf3 Br cf3 cf3 F cf3 cf3 Cl cf3 cf3 Br R9 R14 R22 Cl Br ~----- F Cl Br Cl Cl Br Br Br Br Br Br Br Br Br Br cf3 Br F cf3 Br Cl cf3 Br Br The present disclosure also includes tables 116 to 118, and each I will list the column headings of table 115 (ie, "S system 1; and t system"), replacing = respective columns shown below Except for the title, it is the same as the construction method of Table 115 above. For example, in Table 116, the column headings are rs 2; and the £ 2 is. And R9, R14 and R22 are as defined in Table 115 above. Therefore, the first item in Table 116 explicitly discloses 2_gas_N-[6_gas '3'[[1-[(2Ε)-3-(4-fluorophenyl)_2_propenyl] _4_TB pyridine base] gas base]-4-嗒 [mouth + well] base]-4-pyridine carboxamide. Tables in to 118 are similar architectures. Column heading 201204254 Table 116 117 118 Column headings s is 2; and t is 2. s is 2; and t is 1. s system 3; and t system 1 〇 formulation / utility The compound of the invention will generally be used as an active ingredient in a composition (ie formulation) for controlling invertebrate pests, accompanied by at least one selected from surfactants, solids An additional component of the group consisting of a diluent and a liquid diluent is used as a carrier. The formulation or composition ingredients are selected to match the physical properties of the active ingredient, the type of application and the environmental factors such as soil type, humidity and temperature. Useful formulations include liquid and solid compositions. Liquid compositions include solutions (including emulsions), suspensions, emulsions (including microemulsions and/or suspoemulsions), and the like, and optionally thickened to a gel. Typical types of aqueous liquid compositions are soluble concentrates, suspension concentrates, capsule suspensions, concentrated emulsions, microemulsions and suspension emulsions. Typical types of non-aqueous liquid compositions are emulsions, microemulsions, dispersible concentrates and water-dispersible oil dispersions. Typical types of solid compositions are dusts, powders, granules, pellets, prills, pastilles, tablets, filled films (including seed coatings) And so on, it can be water dispersible ("wettable") or water soluble. Films and coatings formed from film-forming solutions or flowable suspending agents are used in seed treatments in particular for 201204254. The active ingredient can be encapsulated by (-suspension or solid formula; $-encapsulated and step-forming capsules (or "preservation of active ingredient f can or slow the release of active ingredients: wrapper"). The package can be controlled in t: (usually water). Spray _ quantity two = release 15 20 = mixed with water or other suitable medium in the tank: applied to the leaf treatment by = surface application, or the growth of the plant ^ Medium or terrane formula and dry formula can be directly measured = _ liquid system or furrow. Liquid and solid formula can be applied to the seed of the plant, as a seed treatment before sowing, he; It is protected by the roots of the development and other underground plant parts. The 5Tif towel contains (4) the effect of the lower %=: diluent and surfactant, the weight of which will add dihydrate dispersible granules and water-soluble granules. , tablets and powders, water-dispersible oil suspensions, suspensions, emulsions, solutions (including emulsions), weight percent components 0 001-90 1-50

稀釋劑 0-99.999 界面活性劑 0-15 40-99Thinner 0-99.999 Surfactant 0-15 40-99

201204254 . 粉塵 1-25 70-99 0-5 細粒及顆粒 0.001-99 5-99.999 0-15 &quot; 高強度組合物 90-99 〇-1〇 0-2 固體稀釋劑包括例如’像是膨土、微晶高嶺石、厄 帖浦石及高嶺土的黏土、石膏、纖維素、二氧化鈦、氧 化鋅、殿粉、糊精、糖(例如乳糖、蔗糖)、梦石、滑 5 石、雲母、矽藻土、尿素、碳酸鈣、碳酸鈉及碳酸氫鈉 以及硫酸鈉。典型的固體稀釋劑在WatkinSeta1·的著作 中已經描述,Handbook of Insecticide Dust Diluents and Carriers, 2nd Ed.,Dorland Books,Caldwell, New Jersey。 液體豨釋劑包括例如,水、N,N-二甲基烷醯胺(例 ίο 如,N,N-二甲基曱醯胺)、寧烯、二甲基亞砜、N-烷基 吡咯啶酮(例如,N-甲基吡咯啶酮)、乙二醇、三乙二 醇、丙二醇、二丙二醇、聚丙二醇、碳酸伸丙酯、碳酸 伸丁酯、石壞(例如,白礦油、正構烧烴、異燒烴)、 烧基苯、院基萘、甘油、三乙酸甘油g旨(glycerol 15 triacetate)、山梨糖醇、芳烴、脫芳香脂族、烷基苯、 烧基萘、如環己自同、2-庚嗣、異佛爾酮及4-經基-4-甲基 -2-戊酮的酮、如乙酸異戊酯、乙酸己酯、乙酸庚酯、乙 酸辛酯、乙酸壬酯、乙酸十三酯及乙酸異莰酯的乙酸 醋、如燒化乳酸酿(alkyiated lactate ester )、二元酯及γ_ 20 丁内酯的其他酯類、以及醇類,其可為線性、分支、飽 和或不飽和,如甲醇、乙醇、正丙醇、異丙醇、正丁醇、 異丁醇、正己醇、2-乙基己醇、正辛醇、癸醇、異癸醇、 異十八醇、綠壤醇、月桂醇、十三醇、油醇、環已醇、 109 201204254 四氫糠醇、二丙酮醇及苯曱醇。液體稀釋劑也包括飽和 和不飽和脂肪酸的甘油酯(通常為c6-c22),像是植物 種子和水果油(例如橄欖、蓖麻、亞麻仁、芝麻、玉米、 化生、向日蔡、萄狩'、紅花、棉軒、黃豆、油菜軒、 5 椰子和棕櫚仁的油)、動物源性脂肪(例如牛油、豬肉 脂、豬油、鳕魚肝油、魚油)及其混合物。液體稀釋劑 也包括烧化脂肪酸(例如曱基化、乙基化、丁基化), 其中該脂肪酸可藉由水解來自植物和動物來源的甘油 酯而獲得,並可用蒸餾純化。典型的液體稀釋劑已經描 10 述在 Marsden, Solvents Guide,2nd Ed’,Interscience, New York, 1950。 本發明的固體和液體組合物通常包括一個或多個 界面活性劑。當加至液體中時,界面活性劑(也經稱為 「表面活性劑」)通常會改變(最常的是減少)液體的 15 表面張力。根據界面活性劑分子中親水性和親油性基的 性質,界面活性劑可用作為潤_、分㈣、乳化劑或 消泡劑。 界面活性劑可以分為義子性、陰離子性或陽離子 性。對本組合物有用之赫子表面活性劑,其包括,但 20 不限於:賴燒氧基,例如基於自然以及合成的酒精之 酒精烧氧基(其可能為分支或_)錢由酒精以及環 乳乙烧、丙稀氧化物、伸丁基氧化物或其混合物所製備 ,付’胺乙氧酸鹽、燒賴胺以及乙氧基麟醯胺;燒 氧基化甘油二酿,例如乙氧基黃豆、乾麻以及油菜籽 25 '由:烧基盼燒氧基,例如辛苯盼、乙氧酸鹽、壬基笨紛、 乙氧酸鹽、二*基⑽、乙氧酸鹽以及十二麟苯盼、 201204254 乙氧酸鹽、(由酚類 产 基氧化物或其混合物、㈣氧化物、伸丁 散合物由_氧化物及反向錢聚合物,其終端 基化脂肪酸酿以及油ί備=乙氧基化脂肪酸;乙氧 ,,4 . 夂/由月曰,乙氧基化甲基酯類;乙氧基化 其惫仆甘包括那些由環氧乙烷、丙烯氧化物、伸丁 亡m :::混合物製備者);脂肪酸酯、甘油酯類、 平 &gt; 曰土付生物、聚乙氧基酯類,例如聚乙氧基化山 10 15 20 酐月日肪H、聚乙氧基化山梨糖醇脂肪酸自旨以及聚 乙氧基化甘油脂肪酸自旨;其他山梨醇酐衍生物,例如山 梨醇酐1類,聚合的表面活性劑,例如隨機共聚物、嵌 段共聚物、聚乙二醇樹脂、紐或梳狀聚合物以及星狀 聚合物;聚乙烯二醇類(pegs);聚乙二醇脂肪酸酯; 聚矽氧基礎表面活性劑;以及糖衍生物,例如蔗糖酯 類、烷基多糖苷以及烷基多醣。 有用的陰離子表面活性劑,包括,但不限於:烷芳 基石黃酸以及其鹽類;羧化醇或烷基酚乙氧酸鹽;聯苯續 酸鹽衍生物;木質素以及木質素衍生物,例如木質磺酸 鹽;順丁烯二酸或琥珀酸或其酐;埽烴確酸鹽;磷酸鹽 酯類,例如酒精的磷酸鹽酯類,烷基酚的磷酸鹽酯類以 及苯乙烯基苯酚聚氧乙烯醚的磷酸鹽酯類;蛋白質基礎 表面活性劑;肌胺酸衍生物;酚醚硫酸鹽;油及脂肪酸 之磺酸鹽以及硫酸鹽;乙氧基烷基酚之磺酸鹽以及硫酸 鹽;醇之硫酸鹽;乙氧基醇之硫酸鹽;胺類以及醯胺之 磺酸鹽,例如Ν,Ν-烷牛磺酸酯;苯、異丙苯、甲苯、 茬,以及十二烷基苯及十三烷基苯;濃縮萘的磺酸鹽; 111 25 201204254 萘以及烧基萘的罐酸鹽;分顧石油的續酸鹽;石黃班拍醯 胺酸鹽;以及磺琥珀酸鹽以及其衍生物,例如二烷基磺 基琥珀酸酯鹽類。 有用之陽離子表面活性劑,包括,但不限於:醯胺 5 以及乙氧基醮胺;胺類,例如N-炫•基丙二胺、二丙烯 三胺以及二丙烯四胺、以及乙氧基胺類、乙氧基二胺以 及丙氧基胺類(從胺類以及環氧乙烷、丙烯氧化物、伸 丁基氧化物及其混合物製備);胺鹽,例如胺醋酸以及 二胺鹽類;四級氨鹽’例如四級鹽類、乙氧基四級鹽類 10 以及雙四級鹽類;以及胺氧化物,例如烧二甲胺氧化物 以及雙-(2-羥乙基)-烧基胺氧化物。 可用於本發明組合物的還有非離子界面活性劑與 陰離子界面活性劑的混合物,或是非離子界面活性劑與 陽離子界面活性劑的混合物。非離子、陰離子以及陽離 15 子表面活性劑,以及其使用建議在許多的出版參考文獻 中已經揭露,包括 McCutcheon’s Emulsifiers and Detergents, annual American and International Editions published by McCutcheon’s Division,The Manufacturing Confectioner Publishing Co. ; Sisely and Wood, 2〇 Encyclopedia of Surface Active Agents, Chemical Publ.201204254 . Dust 1-25 70-99 0-5 Fine particles and granules 0.001-99 5-99.999 0-15 &quot; High-strength composition 90-99 〇-1〇0-2 Solid diluent includes, for example, 'like swelling Soil, microcrystalline kaolinite, eucalyptus and kaolin clay, gypsum, cellulose, titanium dioxide, zinc oxide, temple powder, dextrin, sugar (such as lactose, sucrose), dream stone, slip 5 stone, mica, 矽Algae, urea, calcium carbonate, sodium carbonate and sodium bicarbonate, and sodium sulfate. Typical solid diluents are described in the work of Watkin Seta1, Handbook of Insecticide Dust Diluents and Carriers, 2nd Ed., Dorland Books, Caldwell, New Jersey. Liquid rinsing agents include, for example, water, N,N-dimethyl decylamine (e.g., N,N-dimethyl decylamine), decene, dimethyl sulfoxide, N-alkylpyrrole An ketone (eg, N-methylpyrrolidone), ethylene glycol, triethylene glycol, propylene glycol, dipropylene glycol, polypropylene glycol, propyl carbonate, butyl carbonate, stone bad (eg, white mineral oil, Normally burned hydrocarbons, isothermal hydrocarbons, alkylated benzene, phthalic acid naphthalene, glycerol, glycerol 15 triacetate, sorbitol, aromatic hydrocarbons, dearomatized aliphatic, alkylbenzene, alkylene naphthalene, Such as cycloheximide, 2-glyoxime, isophorone and 4-keto-4-methyl-2-pentanone ketone, such as isoamyl acetate, hexyl acetate, heptyl acetate, octyl acetate And acetic acid vinegar of decyl acetate, tridecyl acetate and isodecyl acetate, such as alkyiated lactate ester, diester and other esters of γ-20 butyrolactone, and alcohols, which may be Linear, branched, saturated or unsaturated, such as methanol, ethanol, n-propanol, isopropanol, n-butanol, isobutanol, n-hexanol, 2-ethylhexanol, n-octanol, decyl alcohol, Decanol, isostearyl alcohol, green soil alcohol, lauryl alcohol, tridecyl alcohol, oleyl alcohol, cyclohexanol, 109,201,204,254 tetrahydrofurfuryl alcohol, diacetone alcohol and benzyl alcohol Yue. Liquid diluents also include glycerides of saturated and unsaturated fatty acids (usually c6-c22), such as plant seeds and fruit oils (eg olives, ramie, linseed, sesame, corn, metabolites, Xiangri Cai, Liu Hunt', safflower, cotton stalk, soybean, rapeseed, 5 coconut and palm kernel oil), animal-derived fat (such as butter, pork fat, lard, cod liver oil, fish oil) and mixtures thereof. The liquid diluent also includes a burnt fatty acid (e.g., thiolated, ethylated, butylated), wherein the fatty acid can be obtained by hydrolyzing glycerides derived from plant and animal sources, and can be purified by distillation. Typical liquid diluents are described in Marsden, Solvents Guide, 2nd Ed', Interscience, New York, 1950. The solid and liquid compositions of the present invention typically comprise one or more surfactants. Surfactants (also known as "surfactants") typically change (and most often reduce) the surface tension of the liquid 15 when added to a liquid. Depending on the nature of the hydrophilic and lipophilic groups in the surfactant molecule, the surfactant can be used as a moisturizing agent, a sub-(four), an emulsifier or an antifoaming agent. Surfactants can be classified into prostagland, anionic or cationic. Herbicide surfactants useful in the present compositions, including, but not limited to: lyoalkoxy groups, such as alcohol based on natural and synthetic alcohols, which may be branched or _) by alcohol and ring milk Prepared by burning, propylene oxide, butyl oxide or a mixture thereof, adding 'amine ethoxylate, lysine and ethoxylated linaloamine; alkoxylated glycerin, such as ethoxylated soybeans , dry hemp and rapeseed 25 ' from: squid alkoxy, such as octyl phenyl, ethoxylate, sulfhydryl, ethoxylate, bis(10), ethoxylate and twelve lin Benzene, 201204254 ethoxylates, (from phenolic based oxides or mixtures thereof, (iv) oxides, butyl condensates from _oxides and reversed money polymers, terminally based fatty acids and oils Preparation = ethoxylated fatty acids; ethoxy, 4 . 夂 / by 曰, ethoxylated methyl esters; ethoxylated 惫 惫 甘 甘 including those from ethylene oxide, propylene oxide,丁死m :::mixer preparation); fatty acid esters, glycerides, flats > earthworms, polyethoxylates For example, polyethoxylated mountain 10 15 20 anhydride, H, H, polyethoxylated sorbitan fatty acid, and polyethoxylated glycerol fatty acid; other sorbitan derivatives, such as sorbitol Anhydride class 1, polymerized surfactants, such as random copolymers, block copolymers, polyethylene glycol resins, neo- or comb polymers, and star polymers; polyethylene glycols (pegs); polyethylene Alcohol fatty acid esters; polyoxynoxy base surfactants; and sugar derivatives such as sucrose esters, alkyl polyglycosides, and alkyl polysaccharides. Useful anionic surfactants, including, but not limited to, alkylaryllithoic acid and salts thereof; carboxylated or alkylphenol ethoxylates; biphenyl acid salt derivatives; lignin and lignin derivatives , for example, lignosulfonate; maleic acid or succinic acid or its anhydride; terpene hydrocarbon acid salt; phosphate esters, such as phosphate esters of alcohols, phosphate esters of alkylphenols, and styryl groups Phosphate esters of phenol ethoxylates; protein-based surfactants; creatinine derivatives; phenol ether sulfates; sulfonates and sulfates of oils and fatty acids; sulfonates of ethoxylated alkylphenols and Sulfate; sulfate of alcohol; sulfate of ethoxylated alcohol; sulfonate of amine and guanamine, such as hydrazine, decane-alkyl taurate; benzene, cumene, toluene, hydrazine, and twelve Alkylbenzenes and tridecylbenzenes; sulfonates of concentrated naphthalene; 111 25 201204254 Potassates of naphthalene and alkyl naphthalene; oil-removing acid hydrochloride; scutellaria sulphate; Acid salts and derivatives thereof, such as dialkyl sulfosuccinate salts. Useful cationic surfactants, including, but not limited to, decylamine 5 and ethoxylated decylamine; amines such as N-nonyl propylene diamine, dipropylene triamine, and dipropylene tetramine, and ethoxylate Amines, ethoxydiamines and propoxyamines (prepared from amines and ethylene oxide, propylene oxides, butyl oxides and mixtures thereof); amine salts such as amine acetic acid and diamine salts a quaternary ammonium salt such as a quaternary salt, an ethoxy quaternary salt 10 and a double quaternary salt; and an amine oxide such as dimethylamine oxide and bis-(2-hydroxyethyl)- Alkylamine oxide. Also useful in the compositions of the present invention are mixtures of nonionic surfactants with anionic surfactants, or mixtures of nonionic surfactants with cationic surfactants. Nonionic, anionic, and cationic 15 subsurfactants, as well as their use recommendations, have been disclosed in a number of published references, including McCutcheon's Emulsifiers and Detergents, annual American and International Editions published by McCutcheon's Division, The Manufacturing Confectioner Publishing Co.; Sisely and Wood, 2〇Encyclopedia of Surface Active Agents, Chemical Publ.

Co.,Inc.,New York,1964; and A S. Davidson and B。 Milwidsky, Synthetic Detergents, Seventh Edition, John Wiley and Sons, New York, 1987。 本發明組合物亦可包含製劑輔助物及添加劑,及本 25 技藝中熟知之製劑助劑(其中部分亦可視為提供固體稀 釋劑、液體稀釋液或界面活性劑之功能)。這些配方辅Co., Inc., New York, 1964; and A S. Davidson and B. Milwidsky, Synthetic Detergents, Seventh Edition, John Wiley and Sons, New York, 1987. The compositions of the present invention may also contain formulation aids and additives, as well as formulation auxiliaries well known in the art of 25 (some of which may also be considered to provide a function as a solid diluent, liquid diluent or surfactant). These formulas

S 112 201204254 劑以及添加劑可能防治:pH (緩衝溶液)、處理過程中 的發泡(防止14些聚有機矽氧烷發泡)、活性成份的沉 積(懸浮,)、黏滯性(觸變增稠劑)、外殼中之微生物 生長(抗菌劑)、產物的凍結(抗凍劑)、染色(染劑/ 顏料分散劑)、洗除(成膜劑或黏著劑)、蒸發(蒸發延 緩劑)、以及其他配方特性。成膜劑包括例如聚乙酸乙 烯、聚乙酸乙烯共聚物、聚乙烯吡咯烷酮_乙酸乙烯共 聚物、聚乙烯醇、聚乙烯醇共聚物及蠟。配方輔劑以及 添加劑的實例’包含那些列於]\4(^1^比6011,5¥〇11»1^2: Functional Materials, annual International and North American editions published by McCutcheon^s Division, The Manufacturing Confecti〇ner PubHshing c〇 ;以及 PCT公開號wo 03/024222其中之實例。 通常藉由將式1化合物及任何其他的活性成分溶 解於一溶劑中,或在液體或乾稀釋劑中將其磨碎,使該 活性成分併入本發明的組合物中。藉由簡單混合成分可 製備出液劑,包括乳劑。若打算用作為乳劑的液體組合 物之溶劑與水不互溶,則通常會在用水稀釋時,加入乳 化劑以乳化該含活性成分之溶劑。使用介質研磨機濕磨 粒子直徑達到2,000 μιη的活性成分漿體,以獲得平均 直徑在3 μηι以下的粒子。含水漿體可製成成品水懸劑 (參見如U_S. 3,060,084)或藉由喷霧乾燥進一步加工 成水分散粒劑。乾配方通常需要乾磨製程,其產生的平 均粒子直徑在2到1〇 μηι的範圍内。粉塵及粉末製備方 式係採取摻合,且通常加上研磨(如以錘磨或液能研磨 機)。細粒及顆粒製備方式則透過將活性材料噴灑於預 113 201204254 先形成之粒狀載體或以黏聚技術製成。見Browning, “Agglomeration”,Chemical Engineering,December 4, 1967, pp 147-48, Perry’s Chemical Engineer’s Handbook, 4th Ed_,McGraw-Hill, New York, 1963, 8-57 頁以及之 5 後,以及WO 91/13546。微丸劑可以經製備如U.S. 4,172,714所述。水分散性以及水溶性粒狀體可以經製 備如 U.S. 4,144,050、U.S. 3,920,442 以及 DE 3,246,493 所教示。片劑可以經製備如U.S. 5,180,587、U.S. 5,232,701以及U.S. 5,208,030所教示。膜料可以經製備 ίο 如 GB 2,095,558 以及 U.S· 3,299,566 所教示。 有關製劑技術之進一步資訊,見T. S. Woods, “The Formulator’s Toolbox - Product Forms for Modern Agriculture” in Pesticide Chemistry and Bioscience,The Food-Environment Challenge, T. Brooks and T ° R. is Roberts, Eds., Proceedings of the 9th InternationalS 112 201204254 Agents and additives may be controlled: pH (buffer solution), foaming during treatment (preventing 14 polyorganosiloxanes), deposition of active ingredients (suspension), viscosity (thixotropy) Thickener), microbial growth in the outer shell (antibacterial agent), freezing of the product (antifreeze), dyeing (dye/pigment dispersant), washing (filming agent or adhesive), evaporation (evaporation retarder) And other recipe features. Film formers include, for example, polyvinyl acetate, polyvinyl acetate copolymers, polyvinylpyrrolidone-vinyl acetate copolymers, polyvinyl alcohol, polyvinyl alcohol copolymers, and waxes. Examples of formulating adjuvants and additives' include those listed in \4(^1^ ratio 6011,5¥〇11»1^2: Functional Materials, annual International and North American editions published by McCutcheon^s Division, The Manufacturing Confecti 〇ner PubHshing c〇; and PCT Publication No. WO 03/024222, examples of which are generally obtained by dissolving a compound of formula 1 and any other active ingredient in a solvent, or grinding it in a liquid or dry diluent, The active ingredient is incorporated into the composition of the present invention. A liquid preparation, including an emulsion, can be prepared by simply mixing the ingredients. If the solvent of the liquid composition intended to be used as an emulsion is immiscible with water, it is usually diluted with water. An emulsifier is added to emulsify the solvent containing the active ingredient. The slurry of the active ingredient having a particle diameter of 2,000 μm is wet-ground using a media mill to obtain particles having an average diameter of 3 μηη or less. The aqueous slurry can be made into a finished product. The agent (see, for example, U_S. 3, 060, 084) or further processed into a water-dispersible granule by spray drying. The dry formulation usually requires a dry grinding process, which produces a flat The average particle diameter is in the range of 2 to 1 〇μηι. The dust and powder preparation method is blended, and usually added with grinding (such as hammer mill or liquid energy grinder). Fine particle and particle preparation methods are used to The material is sprayed onto a particulate carrier formed in Pre-113 201204254 or by cohesion technique. See Browning, “Agglomeration”, Chemical Engineering, December 4, 1967, pp 147-48, Perry's Chemical Engineer's Handbook, 4th Ed_, McGraw- Hill, New York, 1963, pages 8-57 and 5, and WO 91/13546. Pellets can be prepared as described in US 4,172,714. Water-dispersible and water-soluble granules can be prepared as in US 4 And the teachings of U.S. Patent No. 5, 280, 493, the disclosure of which is incorporated herein by reference to U.S. Pat. , see TS Woods, “The Formulator's Toolbox - Product Forms for Modern Agriculture” in Pesticide Chemistry and Bio Science, The Food-Environment Challenge, T. Brooks and T ° R. is Roberts, Eds., Proceedings of the 9th International

Congress on Pesticide Chemistry, The Royal Society of Chemistry,Cambridge, 1999,第 120-133 頁。也可參見 美國專利第3,235,361號第6欄16行到第7欄19行及 實例10-41 ;美國專利第3,309,192號第5欄43行到第 20 7 攔 62 行及實例 8、12、15、39、4卜 52、53、58、132、 138-140、162-164、166、167 及 169-182 ;美國專利第 2,891,855號第3欄66行到第5攔Π行及實例1-4 ; Klingman, Weed Control as a Science, John Wiley and Sons,Inc.,New York,1961,第 81—96 頁;Hance 等人, 25 Weed Control Handbook,第 8 版,Blackwell ScientificCongress on Pesticide Chemistry, The Royal Society of Chemistry, Cambridge, 1999, pp. 120-133. See also U.S. Patent No. 3,235,361, column 6, line 16 to column 7, line 19, and example 10-41; U.S. Patent No. 3,309,192, column 5, line 43 to column 20, line 62, and examples 8, 12, 15, 39, 4, 52, 53, 58, 132, 138-140, 162-164, 166, 167, and 169-182; US Patent No. 2,891,855, column 3, line 66, line 5, and examples 1-4; Klingman, Weed Control as a Science, John Wiley and Sons, Inc., New York, 1961, pp. 81-96; Hance et al, 25 Weed Control Handbook, 8th edition, Blackwell Scientific

Publications, Oxford, 1989 ;以及 Developments in 201204254 formulation technology, PJB Publications, Richmond, UK, 2000。 在下面的實例中’所有的配方均以常規方式製備。 化合物號碼則參照索引表A-F中的化合物。即使沒有 5 進一步的闡述,相信使用上述說明的本領域具有通常知 識者仍能夠最大程度地利用本發明。因此,以下實例僅 為說明之用,而絕非用於限制本發明之揭露内容。除非 另有說明’百分比為按重量計。Publications, Oxford, 1989; and Developments in 201204254 formulation technology, PJB Publications, Richmond, UK, 2000. In the examples below, all formulations were prepared in a conventional manner. For the compound number, refer to the compounds in the index tables A-F. Even without further elaboration, it is believed that those of ordinary skill in the art in the <RTIgt; Therefore, the following examples are for illustrative purposes only and are not intended to limit the disclosure of the invention. Unless otherwise stated, the percentages are by weight.

10 實例A 高強度濃縮物 化合物1 98.5% 矽氣凝膠 0.5% 合成非晶細碎土 實例B 1.0% 可濕性粉末 化合物2 65.0% 十二烷基酚聚二醇醚 2.0% 木質磺酸鈉 4.0% 石夕铭酸納 6.0% 蒙脫土(鍛燒) 實例C 23.0% 細粒 化合物1 10.0% 厄帖浦土細粒(低揮發物質 ,0.71/0.30 mm ; Q0 0% U.S. S. No. 25-50 篩) 115 15 20120425410 Example A High-intensity concentrate compound 1 98.5% Helium gel 0.5% Synthetic amorphous fine-grained soil Example B 1.0% Wettable powder compound 2 65.0% Dodecylphenol polyglycol ether 2.0% Sodium lignosulfonate 4.0 % 石夕铭酸纳 6.0% montmorillonite (calcined) Example C 23.0% Fine-grain compound 1 10.0% Eudragit soil fine particles (low volatile matter, 0.71/0.30 mm; Q0 0% USS No. 25-50 Sieve) 115 15 201204254

實例D 壓出顆粒 化合物2 25.0% 無水硫酸鈉 10.0% 粗木質磺酸鈣 5.0% 烧基萘續酸納 1.0% 鈣/鎂澎濶土 59.0%Example D Extrusion of particles Compound 2 25.0% anhydrous sodium sulfate 10.0% calcium crude lignosulfonate 5.0% sodium naphthoate 1.0% calcium/magnesium bauxite 59.0%

實例E 乳劑 化合物1 10.0% 聚氧乙稀山梨糖醇己油酸(polyoxyethylene 20.0% sorbitol hexoleate ) C6-C10脂肪酸曱酯 70.0%Example E Emulsion Compound 1 10.0% Polyoxyethylene 20.0% sorbitol hexoleate C6-C10 fatty acid oxime ester 70.0%

實例F 微乳液 化合物2 5.0% 聚乙烯基砒咯烷酮-乙烯乙酸鹽共聚物 30.0% 烧基聚葡萄糖苷(alkylpolyglycoside) 30.0% 甘油單油酸酯(glyceryl monooleate) 15.0% 水 20.0%Example F Microemulsion Compound 2 5.0% Polyvinylpyrrolidone-ethylene acetate copolymer 30.0% alkylpolyglycoside 30.0% glyceryl monooleate 15.0% water 20.0%

S 實例G 種子處理 化合物1 20.00% 聚乙烯基砒咯烷酮-乙烯乙酸鹽共聚物 5.00% 褐煤酸蠟 5.00% 木質磺酸鈣 1.00% 聚氧乙烯/聚氧丙烯塊狀共聚物 1.00% 硬脂醇(P0E 20) 2.00% 聚有機石夕烧(polyorganosilane) 0.20% 紅色染料 0.05% 水 65.75% 116 201204254 實例Η 肥料黏著劑 化合物2 2.5% 吡咯烷酮-苯乙共聚物 4.8% 三苯乙笨基16-乙氧化物(tristyrylphenyl 2.3% 16-ethoxylate ) talc 0.8% 玉米澱粉 5.0%S Example G Seed treatment compound 1 20.00% polyvinylpyrrolidone-ethylene acetate copolymer 5.00% montanic acid wax 5.00% calcium lignosulfonate 1.00% polyoxyethylene/polyoxypropylene block copolymer 1.00% hard fat Alcohol (P0E 20) 2.00% Polyorganosilane 0.20% Red dye 0.05% Water 65.75% 116 201204254 Example 肥料 Fertilizer Adhesive Compound 2 2.5% Pyrrolidone-Benzene Ethylene Copolymer 4.8% Triphenylethylidene 16- Ethoxylate (tristyrylphenyl 2.3% 16-ethoxylate) talc 0.8% corn starch 5.0%

Nitrophoska® Permanent 15-9-15 緩效性肥料 36.0〇/〇 (BASF) 高嶺土 38.0% 水 10.6%Nitrophoska® Permanent 15-9-15 Slow-acting fertilizer 36.0〇/〇 (BASF) Kaolin 38.0% Water 10.6%

實例I 可濕性粉末 化合物31 65.0% 十二烷基酚聚二醇醚 2.0% 木質磺酸鈉 4.0% 矽鋁酸鈉 6.0% 蒙脫土(鍛燒) 23.0%Example I Wettable powder Compound 31 65.0% Dodecylphenol polyglycol ether 2.0% Sodium lignosulfonate 4.0% Sodium strontium aluminate 6.0% Montmorillonite (calcined) 23.0%

實例J 微乳液 化合物147 5.0% 聚乙烯基砒咯烷酮-乙烯乙酸鹽共聚物 30.0% 烧基聚葡萄糖苷(alkylpolyglycoside) 30.0% 甘油單油酸醋(glyceryl monooleate ) 15.0% 水 20.0% 本發明之化合物對許多的無脊椎動物害蟲具有其 活性。這些害蟲包含棲息於不同環境之非脊椎動物,如 10 如植物葉子、根、土壤、採收的農作物或其他食物、建 117 201204254 築結構或動物皮膚。這些害蟲包含無脊椎動物 子(葉片、莖、花及果實)、種子、+ # &amp; 1 、葉 只J種于、木材、紡織纖 動物血液或組織為食’因此造成如生長或儲存農= 物、森林、溫式作物、觀賞性植物1圃作物、儲y 物或纖維產品、房子或其他結構或期内容物之受二 害,或者對人動物健康或公共衛生有害。熟悉該2 之人士將明瞭不是所有化合物對全部寄生蟲的: 長階段皆有相同效果。 10 15 20 本化合物與組合物可用於農藝上保護田間作物, 其免受食植性無脊椎動物害蟲侵害,以及也可在非農蓺 上保護其他園藝作物與植物,使其免受食植性無脊椎&amp; 物害蟲害。此應用包括保護作物與其他植物(意即農 藝的與非農藝的),其内含以遺傳工程導入之遺傳物質 (意即基因轉殖的)或藉基因突變的改良以提供有利的 性狀。該等性狀之實例包含對除草劑的耐受性、植食性 害蟲(如·昆蟲、壁蟲、辑蟲、物蛛、線蟲、蜗牛、植 物病原性真菌、細菌及病毒)抵抗性、改善植物生長、 增加對不利生長條件之耐受性,如高或低溫、低或高土 壤濕度,以及高鹽分、增加開花與結果實、提高產量、 更快成熟、提高收成產品之品質及/或營養值或改善吹 成產物之儲存或處理性質。基因轉殖植物可經改良以表 現多種性狀。植物之實例内含以遺傳工程或基因突變方 式提供之特徵,包括許多種表現殺蘇力菌(Bacillus thuringiensis)毒素之玉米、棉、黃豆及馬鈴薯,如YIELD GARD®、KNOCKOUT®、STARLINK®、BOLLGARD®、 NuCOTN®及NEWLEAF® ’及許多種财除草劑之玉米、 25 201204254 棉' 黃豆及油菜子,如ROUNDUPREADY®、LIBERTY LINK®、IMI®、STS1 CLEARFIELD®,以及表現 Ν· 乙醯基轉換酶(GAT)之作物,其提供草甘膦除草劑之 抵抗性或内含HRA基因之作物,該基因提供對於能抑 制乙醯乳酸合成酶(ALS)之除草劑之抵抗性。本化合 物與組合物可能與經由遺傳工程導入或基因突變改良 方式獲得之特徵產生協同交互作用,因此增加表現型表 現或特徵之有效性,或者增加本化合物與組合物控制無 脊椎動物害蟲之效果。尤其,本發明化合物與組合物可 月b與對無脊椎動物害蟲具有毒性的蛋白質表現型表現 或其他天然產物產生協同作用,以提供大於相加效果的 害蟲控制。 本發明之組合物亦選擇性地包含植物養分,例如, 一種肥料組合物,其包含至少一種選自氮、磷、鉀、硫、 鈣、鎂 '鐵、銅、硼、錳、鋅及鉬之植物養分。值得注 意的是組合物包含至少—種肥料組合物,其包含至少一 種選自氮、磷、鉀、硫、鈣及鎂之植物養分。本發明之 組合物進一步包含至少—種植物養分,其可為液體或固 體的型式。值得注意的是固體配方為粒劑、小桿狀劑 (small sticks)或片劑之型式。包含一種肥料組合物之 固體配方可經由將本發明之化合物或組合物與肥料組 合物連同製劑成分一起混合,接著以如粒化或擠壓之方 法製備該配方而製備。或者固體配方可藉由喷灑在揮發 溶液中之一種本發明化合物或組合物的溶液或懸浮液 至先前製備好之肥料組合物上,並接著將溶劑揮發而製 119 201204254 備 &gt; λ 粒劑、道料組合物為空間穩定的混合物之型式,例如: 小桿狀劑(small sticks)或片劑。 無卷!!農藝用途係指在除作物植物領域外之區域中的 蔹用、全,物害蟲控制。本發明之化合物及組合物之非農 括儲存之穀物、豆類及其_食中及諸如衣服 也,之織物中的無脊椎動物害蟲控制。本發明之化合 j合物之非農藝用途亦包括在觀#植物、森林中、 ,中、路旁及鐵路築路用地旁及在諸如草地、高爾 昜及牧場之草皮上的無脊椎動物害蟲控制。本發明 S物及組合物之非農藝用途亦包括在可由人類及/ 動物、農場動物、牧場動物、動物園動物或其他 動物居住之房屋及其他㈣物中的無脊椎動物害蟲控 制。本發明之化合物及組合物之非農藝用途亦包括控制 15 可破壞木材或建築物中使用之其他結構材料的害蟲,諸 如白犧。 本發明之化合物及組合物之非農藝用途亦包括藉 由控制寄生性或傳播侵染性疾病之無脊椎動物害蟲來 保護人類與動物之健康。動物寄生蟲尤其包括控制寄生 於寄主動物身體表面的外寄生蟲(例如:肩膀、腋窩、 20 腹部、大腿内側)。外寄生性或疾病傳播害蟲包括(例 如)恙蟎、蜱、虱、蚊子、蒼蠅、蟎及跳蚤。本發明之 化合物及組合物適於系統性及/或非系統性控制動物上 寄生蟲之彳文¥或感染。本發明之化合物及組合物適於對 抗外寄生性或疾病傳播害蟲。本發明之化合物及組合物 25 適於用來對抗侵擾農業加工動物的寄生蟲,例如牛、綿 羊、山羊、馬、豬、驢、路銳、水牛、兔、母雞、火雞、 201204254 鴨、鵝及蜜蜂;寵物動物及家畜,例如狗、貓、寵物鳥 及觀賞魚;以及所謂的實驗動物,例如倉鼠、天竺鼠、 大鼠及小鼠。藉由對抗該些寄生蟲,死亡率及效能下降 (依據肉、乳、羊毛、皮、蛋、蜂蜜等)得以降低,因 5 此施用包含本發明化合物之組合物使飼養動物更經濟 且更簡單。 農藝的與非農藝的無脊椎動物害蟲實例包含鱗翅 目(order Lepidoptera)的卵、幼蟲與成體,例如,夜 盜蛾(army worms )、切根蟲(cutworms)、尺礎(loopers) 10 與夜蛾科(Noctuidae)中的夜蛾亞種(heliothines)(例 如,大模(稻姓莖夜蛾(SesamiainferensWalker))、玉 米填(西非姓莖夜蛾(Sesamia nonagrioides Lefebvre))、蓮紋夜盜蟲(南方灰翅夜蛾(Spodoptera eridania Cramer))、草地夜蛾(秋夜盜蛾(Spodoptera 15 fugiperdaJ. E. Smith))、甜菜黏蟲(甜菜夜蛾(Spodoptera exigua Hiibner))、斜紋夜蛾(海灰翅夜蛾(Spodoptera littoralis Boisduval ))、黃帶夜盜蛾(黃條黏蟲 (Spodoptera ornithogalli Guerre ))、黑切根蟲(球菜夜 蛾(Agrotis ipsilon Hufnagel))、豆夜蛾(黎豆夜蛾 2〇 ( Anticarsia gemmatalis Hiibner))、大青蟲(觸角夜蛾 (Lithophane antennata Walker))、甘藍夜蛾(油菜甘蓝 夜蛾(Barathra brassicae Linnaeus))、大豆尺礎(大豆 夜蛾(Pseudoplusia includens Walker))、擬尺礎(粉斑 夜蛾(Trichoplusiani Hiibner))、菸草夜蛾(菸芽夜蛾 25 ( Heliothis virescens Fabricius));蠤(borers)、勒蛾 (casebearers )、網蛾類(webworms )、鱗翅目蛾類 121 201204254 (coneworms )、甘藍菜蟲(cabbageworms )及雕葉蟲填 蛾科(Pyralidae)中的雕葉蟲(skeletonizers)(例如: 歐洲玉米螺(歐洲玉米填蟲(Ostrinia nubilalis Httbner ))、臍橙蟲(臍橙煩(Amyelois transitella 5 Walker))、玉米根網蛾(朦草填(Crambus caliginosellus Clemens))、草地網蛾(螟蛾科(Pyralidae):草填亞科 (Crambinae))像是草地蟲(草地結網毛蟲 (Herpetogramma licarsisalis Walker))、甘蔗堪蟲(甘 嚴二點填(Chilo infuscatellus Snellen))、番茄小姓蟲(優 10 美填蟲(Neoleucinodes elegantalis Guen6e))、綠色小卷 葉蛾(Cnaphalocerusmedinalis)、葡萄小卷葉蛾(葡萄 野模(Desmia funeralis Httbner ))、甜瓜蟲(瓜野模 (Diaphania nitidalis Stoll ))、甘藍内部幼蟲(甘藍姐 (Helluala hydralis Guende )、黃色姓莖蟲(三化螺 15 (Scirpophaga incertulas Walker))、早芽姓蟲(黃尾白填 (Scirpophagainfuscatellus Snellen))、白色姓莖蟲(稻 白镇(ScirpophagainnotataWalker))、頂芽姓蟲(黃尾 白娱(Scirpophaga nivella Fabricius))、深色頭稻姓蟲(臺 灣稻模((^1〇口〇1&gt;^1«75115]\46&gt;〇^1〇)、甘藍煙草夜蛾(大 2〇 菜填(Crocidolomia binotalis English ));卷蛾科 (Tortricidae)之小卷葉蛾、蚜蟲、種子蟲及果實蟲(例 如:蘋果卷葉蛾(韻果蠹蛾(Cydia pomonella Linnaeus ))、葡萄漿果小卷蛾(葡萄堪蛾(Endopiza viteana Clemens ))、東方果蠹蛾(梨小食心蟲(Grapholita 25 molesta Busck))、柑橘偽蘋果蠢蛾(蘋果異形小卷蛾 (Cryptophlebia leucotreta Meyrick))、柑橘姓蟲(掛橘Example J Microemulsion Compound 147 5.0% Polyvinylpyrrolidone-ethylene acetate copolymer 30.0% alkylpolyglycoside 30.0% glyceryl monooleate 15.0% water 20.0% The compounds have activity against many invertebrate pests. These pests include invertebrates that inhabit different environments, such as plant leaves, roots, soil, harvested crops or other foods, or animal skin. These pests contain invertebrate seeds (leaves, stems, flowers and fruits), seeds, + # &amp; 1 , leaves only J, wood, textile fiber animal blood or tissue for food 'thus causing growth or storage of agriculture = Harmfulness of crops, forests, warm crops, ornamental crops, storage or fiber products, houses or other structures or period contents, or harmful to human animal health or public health. Those familiar with this 2 will understand that not all compounds are present for all parasites: the long-term effects are the same. 10 15 20 The compounds and compositions are useful for agronomically protecting field crops from herbivorous invertebrate pests and also protecting other horticultural crops and plants from non-farm farming from herbivores. Invertebrates & pests. This application includes the protection of crops from other plants (i.e., agronomic and non-agronomic) containing genetically engineered genetic material (meaning genetically transgenic) or genetic modification to provide favorable traits. Examples of such traits include tolerance to herbicides, resistance to herbivorous pests (eg, insects, wallworms, worms, spiders, nematodes, snails, phytopathogenic fungi, bacteria, and viruses), and improved plant growth. Increase tolerance to adverse growth conditions, such as high or low temperature, low or high soil moisture, and high salinity, increased flowering and fruiting, increased yield, faster maturity, improved quality and/or nutritional value of the harvested product or Improve the storage or handling properties of the blown product. Genetically transformed plants can be modified to exhibit a variety of traits. Examples of plants contain features provided by genetic engineering or genetic mutations, including many types of corn, cotton, soybeans and potatoes that express Bacillus thuringiensis toxins such as YIELD GARD®, KNOCKOUT®, STARLINK®, BOLLGARD ®, NuCOTN® and NEWLEAF® 'and many kinds of corn herbicides, 25 201204254 cotton 'soya and rapeseed, such as ROUNDUPREADY®, LIBERTY LINK®, IMI®, STS1 CLEARFIELD®, and the performance of Ν· acetyl-transferase (GAT) crops that provide resistance to glyphosate herbicides or crops containing HRA genes that provide resistance to herbicides that inhibit acetate lactate synthase (ALS). The compounds and compositions may interact synergistically with features obtained by genetic engineering introduction or genetic mutation modification, thereby increasing the effectiveness of phenotypic expression or characteristics, or increasing the effectiveness of the present compounds and compositions to control invertebrate pests. In particular, the compounds and compositions of the present invention may act synergistically with protein phenotypes or other natural products that are toxic to invertebrate pests to provide pest control greater than the additive effect. The composition of the present invention also optionally comprises a plant nutrient, for example, a fertilizer composition comprising at least one member selected from the group consisting of nitrogen, phosphorus, potassium, sulfur, calcium, magnesium 'iron, copper, boron, manganese, zinc and molybdenum. Plant nutrients. It is noted that the composition comprises at least one fertilizer composition comprising at least one plant nutrient selected from the group consisting of nitrogen, phosphorus, potassium, sulfur, calcium and magnesium. The composition of the present invention further comprises at least a plant nutrient which may be in the form of a liquid or a solid. It is worth noting that the solid formulation is in the form of granules, small sticks or tablets. A solid formulation comprising a fertilizer composition can be prepared by mixing the compound or composition of the present invention with a fertilizer composition together with the formulation ingredients, followed by preparation of the formulation in a manner such as granulation or extrusion. Alternatively, the solid formulation can be prepared by spraying a solution or suspension of a compound or composition of the present invention in a volatile solution onto a previously prepared fertilizer composition, and then volatilizing the solvent to produce 119 201204254 Preparation &gt; λ granules The ballast composition is in the form of a sterically stable mixture, such as: small sticks or tablets. No roll!! Agronomic use refers to the use of pest control in all areas except crop plants. The compounds and compositions of the present invention are controlled by non-agriculturally stored cereals, legumes, and invertebrate pests in fabrics such as clothing. The non-agronomic uses of the compounds of the present invention also include invertebrate pest control on the view, plants, forests, middle, roadside and railway road construction sites and on turf such as grassland, gorge and pasture. The non-agronomic uses of the S compositions and compositions of the present invention are also controlled by invertebrate pests in houses and other (four) that can be inhabited by humans and/or animals, farm animals, pasture animals, zoo animals or other animals. The non-agronomic use of the compounds and compositions of the present invention also includes the control of pests that can damage wood or other structural materials used in buildings, such as white sacrifice. The non-agronomic use of the compounds and compositions of the present invention also includes the protection of human and animal health by controlling invertebrate pests that parasitic or spread infectious diseases. Animal parasites include, inter alia, controlling ectoparasites that are parasitic on the surface of the host animal (eg, shoulders, armpits, 20 abdomen, inner thighs). Parasitic or disease-transmitting pests include, for example, ticks, ticks, ticks, mosquitoes, flies, ticks, and fleas. The compounds and compositions of the present invention are suitable for systemic and/or non-systematic control of parasites or infections in animals. The compounds and compositions of the present invention are suitable for the propagation of pests against ectoparasites or diseases. The compounds and compositions 25 of the present invention are suitable for combating parasites that infest agriculturally processed animals, such as cattle, sheep, goats, horses, pigs, donkeys, lures, buffalo, rabbits, hens, turkeys, 201204254 ducks, Goose and bees; pet animals and livestock such as dogs, cats, pet birds and ornamental fish; and so-called experimental animals such as hamsters, guinea pigs, rats and mice. By combating these parasites, mortality and efficacy are reduced (by meat, milk, wool, hide, egg, honey, etc.), as this application of a compound comprising a compound of the invention makes feeding animals more economical and simpler . Examples of agronomic and non-agronomic invertebrate pests include eggs, larvae and adults of the order Lepidoptera, for example, army worms, cutworms, loopers 10 and Heliothines in Noctuidae (eg, large mold (Sesamiainferens Walker), corn fill (Sesamia nonagrioides Lefebvre), lotus night thief Insects (Spodoptera eridania Cramer), Spodoptera 15 fugiperda J. E. Smith, Spodoptera exigua Hiibner, Spodoptera litura (Spodoptera littoralis Boisduval), yellow-spotted moth (Spodoptera ornithogalli Guerre), black-cutting rootworm (Agrotis ipsilon Hufnagel), Beanworm ( Anticarsia gemmatalis Hiibner), Lithophane antennata Walker, Barathra brassicae Linnaeus, Soybean base (soybean) Pseudoplusia includens Walker), Trichoplusiani Hiibner, Heliothis virescens Fabricius, Borers, casebearers, nets Moths (webworms), Lepidoptera moths 121 201204254 (coneworms), cabbageworms (cabbageworms) and larvae (Pyralidae) in the snail (skeletonizers) (eg: European corn snails (European corn snails) Ostrinia nubilalis Httbner), Amyelois transitella 5 Walker, Cornus caliginosellus Clemens, Grassland Moth (Pyralidae: Grass Filling) Crambinae) is like a grass worm (Herpetogramma licarsisalis Walker), a sugarcane caterpillar (Chilo infuscatellus Snellen), a tomato minor worm (Neoleucinodes elegantalis Guen6e) )), Cnaphalocerusmedinalis, Desmia funeralis Httbner, Melonia (Diaphania niti) Dalis Stoll )), larvae inside the cabbage (Helluala hydralis Guende), yellow snail (Scirpophaga incertulas Walker), early budworm (Scirpophagainfuscatellus Snellen), white name stem Insect (Scirpophagainnotata Walker), bud worm (Scirpophaga nivella Fabricius), dark-headed rice worm (Taiwan rice mold ((^1〇口〇1&gt;^1«75115]\ 46&gt;〇^1〇), Brassica chinensis (Crocidolomia binotalis English); Torricidae's small leaf moth, aphid, seed worm and fruit worm (eg apple leaf curl) Moth (Cydia pomonella Linnaeus), grape berry moth (Endopiza viteana Clemens), oriental fruit moth (Grapholita 25 molesta Busck), citrus pseudo-apple moth (Cryptophlebia leucotreta Meyrick), citrus surname (hanging orange)

S 122 201204254 填蟲(Ecdytolopha aurantiana Lima ))、紅帶小卷葉蛾(紅 帶卷蛾(Argyrotaenia velutinana Walker ))、斜帶小卷葉 蛾(斜紋卷葉蛾(ChoristoneurarosaceanaHarris))、蘋 果淺褐卷葉蛾(淺棕蘋果蛾(Epiphyas postvittana 5 Walker ))、歐洲葡萄漿果蛾(葡萄螟蛾(Eupoecilia ambiguella Httbner ))、蘋果頂芽卷葉蛾(褐卷蛾 (Pandemis pyrusana Kearfott))、雜食性小卷葉蛾(荷 蘭石竹小卷蛾(Platynota stultana Walsingham))、棒狀 果樹卷葉蛾(疆褐卷蛾(Pandemis cerasanaHubner))、 ίο 蘋果褐卷葉蛾(Pandemis heparana Denis &amp; Schiffermliller ));以及許多其他經濟上重要的鱗翅類 (例如:鑽紋蛾(小菜蛾(Plutella xylostella Linnaeus ))、棉紅鈴蟲(紅鈐麥蛾(Pectinophora gossypiella Saunders))、舞毒蛾(吉普赛舞蛾(Lymantria 15 dispar Linnaeus))、桃小食心蟲(桃姓果蛾(Carposina niponensis Walsingham))、桃芽蛾(桃枝麥蛾(Anarsia lineatella Zeller ))、馬鈴薯麥蛾(馬鈴薯蠢蛾 (Phthorimaea operculella Zeller))、斑帶潛葉罐(蘋果 細蛾(Lithocolletis blancardella Fabricius))、亞洲蘋果 2〇 潛葉繩(金紋细蛾(Lithocolletis ringoniellaS 122 201204254 Ecdytolopha aurantiana Lima ), Argyrotaenia velutinana Walker, Choristoneurarosaceana Harris, apple light brown Leaf moth (Epiphyas postvittana 5 Walker), European berry moth (Eupoecilia ambiguella Httbner), apple bud leaf moth (Pandemis pyrusana Kearfott), small omnivorous Leaf moth (Platynota stultana Walsingham), Pandemis cerasana (Hubner), ίο Pandemis heparana Denis &amp;Schiffermliller); Many other economically important lepidoptera (eg, Plutella xylostella Linnaeus), cotton red bollworm (Pectinophora gossypiella Saunders), gypsy moth (Gypsy moth (Lymantria 15 dispar) Linnaeus)), Carpathina niponensis Walsingham, peach bud moth (Anarsia li Neatella Zeller )), potato moth (Phthorimaea operculella Zeller), spotted leaf pot (Lithocolletis blancardella Fabricius), Asian apple 2〇 Loose leaf rope (Lithocolletis ringoniella

Matsumura))、瘤野填(稻縱捲葉模(Lerodea eufala Edwards))、蘋果潛葉蠅(蘋果潛蛾(Leucoptera scitella Zeller)));蜚蠊目(order Blattodea)的卵、若蟲與成 體,包括姬裴蠊科與S蠊科中的蟑螂(例如:東方蟑螂 25 (東方蜚蠊(Blatta oriental is Linnaeus ))、亞洲緯螂(亞 洲姬蠊(Blatella asahinai Mizukubo))、德國蟑螂(德國 123 201204254 姬蠊(Blattella germanica Linnaeus))、棕帶蟑螂(棕帶 * ’ 蜚蠊(Supella longipalpa Fabricius))、美洲蟑螂(美洲 大蠊(Periplaneta americana Linnaeus))、棕色緯螂(掠 · 色家蠊(Periplaneta brunnea Burmeister))、馬得拉緯螂 5 (馬得拉蜚蠊(Leucophaea maderae Fabricius))、煙色 嫜螂(黑胸大蠊(Periplaneta fuliginosa Service))、澳 洲蟑螂(澳洲家蠊(Periplaneta australasiae Fabr.))、龍 蝦璋螂(灰色蜚蠊(Nauphoeta cinerea Olivier))以及 平滑蟑螂(淡白森蠊(Symploce pallens Stephens))); ίο 朝翅目(order Coleoptera)的卵、食葉性、食果性、食 根性、食籽性與吃泡狀組織的幼蟲以及成體,包括長角 象鼻蟲科、豆象科與象鼻蟲科的象鼻蟲(例如:棉子象 鼻蟲(棉鈴象鼻蟲(Anthonomus grandis Boheman))、 水稻水象鼻蟲(稻水象甲(Lissorhoptrus oryzophilus i5 Kuschel ))、穀象(小紅鰹節蟲(Sitophilus granarius Linnaeus ))、米象鼻蟲(米象(Sitophilus oryzae Linnaeus ))、一年生藍草象鼻蟲(早熟禾象鼻蟲 (Listronotus maculicollis Dietz ))、藍草象曱(莓系牧 草榖象(Sphenophorus parvulus Gyllenhal))、 獵穀象(小 2〇 赭穀喙曱(Sphenophorus venatus vestitus))、丹佛穀象 (Sphenophorus cicatristriatus Fahraeus ));葉曱科 (Chrysomelidae)之跳甲、黃瓜葉甲、根蟲、葉曱、馬 龄薯甲蟲及潛葉蛾(如:科羅拉多馬铃薯曱蟲(Colorado potato beetle)馬铃薯曱蟲(Leptinotarsa decemlineata 25 Say)、西方玉米根蟲(玉米根螢葉曱(Diabrotica virgifera virgifera LeConte)));金龜子及其他金龜子科(famiiyMatsumura)), tumor fill (Lerodea eufala Edwards), apple leaf miner (Leucoptera scitella Zeller); eggs of order Blattodea, nymphs and adults Including 裴蠊 裴蠊 与 蟑螂 ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( ( Blattella germanica Linnaeus), Supella longipalpa Fabricius, Periplaneta americana Linnaeus, brown weft (Periplaneta brunnea) Burmeister)), Leucophaea maderae Fabricius, Periplaneta fuliginosa Service, Australian eagle (Periplaneta australasiae Fabr.) )), lobster Na (Nauphoeta cinerea Olivier) and smooth 蟑螂 (Symploce pallens Stephens)); ίο 朝朝 (orde r Coleoptera) eggs, leaf-feeding, fruit-feeding, root-feeding, seed-feeding and larvae and adulthoods of vesicular tissues, including the elephant trunks of the genus Corydalis, the genus Insects (eg, cotton weevil (Anthonomus grandis Boheman), rice water weevil (Lissorhoptrus oryzophilus i5 Kuschel), valley elephant (Sitophilus granarius Linnaeus) )), rice weevil (Sitophilus oryzae Linnaeus), annual blue weevil (Listronotus maculicollis Dietz), bluegrass elephant (Sphenophorus parvulus Gyllenhal) )), Hunting Elephant (Sphenophorus venatus vestitus), Sphenophorus cicatristriatus Fahraeus; Chrysomelidae's Flea, Cucumber Leaf, Rootworm, Leafhopper , horse-eared potato beetle and leaf miner (eg, Colorado potato beetle potato aphid (Leptinotarsa decemlineata 25 Say), western corn rootworm (corn root leafhopper (Diabrotic) a virgifera virgifera LeConte))); chafer and other chafers (famiiy

S 124 201204254S 124 201204254

Scarabaeidae )的甲蟲(例如:日本麗金龜(Popillia japonica Newman)、東方麗金龜((Anomala orientalis Waterhouse ) 、 Exomala orientalis(Waterhouse)Scarabaeidae) beetle (eg, Popillia japonica Newman, Anomala orientalis Waterhouse, Exomala orientalis (Waterhouse)

Baraud ))、圓頭犀金龜(Cyclocephala borealis Arrow )、 5 圓頭無斑犀金龜(Cyclocephala immaculata Olivier 或 C. lurida Bland )、蛘金龜及白蜻槽(Aphodius spp.)、黑 金龜(Ataenius spretulus Haldeman )、青銅金龜(Cotinis nitida Linnaeus)、紫絨總角金龜(Maladera castanea Arrow)、臺灣青銅金龜(Phyllophagaspp.)及歐洲金龜 ίο ( Rhizotrogus majalis Razoumowsky ));缠節蟲科 (Dermestidae)之地毯曱蟲;叩甲科(Elateridae)之 線蟲;小蠹科(Scolytidae)之小蠹蟲(bark beetles)及 擬步甲料(Tenebrionidae)之粉曱蟲(barkbeetles)。此 外,農藝及非農藝害蟲包括:革翅目(order Dermaptera ) 15 的卵、成體與幼蟲包括蠼螋科的蠼螋(例如:地蜈蚣(歐 洲球蠼螋(Forficula auricularia Linnaeus ))、黑蠼螋(塾 附螋(Chelisoches morio Fabricius )));半翅目 (Hemiptera)及同翅目(Homoptera)之卵、未成熟蟲、 成蟲及若蟲,像是盲樁科(Miridae )之盲樁、禪科 20 (Cicadidae)之蟬、葉蟬科(Cicadellidae)之葉蟬(例 如’微葉蟬屬(Empoasca spp.))、臭蟲科(Cimicidae ) 之床蟲(例如:溫帶臭蟲(Cimex lectularius Linnaeus ))、 蠟蟬科(Fulgoroidae)及飛虱科(Deiphaddae)之蠟蟬, 角蟬科(Membracidae)之角蟬(treeh〇ppers)、木風科 25 (Psyllidae)之木虱(psyllids)、粉虱科(Aleyrodidae ) 之白粉風(hiteflies)、虫牙科(Aphididae)之財蟲、根瘤 125 201204254 蚜科(Phylloxeridae )之根瘤蚜蟲、粉蛉科 .. (Pseudococcidae )之粉蚧(meaiybugs )、紛科 * (Coccidae )、盾蛉科(Diaspididae )及珠紛科 · (Margarodidae)之介殼蟲、網蝽科(Tingidae)之網蝽、 5 蜂科(Pentatomidae)之培、長墙科(Lygaeidae)之長蜂 (例如.多毛蝽(多毛長培(Blissus leucopterus hirtus Montandon )及南方(南方長蝽(BUssus insularisBaraud )), Cyclocephala borealis Arrow, 5 Cyclocephala immaculata Olivier or C. lurida Bland, Aphidius spp., Ataenius spretulus Haldeman ), Cotinis nitida Linnaeus, Maladera castanea Arrow, Phyllophagaspp. and Rhizotrogus majalis Razoumowsky; Carnival aphid of Dermestidae ; Neelidae's nematode; Scolytidae's bark beetles and Tenebrionidae's barkbeetles. In addition, agronomic and non-agronomic pests include: eggs of the order Dermaptera 15 , adult and larvae including the mites of the family Polygonaceae (eg, the mantle (Forficula auricularia Linnaeus), black mites) C (Chelisoches morio Fabricius)); Hemiptera and Homoptera eggs, immature worms, adults and nymphs, such as the blind pile of the Miladae, Zen A genus of the genus Cicadidae, a leaf bud of the genus Cicadelidae (eg, 'Empoasca spp.), a bed bug of the genus Cimicidae (eg, Cimex lectularius Linnaeus) , the genus Fulgoroidae and the genus Deiphaddae, the genus of the genus Membracidae (treeh〇ppers), the psyllids of the genus Psyllidae, the genus (Aleyrodidae) white air (hiteflies), insect dentistry (Aphididae), insects, nodules 125 201204254 Phylloxeridae root nodule, whitefly (.Pseudococcidae) of white 蚧 (meaiybugs), 科科* ( Coccidae ), Shield (Di Aspididae and Margarodidae's scale insects, Tingidae's nettle, 5 Pentatomidae's cultivar, Lygaeidae's long bee (eg, polychaete (long hairy) Blissus leucopterus hirtus Montandon and the South (BUssus insularis)

Barber)))及及其他種子蝽、沫蟬科(Cerc〇pidae)之 沫蟬、緣蝽科(Coreidae )之緣蝽及紅蝽科 ίο ( pyrrh〇c〇ridae)之紅蝽及汙棉蟲。亦包括碑蟎科 (Acad)(蜗)之卵、幼蟲、若蟲及成蟲,像是葉蟎科 (Tetranychidae)之蛛蟎及紅蟎(例如:歐洲紅蟎(蘋 果全爪(Panonychus ulmi Koch))、二點葉蟎(棉葉蟎 (Tetranychus urticae Koch))、邁氏葉蟎(Tetranychus 15 mcdanieli McGregor));細鬚蟎科(Tenuipalpidae)之短 鬚蟎(例如:桔短鬚蟎(citrus flat mite)(劉氏短鬚蟎 (Brevipalpus lewisi McGregor )));癭蟎科 (Eriophyidae)之鏽蟎及芽蟎及其他食葉蟎及對於人類 及動物健康重要之蜗,亦即表皮蜗科(gpidermoptidae) 2〇 之塵蜗、蠕形蟎科(Demodicidae)之螺形蟎、食甜蟎 科(Glycyphagidae)之穀瞒,硬碑科之蜱, 通吊稱為硬碑(例如·鹿蜱(黑腳硬碑(Ix〇des scapUiaris Say))、澳大利亞致癱痕碑(全環硬碑(ix〇des h〇i〇cyclus Neumann))、美洲狗碑(變異草碑(Dermacentor variabilis 25 Say))、孤星壁風(美洲花碑(Amblyomma americanum Linnaeus)))及軟蜱科(Argasidae)之蜱,通常稱為軟 126Barber))) and other seed mites, the genus Cerc〇pidae, the genus of Coreidae, and the red mites and mites of the pyrrh〇c〇ridae . Also included are the eggs, larvae, nymphs and adults of the Acad (Acre), such as the spiders of the Tetranychidae and the red dragonfly (eg European red pheasant (Panonychus ulmi Koch)) , Tetranychus urticae Koch, Tetranychus 15 mcdanieli McGregor; Tequila pygmaea (eg, citrus flat mite) (Brevipalpus lewisi McGregor)); Eriophyidae rust and buds and other leafhoppers and worms important for human and animal health, namely epidermoptidae 2 尘 尘 、 D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D D Monument (Ix〇des scapUiaris Say)), Australia to the eclipse monument (ix〇des h〇i〇cyclus Neumann), the American dog monument (Dermacentor variabilis 25 Say), lone star Wall wind (Amblyomma americanum Linnaeus) and Argasidae Ticks, commonly referred to as a soft 126

S 201204254 碑(例如:回歸熱蜱(relapsing fever tick)(特氏鈍緣 蜱(Omithodorosturicata))、常見雞蜱(放射狀銳緣蜱 (Argas radiatus )));癢蟎科(soroptidae )、蒲蟎科 (Pyemotidae)及疥蟎科(Sarcoptidae)之疥蟎;直翅 5 目(Orthoptera)之卵、成蟲及未成熟蟲,包括蚱蜢、 虫皇蟲及蛾、蟀(例如:遷徙蚱猛(migratory grasshoppers) (例如,草地血黑壇(Melanoplus sanguinipes Fabricius)、殊種4皇(M. differentials Thomas))、美洲 蚱猛(例如:南美沙漠惶(Schistocerca americana ίο Drury ))、沙漠飛虫皇(沙漠墙(Schistocerca gregaria Forskal ))、飛虫皇(migratory locust) ( Locusta migratoria Linnaeus)、灌木幢蟲(腺惶屬(Zonocerus spp.))、家 蝝蟀(Acheta domesticus Linnaeus )、螻蛄(例如:褐色 螻蛄(Scapteriscus vicinus Scudder ))及南方螻蛄 i5 ( Scapteriscus borellii Giglio-Tos));雙翅目(Diptera) 之卵、成蟲及未成熟蟲,包括潛葉蛾(例如:斑潛蠅屬 (Liriomyza spp.),像是蛇狀菜潛葉繩(serpentine vegetable leafminer )(美洲斑潛蠅(Liriomyza sativae Blanchard)))、蠓、果蠅(實蠅科(Tephritidae ))、黃潛 2〇 蠅(如:瑞典桿罐(Oscinella frit Linnaeus ))、土 壤姐、 家場(如,舍繩(Muscadomestica Linnaeus))、小型家 繩(例如:黃腹處蠅(Fannia canicularis Linnaeus、股 問廄繩(F. femoralis Stein))、廄竭(如:廄螫蠅(Stomoxys calcitransLinnaeus))、面繩、角繩、黑蠅(例如,金蠅 25 屬(Chrysomya spp.)、伏娜屬(Phormia spp.))及其他 蘚狀蠅害蟲、馬蠅(如:虻屬(Tabanusspp·)、胃蠅(bot 127 201204254 flies )(如:胃繩屬(Gastrophilus spp.)、狂繩屬(Oestrus spp.)、牛皮繩(cattle grubs)(如:皮繩屬 Hypoderma spp·))、鹿蠅(如:斑虹:屬(Chrysops spp.))、羊蜱蜗 (如:綿羊風繩(Melophagus ovinus Linnaeus))及其 5 他短角亞目(Brachycera)、蚊子(如:伊蚊屬(Aedes spp_ )、瘧蚊屬(Anopheles spp.)、庫蚊屬(Culex spp.))、 墨虫文(Prosimulium spp_ )、蚋屬(Simulium spp.)、 蠓、 砂蠅、尖眼蕈蚊及其他長角亞目(Nematocera);纓翅 目(orderThysanoptera)的卵、成體與未成熟個體包括 ίο 洋蔥薊馬(蔥薊馬(Thrips tabaci Lindeman ))、花薊馬 (花薊馬屬(Frankliniellaspp·))與其他食葉性薊馬; 膜翅目(order Hymenoptera)昆蟲害蟲,包括螞蟻蟻科 中的螞蟻包含佛羅里達木蟻(佛羅里達弓背蟻 (Camponotus floridanus Buckley))、紅木犧(紅弓背蟻 is ( Camponotus ferrugineus Fabricius ))、黑木蠘(賓州黑 木蟻(Camponotus pennsylvanicus De Geer))、白足蛾(白 足扁蟻(Technomyrmex albipes fr. Smith ))、大頭蟻(大 頭家蟻(Pheidole sp.))、幽靈蠛(黑頭酸臭蟻(Tapinoma melanocephalum Fabricius));法老蟻(Pharaoh ant)(蔚 2〇 蟻(Monomorium pharaonis Linnaeus))、小火蟻(小火 紅蟻(WasmanniaauropunctataRoger))、火犧(熱帶火 蠘(Solenopsis geminata Fabricius ))、入侵紅火蟻 (Solenopsis invicta Buren)、阿根廷蟻(Iridomyrmex humilis Mayr )、狂蟻(長角黃山蠘(Paratrechina 25 longicornis Latreille))、鋪道蟻(路舍蟻(Tetramorium caespitum Linnaeus ))、玉米田蟻(異色草蠘(Lasius s 128 201204254 alienus FOrster))及臭家蟻(酸臭蟻(Tapinoma sessile Say))。其他膜翅目(Hymenoptera)包括蜜蜂(包括木 蜂)、大黃蜂、小黃蜂、胡蜂及鑛蜂(新松葉蜂屬 (Neodiprion spp.);灰翅麥莖蜂屬(Cephusspp.));等 5 翅目(order Isoptera)昆蟲害蟲包含白蟻科中的白礒(例 如:大白蟻(Macrotermes spp.)、胖 土白蟻(Odontotermes obesus Rambur ))、木白蠘科(例如:乾木白蟻 (Cryptotermes spp.))與鼻白蟻科(例如:散白蟻 (Reticulitermes spp.) ' 家白蟻(Coptotermes spp.)、大 ίο 别山散白蟻(Heterotermes tenuis Hagen))、東方地下白 蟻(黃肢散白蠘(Reticulitermes flavipes Kollar))、西 方地下白蟻(西方散白蠘(Reticulitermes hesperus Banks ))、台灣地下白蟻(台灣乳白蛾(Coptotermes formosanus Shiraki ))、西印度乾木白蟻(小楹白蠘 is ( Incisitermes immigrans Snyder))、粉白蟻(麻頭堆砂 白蟻(Cryptotermes brevis Walker))、乾木白蟻(斯氏 楹白蟻(Incisitermes snyderi Light))、東南地下白蟻(南 方散白蟻(Reticulitermes virginicus Banks ))、西方乾木 白蟻(小楹白蟻(Incisitermes minor Hagen ))、樹白蟻, 2〇 如象白蟻屬(Nasutitermes sp.)及具有經濟重要性之其 他白蟻;總尾目(order Thysanura)的昆蟲害蟲,例如 橐魚(西洋衣魚(Lepisma saccharina Linnaeus))與家 衣魚(斑衣魚(Thermobia domestica Packard));食毛 目(orderMallophaga)昆蟲害蟲,且包括頭蝨(人頭蝨 25 ( Pediculus humanus capitis De Geer))、體益(人體益 (Pediculus humanus Linnaeus ))、雞體益(大雞益 129 201204254 (Menacanthus stramineus Nitszch))、狗盘(犬屬响毛 盘(Trichodectes canis De Geer))、絨毛盘(雞圓羽齒 (Goniocotes gallinae De Geer))、綿羊體為(綿羊牛毛 蝨(Bovicola ovis Schrank ))、短鼻牛蝨(寬胸血蝨 5 ( Haematopinus eurysternus Nitzsch))、長鼻牛為(牛顎 兹(Linognathusvituli Linnaeus))以及其他攻擊人與動 物的吸σ允益與呕°爵麻痒益;蛋目(orderSiphonoptera) 的昆蟲害蟲’包含熱帶鼠蛋(印鼠客蛋(Xenopsylla cheopis Rothschild ))、貓蚤(貓櫛首蚤(Ctenocephalides 10 felis Bouche ))、狗蚤(犬蚤(Ctenocephalides canis Curtis ))、禽蚤(歐洲雞蚤(Ceratophyllus gallinae Schrank ))、黏貼蚤(禽角頭蚤(Echidnophaga gallinacea Westwood))、人蚤(致癢蚤(Pulexirritans Linnaeus)) 以及其他困擾哺乳類動物與鳥類的蚤類;涵蓋之其他節 15 肢動物害蟲包括:物蛛目(Araneae)之Φ知蛛,例如: 褐絲蛛(Loxosceles reclusa Gertsch &amp; Mulaik ))以及黑 寡婦物蛛(紅斑寇蛛(Latrodectus mactans Fabricius)), 和石娱讼目(order Scutigeromorpha)的娱蛤,如姑挺 (油蜒(Scutigera coleoptrata Linnaeus)) ° 2〇 本發明之化合物顯示對抗鱗翅目之害蟲具有特別 高之活性(例如:棉葉蟲(Alabama argillacea Httbner (cotton leaf worm))、果樹黃卷蛾(Archips argyrospila Walker (果樹卷葉蛾(fruit tree leaf roller)))、玫瑰卷 葉蛾(A.(歐洲捲葉蟲)以及其他捲蛾科(Archips )物 25 種、二化煩蟲(Chilo suppressalis Walker)(水稻鎮心 蟲)、野填(Cnaphalocrosis medinalis Guen6e)(稻捲葉 201204254 蟲)、暗草填(Crambus caliginosellus Clemens)(玉米 根網蛾)、泰特羅草填(Crambus teterrellus Zincken )(藍 草網蛾)、蘋果蠹蛾(Cydia pomonella Linnaeus )(蘋果 蠹蛾)、埃及金剛鑽(Earias insulana Boisduval)(金剛 5 鑽)、翠紋鑽瘤蛾(Earias vittella Fabricius )(斑棉鈴 蟲)、棉龄實夜蛾(Helicoverpa armigera Hiibner)(棉鈴 蟲)、玉米穗蟲(Helicoverpa zea Boddie)(棉鈴蟲)、 終芽夜蛾(Heliothis virescens Fabricius)(烟青蟲)、稻 切葉野娱(Herpetogramma licarsisalis Walker)(草地 ίο 填)、葡萄小卷葉蛾(Lobesia botrana Denis &amp;S 201204254 Monument (for example: relapsing fever tick (Omithodorosturicata), common chicken mites (Argas radiatus); soroptidae, pampas Pyemotidae and Sarcopteridae; Orthoptera eggs, adult and immature worms, including cockroaches, worms, moths, and crickets (eg migratory grasshoppers) (For example, Melanoplus sanguinipes Fabricius, M. differentials Thomas), American cockroaches (for example: Schistocerca americana ίο Drury), desert flying insects (desert wall) (Schistocerca gregaria Forskal )), migratory locust (Locusta migratoria Linnaeus), shrub worm (Zonocerus spp.), ape (Acheta domesticus Linnaeus), cockroach (eg brown 蝼蛄 ( Scapteriscus vicinus Scudder )) and southern 蝼蛄i5 (Scapteriscus borellii Giglio-Tos); eggs of the Diptera (Diptera), adults and immature worms, including the leaf miner (eg Liriomyza spp., such as serpentine vegetable leafminer (Liriomyza sativae Blanchard), earthworm, fruit fly (Tephritidae), yellow 2 scorpion flies (eg: Oscinella frit Linnaeus), soil sisters, homes (eg, Muscadomestica Linnaeus), small home ropes (eg, yellow-bellied flies (Fannia canicularis Linnaeus, stocks) F. femoralis Stein), exhaustion (eg, Stomoxys calcitrans Linnaeus), facial rope, horn rope, black fly (eg, Chrysomya spp., Phormia) Spp.)) and other scorpion pests, horse flies (such as: genus Tabanusspp, bot 127 201204254 flies) (eg: Gastrophilus spp., Oestrus spp. ), cowhide rope (cattle grubs) (eg, Hypoderma spp.), deer flies (eg, Chrysops spp.), sheep snails (eg, sheep wind rope (Melophagus ovinus Linnaeus) And its 5 short-horned suborders (Brachycera), mosquitoes (eg Aedes sp.) P_ ), Anopheles spp., Culex spp., Prosimulium spp_, Simulium spp., cockroach, sand fly, cockroach and other long Nematocera; eggs, adult and immature individuals of order Thysanoptera include ίο onion thrip horse (Thrips tabaci Lindeman), flower thrip horse (Frankliniellaspp.) ) and other leaf-feeding thrips; the order Hymenoptera insect pests, including ants in the ant family, contain Florida wood ants (Camponotus floridanus Buckley), redwood sacrifice (red bow ant is is ( Camponotus ferrugineus Fabricius )), black carp (Camponotus pennsylvanicus De Geer), white foot moth (Technomyrmex albipes fr. Smith), big ant (Pheidole sp .)), pin 蠛 (Tapinoma melanocephalum Fabricius); Pharaoh ant (Monomorium pharaonis Linnaeus), small fire ant (Wasmanniaauropunctata Roger), Sacrifice (Solenopsis geminata Fabricius), Insecurious Red Fire Ant (Solenopsis invicta Buren), Argentine ant (Iridomyrmex humilis Mayr), mad ant (Paratrechina 25 longicornis Latreille), paving ant (road ant (Tetramorium caespitum Linnaeus)), corn field ants (Lasius s 128 201204254 alienus FOrster) and odorant ants (Tapinoma sessile Say). Other Hymenoptera include honeybees (including wood bees), bumblebees, wasps, wasps, and miners (Neodiprion spp.; Cephusspp.); Order Isoptera insect pests include white mites in the termite family (eg, Macrotermes spp., Odontotermes obesus Rambur), and woody genus (eg, Cryptotermes spp. )) and the termite termites (for example: Reticulitermes spp. 'Coptotermes spp.', 'Heterotermes tenuis Hagen'), and oriental subterranean termites (Reticulitermes flavipes) Kollar)), Western subterranean termites (Reticulitermes hesperus Banks), Taiwan's underground termites (Coptotermes formosanus Shiraki), West Indian dry wood termites (Indigenous white scorpion is (Indigenous white scorpion is (Casisitermes immigrans Snyder) ), termites (Cryptotermes brevis Walker), dry wood termites (Incisitermes snyderi Light), southeast subterranean termites (South) Reticulitermes virginicus Banks), Western stem wood termites (Incisitermes minor Hagen), tree termites, 2 such as the termite genus (Nasutitermes sp.) and other economically important termites; Order Thysanura) insect pests such as squid (Lepisma saccharina Linnaeus) and house fish (Thermobia domestica Packard); orderMallophaga insect pests, including head lice (human Pediculus humanus capitis De Geer), physiology (Pediculus humanus Linnaeus), chicken body benefit (大鸡益129 201204254 (Menacanthus stramineus Nitszch)), dog dish (Canine 响毛盘(Trichodectes) Canis De Geer)), fluffy plate (Goniocotes gallinae De Geer), sheep body (Bovicola ovis Schrank), short-nose calf (Haematopinus eurysternus Nitzsch) ), long-nosed cattle are (Linognathusvituli Linnaeus) and other attacks on humans and animals, stimulating and vomiting; erSiphonoptera) insect insects contain tropical rat eggs (Xenopsylla cheopis Rothschild), cat mites (Ctenocephalides 10 felis Bouche), dog mites (Ctenocephalides canis Curtis), poultry C (Ceratophyllus gallinae Schrank), chi E (Echidnophaga gallinacea Westwood), 蚤 P (Pulexirritans Linnaeus) and other mites that afflict mammals and birds; covered Other section 15 Limb pests include: Araneae's Φ spiders, such as: Loxosceles reclusa Gertsch &amp; Mulaik, and the black widow spider (Latrodectus mactans Fabricius), and The entertainment of the order Scutigeromorpha, such as Scutigera coleoptrata Linnaeus ° 2 The compound of the present invention shows a particularly high activity against pests of the order Lepidoptera (eg: cotton leaf worm (Alabama) Argillacea Httbner (cotton leaf worm)), fruit tree yellow moth (Archips argyrospila Walker (fruit tree leaf moth) Af roller))), rose leaf moth (A. (European leaf curler) and other species of Archips (Archips) 25 species, Chilo suppressalis Walker (rice worm), wild filling ( Cnaphalocrosis medinalis Guen6e) (rice leaf 201204254 insect), Crambus caliginosellus Clemens (corn root moth), Crambus teterrellus Zincken (bluegrass moth), apple moth (Cydia pomonella) Linnaeus), Earias insulana Boisduval (King Kong 5 diamonds), Erias vittella Fabricius (Hymenoptera), Helicoverpa armigera Hiibner (H. ), Helicoverpa zea Boddie (H. armigera), Heliothis virescens Fabricius (tobacco budworm), Herpetogramma licarsisalis Walker (grass ίο), grape leaflet Moth (Lobesia botrana Denis &amp;

Schiffermttller (葡萄漿果小捲蛾))、棉紅鈴蟲 (Pectinophora gossypiella Saunders (紅鈴蟲))、橘細潛 蛾(PhyllocnistiscitrellaStainton (柑橘潛葉蛾))、大菜 粉蝶(Pieris brassicae Linnaeus (大白粉蝶))、小菜粉 15 蝶(Pieris rapae Linnaeus (小紋白蝶))、小菜蛾(Plutella xylostella Linnaeus (菱紋背蛾))、甜菜夜蛾(Spodoptera exigua Hubner (甜菜行軍蟲))、斜紋夜蛾(Spodoptera litura Fabricius (煙草夜盜蟲、二點偽鉤翅蛾))、草地 貪夜蛾(Spodoptera frugiperda J· E. Smith)(草地夜 2〇 蛾)、粉斑夜蛾(Trichoplusia ni Hiibner)(擬尺蠖)以 及蕃% 斑潛繩(Tuta absoluta Meyrick )(繪·圖蟲))〇 本發明之化合物亦對同翅目(Homoptera)成員具 有顯者活性,該成貝包括:丑長管财(Acyrthosiphon pisum Harris)(婉豆蚜)、黑豆财(Aphis craccivora Koch ) 25 (紅豆詞1蟲)、黑豆财(Aphis fabae Scopoli)(黑豆财 蟲)、棉蚜(Aphis gossypii Glover)(棉蚜蟲、瓜蚜蟲)、 131 201204254 蘋果蚜(Aphis pomi De Geer)(蘋果蚜蟲)、綉線菊财 (Aphis spiraecola Patch )(捲葉蚜)、馬鈴薯财 (Aulacorthum solani Kaltenbach )(蘇無網虫牙)、草莓毛 管财(Chaetosiphon fragaefolii Cockerell)(草每胡:蟲)、 5 俄國小麥雙尾蚜 (Diuraphis n〇xia KurdjumoWMordvilko)(俄羅斯小麥蚜)、車前西圓尾财 (Dysaphis plantaginea Paaserini)(玫瑰蘋果財)、頻果 綿财(Eriosoma lanigerum Hausmann)(蘋果、綿财)、相匕 粉大尾蚜(Hyalopterus pruni Geoffroy)(桃粉财)、偽 10 菜財(Lipaphis erysimi Kaltenbach)(芥菜辑)、麥無網 長管财(Metopolophium dirrhodum Walker)(穀财蟲)、Schiffermttller (P. berry), cotton red bollworm (Pectinophora gossypiella Saunders), Phyllocnistiscitrella Stainton, and Pieris brassicae Linnaeus (Pieris brassicae Linnaeus) , Cabbage 15 butterfly (Pieris rapae Linnaeus), Plutella xylostella Linnaeus, Spodoptera exigua Hubner, Spodoptera litura Fabricius (Tobacco night worm, two-pointed false-winged moth), Spodoptera frugiperda J. E. Smith (Tropical night 2 moth), Trichoplusia ni Hiibner (prototype) Tuta absoluta Meyrick (painted and photographed worm) 〇 The compound of the present invention also has significant activity against members of the Homoptera, including: Acyrthosiphon pisum Harris (婉豆蚜), Black Beans (Aphis craccivora Koch) 25 (Red Beans 1 worm), Black Beans (Aphis fabae Scopoli) (Black Beans), Cotton (Aphis gossypii Glover), 131 201204254 Aphis pomi De Geer (Apple locust), Aphis spiraecola Patch (Aphis spiraecola Patch), Acacorthum solani Kaltenbach (Suu worm), Chaetosiphon fragaefolii Cockerell (grass per worm: worm), 5 Russian wheat double-tailed pheasant (Diuraphis n〇xia KurdjumoWMordvilko) (Russian wheat glutinous rice), the front of the car, Dysaphis plantaginea Paaserini), Eriosoma lanigerum Hausmann (Apple, Miancai), Hyalopterus pruni Geoffroy (Peach Pink), Pseudo 10 (Lipaphis erysimi Kaltenbach) (Mustard Series), Metopolophium dirrhodum Walker (Valley)

馬鈴薯網管财(Macrosiphum euphorbiae Thomas )(另S 長管蚜)、桃蚜(Myzus persicae Sulzer)(桃辑、桃財)、 萵苣蚜蟲(Nasonovia ribisnigri Mosley )(萵苣財蟲)、 15 痩棉蜻屬(Pemphigus spp.)(稻根蚜與癭蚜)、亞洲玉 米镇(Rhopalosiphum maidis Fitch )(玉米葉对)、稻麥 財(Rhopalosiphum padi Linnaeus)(黍溢财)、麥二叉 财(Schizaphis graminum Rondani)(綠蟲)、長角麥虫牙 (Sitobion avenae Fabricius )(穀财)、g 五點芽 2〇 ( Therioaphis maculata Buckton)(苜蓿斑財)、小桔财 (Toxoptera aurantii Boyer de Fonscolombe)(黑色橘财) 以及大桔財(Toxoptera citricida Kirkaldy)(棕色橘蚜); 球蚜屬(Adelges spp.(球蚜));長山核桃根瘤蚜 (Phylloxera devastatrix Pergande (美洲山核桃根瘤 25 财);煙草粉虱(Bemisia tabaci Gennadius (煙粉藏、甘 薯粉風)、銀葉粉虱(Bemisia argentifolii Bellows &amp; s 132 201204254Macrosiphum euphorbiae Thomas (other S long tube), Myzus persicae Sulzer (Peach, peach), Nasonovia ribisnigri Mosley (Lettuce), 15 痩Aphis ( Pemphigus spp.), Rhopalosiphum maidis Fitch (corn leaf pair), Rhopalosiphum padi Linnaeus (黍溢财), Schizaphis graminum Rondani (Green worm), Sitobion avenae Fabricius (Guicai), g Therioaphis maculata Buckton (苜蓿 财 财), 小 财 财 (Toxoptera aurantii Boyer de Fonscolombe) (Black Tang Cai ) and Toxoptera citricida Kirkaldy (brown tangerine); Adelges spp.; Phylloxera devastatrix Pergande (Peas fuliginea 25); Tobacco whitefly ( Bemisia tabaci Gennadius (smoke powder, sweet potato powder wind), silver leaf whitefly (Bemisia argentifolii Bellows &amp; s 132 201204254

Perring (銀葉粉風))、柑橘粉乱(Dialeurodes citri Ashmead (桔粉風))及溫室粉風(Trialeurodes vaporariorum Westwood (溫室粉乱));馬鈴薯小綠葉嬋 (Empoasca fabae Harris (馬鈴薯葉蟬))、灰飛風 5 (Laodelphax striatellus Fallen (小褐飛II))、四帶葉輝 (Macrolestes quadrilineatus Forbes (紫莞葉蟬))、綠葉 嬋(Nephotettix cinticeps Uhler (青葉蟬))、黑尾葉蟬 (Nephotettix nigropictus St纪(稻葉蟬))、褐稻虱 (Nilaparvata lugens StM (褐飛乱))、玉米花翅飛致 ίο ( Peregrinus maidis Ashmead (玉米飛風))、白背飛風 (Sogatella furcifera Horvath (白背飛風))、美洲稻飛蟲 (Sogatodes orizicola Muir (稻飛益))、蘋果白葉蟬 (Typhlocyba pomaria McAtee (蘋果白葉蟬))、葡萄葉 蟬屬(Erythroneoura spp.(葡萄葉蟬));十七年蟬 is ( Magicidada septendecim Linnaeus (週期蟬));吹綿紛 殼蟲(IceryapurchasiMaskell (綿團矫殼蟲))、梨圓盾 虫介(Quadraspidiotus perniciosus Comstock .(聖約瑟 蟲));掛橘粉纷(Planococcus citri Risso (桔粉紛)); 粉虫介屬(Pseudococcus spp.(其他粉岭複合物));梨木 2〇 虱(Cacopsylla pyricola Foerster (梨木虱))及柿木風 (Trioza diospyri Ashmead (柿木風))。 本發明之化合物亦對半翅目成員具有活性,該等成 員包括:綠蝽(Acrosternum hilare Say (綠蝽))、南瓜 緣蜂(Anasatristis De Geer(南瓜蟲))、多毛長蝽(Blissus 25 leucopterus leucopterus Say (長蝽))、溫帶臭蟲(cimex lectularius Linnaeus(床藏))、棉網培(Corythuca gossypii 133 201204254Perring (Silver Leaf Powder), Dialeurodes citri Ashmead and Trialeurodes vaporariorum Westwood; Potato Leafhopper (Empoasca fabae Harris) ), Laodelphax striatellus Fallen, Macrollestes quadrilineatus Forbes, Nephotettix cinticeps Uhler, Black-tailed spider mites (Nephotettix nigropictus St (Indica), brown rice glutinous rice (Nilaparvata lugens StM), corn pterygium γ (Peregrinus maidis Ashmead), white back fly (Sogatella furcifera Horvath) (White-backed wind)), American rice-flying insect (Sogatodes orizicola Muir), apple white-leaf (Typhlocyba pomaria McAtee), and Erythroneoura spp. ); 17 years of 蝉is (Magicidada septendecim Linnaeus (cycle)); blowing insects (IceryapurchasiMaskell) Dra 盾 盾 ( (Quadraspidiotus perniciosus Comstock.); ococcus 橘 橘 (Planococcus citri Risso (orange powder)); Membrane (Pseudococcus spp. (Other Fanling Complex)); Cacopsylla pyricola Foerster and Trioza diospyri Ashmead. The compounds of the invention are also active against members of the Hemiptera, including: Acrosternum hilare Say, Anasatristis De Geer, and Blissus 25 leucopterus. Leucopterus Say (long carp), temperate bed bug (cimex lectularius Linnaeus (bed)), cotton net culture (Corythuca gossypii 133 201204254

Fabricius (棉網))、番另S 蝽(Cyrtopeltis modesta Distant (番蘇臭蟲))、棉蝽象(Dysdercus suturellus Herrich-Schaffer (汙棉蟲))、褐臭蜂(Euchistus servus Say(褐臭蜂))、一斑堵象(Euchistus variolarius Palisot 5 de Beauvois (—斑蝽象))、Graptosthetus spp_ (種蝽複 合體)、松樹緣蝽(Leptoglossus corculus Say (松籽緣 蝽)、牧草盲蝽(Lygus lineolaris Palisot de Beauvois (植 食性盲蝽)、稻綠培(Nezara viridula Linnaeus (南方綠 蟠))、稻缚(Oebalus pugnax Fabricius (稻蝽象))、美 ι〇 洲脊胸長椿(Oncopeltus fasciatus Dallas (大型乳草屬 植物蜂))及棉盲蝽(Pseudatomoscelis seriatus Reuter (棉盲蝽))。經本發明之化合物控制之其他昆蟲目包括 纓翅目(Thysanoptera)(例如:西方花薊馬(Frankliniella occidentals Pergande (西方花薊馬))、柑橘薊馬 is ( Scirthothrips citri Moulton (柑棺薊馬))、黃豆薊 (Sericothrips variabilis Beach (大豆薊馬))及煙薊馬 (Thrips tabaci Lindeman (洋蔥薊馬));與鞘翅目(orcjer Coleoptera )(例如:科羅拉多金花蟲(Leptinotarsa decemlineata Say )(科羅拉多薯蟲)、墨西哥豆瓢蟲 2〇 (Epilachna varivestis Mulsant)(墨西哥豆曱蟲)和叩 頭蟲屬(Agriotes)的鐵線蟲、叩頭蟲(Athous)屬或金針 蟲(Limonius)屬)。 注意當代一些分類系統將同翅目(Homoptera )歸 為半翅目(Hemiptera)下之亞目。 25 值得注意的為本發明之化合物用於防治銀葉粉虱 (銀葉粉蝨(Bemisia argentifolii))之用途。值得注意Fabricius (cotton net)), Cyrtopeltis modesta Distant, Dysdercus suturellus Herrich-Schaffer, Euchistus servus Say ), a stagnation (Euchistus variolarius Palisot 5 de Beauvois), Groptosthetus spp_ (species 蝽 complex), pine rim (Leptoglossus corculus Say), Lygus lineolaris Palisot De Beauvois (herbivore), rice green (Nezara viridula Linnaeus), rice (Oebalus pugnax Fabricius), Oncopeltus fasciatus Dallas Milkweed bee) and cotton blind mites (Pseudatomoscelis seriatus Reuter). Other insects controlled by the compounds of the present invention include Thysanoptera (eg, Frankliniella occidentals Pergande ( Western flower thrips)), Citrus thrips is (Scirthothrips citri Moulton), Soybean rips (Sericothrips var) Iabilis Beach (), and Thrips tabaci Lindeman (onion thrips); and coleoptera (orcjer Coleoptera) (eg, Leptinotarsa decemlineata Say (Colorado potato), Mexican beans Ladybug 2 (Epilachna varivestis Mulsant) and Mexican genus, the iron worm, the Athous genus or the genus Limonius. Note that some contemporary classification systems will be Homoptera. (Homoptera) is classified as a suborder under Hemiptera. 25 Notable is the use of the compound of the present invention for controlling silver leaf whitefly (Bemisia argentifolii).

S 134 201204254 的為本發明之化合物用於防治西方花薊馬(西方花莉馬 (Frankliniella occidentals))之用途。值得注意的為本 發明之化合物用於防治綠桃財(桃财(Myzus persicae)) 之用途。值得注意的為本發明之化合物用於防治菱紋背 蛾(小菜蛾(Plutellaxylostella))之用途。值得注意的 為本發明之化合物用於防治秋天行軍蟲(草地貪夜蛾 (Spodoptera frugiperda))之用途。 也可將本發明化合物與一個或多個其他具有生物 活性的化合物或包括殺真菌劑、殺蟲劑、殺線蟲劑、殺 菌劑、殺蟎劑、除草劑、除草劑解毒劑、如昆蟲蛻皮抑 制劑及生根興奮劑(rooting stimulants )的生長調節素、 化學滅菌劑、化學傳訊素(semiochemicals )、驅蟲劑 (repellents )、引誘劑、費洛蒙、激食因子(feeding stimulants)、植物營養劑的劑、其他具有生物活性的化 合物或蟲生細菌、病毒或真菌混合,以形成一多成分殺 蟲劑’提供更廣泛的農業保護。因此本發明亦關於一種 組合物’其包含生物有效劑量之式1化合物、至少一個 選自由表面活性劑、固體稀釋劑與液體稀釋劑所組成群 組的額外組分,以及至少一種額外的生物活性化合物或 藥劑。關於本發明混合物,可將其他具有生物活性的化 合物或藥劑與包含式1之該化合物一同配製,以形成一 預混物或將一個或多個其他具有生物活性的化合物或 劑與含式1之本發明化合物分開配製,並在施用前將配 方結合在一起(例如在一喷灑槽中),或者接續施用。 該可與本發明化合物配製之生物活性化合物或試 劑為以下殺蟲劑:像是阿巴汀(abamectin )、殿殺松 135 201204254 (acephate )、亞職蜗(aceqUin0Cyi )、亞滅培 (acetamiprid )、乙酿蟲腈(acet〇pr〇ie )阿納寧 (acrinathrin )、續胺蜗 g旨(amid〇fjumet )、三亞瞒 (amitraz )、阿佛菌素(avermectjn )、印楝素 5 ( azadirachtin )、谷速松(azjnph〇s_methyl )、畢芬寧 (bifenthdn )、聯苯肼酯(bifenazate )、雙三氟蟲脲 (bistrifluron)、硼酸鹽、布芬淨(bupr〇fezin)、硫線磷 (cadusafos )、加保利(carbaryi)、加保扶(carb〇furan )、 培丹(cartap )、酸酯蟎(carz〇1 )、剋安勃 10 ( chl〇rantraniHpr〇le)、克凡派(chi〇rfenapyr)、克福隆 (chlorfluazuron)、陶斯松(chi〇rpyrifos)、曱基陶斯松 (chlorpyrifos-methyl)、可芬諾(chr〇mafenozide)、克 芬蜗(clofentezin )、可尼丁( ci〇thianidin )、氰特破 (cyantraniliprole(3·溴-1-(3-氣-2-吡啶基)_Ν·[4·氰基-2- 15 甲基[(曱胺基)幾基]苯基]-lH-n比唾-5-竣醯胺)、赛芬 蟎(cyflumetofen )、赛扶寧(cyfluthrin)、β 赛扶寧 (beta-cyfluthrin )、赛洛寧(cyhal〇thrin )、γ 賽洛寧 (gamma-cyhalothrin )、λ 赛洛寧(lambda-cyhalothrin)、 赛滅寧(cypermethrin )、α 赛滅寧(alpha-cypermethrin)、 2〇 ζ 賽滅寧(zeta-cypermethrin)、赛滅淨(cyromazine)、 第滅寧(deltamethrin)、汰芬隆(diafenthiuron)、大利 松(diazinon )、地特靈(dieldrin )、二福隆 (diflubenzuron)、四氟曱醚菊酯(dimefluthrin)、殺蟲 雙(dimehypo )、大滅松(dimethoate )、達特南 25 ( dinotefuran )、苯蟲醚(diofenolan )、因滅汀 (emamectin )、安殺番(endosulfan )、益化利S 134 201204254 The use of a compound of the invention for the control of western flower thrips (Frankliniella occidentals). It is worth noting that the compounds of the present invention are useful for controlling the use of Myzus persicae. Of note, the use of the compounds of the invention for the control of the diamondback moth (Plutella xylostella). It is worth noting that the compounds of the present invention are useful for controlling autumn army worms (Spodoptera frugiperda). The compounds of the invention may also be inhibited with one or more other biologically active compounds or including fungicides, insecticides, nematicides, bactericides, acaricides, herbicides, herbicide antidote, such as insect molting Agents and rooting stimulants of growth regulators, chemical sterilants, semiochemicals, repellents, attractants, pheromones, feeding stimulants, plant nutrients Agents, other biologically active compounds or a mixture of entomopathogenic bacteria, viruses or fungi to form a multi-component pesticide' provide a wider range of agricultural protection. The invention therefore also relates to a composition comprising a biologically effective amount of a compound of formula 1, at least one additional component selected from the group consisting of a surfactant, a solid diluent and a liquid diluent, and at least one additional biological activity. a compound or agent. With regard to the mixtures of the invention, other biologically active compounds or agents may be formulated with the compound of Formula 1 to form a premix or one or more other biologically active compounds or agents with Formula 1 The compounds of the invention are formulated separately and the formulations are combined together (e.g., in a spray tank) prior to administration, or successively. The bioactive compound or agent which can be formulated with the compound of the present invention is an insecticide such as abamectin, dinosaur 135 201204254 (acephate), sub-volume (aceqUin0Cyi), acetamiprid. , acet〇pr〇ie, acrinathrin, azudfjumet, amitraz, avermectjn, azadirachtin , azjnph〇s_methyl, bifenthdn, bifenazate, bistrifluron, borate, bupr〇fezin, cadusafos , carbaryi, carb〇furan, cartap, carz〇1, chl〇rantraniHpr〇le, chifany ), chlorfluazuron, chi〇rpyrifos, chlorpyrifos-methyl, chr〇mafenozide, clofentezin, ci〇thianidin, Cyanotrapro (3·bromo-1-(3-Ga-2-pyridyl)_Ν· [4. Cyano-2- 15 methyl [(decyl)) phenyl]-lH-n than sal-5-nonylamine), cyflumetofen, cyfluthrin , beta-cyfluthrin, cyhal〇thrin, gamma-cyhalothrin, lambda-cyhalothrin, cypermethrin, alpha Alpha (alpha-cypermethrin), 2〇ζze-cypermethrin, cyromazine, deltamethrin, diafenthiuron, diazinon, and diltiag ( Dieldrin ), diflubenzuron, dimefluthrin, dimehypo, dimethoate, dinotefuran, diofenolan, Emmectin, endosulfan, Yihuali

S 136 201204254 (esfenvalerate )、乙蟲清(ethiprole )、依芬寧 (etofenprox)、依殺蟎(etoxazole)、芬佈賜(fenbutatin oxide)、芬硫克(fenothiocarb)、芬諾克(fenoxycarb)、 芬普寧(fenpropathrin)、芬化利(fenvalerate)、芬普尼 (fipronil )、氟尼胺(flonicamid )、氟蟲酿胺 (flubendiamide )、護赛寧(flUCythrinate )、嘧蟲胺 (flufenerim )、氟芬隆(flufenoxur〇n )、福化利 (fluvalinate )、陶福化利(tau-fluvalinate )、大福松 (fonophos )、覆滅蟎(formetanate )、福赛絕 (fosthiazate )、合芬隆(halofenozide )、六伏隆 (hexaflumuron )、合赛多(hexythiazox )、愛美松 (hydramethylnon )、益達胺(imidacloprid )、因得克 (indoxacarb)、殺蟲肥皂(insecticidal soaps)、亞芬松 (isofenphos )、祿芬隆(lufenuron )、馬拉松 (malathion )、美 I 寧(mepyrfluthrin )、美氟綜 (metaflumizone )、滅蝸靈(metaidehyde )、達馬松 (methamidophos )、滅大松(methidathion )、滅賜克 (methiodicarb )、納乃得(meth〇myl )、美賜平 (methoprene )、曱氧 DDT ( methoxychlor)、滅芬諾 (methoxyfenozide)、美特寧(metofluthrin)、米爾貝肟 (milbemycin oxime)、亞素靈(monocrotophos)、尼古 丁( nicotine )、稀咬蟲胺(nitenpyram )、尼殺赛 (nithiazine )、諾伐隆(novaluron )、諾伏隆 (noviflumuron )、毆殺滅(oxamyl )、巴拉松 (parathion)、曱基巴拉松(parathi〇n-methyl)、百滅寧 (permethrin)、福瑞松(ph〇rate )、裕必松(phosalone )、 137 201204254 益滅松(phosmet)、福賜米松(phosphamidon)、比加 普(pirimicarb )、佈飛松(profenofos )、佈福靈 (profluthrin )、歐蜗多(propargite )、佈芬佈 (protrifenbute )、派滅淨(pymetrozine )、派福羅 5 ( pyrafluprole )、除蟲菊精(pyrethrin )、畢連本 (pyridaben )、啶蟲丙醚(pyridalyl )、彼福貴 (pyrifluquinazon )、披綠羅(pyriprole )、百利普芬 (pyriproxyfen )、魚藤精(rotenone )、魚尼丁 (ryanodine )、賜托拉(spinetoram )、賜諾殺(spinosad )、 10 賜派芬(spiridiclofen)、螺甲蜗醋(spiromesifen )、螺 蟲乙酯(spirotetramat)、賜殺羅(sulfoxaflor)、甲丙硫 填(sulprofos )、得芬諾(tebufenozide )、得芬瑞 (tebufenpyrad )、得福隆(teflubenzuron )、七氟菊 _ (tefluthrin )、托福松(terbufos )、殺蟲畏 15 (tetrachlorvinphos )、治滅寧(tetramethrin )、四甲氟菊 酯(tetramethylfluthrin)、赛果培(thiacloprid)、赛速安 (thiamethoxam )、硫敵克(thiodicarb )、殺蟲單 (thiosultap-sodium )、脫芬瑞(tolfenpyrad )、泰滅寧 (tralomethrin )、唑蚜威(triazamate )、三氣松 2〇 (trichlorfon )、三福隆(triflumuron )、蘇力菌(Bacillus thuringiensis) δ内毒素、蟲生細菌、蟲生病毒及蟲生真 菌。值得注意的是前述表列包括乙醯蟲腈 (acetoprole )、美氟寧(mepyrfluthrin )、氟啶蟲胺腈 (sulfoxaflor )及四甲氟菊酯(tetramethylfluthrin)。 25 值得注意的是用於與本發明之化合物組合的殺蟲 劑例如阿巴汀(abamectin)、亞滅培(acetamiprid)、阿S 136 201204254 (esfenvalerate ), ethiprole, etofenprox, etoxazole, fenbutatin oxide, fenothiocarb, fenoxycarb, Fenpropathin, fenvalerate, fipronil, flonicamid, flubendiamide, flUCythrinate, flufenerim, fluoride Flufenoxur〇n, fluvalinate, tau-fluvalinate, fonophos, formetanate, fosthiazate, halofenozide, six Hexaflumuron, hexythiazox, hydramethylnon, imidacloprid, indoxacarb, insecticidal soaps, isofenphos, lufen Lufenuron, malathion, mepyrfluthrin, metaflumizone, metadehyde, methamidophos, methidathion, annihilation (methiodicarb), meth〇myl, metheprene, methoxychlor, methoxyfenozide, metofluthrin, milbemycin oxime, sub Monocrotophos, nicotine, nitenpyram, nithiazine, novaluron, noviflumuron, oxamyl, balason (parathion), parathi〇n-methyl, permethrin, ph〇rate, phosalone, 137 201204254 phosmet, blessing Phomamidon, pirimicarb, profenofos, profluthrin, propargite, protrifenbute, pymetrozine, Pefolo 5 (pyrafluprole), pyrethrin (pyrethrin), pyridaben, pyridalyl, pyrifluquinazon, pyriprole, pyriproxyfen, vine Ronetone (rotenone), fish nitin (ry Anodine ), spinetoram, spinosad, 10 spiridiclofen, spiromesifen, spirotetramat, sulfoxaflor, propylene Sulfur-filled (sulprofos), tebufenozide, tebufenpyrad, teflubenzuron, tefluthrin, terbufos, tetrachlorvinphos, Tetramethrin, tetramethylfluthrin, thiacloprid, thiamethoxam, thiodicarb, thiosultap-sodium, tolfenpyrad ), tramamethrin, triazamate, trichlorfon, triflumuron, Bacillus thuringiensis delta endotoxin, entomopathogenic bacteria, entomopathogenic virus And entomopathogenic fungi. It is worth noting that the aforementioned list includes acetoprole, mepyrfluthrin, sulfoxaflor and tetramethylfluthrin. 25 Notable are insecticides for use in combination with the compounds of the invention such as abamectin, acetamiprid, A.

S 138 201204254 納寧(acrinathrin )、三亞蹣(amitraz )、阿佛菌素 (avermectin )、印楝素(azadirachtin )、畢芬寧 (bifenthrin )、布芬淨(buprofezin )、硫線鱗 (cadusafos)、加保利(carbaryl)、培丹(cartap)、勉 安勃(chlorantraniliprole)、克凡派(chlorfenapyr)、陶 斯松(chlorpyrifos )、可尼丁( clothianidin )、氰特破 (cyantraniliprole )、赛扶寧(cyfluthrin )、β 赛扶寧 (beta-cyfluthrin )、赛洛寧(cyhalothrin )、γ 赛洛寧 (gamma-cyhalothrin )、λ 赛洛寧(lambda-cyhalothrin )、 赛滅寧(cypermethrin )、a 赛滅寧(alpha-cypermethrin )、 ζ 赛滅寧(zeta-cypermethrin)、賽滅淨(cyromazine)、 第滅寧(deltamethrin )、地特靈(dieldrin )、達特南 (dinotefuran )、苯蟲醚(diofenolan )、因滅汀 (emamectin )、安殺番(endosulfan )、益化利 (esfenvalerate )、乙蟲清(ethiprole )、依芬寧 (etofenprox )、依殺蟎(etoxazole )、芬硫克 (fenothiocarb )、芬諾克(fen0XyCarb )、芬化利 (fenvalerate)、芬普尼(fipronii)、氟尼胺(fl0nicamid )、 氟蟲醯胺(flubendiamide)、氟芬隆(flufenoxuron)、福 化利(fluvalinate )、覆滅蟎(formetanate)、福赛絕 (fosthiazate )、六伏隆(hexaflumuron )、愛美松 (hydramethylnon )、益達胺(imidac丨oprid )、因得克 (indoxacarb )、祿芬隆(iufenuron )、美氣寧 (mepyrfluthrin )、美氟綜(metaflumizone )、滅賜克 (methiodicarb )、納乃得(meth〇myl )、美賜平 (methoprene)、滅芬諾(meth〇xyfenozide)、烯咬蟲胺 139 201204254 (nitenpyram )、尼殺赛(nithiazine )、諾伐隆 (novaluron)、跋殺滅(oxamyl)、派滅淨(pymetrozine)、 除蟲菊精(pyrethrin)、畢達本(pyridaben)、啶蟲丙醚 (pyridalyl ) ' 百利普芬(pyripr0Xyfen )、魚尼丁 5 ( ryanodine )、賜托拉(spinetoram )、賜諾殺(spinosad )、 賜派芬(spirodiclofen)、螺甲瞒醋(spiromesifen)、螺 蟲乙酯(spirotetramat)、氟啶蟲胺腈(suifoxaflor)、得 芬諾(tebufenozide)、治滅寧(tetramethrin)、四甲基 扶寧(tetramethylfluthrin)、噻蟲啉(thiacloprid)、赛速 ίο 安(thiamethoxam )、硫敵克(thiodicarb )、殺蟲單 (thiosultap-sodium)、泰滅寧(tralomethrin)、唑蚜威 (triazamate )、三福隆(triflumuron )、蘇力菌(Bacillus thuringiensis) δ 内毒素、蘇力菌(Bacillus thuringiensis) 的所有品系及核多角體病毒(Nucleo polyhydrosis is viruses)的所有品系所組成之群組。值得注意的是不包 括美氟寧(mepyrfliithrin)、氟啶蟲胺腈(suifoxaflor) 及四曱氟菊酯(tetramethylfluthrin)的前述表列。 用於與本發明化合物混合的生物試劑之具體實施 例包括蟲生細菌,例如蘇力菌(Bacillus thuringiensis ), 2〇 及囊封的蘇力菌(Bacillus thuringiensis ) δ内毒素(例 如 ’ Cellcap、MPV、MPVII);蟲生真菌(entomopathogenic fungi ),如綠蠶黴菌(green muscardine fungus );及蟲 生病毒(entomopathogenic viruses (包含自然發生及基 因改良),包含桿狀病毒、核多角體病毒 25 ( nucleopolyhedro virus (NPV)),如:棉鈐蟲核多角體 病毒 (Helicoverpa zea nucleopolyhedrovirus 201204254 (HzNPV ))、芹菜夜蛾核多角體病毒(Anagrapha falcifera nucleopolyhedrovirus ( AfNPV );及顆粒體病毒 (GV ),如蘋果蠹蛾顆粒體病毒(Cydia pomonella granulosis virus (CpGV)) ° 5 值得特別注意的是,上述的組合中該其他無脊椎動 物害蟲防治有效成分與式1化合物屬於不同化學類別 或具有不同的作用位。在某些實例中,與至少一種其他 無脊椎動物害蟲防治有效成分的組合,其具有相似的防 治範圍但具有不同的作用位,將特別有助於抗性處理。 10 因此,本發明之組合物可進一步包含至少一種生物有效 量之其他無脊椎動物害蟲控制活性成分,其有相似控制 範圍但屬於不同化學種類或有不同之作用位置。這些其 他生物活性化合物或試劑包括但不限於:畢芬寧 (bifenthrin )、赛滅寧(Cypermethrin )、賽洛寧 15 ( cyhalothrin)、拉目達賽洛寧(ianibda-cyhalothrin)、 赛扶寧(cyfluthrin)、貝他赛扶寧(beta-cyfluthrin)、第 滅寧(deltamethrin)、四氟甲醚菊酯(dimefluthrin )、 益化利(esfenvalerate)、芬化利(fenvalerate)、因得克 (indoxacarb )、美氟寧(mepyrfluthrin )、美特寧 2〇 ( metofluthrin )、佈福靈(profluthrin )、除蟲菊精 (pyrethrin)、四曱氟菊醋(tetramethylfluthrin)及泰滅 寧(tralomethrin );膽鹼酯酶抑制劑,如陶斯松 (chlorpyrifos)、納乃得(methomyl)、殿殺滅(oxamyl)、 硫歒克(thiodicarb)及唾财威(triazamate);新於驗類 25 ( neonicotinoids ),如亞滅培(acetamiprid )、可尼丁 (clothianidin )、達特南(dinotefuran )、益達胺 201204254 (imidacloprid )、締 η定蟲胺(nitenpyram )、尼殺赛 (nithiazine )、赛果培(thiacloprid )及赛速安 (thiamethoxam );殺蟲的巨環内醋(macrocyclic lactones )’ 如賜托拉(spinetoram )、賜諾殺(spinosad )、 5 阿巴》丁( abamectin)、阿佛菌素(averniectin)及因滅、;丁 (emamectin) ; GABA (γ-胺丁酸)-調控氯離子通道拮 抗劑’如阿佛菌素(avermectin)或阻斷劑,如乙蟲清 (ethiprole)與芬普尼(fipronil);幾丁質合成抑制劑, 如布芬淨(buprofezin )、赛滅淨(cyr〇mazine )、氟芬隆、 10 六伏隆(hexaflumuron)、祿芬隆(lufenur〇n )、諾伐隆 (novaluron )、諾伏隆(noviflumuron )及三福隆 (triflumuron );青春激素類似物,如苯蟲醚 (diofenolan )、芬諾克(fen〇xycarb),美賜平 (methoprene )及百利普芬(pyriproxyfeil);章魚胺 15 ( 〇ct〇pamine )接受器配體,例如三亞蹣(amitraz); 蛻皮抑制劑及蛻皮激素促效劑,如印楝素 (azadirachtin) ’ 滅芬諾(methoxyfenozide)及得芬諾 (tebufenozide);魚尼丁(ryan〇dine)接受器配體,如 魚尼丁( ryanodine )、鄰胺苯甲二醯胺(anthranilic 2〇 diamides) ’ 如 Μ安勃(chlorantraniliprole)、及氰特破 (cyantraniliprole)及氟蟲醯胺(flubendiamide);沙蠶 毒素類似物(nereistoxin analogs),如培丹(cartap); 粒線體電子傳遞抑制劑,如克凡派(chlorfenapyr)、愛 美松(hydramethylnon)及畢達本(pyridaben);脂質合 25 成抑制劑’如賜派芬(spirodiclofen )及螺甲蜗酉旨 (spiromesifen );環二烯類殺蟲劑(cycl〇diene 142 201204254 insecticides ),如地特靈(dieldrin )或安殺番 (endosulfan);除蟲菊西旨;胺甲酸鹽(carbamates);腺 殺真菌劑(insecticidal ureas);以及生物試劑包括核多 角體病毒(NPV)、蘇力菌(Bacillus thuringiensis)之 5 成員、囊封的蘇力菌(Bacillus thuringiensis ) δ内毒素, 以及其他自然產生或基因改良之殺蟲病毒。 可與本發明化合物配置之生物活性化合物或藥劑 之進一步實例為:殺真菌劑,例如阿拉酸式苯 (acibenzolar )(即阿拉酸式苯-S-甲基 ίο (已(;比61^〇131&gt;-8-11^1^1))、4-十二烧基-2,6-二甲基嗎淋 (aldimorph )、辛唾0密菌胺(ametoctradin )、〇引0坐績菌 胺(amisulbrom )、敵菌靈(anilazine )、阿扎康唑 (azaconazole )、亞托敏(azoxystrobin )、右本達樂 (benalaxyl)(包含右本達樂-M ( benalaxyl-M))、麥鏽 15 靈(benodanil )、免賴得(benomyl )、苯噻菌胺 ( benthiavalicarb ) 苯0塞菌胺 (benthiavalicarb-isopropyl)、貝殺新(bethoxazin)、百 蟎克(binapacryl )、雙諾邁(binomial )、聯苯(biphenyl)、 比多農(bitertanol )、百殺芬(bixafen )、保米黴素 2〇 ( blasticidin_S )、波爾多混合物(Bordeaux mixture)(三 元硫酸銅)、啶醯菌胺(白克列(boscalid) /奈克芬 (nicobifen ))、漠克座(bromuconazole )、布瑞莫 (bupirimate )、得滅多(buthiobate )、萎鏽靈 (carboxin)、加普胺(carpropamid)、敵菌丹(captafol)、 25 克菌丹(captan )、貝芬替(carbendazim )、瞒離丹 (chinomethionat)、地茂丹(chloroneb )、四氣異苯腈 143 201204254 (chlorothalonil )、克氯得(chlozoHnate )、克黴唑 (clotrimazole )、氣氧化銅(〇XyChl〇ride )、銅鹽(例如: 硫酸銅及氫氧化銅)、赛座滅(cyazofamid)、環氟菌胺 (cyflufenamid )、克絕(cyin〇xanil )、環克座 5 ( cyproconazole )、赛普洛(Cypr〇dinil )、益發靈 (dichlofluanid )、雙氣氰菌胺(diclocymet)、達菌酉同 (diclomezine )、氣硝胺(dicloran )、乙霉威 (diethofencarb )、待克利(diethofencarb )、二氟林 (diflumetorim )、二曱》密盼(dimethirimol )、達滅芬 ίο ( dimethomorph )、醚菌胺(dimoxystrobin )、達克利 (diniconazole)、達克利-M (diniconazole-M)、敵諾普 (dinocap )、敵克賓(discostrobin )、腈硫酿(dithianon )、 十二環嗎琳(dodemorph )、多寧(dodine )、益康嗤 (econazole )、稀肪菌酯(enestroburin )、乙環嗤 is ( etaconazole )、護粒松(edifenphos )、依普座 (epoxiconazole )、噻唑菌胺(ethaboxam )、依瑞莫 (ethirimol )、依得利(etridiazole )、凡殺克絕 (famoxadone )、0米 σ坐菌酮(fenamidone )、芬瑞莫 (fenarimol )、芬克座(fenbuconazole )、纈黴威 2〇 ( fencaramid )、曱呋醯胺(fenfuram )、環醯菌胺 (fenhexamide )、氰菌胺(fenoxanil )、拌種咯 (fenpiclonil )、苯鏽啶(fenpropidin )、芬普福 (fenpropimorph)、三苯醋錫(fentin acetate)、二苯經 锡(fentin hydroxide )、二甲胺甲硫輕幾酸鐵(ferbam )、 25 富雷唑(ferfurazoate )、富米綜(ferimzone)、扶吉胺 (fluazinam )、0各菌醋(fludioxonil )、氟酿菌胺S 138 201204254 纳rina (acrinathrin), amitraz, avermectin, azadirachtin, bifenthrin, buprofezin, cadusafos, plus Carbaryl, cartap, chlorantraniliprole, chlorfenapyr, chlorpyrifos, clothianidin, cyantraniliprole, cyfluthrin , beta-cyfluthrin, cyhalothrin, gamma-cyhalothrin, lambda-cyhalothrin, cypermethrin, a cyanomethine Alpha-cypermethrin ), zeta-cypermethrin, cyromazine, deltamethrin, dieldrin, dinotefuran, diofenolan, Emamectin, endosulfan, esfenvalerate, ethiprole, etofenprox, etoxazole, fenothiocarb, fen Knock fen0XyCarb ), fenvalerate, fipronii, flnnicamid, flubendiamide, flufenoxuron, fluvalinate, formetanate ), fosthiazate, hexaflumuron, hydramethylnon, imidac丨oprid, indoxacarb, iufenuron, mepyrfluthrin ), metaflumizone, methiodicarb, meth〇myl, metoprene, meth〇xyfenozide, enebitilamine 139 201204254 (nitenpyram ) , nithiazine, novaluron, oxamyl, pymetrozine, pyrethrin, pyridaben, pyridalyl ) 'pyripr0Xyfen, ryanodine, spinetoram, spinosad, spirodiclofen, spiromesifen, spirochete B Spirotetramat, flonicamidonitrile (s Uifoxaflor), tebufenozide, tetramethrin, tetramethylfluthrin, thiacloprid, thiamethoxam, thiodicarb, insecticide Monosultap-sodium, tralmethrin, triazamate, triflumuron, Bacillus thuringiensis δ endotoxin, all strains of Bacillus thuringiensis and A group consisting of all strains of Nucleo polyhydrosis is viruses. It is worth noting that the aforementioned list of mepyrfliithrin, suifoxaflor and tetramethylfluthrin is not included. Specific examples of biological agents for mixing with the compounds of the present invention include entomopathogenic bacteria such as Bacillus thuringiensis, 2〇 and encapsulated Bacillus thuringiensis delta endotoxin (e.g. 'Cellcap, MPV , MPVII); entomopathogenic fungi, such as green muscardine fungus; and entomopathogenic viruses (including naturally occurring and genetically modified), including baculovirus, nuclear polyhedrosis virus 25 (nucleopolyhedro Virus (NPV), such as: Helicoverpa zea nucleopolyhedrovirus 201204254 (HzNPV), Anagrapha falcifera nucleopolyhedrovirus (AfNPV); and granulosis virus (GV), such as apple Cydia pomonella granulosis virus (CpGV) ° 5 It is worth noting that the other invertebrate pest control active ingredients in the above combination belong to different chemical classes or have different action sites. In some instances, with at least one other invertebrate pest Combinations of control active ingredients which have similar ranges of control but which have different levels of action will be particularly useful for resistance treatment. 10 Thus, the compositions of the present invention may further comprise at least one biologically effective amount of other invertebrate pests. Control the active ingredients, which have similar control ranges but belong to different chemical classes or have different action sites. These other biologically active compounds or reagents include but are not limited to: bifenthrin, Cypermethrin, Xeronine 15 ( Cyhalothrin), ianibda-cyhalothrin, cyfluthrin, beta-cyfluthrin, deltamethrin, dimefluthrin, Esfenvalerate, fenvalerate, indoxacarb, mepyrfluthrin, metofluthrin, profluthrin, pyrethrin ), tetramethylfluthrin (tralomethrin); cholinesterase inhibitors, such as chlorpyrifos, nanet (me) Thomyl), oxamyl, thiodicarb, and triazamate; neonicotinoids, such as acetamiprid, clothianidin, Dart Dinotefuran, ideda 201204254 (imidacloprid), nitenpyram, nithiazine, thiacloprid and thiamethoxam; insecticidal giant ring vinegar (macrocyclic lactones)' such as spinetaram, spinosad, 5 abamectin, averniectin and genus, emmectin; GABA (γ- Aminobutyric acid) - a modulator of chloride channel antagonists such as avermectin or blockers such as ethiprole and fipronil; chitin synthesis inhibitors such as buffin Buprofezin, cyr〇mazine, flufenadol, hexaflumuron, lufenur〇n, novaluron, noivifuron and three Triflumuron; youth hormone analogues such as difenolan, fenofol (fen〇xycarb), metopor and pyriproxyfeil; octopamine 15 ( 〇ct〇pamine ) receptor ligands, such as amitraz; quercetin and ecdysone Agents such as azadirachtin 'methoxyfenozide and tebufenozide; ryan〇dine receptor ligands such as ryanodine and ortho-aniline Anthranilic 2〇diamides ' chlorantraniliprole, and cyantraniliprole and flubendiamide; nereistoxin analogs, such as cartap; Mitochondrial electron transport inhibitors, such as chlorfenapyr, hydramethylnon, and pyridaben; lipid-binding inhibitors such as spirodiclofen and snail Spiromesifen); cyclodextene insecticide (cycl〇diene 142 201204254 insecticides), such as dieldrin or endosulfan; pyrethrum; carbamate; glandular killing Fungal agent (insecticidal ureas); And biological agents include nuclear polyhedrosis virus (NPV), 5 members of Bacillus thuringiensis, encapsulated Bacillus thuringiensis delta endotoxin, and other naturally occurring or genetically modified insecticidal viruses. Further examples of bioactive compounds or agents which may be formulated with the compounds of the invention are: fungicides, such as acibenzolar (i.e., arsenic acid benzene-S-methyl ίο (already; (by 61^〇131&gt;;-8-11^1^1)), 4-dodecyl-2,6-dimethyl-allinate (aldimorph), octanoic acid (ametoctradin), 〇引0素素素Amisulbrom ), anilazine, azaconazole, azoxystrobin, benalaxyl (including benalaxyl-M), wheat rust 15 Benodanil, benomyl, benthiavalicarb, benthiavalicarb-isopropyl, bethoxazin, binapacryl, binomial , biphenyl, bitertanol, bixafen, blasticidin_S, Bordeaux mixture (tribasic copper sulfate), acetamiprid (white) Boscalid / nicobifen), bromuconazole, bupirimate, 得灭多 (bu Thiobate ), carboxin, carpropamid, captafol, captan, carbendazim, chinomethionat, dimodan Chloronib), tetra-isophthalonitrile 143 201204254 (chlorothalonil), chlozoHnate, clotrimazole, copper oxide (XyChl〇ride), copper salts (eg copper sulfate and copper hydroxide) , cyazofamid, cyflufenamid, cyin〇xanil, cyproconazole, Cypr〇dinil, dichlofluanid, dicyanidin Diclocymet, diclomezine, dicloran, diethofencarb, diethofencarb, diflumetorim, dimethirimol, Dimethomorph, dimoxystrobin, diniconazole, diniconazole-M, dinocap, discostrobin, dithianon ), twelve rings of dodemorph Dodine, econazole, enestroburin, etaconazole, edifenphos, epoxiconazole, ethaboxam, Ethirimol, etridiazole, famoxadone, fenamidone, fenarimol, fenbuconazole, guanfuwei 2 Fencaramid, fenfuram, fenhexamide, fenoxanil, fenpiclonil, fenpropidin, fenpropimorph, three Fentin acetate, fentin hydroxide, dimethylamine thiocarbamate (ferbam), 25 ferfurazoate, ferimzone, giazinam ), 0 fludioxonil, flubenzamide

S 144 201204254 (flumetover )、氟嗎啉(flumorph )、氟比來 (fluopicolide )、氟《比菌醯胺(fluopyram )、唑呋草 (fluoroimide )、氟嘴菌西旨(fluoxastrobin )、氟唾嗤 (fluquinconazole )、護矽得(flusilazole )、氟硫滅 5 ( flusulfamide )、福多寧(flutolanil )、護汰芬 (flutriafol)、福批殺(fluxapyroxad)、福爾培(folpet)、 福赛得(fosetyl-aluminum)、麥穗寧(fuberidazole)、 吱霜靈(furalaxyl)、福拉比(furametapyr )、菲克利 (hexaconazole )、殺紋寧(hymexazol )、克熱淨 ίο ( hymexazol )、克熱淨(guazatine )、依滅列(imazalil)、 易胺座(imibenconazole)、雙胍辛烧(iminoctadino)、敵 克(iodicarb )、種菌唾(ipconazole )、丙基喜樂松 (iprobenfos )、依普同(iprodione )、異丙菌胺 (iprovalicarb )、異康 α坐(isoconazole )、亞賜圃 is ( isoprothiolane )、異派來桑(isopyrazam )、異嗔菌胺 (isotianil )、嘉賜黴素(kasugamycin )、克收欣 (kresoxim-methyl)、鋅锰乃浦(mancozeb)、雙坱醯菌 胺(mandipropamid )、猛乃浦(maneb )、滅派林 (mapanipyrin )、右滅達樂(mefenoxam )、滅普寧 2〇 ( mepronil )、氧乙酸基白粉克(meptyldinocap )、滅達 樂(metalaxyl )(包含滅達樂-M )、滅特座 (metconazole )、滅速克(methasulfocarb )、免得爛 ( metiram ) 苯 氧菌胺 ((metominostrobin/fenominostrobin ) 、 0密菌胺 25 ( mepanipyrim )、滅芬農(metrafenone )、σ米可納口坐 (miconazole )、邁克尼(myclobutanil )、新阿蘇仁 145 201204254 (neo-asozin) ( ferric methanearsonate (鐵曱石申酸錄))、 尼瑞莫(nuarimol )、辛°塞酮(octhilinone )、e夫醯胺 (ofurace )、聘醚菌胺(orysastrobin )、歐殺斯 (oxadixyl )、歐索林酸(oxolinic acid )、°惡味 0坐 5 ( oxpoconazole )、氧萎鏽靈(oxycarboxin )、多效嗤 (paclobutrazol )、平克座(penconazole )、賓克隆 (pencycuron )、派福芬(penflufen )、0比 p塞菌胺 (penthiopyrad )、稻瘟酯(perfurazoate )、膦酸(即亞 填酸及其鹽類)、熱必斯(phthalide )、必高必殺 ίο ( picobenzamid )、°定氧菌酉旨(picoxystrobin )、粉病靈 (piperalin )、多氧菌素(p〇ly〇xin )、撲殺熱 (probenazole )、撲克拉(prochloraz )、撲滅寧 (procymidone)、普拔克(pr〇pamocarb)、普拔克鹽酸 鹽(propamocarb-hydrochloride )、普克利 15 (propiconazole)、甲基鋅乃浦(pr〇pineb)、丙氧喹啉 (proquinazid )、硫菌威(pr〇thiocarb )、丙硫菌唑 (prothioconazole)、百克敏(pyraci〇str〇bin)、唾胺菌 醋(pyrametostrobin )、〇垒菌酉旨(pyraoXyStr〇bin)、白粉 松(pyrazophos )、防霉丹(pyribencarb )、稗草畏 2〇 ( Pyributicarb )、比芬諾(pyrifenox )、嘧霉胺 (pyrimethanil )、比芬諾(pyrifenox )、派芬農 (pyriofenone )、吡咯尼群(pyrrolnitrin )、百快隆 (pyroquilon )、奎因克座(qUjnconaz〇ie )、快諾芬 (quinoxyfen )、五氣硝苯(quint〇zene )、赛得先 25 ( sedaxane )、矽噻菌胺(silthiofam )、矽氟唑 (simeconazole )、葚孢菌素(Spiroxamine )、鏈黴素S 144 201204254 (flumetover ), flumorph, fluopicolide, fluorine, fluopyram, fluoroimide, fluoxastrobin, flurazepam (fluquinconazole), flusilazole, flusulfamide, flutolanil, flutriafol, fluxapyroxad, folfet, forsythia (fosetyl-aluminum), fuberidazole, furalaxyl, furametapyr, hexaconazole, hymexazol, hymexazol, gram fever Guazatine, imazalil, imibenconazole, iminoctadino, iodicarb, ipoconazole, iprobenfos, yiputong Iprodione), iprovalicarb, isoconazole, isoprothiolane, isopyrazam, isotianil, kasugamycin Ke Kexin (kresoxim-me Thyl), mancozeb, mandipropamid, maneb, mapanipyrin, mefenoxam, mepronil, Oxyacetic acid-based white powder (meptyldinocap), metalaxyl (including mettalol-M), metconazole, methasulfocarb, metiram, methamphetamine (metominostrobin) /fenominostrobin ), 0 mepanipyrim, metrafenone, miconazole, myclobutanil, new azuren 145 201204254 (neo-asozin) ( ferric methanearsonate ( Whetstone Shenshen)), nuarimol, octhilinone, ofurace, oressastrobin, oxadixyl, oxolin Oxolinic acid, oxpoconazole, oxycarboxin, paclobutrazol, penconazole, pencycuron, penflufen , 0 to pceporin (penthiopyrad), rice Perfurazoate, phosphonic acid (ie, sub-acid and its salts), phthalide, picobenzamid, picoxystrobin, piperalin , p〇ly〇xin, probenazole, prochloraz, procymidone, pr〇pamocarb, propamocarb-hydrochloride ), propiconazole, pr〇pineb, proquinazid, pr〇thiocarb, prothioconazole, pyracino Str〇bin), pyramitostrobin, pyraoXyStr〇bin, pyrazophos, pyribencarb, Pyributicarb, bifenfen ( Pyrifenox ), pyrimethanil, pyrifenox, pyriofenone, pyrrolnitrin, pyroquilon, quinck (qUjnconaz〇ie), venofen (quinoxyfen), five-gas benzene (quint〇zene), match First 25 (sedaxane), silicon penthiopyrad (silthiofam), silicon-fluoro-oxazole (simeconazole), mulberry cyclosporine (Spiroxamine), streptomycin

S 146 201204254 (streptomycin )、硫黃(sulfur )、得克利(tebuconazole )、 泰伏勤(tebufloquin)、克枯爛(teci〇ftaiam)、四氯硝 基苯(tecnazene )、四克利(tetraconaz〇ie )、腐絕 (thiabendazole )、賽氟滅(thifluzamide )、多保淨 (thiophanate)、甲基多保淨(thiophanate-methyl)、得 恩地(thiram )、噻醯菌胺(tia(jinil )、脫克松 (tolclofos-methyl)、甲基益發靈(toiyifluanid)、三唑 酮(triadimefon )、三唾醇(triadimenol )、嘴菌醇 (triarimol )、咪唑【口 +井】(triaz0Xide )、十三嗎啉 (tridemorph )、賽福座(triflumizole )、三嗎啉醯胺 (trimorphamide )、三赛唑(tricyciaz〇ie )、三氟敏 (trifloxystrobin )、赛福寧(triforine )、滅菌唑 (triticonazole )、烯效唑(uniconazole )、維利黴素 (validamycin )、及瓦芬耐(validamycin )、免克寧 (vinclozolin)、鋅乃浦(Zineb)、福美鋅(Ziram)及座 賽胺(zoxamide);殺線蟲劑,像是得滅克(aidicarb)、 新煙鹼類(imicyafos)、毆殺滅(oxamyl)及芬滅松 (fenamiphos);殺菌劑,像是鏈黴素;殺蟎劑,如三亞 蹣(amitraz )、蟎離丹(chinomethionat )、克氣苯 (chlorobenzilate )、錫蟎丹(cyhexatin )、大克蟎 (dicofol)、得氣瞒(dienochlor)、依殺蜗(etoxazole)、 芬殺蜗(fenazaquin)、芬佈賜(fenbutatin oxide)、芬普 寧(fenpropathrin )、芬普蟎(fenpyroximate )、合賽多 (hexythiazox )、毆蟎多(propargite )、畢達本(pyridaben ) 及得芬瑞(tebufenpyrad)。值得注意的是,不包括敵菌 靈(anilazine )、麥鏽靈(benodanil )、貝殺新 147 201204254 (bethoxazin )、百蜗克(binapacryl)、百殺芬(bixafen )、 蟎離丹(chinomethionat)、二氟林(diflumetorim)、二 甲嘧酚(dimethirimol)、烯肟菌酯(enestroburin )、氟 嗎琳(flumorph )、氟吡菌醯胺(fluopyram )、唑呋草 5 ( fluoroimide )、福批殺(fluxapyroxad )、異派來桑 (isopyrazam )、異噻菌胺(isotrianil )、氧乙酸基白粉 克(meptyldinocap )、粉病靈(piperalin )、硫菌威 (prothiocarb )、稗草畏(pyributicarb )、派芬農 (pyriofenone )、赛得先(sedaxane )及赛福座 ίο (triflumizole)的前述表列。 在某些實例中,本發明化合物與其他有生物活性 (特別為無脊椎害蟲之控制)化合物或試劑(意即活性 成份)可導致一加一大於二的效果(即協同作用)。因 此可以降低活性成分的環境排放量,同時確保有效之害 15 蟲防治效果。當無脊椎害蟲防治活性成分於施用比例展 現農藝上足夠程度之無脊椎動物害蟲防治協同作用,該 組合可有益於減少作物生產成本及降低環境負擔。 本發明化合物及其組合物可應用於經過基因轉殖 的植物’以表現對無脊椎動物害蟲有毒蛋白(如蘇力菌 20 (BaciUus thuringiensis) δ-内毒素)。該應用可提供更大 範圍的植物保護,以及有利於抗藥性管理。從外部施用 的本發明無脊椎動物害蟲控制化合物之效果可能會與 该表現的毒蛋白產生協同作用。 這些農業保護劑的一般參考文獻(即殺蟲劑、殺真 25 菌劑、殺線蟲劑、殺蟎劑、除草劑及生物藥劑)的一般S 146 201204254 (streptomycin), sulfur (sulfur), tebuconazole, tebufloquin, teci〇ftaiam, tecnazene, tetraconaz〇ie ), thiabendazole, thifluzamide, thiophanate, thiophanate-methyl, thiram, tia (jinil), detached Tolclofos-methyl, toiyifluanid, triadimefon, triadimenol, triarimol, imidazole [triaz0Xide], thirteen? Tridemorph, triflumizole, trimorphamide, tricyciaz〇ie, trifloxystrobin, triforine, triticonazole, Uniconazole, validamycin, and validamycin, vinclozolin, Zineb, Ziram, and zoxamide; Nematicides, like aidicarb, Nicotine (imicyafos), oxamyl and fenamiphos; fungicides, such as streptomycin; acaricides such as amitraz, chinomethionat, gram Benzene (chlorobenzilate), cyhexatin, dicofol, dienochlor, etoxazole, fenazaquin, fenbutatin oxide, fenpenin (fenpropathrin), fenpyroximate, hexythiazox, propargite, pyridaben, and tebufenpyrad. It is worth noting that it does not include carbendazim ( Anilazine ), benodanil, bei xinxin 147 201204254 (bethoxazin), binapacryl, bixafen, chinomethionat, diflumetorim, dipyrimidine Dimethirimol, enestroburin, flumorph, fluopyram, fluoroimide, fluxapyroxad, isopyrazam ), Isotianil (isotrianil) , oxyacetate-based white powder (meptyldinocap), powderalin (piperalin), prothiocarb, pyributicarb, pyrofenone, sedaxane, and safari ίο ( The aforementioned list of triflumizole). In certain instances, the compounds of the invention and other biologically active (particularly invertebrate pest control) compounds or agents (i.e., active ingredients) may result in an effect of one plus one greater than two (i.e., synergistic). Therefore, the environmental discharge of the active ingredient can be reduced, and at the same time, the effective control effect can be ensured. When the invertebrate pest control active ingredient exhibits a synergistic effect on the agronomically sufficient level of invertebrate pest control, the combination can be beneficial for reducing crop production costs and reducing environmental burden. The compounds of the present invention and compositions thereof are applicable to genetically transformed plants to express toxic proteins to invertebrate pests (e.g., BaciUus thuringiensis δ-endotoxin). This application provides a wider range of plant protection as well as resistance to drug resistance management. The effect of the invertebrate pest control compound of the present invention applied externally may synergize with the toxic protein of the expression. General references for these agricultural protective agents (ie insecticides, fungicides, nematicides, acaricides, herbicides and biological agents)

參考文獻包括 The Pesticide Manual,13th Edition,C. D 201204254 S. Tomlin, Ed., British Crop Protection Council, Farnham, Surrey,U.K., 2003 以及 The BioPesticide Manual,2nd Edition, L. G. Copping, Ed., British Crop ProtectionReferences include The Pesticide Manual, 13th Edition, C. D 201204254 S. Tomlin, Ed., British Crop Protection Council, Farnham, Surrey, U.K., 2003 and The BioPesticide Manual, 2nd Edition, L. G. Copping, Ed., British Crop Protection

Council, Famham, Surrey, U.K·, 2001。 5 在使用一個或多個這些各種不同的混合部分的實 施例中,這些各種不同的混合部分(全部)與式1化合 物的重量百分比通常在約1:3〇〇〇與約3000:1之間。值 得注意的是在約1:300及約300:1之間的重量百分比(例 如’在約1:30及約30:1之間的百分比)。精於此技藝人 ίο 士可經由簡單實驗,輕易決定活性成分達成所需生物活 性範圍必要之生物有效量。顯而易見地是,包含這些額 外成分可擴展無脊椎動物害蟲防治的範圍,使其超出單 獨使用式1化合物所防治的範圍。 表A列出式1化合物與其他無脊椎動物害蟲防治劑 15 之特疋組合,其說明本發明混合物、組合物與方法。表 A第一攔列出該特定無脊椎動物害蟲控制劑(例如:第 一行中的「阿巴汀(abamectin)」)。在表A中的第二欄中 列出5亥無脊椎害蟲控制劑作用模式(若為已知)或化學 種類。在表A中的第三欄中列出該無脊椎害蟲防治劑相 20 對於式1化合物的重量比範圍之實施例(例如,阿巴汀 (abamectin)與式X化合物之重量比為「5〇:1至 1:50」)。因此,例如,表A之第一行具體揭露式】化人 物之組合物與阿巴汀(abamectin)之組合物,其使用: 重量百分比介於50 : 1至1 : 5〇。表D1其餘行的架構 25 類似’得進-步注意的為表人列出特定的式i化合物 與其他無脊椎動物害蟲防治綱組合,其說明本發明之 149 201204254 混合物、組合物與方法,以及包括其他施用比率的重量 比例範圍之實施例。Council, Famham, Surrey, U.K., 2001. 5 In embodiments in which one or more of these various different mixing moieties are used, the weight percentage of these various mixed moieties (all) to the compound of Formula 1 is typically between about 1:3 Torr and about 3000:1. . It is noted that the weight percentage is between about 1:300 and about 300:1 (e.g., a percentage between about 1:30 and about 30:1). This artist can easily determine the biologically effective amount necessary for the active ingredient to achieve the desired biological activity range through simple experiments. It is evident that the inclusion of these additional ingredients extends the range of invertebrate pest control beyond the scope of the single use of the compound of formula 1. Table A lists the combination of the compound of Formula 1 with other invertebrate pest control agents 15 which illustrate the mixtures, compositions and methods of the present invention. Table A first lists the specific invertebrate pest control agent (for example, "abamectin" in the first row). The mode of action (if known) or chemical species of the 5 hai invertebrate pest control agent is listed in the second column of Table A. An example of the weight ratio range of the invertebrate pest control agent phase 20 to the compound of formula 1 is listed in the third column of Table A (for example, the weight ratio of abamectin to the compound of formula X is "5" :1 to 1:50"). Thus, for example, the first row of Table A specifically discloses a composition of a humanoid composition with abamectin using: a weight percentage between 50:1 and 1:5. The structure 25 of the remaining rows of Table D1 is similar to the 'step-by-step note for the list of specific compounds of formula i in combination with other invertebrate pest control classes, which illustrate the 149 201204254 mixture, composition and method of the present invention, and Examples of ranges of weight ratios including other application rates are included.

表ATable A

S 無脊椎動物害蟲防治劑 作用方式或化學分類 通常 重量比 阿巴汀 巨内酯環類 50:1 至 1:50 亞滅培 新菸鹼類 150:1 至 1:200 雙甲脒 縴胺受體配體類 200:1 至 1:100 阿維菌素 巨内酯環類 50:1 至 1:50 印楝素 脫皮激素促效劑 100:1 至 1:120 貝塔-赛扶寧 鈉通道調控劑 150:1 至 1:200 畢芬寧 鈉通道調控劑 100:1 至 1:10 布芬淨 幾丁質合成抑制劑 500:1 至 1:50 培丹 沙蠶毒素類似物 100:1 至 1:200 剋安勃 魚尼丁受體配體 100:1 至 1:120 克凡派 線粒體電子傳遞抑制劑 300:1 至 1:200 陶斯松 膽鹼酯酶抑制劑 500:1 至 1:200 可尼丁 新菸鹼類 100:1 至 1:400 氣特破(cyantraniliprole) 魚尼丁受體配體 100:1 至 1:120 赛扶寧 鈉通道調控劑 150:1 至 1:200 赛洛寧 鈉通道調控劑 150:1 至 1:200 赛滅寧 鈉通道調控劑 150:1 至 1:200 赛滅淨 幾丁質合成抑制劑 400:1 至 1:50 第滅寧 鈉通道調控劑 50:1 至 1:400 地特靈 環雙烯殺蟲劑類 200:1 至 1:100 達特南 新菸鹼類 150:1 至 1:200 苯蟲醚 脫皮抑制劑 150:1 至 1:200 絕蟲靈 巨内酯環類 50:1 至 1:10 安殺番 環雙烯殺蟲劑類 200:1 至 1:100 益化利 鈉通道調控劑 100:1 至 1:400 乙蟲清 GABA調節氯離子通道阻斷劑 200:1 至 1:100 分硫克 150:1 至 1:200 芬諾克 青春激素類似物 500:1 至 1:100 芬化利 鈉通道調控劑 150:1 至 1:200 芬普尼 GABA調節氣離子通道阻斷劑 150:1 至 1:100 氟尼胺 200:1 至 1:100 氟蟲醯胺 魚尼丁受體配體 100:1 至 1:120 氟芬隆 幾丁質合成抑制劑 200:1 至 1:100 六伏隆 幾丁質合成抑制劑 300:1 至 1:50 150 201204254 無脊椎動物害蟲防治劑 作用方式或化學分類 通常 重量比 愛美松 線粒體電子傳遞抑制劑 150:1 至 1:250 益達胺 新菸鹼類 1000:1 至 1:1000 因得克 鈉通道調控劑 200:1 至 1:50 λ賽洛寧 鈉通道調控劑 50:1 至 1:250 祿芬隆 幾丁質合成抑制劑 500:1 至 1:250 美氟寧(mepyrfluthrin) 鈉通道調控劑 100:1 至 1:400 美氟综 200:1 至 1:200 納乃得 膽鹼酯酶抑制劑 500:1 至 1:100 美賜平 青春激素類似物 500:1 至 1:100 滅芬諾 脫皮激素促效劑 50:1 至 1:50 烯啶蟲胺 新菸鹼類 150:1 至 1:200 硝乙脲噻唑 新菸鹼類 150:1 至 1:200 諾伐隆 幾丁質合成抑制劑 500:1 至 1:150 毆殺滅 膽鹼酯酶抑制劑 200:1 至 1:200 派滅淨 200:1 至 1:100 除蟲菊精 鈉通道調控劑 100:1 至 1:10 畢達本 線粒體電子傳遞抑制劑 200:1 至 1:100 ϋ定蟲丙鱗 200:1 至 1:100 百利普芬 青春激素類似物 500:1 至 1:100 魚尼丁 魚尼丁受體配體 100:1 至 1:120 賜諾特 巨内酯環類 150:1 至 1:100 賜諾殺 巨内酯環類 500:1 至 1:10 賜派芬 脂質生物合成抑制劑 200:1 至 1:200 曱蟎酯 脂質生物合成抑制劑 200:1 至 1:200 殺福分(sulfoxaflor) 200:1 至 1:200 得芬諾 脫皮激素促效劑 500:1 至 1:250 四氟醚菊酯 (Tetramethylfluthrin) 鈉通道調控劑 100:1 至 1:40 賽果培 新菸鹼類 100:1 至 1:200 赛速安 新於驗類 1250:1 至 1:1000 硫敵克 膽鹼酯酶抑制劑 500:1 至 1:400 殺蟲雙 150:1 至 1:100 四溴菊酯 鈉通道調控劑 150:1 至 1:200 唑蚜威 膽鹼酯酶抑制劑 250:1 至 1:100 三福隆 幾丁質合成抑制劑 200:1 至 1:100 蘇力菌 生物劑 50:1 至 1:10 蘇雲金芽孢桿菌δ内毒素 生物劑 50:1 至 1:10 核型多角體病毒 (如,Gemstar) 生物劑 50:1 至 1:10 151 201204254 值得注意的是本發明之化合物包含至少一種其他 具有生物活性的化合物或藥劑’其選自列於表A之無脊 椎動物害蟲防治劑。 化合物(包括式1化合物、其N-氧化物或其鹽類) 與其他無脊椎動物害蟲防治劑之重量比通常介於 1000:1及1:1000之間,有一實施例為介於500:1及1:500 之間,另一個實施例為介於250:1及1:200之間,且另 一個實施例為介於100:1及1:5〇之間。 列於下表B1至B45為包含式1化合物(化合物號 碼(Cmpd. No.)參考索引表a至F中之化合物)與其 他無脊椎害蟲防治劑的特定組合物之實施例 表B1 混合物 號碼 化合物 號碼 以及 無脊椎動物害蟲防治 劑 混合物 號碼 化合物 號碼 以及 無脊椎動物害蟲防治 劑 A-1 1 以及 阿巴汀 A-37 1 以及 因得克 A-2 1 以及 亞滅培 A-38 1 以及 拉姆達-#洛寧 A-3 1 以及 雙甲脒 A-39 1 以及 祿芬隆 A-4 1 以及 阿維菌素 A-40 1 以及 美氟寧 (mepyrfluthrin) A-5 1 以及 印棟素 A-41 1 以及 美氣綜 A-6 1 以及 貝塔·赛扶寧 A-42 1 以及 納乃得 A-7 1 以及 畢芬寧 A-43 1 以及 美賜平 A-8 1 以及 布芬淨 A-44 1 以及 滅芬法 A-9 1 以及 培丹 A-45 1 以及 烯啶蟲胺 A-10 1 以及 剋安勃 A-46 1 以及 硝乙脲噻唑 A-11 1 以及 克凡派 A-47 1 以及 諾伐隆 A-12 1 以及 陶斯松 A-48 1 以及 毆殺滅 A-13 1 以及 可尼丁 A-49 1 以及 派滅淨 A-14 1 以及 氱特破 (cyantraniliprole ) A-50 1 以及 除蟲菊精 A-15 1 以及 赛扶寧 Α·51 1 以及 畢達本 A-16 1 以及 赛洛寧 Α·52 1 以及 咬息丙鍵 A-17 1 以及 赛滅寧 Α-53 1 以及 百利普芬S Invertebrate pest control agent mode of action or chemical classification usually weight ratio of abatatin giant lactone ring 50:1 to 1:50 sub-exeter neonicotinoid 150:1 to 1:200 double-mercapto fibrin Body ligands 200:1 to 1:100 Abamectin macro lactone ring 50:1 to 1:50 Azadirachtin ecdysone agonist 100:1 to 1:120 Beta-Secuna sodium channel regulation Agent 150:1 to 1:200 Phenfenin sodium channel modulator 100:1 to 1:10 Buphin net chitin synthesis inhibitor 500:1 to 1:50 Pedanic silkworm toxin analogue 100:1 to 1:200克安布内丁丁Receptor ligand 100:1 to 1:120 克凡派 mitochondrial electron transport inhibitor 300:1 to 1:200 Tausson cholinesterase inhibitor 500:1 to 1:200 Cotinine Nicotinic 100:1 to 1:400 gas cyrantraniliprole Fish nitin receptor ligand 100:1 to 1:120 Saifuning sodium channel modulator 150:1 to 1:200 Cylonine channel regulation Agent 150:1 to 1:200 Safranine Channel Modulator 150:1 to 1:200 Saline Synthetic Inhibitor 400:1 to 1:50 Sodium Channel Suppressor 50:1 to 1 :400 ground Ringer diene insecticides 200:1 to 1:100 Datnam neonicotinoids 150:1 to 1:200 Benzolid ether peeling inhibitor 150:1 to 1:200 chlorfenapyr macrolides 50:1 to 1:10 killing cyclopentene insecticides 200:1 to 1:100 Yihuali sodium channel regulator 100:1 to 1:400 Ethylamine GABA-regulated chloride channel blocker 200 :1 to 1:100 thiol 150:1 to 1:200 Fenokee youth hormone analogue 500:1 to 1:100 Fenicide sodium channel modulator 150:1 to 1:200 Fenpney GABA regulating gas Ion channel blocker 150:1 to 1:100 fluniamine 200:1 to 1:100 flufenamide nicotine receptor ligand 100:1 to 1:120 flufenazone chitin synthesis inhibitor 200 :1 to 1:100 hexamone chitin synthesis inhibitor 300:1 to 1:50 150 201204254 Invertebrate pest control agent action mode or chemical classification usually weight ratio Amesson mitochondrial electron transport inhibitor 150:1 to 1 :250 EDTA neonicotinoids 1000:1 to 1:1000 Indacyl channel modulators 200:1 to 1:50 λ Xeronine channel modulators 50:1 to 1:250 Lufenlong Qualitative Inhibitor 500:1 to 1:250 mepyrfluthrin sodium channel modulator 100:1 to 1:400 US fluoride 200:1 to 1:200 nanodine cholinesterase inhibitor 500:1 to 1 :100 Maximal Youth Hormone Analog 500:1 to 1:100 Defenofin Ecdysone agonist 50:1 to 1:50 Nitenpyram neonicotinoid 150:1 to 1:200 Nitroacetamide Neonicotinoids 150:1 to 1:200 Novalon chitin synthesis inhibitor 500:1 to 1:150 殴kill cholinesterase inhibitor 200:1 to 1:200 Defeated 200:1 to 1:100 Pyrethrin Sodium Channel Modulator 100:1 to 1:10 Pythaben mitochondrial electron transport inhibitor 200:1 to 1:100 ϋ定虫丙鳞200:1 to 1:100 Bollipane youth Hormone Analogs 500:1 to 1:100 Fish Nitinus Nitin Receptor Ligand 100:1 to 1:120 Cinotex Macrolide Rings 150:1 to 1:100 500:1 to 1:10 Schiffin lipid biosynthesis inhibitor 200:1 to 1:200 Oxime ester lipid biosynthesis inhibitor 200:1 to 1:200 Sulfoxaflor 200:1 to 1:200 Defenofin ecdysone agonist 500:1 1:250 Tetramethylfluthrin sodium channel regulator 100:1 to 1:40 Sai Pei neonicotinoid 100:1 to 1:200 Sai Su Anxin in the test class 1250:1 to 1:1000 Sulfuric acid cholinesterase inhibitor 500:1 to 1:400 insecticidal double 150:1 to 1:100 tetramethrin sodium channel modulator 150:1 to 1:200 oxazolidine cholinesterase inhibitor 250:1 to 1:100 Sanford Chitin Synthetic Inhibitor 200:1 to 1:100 Suzyme Biological Agent 50:1 to 1:10 Bacillus thuringiensis δ endotoxin biologic 50:1 to 1:10 Nuclear polyhedrosis virus (eg, Gemstar) biological agent 50:1 to 1:10 151 201204254 It is noted that the compounds of the invention comprise at least one other biologically active compound or agent which is selected from the list listed in Table A. Vertebrate pest control agent. The weight ratio of the compound (including the compound of formula 1, its N-oxide or its salt) to other invertebrate pest control agents is usually between 1000:1 and 1:1000, and one embodiment is between 500:1. Between 1:500, another embodiment is between 250:1 and 1:200, and another embodiment is between 100:1 and 1:5〇. The following Tables B1 to B45 are examples of specific compositions comprising the compound of Formula 1 (Compound No. (Cmpd. No.) Reference Index Tables a to F) and other invertebrate pest control agents. Table B1 Mixture Number Compound Number and invertebrate pest control mixture number compound number and invertebrate pest control agent A-1 1 and Abatin A-37 1 as well as Indek A-2 1 and Amphibious A-38 1 and Ram达##洛宁A-3 1 and amitraz A-39 1 as well as rifampin A-4 1 and avermectin A-40 1 as well as mepyrfluthrin A-5 1 and indosin A -41 1 and US Gas A-6 1 and Beta Savoning A-42 1 and Na Nai A-7 1 and Bifennin A-43 1 and Meiseiping A-8 1 and Bufenjing A-44 1 and fentanyl A-9 1 as well as Pedan A-45 1 and nitenpyram A-10 1 as well as gram A-46 1 and nitrile thiazole A-11 1 and kefanai A-47 1 And Norvaron A-12 1 and Dossson A-48 1 as well as cockroach A-13 1 and konidine A-49 1派灭净 A-14 1 and cyantraniliprole A-50 1 and pyrethrin A-15 1 as well as Sai Fanning 51 51 1 and Pythamoto A-16 1 and Xeron Α · 52 1 and bite C-A-17 1 and Sai-Ning-53 1 and Balippfen

152 S 201204254 混合物 號碼 化合物 號碼 以及 無脊椎動物害蟲防治 劑 A-18 1 以及 赛滅淨 A-19 1 以及 第滅寧 Α·20 1 以及 地特靈 Α-21 1 以及 達特南 Α-22 1 以及 笨蟲醚 Α-23 1 以及 絕蟲靈 Α-24 1 以及 安殺番 Α-25 1 以及 益化利 Α-26 1 以及 乙蟲清 Α-27 1 以及 芬硫克 Α-28 1 以及 芬諾克 Α-29 1 以及 芬化利 Α-30 1 以及 芬普尼 Α-31 1 以及 氟尼胺 Α-32 1 以及 氟蟲醯胺 Α-33 1 以及 氟芬隆 Α·34 1 以及 六伏隆 Α-35 1 以及 愛美松 Α-36 1 以及 益達胺 混合物 化合物 以及 無脊椎動物害蟲防治 號碼 號碼 劑 Α-54 1 以及 魚尼丁 Α-55 1 以及 賜諾特 Α-56 1 以及 賜諾殺 Α-57 1 以及 賜派分 Α-58 1 以及 甲蟎酯 Α-59 1 以及 殺福分 (sulfoxaflor) Α-60 1 以及 得芬諾 Α-61 1 以及 四氟醚菊酯 (Tetramethylfluthrin) Α-62 1 以及 赛果培 Α-63 1 以及 赛速安 Α-64 1 以及 硫敵克 Α-65 1 以及 殺蟲雙 Α-66 1 以及 四溴菊酯 Α-67 1 以及 嗤蚜威 Α-68 1 以及 三福隆 Α-69 1 以及 蘇力菌 Α-70 1 以及 蘇雲金芽孢桿菌δ内毒 素 Α-71 1 以及 核型多角體病毒 (如,Gemstar) 表B2到B45各與上述表B1的建構相似,除了將襴標題 「化合物號碼」下的項目分別以下方所列的化合物號碼 攔項目取代。因此,例如,在表B2中,欄標題「化合 物號碼」下的項目皆列舉「化合物2」,且表B2中的欄 標題下第一行具體揭露一種化合物2及阿巴汀 (abamectin)的混合物。表B3至B45具有相似的結構。 表格號碼 化合物號碼爛項目 表格號碼 B2 化合物2 ~ B24 B3 化合物3 B25 B4 化合物5 B26 化合物號碼欄項目 化合物112 化合物114 化合物119 153 201204254 格號碼 化合物號碼攔項目 表格號碼 化合物號碼攔項目 B5 化合物16 B27 化合物120 B6 化合物17 B28 化合物121 B7 化合物25 B29 化合物122 B8 化合物29 B30 化合物123 B9 化合物35 B31 化合物127 B10 化合物52 B32 化合物130 B11 化合物58 B33 化合物131 B12 化合物59 B34 化合物147 B13 化合物60 B35 化合物150 B14 化合物66 B36 化合物152 B15 化合物68 B37 化合物153 B16 化合物69 B38 化合物155 B17 化合物71 B39 化合物158 B18 化合物72 B40 化合物163 B19 化合物80 B41 化合物168 B20 化合物85 B42 化合物170 B21 化合物91 B43 化合物179 B22 化合物94 B44 化合物181 B23 化合物103 B45 化合物183 列於表B1至B45内之特定混合物 ,其通常結合式 1之化合物與其他無脊椎害蟲藥劑,此兩者特定比例列 於表A中。 5 在農藝及非農藝應用中,藉由將生物有效量之一或 多種本發明化合物(通常呈組合物形式)施用至害蟲環 境(包括農藝及/或非農藝侵染地區)、有待保護之區域 或直接施用至有待控制之害蟲來控制無脊椎動物害蟲。 因此,本發明包含對農藝及/或非農藝應用中控制 10 無脊椎動物害蟲之方法,其包含使該無脊椎動物害蟲或 其環境與生物上有效量之一或多種本發明化合物接152 S 201204254 Mixture number compound number and invertebrate pest control agent A-18 1 and cyanobacteria A-19 1 and 灭宁Α·20 1 and Descendants Α-21 1 and Datnam Α-22 1 And P. sinensis -23 1 and Pseudomonas Α-24 1 and amphibious Pan Α-25 1 and Yihua Li Α -26 1 and B. sinensis -27 1 and fenthion -28 1 and fen Knock -29 1 and Fennel Α-30 1 as well as Fenpini Α-31 1 and flunislide 32-32 1 and flufenamide 33-33 1 and flufenonone 34 1 and 6 volts隆Α-35 1 and Amy Pine-36 1 and edaramine mixture compound and invertebrate pest control number number Α-54 1 and 尼尼丁Α-55 1 and 诺诺Α-56 1 and Killing -57 1 and giving points -58 1 and formazan Α-59 1 and sulfoxaflor Α-60 1 as well as fenfenone-61 1 and Tetramethylfluthrin Α -62 1 and Sai Pei-Α -63 1 and Sai An An-64 1 and Sulfur -65 1 and insecticidal biguanide-66 1 and tetramethrin Α-67 1 as well as 嗤蚜威Α-68 1 and Sanfulong Α-69 1 and Su bacterium Α-70 1 and Bacillus thuringiensis δ Toxin 71-71 1 and nuclear polyhedrosis virus (eg, Gemstar) Tables B2 to B45 are each similar to the construction of Table B1 above, except that the items listed under the heading "Compound Number" are listed below. Replace. Therefore, for example, in Table B2, the items under the column heading "Compound Number" are listed as "Compound 2", and the first line under the column heading in Table B2 specifically discloses a mixture of Compound 2 and abamectin. . Tables B3 to B45 have similar structures. Form number Compound number rotten item Form number B2 Compound 2 ~ B24 B3 Compound 3 B25 B4 Compound 5 B26 Compound number column Item Compound 112 Compound 114 Compound 119 153 201204254 Grid number Compound number block item table number Compound number block item B5 Compound 16 B27 compound 120 B6 Compound 17 B28 Compound 121 B7 Compound 25 B29 Compound 122 B8 Compound 29 B30 Compound 123 B9 Compound 35 B31 Compound 127 B10 Compound 52 B32 Compound 130 B11 Compound 58 B33 Compound 131 B12 Compound 59 B34 Compound 147 B13 Compound 60 B35 Compound 150 B14 Compound 66 B36 Compound 152 B15 Compound 68 B37 Compound 153 B16 Compound 69 B38 Compound 155 B17 Compound 71 B39 Compound 158 B18 Compound 72 B40 Compound 163 B19 Compound 80 B41 Compound 168 B20 Compound 85 B42 Compound 170 B21 Compound 91 B43 Compound 179 B22 Compound 94 B44 Compound 181 B23 Compound 103 B45 Compound 183 is listed as a specific mixture in Tables B1 to B45, which typically combines the compound of Formula 1 with Other invertebrate pest agents, the specific ratios of which are listed in Table A. 5 In agronomic and non-agronomic applications, by applying one or more biologically effective amounts of a compound of the invention (usually in the form of a composition) to a pest environment (including agronomic and/or non-agronomically infested areas), areas to be protected Or directly applied to the pests to be controlled to control invertebrate pests. Accordingly, the invention encompasses a method of controlling 10 invertebrate pests in agronomic and/or non-agronomic applications comprising subjecting the invertebrate pest or its environment to a biologically effective amount of one or more compounds of the invention

S 154 201204254 觸’或與包含至少一種該化合物之組合物,或包含至少 一種該化合物及生物有效量之至少一種其他生物活性 化合物或試劑的組合物接觸。值得注意的是,前述方法 中’無脊椎動物害蟲環境中的植物係與生物有效劑量的 5 本發明化合物接觸(例如:以本發明組合物之形式)。 包含本發明化合物及生物有效量之至少一種其他生物 活性化合物或試劑的合適組合物之實例包括顆粒組合 物’其中其他活性化合物存在於與本發明化合物相同之 顆粒上,或存在於獨立於本發明化合物所存在之彼等顆 10 粒之顆粒上。 為達成與本發明之化合物或組合物接觸以保護農 作物免遭無脊椎動物害蟲侵害,該化合物或組合物通常 施用於種植之前的植物種子、作物植物之葉枝(例如, 葉 '里、花、果實)或作物種植之前或之後的土壤或其 15 他生長介質。 一種接觸之方法的實施例係透過喷灑。再者,一包 含本發明化合物之粒劑組合物可用於植物之葉或土 壤。藉由以包含本化合物之組合物用做為液體配方之土 壤澆灌劑、粒劑配方至土壤、苗箱處理或移植物之浸泡 20 液接觸植物,經植物的吸收本發明之化合物亦可有效地 傳送。值得/主思的疋此本發明之組合物以土壤試劑液體 配方之型式。亦值得注意的是一種控制無脊椎動物害蟲 之方法,其包含使無脊椎動物害蟲或其環境與生物有效 量之本發》明化合物接觸,或與包含生物有效量之本發明 25 化合物的組合物接觸。進一步值得注意的是此方法中之 環境為土壤,以及將該組合物做為土壤試劑用於土讓 155 201204254 上進-步值付注意的是其中本發明之化合物 3=使二T效果。其他接觸方法包括直3 霧j (aerosol)、粉劑與許多其他的 觸方1 :實施例為包含本發明之化合物或組合物 二肥料顆粒、棒或_。本發明之化合物亦可注1:: =裝-種無脊椎控制裝置(例如,防蟲網)/ 遭無脊椎^ ^ HiΓ可用於種子處理以保護種子免 之内容中,。在本發明揭露及申請專利範圍 本發明將該種子接觸生物有效劑量之 == 其通f配製成本發明之組合物。此種子 …4種子保護該種子免受 15 20 25 二3對與土壤接觸從發芽種子發育出的幼苗,3 内透過發育植物 子或自' ί:ί本發明之一態樣係-種保護種 法^人出之植物免受無脊椎動物害蟲侵害之方 Ν 種子與一生物有效劑量之式1化合物、其 戈其鹽類(例如:做為一經調配之組合物)接 特定特徵之發芽A因轉種子’包括那些表現 =椎,蟲;毒=:=== (其提S供對現草:草等S 154 201204254 is contacted or contacted with a composition comprising at least one such compound, or a composition comprising at least one such compound and a biologically effective amount of at least one other biologically active compound or agent. Notably, the plant line in the 'invertebrate pest environment' of the foregoing method is contacted with a biologically effective amount of the compound of the invention (e.g., in the form of a composition of the invention). Examples of suitable compositions comprising a compound of the invention and a biologically effective amount of at least one other biologically active compound or agent include a particulate composition wherein the other active compound is present on the same particles as the compound of the invention, or is present independently of the invention The compound is present on 10 particles of each of them. In order to achieve contact with a compound or composition of the invention to protect crops from invertebrate pests, the compound or composition is typically applied to plant seeds prior to planting, to foliage branches of crop plants (eg, leaves, flowers, fruits) ) or soil before or after crop planting or its 15 growth medium. An embodiment of a method of contacting is by spraying. Further, a granule composition comprising the compound of the present invention can be used for the leaves or soil of plants. By contacting the plant with a soil watering agent, a granule formulation, a soil formulation, a seedling treatment or a soaking solution of the graft, the composition of the present invention is used, and the compound of the present invention can be effectively absorbed by the plant. Transfer. It is worthwhile to think that the composition of the present invention is in the form of a soil reagent liquid formulation. Also of note is a method of controlling an invertebrate pest comprising contacting an invertebrate pest or an environment thereof with a biologically effective amount of a compound of the invention, or a composition comprising a biologically effective amount of a compound of the invention 25 contact. It is further noted that the environment in this method is soil, and the composition is used as a soil reagent for soiling. 155 201204254 The above-mentioned step value is noted in which the compound of the present invention 3 = makes the two T effect. Other methods of contact include aerosol, powders, and many other touches. 1 : Examples are compounds or compositions comprising the present invention. Two fertilizer granules, rods or _. The compounds of the present invention may also be used in the following:: = Implanted invertebrate control device (e.g., insect net) / invertebrate ^ ^ HiΓ can be used for seed treatment to protect seed free content. The present invention discloses and claims the invention. The present invention is formulated into a composition of the invention by contacting the seed with a biologically effective dose of ==. This seed...4 seed protects the seed from 15 20 25 2 3 pairs of seedlings developed from germinating seeds in contact with the soil, 3 through the development of plant seeds or from the state of the invention - a species of protection A method for the protection of plants from human insults by invertebrate pests. Seeds and a biologically effective amount of a compound of formula 1 and its genomic salts (for example, as a formulated composition) with specific characteristics of germination A Turn seed 'including those performance = vertebra, insect; poison =:=== (its mention S for the current grass: grass, etc.

S 156 201204254 一種種子處理之方法,其係利用將本發明之化合物 (意即如一配製的組合物)在播種前以噴灑或灑粉之方 式投予至該種子上。配製成用於種子處理之組合物,通 常包含成膜劑或黏合劑。因此塗覆本發明組合物之種子 5 通常包含生物有效量之式1化合物、其N-氧化物或其 鹽類’以及成膜劑或黏合劑。因此,使用該組合物的處 理包含將種子以式i化合物、其^氧化物或其鹽類(即 以生物有效量)、塗覆,言亥式1化合物、其N•氧化物或 其鹽類係調配如一種包含成膜劑或黏合劑之組合物。可 10 藉由喷灑懸浮濃縮物之方式直接投至種子之翻滾床塗 覆該種子,接著將種子乾燥。或者,像是濕粉、溶液、 懸浮乳劑、可乳化》辰縮劑及乳劑之其他配方類型喷 於種子上。此過程係對種子的膜塗覆應用特=喷; 種不同的塗覆機器與方法可為該領域具有通常知識者 15 獲得。適合的方法包含列於p. Kosters et al.,Seed Treatment: Progress and Prospects, 1994 BCPC Mongraph No. 57及其中列出之參考文獻中所列出之彼等方法。 處理之種子通常包含本發明之化合物,其含量約為 每100 kg的種子含〇·ι g至1 kg的化合物(意即從約 20 0.0001至1個處理前種子的重量百分比)以提供生物有 效量。用於種子處理之懸浮配方通常包含約從〇5至 70%的活性成分、0.5至30%的成膜黏著劑、〇.5至20% 分散劑、0至5%的增稠劑、〇至5%的色素及/或染料、 0至2%的防沫劑、〇至1%的防腐劑與〇至75%的揮發 25 性液體稀釋劑。 157 201204254 本發明之化合物可併入為無脊椎動物害蟲取食或 在像是陷阱、誘餌台及其類似物之裝置中使用之誘^組 合物中。這種誘餌組合物可為顆粒形式包含活= 成分’即生物有效量的式1化合物、其N_氧化物或盆 鹽類;(b) —種或更多種食物材料;選擇性之(c) ^ ,劑;及選擇性之(d) —或多種保溼劑。值得注意的 疋包含約0.001至5%之間的活性成分、約4〇至食 物材料及/或引;及選擇性地約⑽至1()%保護: 之顆粒或誘餌組合物,其在極低施用率下、尤其在藉由 攝取而非藉由直接接觸而致命的活性成分劑量下,可有 欵防治土壤無脊椎動物害蟲。一些食物材料可充當食物 溽與引誘劑兩者。食物材料包括碳水化合物、蛋白質及 月曰質。食物材料之實例為植物粉、糖、澱粉、動物脂肪、 植物油、酵母萃取物及乳固體。引誘劑之實例為氣曰味劑 及芳香劑,像是水果或植物萃取物、香料或其他動物或 植物組分、費洛蒙或已知可吸引目標無脊椎動物害蟲之 其他試劑。保溼劑(即濕度保持劑)之實例為二醇或其 他多元醇、甘油及山梨糖醇。值得注意的是一種用以控 =至少一種選自由螞蟻、白犧及蟑螂所組成之群組之無 脊椎動物害蟲的誘餌組合物(及一種利用該誘餌組合物 之方法)。一種用於控制無脊椎動物害蟲之裝置可包含 本發明之誘僻組合物及一適合收納該誘輯組合物之外 %,其中該外殼具有至少一開口,該開口之尺寸訂定為 允許該無脊椎動物害蟲通過該開口,因此該無脊椎動物 害蟲可自外殼外部之位置接近該誘餌組合物,且其中該S 156 201204254 A method of seed treatment by administering a compound of the invention (i.e., a formulated composition) to the seed by spraying or dusting prior to sowing. Compositions for seed treatment are typically formulated, including film formers or binders. Thus, the seed 5 coated with the composition of the present invention typically comprises a biologically effective amount of a compound of formula 1, an N-oxide or a salt thereof, and a film former or binder. Thus, the treatment using the composition comprises coating the seed with a compound of formula i, an oxide thereof or a salt thereof (i.e., in a biologically effective amount), a compound of the formula 1, a N•oxide thereof or a salt thereof. A composition such as a film-forming agent or a binder is formulated. The seed can be applied by spraying the suspension concentrate directly onto the tumbling bed of the seed, followed by drying the seed. Alternatively, other formulation types such as wet powders, solutions, suspoemulsions, emulsifiable emulsifiers and emulsions are sprayed onto the seeds. This process applies a special spray to the film coating of the seed; a variety of coating machines and methods are available to those of ordinary skill in the art. Suitable methods include those listed in p. Kosters et al., Seed Treatment: Progress and Prospects, 1994 BCPC Mongraph No. 57 and the references listed therein. The treated seed typically comprises a compound of the invention in an amount of from about ιg to 1 kg per 100 kg of seed (i.e., from about 20 0.0001 to 1 weight percent of pre-treated seed) to provide biological effectiveness. the amount. Suspension formulations for seed treatment typically comprise from about 5 to 70% active ingredient, from 0.5 to 30% film-forming adhesive, from 5 to 20% dispersant, from 0 to 5% thickener, to 5% pigment and / or dye, 0 to 2% antifoam, 〇 to 1% preservative and 〇 to 75% volatile 25 liquid diluent. 157 201204254 The compounds of the invention may be incorporated into inducing compositions for use by invertebrate pests or in devices such as traps, bait tables and the like. Such a bait composition may be in the form of granules comprising a living = ingredient 'i.e., a biologically effective amount of a compound of formula 1, an N-oxide or a basin salt thereof; (b) one or more food materials; ^, agent; and selective (d) - or a variety of humectants. Notably, the mash comprises between about 0.001 and 5% active ingredient, about 4 ounces to the food material and/or lead; and optionally about (10) to 1 (%) protection: the granule or bait composition, which is at the extreme Soil invertebrate pests can be controlled at low application rates, especially at doses of active ingredients that are fatal by ingestion rather than by direct contact. Some food materials can act as both food and attractants. Food materials include carbohydrates, protein and glutinous. Examples of food materials are vegetable flour, sugar, starch, animal fat, vegetable oil, yeast extract and milk solids. Examples of attractants are gas odorants and fragrances, such as fruit or plant extracts, flavors or other animal or plant components, pheromones or other agents known to attract target invertebrate pests. Examples of humectants (i.e., moisture retaining agents) are diols or other polyols, glycerin, and sorbitol. Of note is a bait composition (and a method of using the bait composition) for controlling at least one invertebrate pest selected from the group consisting of ants, white sacrifice and cockroaches. A device for controlling an invertebrate pest can comprise a tempting composition of the present invention and a % other than the accommodating composition, wherein the outer casing has at least one opening, the opening being sized to allow the The vertebrate pest passes through the opening such that the invertebrate pest can approach the bait composition from a location external to the outer casing, and wherein the

S 158 201204254 . 外殼進一步適合置放在無脊推動物害蟲之潛在或已知 • 活動地點或其附近。 本發明之化合物可在無其他佐劑的情況下施用,但 最通常的施用為-配方,其包含—或多種具有合適戟 5 冑、稀釋劑及介面活性劑的活性成分’且視預期最終用 途而定可能與食物Μ合。—種施財法包括喷灑本發明 化合物之水分散液或精製油溶液。與喷霧油、喷霧油濃 縮物、黏展劑、佐劑、其他溶劑、及像是向曰葵基丁 化物之增效顯合通常可增強化合物功效。對於非農鼓 10 用途而言’該等噴霧可自諸如罐、瓶或其他外殼之喷; 外殼,藉助於泵或藉由使其自加壓外殼(例如,加壓 霧劑噴霧罐)釋放而施用。該等喷霧組合物可採用多種 形^ ’例如喷霧、薄霧、泡沫、煙霧或霧。因此此^劑 組合物更能失帶推進物、泡沫媒介等 15 ^值得注意的是包t物有效量之 =及_的嘴麻合物。此類喷霧組合物之一=例 本發明化合物或組合物及二 ==;不限於)甲烧、乙燒、,、丁-、 J邱戊垸、異戊烷、新戊烷、戊嫌^ 20 化物、氣氟碳化物一 _μu虱亂反 、、兰音沾a ^ 〜甲醚及刖述物質之混合物。值得 ::、疋-種用以控制至少—種選自由以 、=群組之無脊椎動物㈣的喷霧組合物(及—二 、霧外殼施配此_雜合物时法): 廄蠅、鹿蠅、馬蠅、胡蜂、小黃蜂、大黃蜂:',、、:、 25螞蟻、蚋及其類似害蟲,包括個別或組合。碑、虫知蛛、 159 201204254 物,括㈣祕(具體Μ為脊椎動 t類如:哺乳類動物或 生害蟲的侵擾,:二1)免受無脊椎動物寄 (即生物^欲㈣動物殺寄生物有效 &gt;里的本發明化合物(通常 時係調配輕合物料)。因錄躲意岐= 方法包含施予該動物殺寄生物有效= =二:Γ1如本揭露内容與中請專利範圍所述,該 10 15 20 」與「殺寄生蟲地」意指在無脊椎寄 生:蟲上可觀察到的效果’以提供動物免受害蟲侵害的 保護。殺寄生蟲的效果—般係關於減低目標無脊椎動物 寄生性害蟲m活動力。此種在害蟲上之效果包 括壞死死亡、生長遲緩、活動力減低或維持在宿主 動物身上或其内之能力下降、攝食減低與繁殖抑制。此 等在無脊椎動物寄生害蟲之效果上,其提供動物寄生感 染或傳染之控制(包括預防、減低或消除)。藉由向有 待保護之動物投予殺寄生蟲有效量之本發明化合物而 防治之無脊椎寄生害森的實例,特別包括體外寄生蟲 (節肢勤物、蟎等)。特別是’本發明之化合物能有效 對抗體外寄生蟲,包括:罐,諸如擾血罐(擾角繩 (Lyperosia irritans))(角蠅)、廄刺蠅(St〇m〇xys calcitrans)(廄繩)、蚋屬(Simulium spp.)(黑繩)、舌 蠅屬(Glossinaspp·)(采釆繩)、擾齒股蠅(Hydrotaea irritans)(頭繩)、秋家罐(Musca autumnalis)(面繩)、 舍蠅(Musca domestica)(家蠅)、簡蠅(Morellia simplex) (汗繩)、妃:屬(Tabanus spp.)(馬繩)、牛皮繩(Hypoderma 25 201204254 bovis)、紋皮蠅(Hypoderma lineatum)、絲光綠竭(Lucilia sericata )、銅綠蝇(Lucilia cuprina)(綠色麗繩)、麗蠅 屬(Calliphoraspp.)(麗繩)、原伏繩屬(Protophormia spp.)、羊鼻繩(鼻部馬绳)、庫蠓屬(Culicoides spp.) 5 (蠓)、馬藏繩(Hippobosca equine )、馬胃繩 (Gastrophilus )、紅尾胃繩(Gastrophilus haemorrhoidalis)及納斯利胃蠅(Gastrophilus naslis); 兹例如牛毛兹(Bovicola (Damalinia) bovis)'馬毛齒 (Bovicolaequi)、馬驢血兹(Haematopinus asini )、描 ίο 毛兹(Felicola subrostratus )、狗兹(Heterodoxus spiniger )、犬乱(Lignonathus setosus )及犬食毛益 (Trichodectes canis );碑例如綿羊益蠅(Melophagus ovinus );蜗例如旅恙蟲屬(Psoroptes spp.)、節肢動物 挤(Sarcoptes scabei)、牛济癣(Chorioptes bovis)、馬 15 螺形蜗(Demodex equi)、姬螯蜗屬(Cheyletiella spp.)、 書苗旅蜗(Notoedrescati)、秋恙蟲屬(Trombiculaspp.) 及耳癢瞒(Otodectes cyanotis)(耳蜗);蜱,諸如硬蜱 屬(Ixodesspp.)、牛蜱屬(Boophilusspp·)、扇頭蜱屬 (Rhipicephalus spp.)、花蜱屬(Amblyomma spp.)、革 2〇 蟬屬(Dermacentor spp.)、玻眼蜱屬(Hyalomma spp_) 及血碑屬(Haemaphysalis spp.);及蚤例如貓蚤 (Ctenocephalides felis(貓蚤))及狗蚤(Ctenocephalides canis (狗蚤))。 獸醫學部門中之非農藝應用係藉由傳統方式,諸如 25 藉由以例如錠劑、膠囊、飲料、澆灌製劑、顆粒、漿液、 博力(boli)、經由餵食之程式或栓劑之形式腸内投予; 161 201204254 =由腸外投予’諸如藉由注射液(包括肌_、皮下、 =内、腹膜内)或植人物;藉由經鼻投予;藉由局部 以浸泡或浸潰、喷霧、洗務、以散劑塗佈或 5 10 15 20 j之較小區域之形式,及經由包含本發明之化 &amp;物或組合物之物品(諸如頸環、耳環、尾帶、肢帶或 韁繩)。 依本發明之典型殺寄生蟲組合物,包含式1化合 物其N氧化物或鹽類之化合物,併以一或更多藥學 或獸醫上可接受的載體,包括所選擇有關於應用途徑的 辅藥和輔劑(例如口服、局部或非口服的,如注射), 以及按照標準實務。局部投藥可提供最佳的治療指標。 此外,合適載劑係基於與組合物中之一或多種活性成分 之相谷性(包括諸如相對於pH值之穩定性及水分含量 之因素)來選擇。因此,值得注意的是一種用於保護動 物免遭無脊椎寄生害蟲侵害之組合物,其包含殺寄生蟲 有效量之本發明化合物及至少一種載劑。 對於包括靜脈内、肌肉内及皮下注射之非經腸投予 而言,本發明之化合物可調配為於油性或水性媒劑中之 懸浮液、溶液或乳液,且可含有諸如懸浮液、穩定劑及 /或分散劑之添加劑。用於注射之醫藥組合物包括水溶 性形式活1性成分(例如,活性化合物之鹽)之水溶液, 較佳於含有醫藥調配技術中已知之其他賦形劑或助劑 的生理學相容緩衝劑中之水溶液。 對於以溶液(對於吸收最易利用之形式)、乳液、 懸浮液、糊劑、凝膠、膠囊、錠劑、大藥丸、散劑、顆 粒、瘤胃保留物及飼料/水/添瑰(lickblocks)之形式經S 158 201204254 . The outer casing is further adapted to be placed at or near the site of potential or known activity of the ridgeless pusher pest. The compounds of the present invention can be administered without other adjuvants, but the most common application is a formulation comprising - or a plurality of active ingredients with suitable hydrazines, diluents and surfactants' and depending on the intended end use It may be combined with food. A method of financing includes spraying an aqueous dispersion or a refined oil solution of a compound of the present invention. Synergistic effects with spray oils, spray oil concentrates, binders, adjuvants, other solvents, and, for example, geranium-based butyrate generally enhance compound efficacy. For non-agricultural drum 10 applications, such sprays may be sprayed from, for example, cans, bottles or other outer casing; the outer casing, by means of a pump or by releasing it from a pressurized outer casing (for example, a pressurized aerosol spray can) Apply. The spray compositions can take a variety of forms such as sprays, mists, foams, fumes or mists. Therefore, the composition of the composition is more likely to lose the propellant, the foam medium, etc. 15 ^ It is worth noting that the effective amount of the package t is the same as that of the mouth. One of such spray compositions = examples of the compounds or compositions of the present invention and two ==; not limited to) toxin, ethylene, butyl, ketone, isopentane, neopentane, ^ 20 Compounds, gas fluorocarbons - _μu 虱 反, 兰 沾 a a ^ ~ methyl ether and a mixture of substances. It is worthwhile to::, 疋-species to control at least one type of spray composition selected from the group of invertebrates (four) (and two, the fog shell to apply this _ hybrid method): , deer flies, horse flies, wasps, small wasps, bumblebees: ',,,:, 25 ants, cockroaches and similar pests, including individual or combination. Monument, insect known spider, 159 201204254 Objects, including (four) secret (specifically, the spine moves t such as: mammals or insects infested, two: 1) from invertebrates (ie bio-desire (four) animal killing The compound of the present invention in biologically effective &gt; (usually formulated as a light-weight material). The method of occlusion is as follows: the method comprises administering the animal parasiticidally effective == two: Γ1 as disclosed in the disclosure and the scope of the patent application As stated, the "10 15 20" and "parasitic ground" mean the effect observed on invertebrate parasites: insects to provide protection against pests. The effect of parasitic killing is to reduce the target. Invertebrate parasitic pests m activity. Such effects on pests include necrotic death, growth retardation, decreased motility or decreased ability to maintain or be in the host animal, reduced feeding and inhibition of reproduction. In the effect of vertebrate parasitic pests, it provides control (including prevention, reduction or elimination) of parasitic infections or infections of animals. By administering a parasiticidally effective amount of a compound of the invention to an animal to be protected Examples of invertebrate parasitic diseases to be controlled include, in particular, ectoparasites (arthropods, cockroaches, etc.). In particular, the compounds of the present invention are effective against ectoparasites, including: cans, such as blood-sucking tanks (scrabble angles) (Lyperosia irritans), 〇 蝇 〇 (St〇m〇xys calcitrans) (廄), mul (Simulium spp.) (black rope), genus Glossinaspp (Glossinaspp·) ), Hydrotaea irritans (head rope), Musca autumnalis (face rope), Musca domestica (Housefly), Morellia simplex (sweat), 妃: Genus (Tabanus spp.) (horse rope), cowhide rope (Hypoderma 25 201204254 bovis), Hypoderma lineatum, Lucilia sericata, Lucilia cuprina (green rope), Blowfly Genus (Calliphoraspp.) (Lilyo), Protophormia spp., sheep nose rope (nasal horse rope), Culicoides spp. 5 (蠓), Horseshoe rope (Hippobosca equine) , Gastrophilus, Gastrophilus haemorrhoidalis and Gastrophilus naslis; for example, Bovicola (Damalinia bovis) 'Bovicolaequi, Haematopinus asini, Felicola subrostratus, Heterodoxus spiniger ), Lignonathus setosus and Trichodectes canis; monuments such as Melophagus ovinus; snails such as Psoroptes spp., Sarcoptes scabei, and cattle Chorioptes bovis, Demodex equi, Cheyletiella spp., Notoedrescati, Trombulaspp. and Otodectes cyanotis (cochlea); 蜱, such as Ixodesspp., Boophilus spp., Rhipicephalus spp., Amblyomma spp., Dermacentor spp .), Hyalomama spp_ and Haemaphysalis spp.; and 蚤 such as cat cephal (Ctenocephalides felis) and dog ticks (Ctenocephalides canis). Non-agronomic applications in the veterinary department are performed in a conventional manner, such as by using in the form of, for example, lozenges, capsules, beverages, watering preparations, granules, serum, boli, via feeding procedures or suppositories. 161 201204254 = by parenteral administration 'such as by injection (including muscle_, subcutaneous, intra-, intraperitoneal) or planting a person; by nasal administration; by topical soaking or impregnation, Spray, wash, spray coating or a smaller area of 5 10 15 20 j, and articles (such as neck rings, earrings, tail bands, limbs) containing the chemicals &amp; compositions or compositions of the present invention Or reins). A typical parasiticidal composition according to the invention, comprising a compound of formula 1 as an N-oxide or a salt thereof, and in one or more pharmaceutically or veterinary acceptable carriers, including adjuvants selected for the route of administration And adjuvants (such as oral, topical or non-oral, such as injection), and in accordance with standard practice. Topical administration provides the best therapeutic indication. In addition, suitable carriers are selected based on the phase of the phase with one or more of the active ingredients in the composition, including factors such as stability relative to pH and moisture content. Accordingly, it is worth noting that a composition for protecting an animal from invertebrate parasitic pests comprises a parasiticidally effective amount of a compound of the invention and at least one carrier. For parenteral administration including intravenous, intramuscular and subcutaneous injection, the compounds of the invention may be formulated as suspensions, solutions or emulsions in oily or aqueous vehicles, and may contain, for example, suspensions, stabilizers And/or additives to the dispersant. The pharmaceutical composition for injection comprises an aqueous solution of a water-soluble form of a living ingredient (for example, a salt of the active compound), preferably a physiologically compatible buffer containing other excipients or auxiliaries known in the pharmaceutical formulation technique. Aqueous solution in the middle. For solutions (in the form most readily available for absorption), emulsions, suspensions, pastes, gels, capsules, lozenges, large pills, powders, granules, rumen retentate and feed/water/lickblocks Form

S 162 25 201204254S 162 25 201204254

鎮^破碎劑(例如,交聯之聚乙烯吡咯啶酮、瓊脂、 褐澡酸)及染料或顏料。糊劑及凝膠通常亦含有^ (例如,阿拉伯膠、褐藻酸、膨潤土、纖維素、三仙膠、 膠狀矽酸鋁鎂)以幫助保持組合物與口腔接觸且不易喷 出。 、 若殺寄生蟲組合物呈飼料濃縮物形式,則載劑通常 選自高效能飼料、飼料用縠類或蛋白質濃縮物。除殺寄 生蟲活性成分外,該等含有飼料濃縮物之組合物可包含 促進動物健康或生長、改良屠宰動物之肉質或以其他方 式適用於畜牧業之添加劑。此等添加劑可包括(例如) 維生素、抗生素、化學治療劑、抑菌劑、抑真菌劑、球 蟲抑制劑及激素。 本發明之化合物可能具有有利之藥物動力學及藥 致學性質,提供自經口投藥及攝入之系統可用性。因 此,在經有待保護之動物攝入後,血流中殺寄生蟲有效 濃度之本發明化合物保護所治療之動物免遭吸血害蟲 (諸如,跳蚤、蜱及虱)侵害。因此,值得注意的是一 種用於保護動物免遭無脊椎寄生害蟲侵害之呈用於經 163 201204254 口投藥之形式的組合物(亦即,除殺寄生騎效量之本 發明化合物外’亦包含—或多種選自適於經〇投藥之黏 合劑及填充劑與飼料濃縮物載劑的載劑)。 用於局部投予之配方通常呈散劑、乳f、懸浮液、 喷霧、乳m義、氣雜、軟膏、油膏或凝膠 之形式。局部配方更通常為水溶性溶液,其可呈在使用 之前稀釋之濃縮物形式。適於局部投予之殺寄生蟲組人 物通常包含本發明之化合物及一或多種局部合適之&amp; 劑。在將殺寄生蟲組合物局部塗覆於動物外表呈線狀或 點狀(亦即’「噴滴(spot_on)」治療)的過程中活性 成分在動物表面上遷移以覆蓋其大部分或所有外表面 區域。因此,經治療之動物尤其免遭取食於動物表皮之 無脊椎動物害蟲(諸如,蜱、跳蚤及虱)侵害。因此, 用於局部定位投予之配方通常包含至少一種便於活性 成分在皮上遷移及/或滲入動物表皮中之有機溶劑。一 般用做載劑的溶劑包括:丙二醇、二醇'石蠟、芳香族 化合物、S曰(諸如肉豆蔻酸異丙酯)、二醇鍵、醇類(諸 如乙醇及正丙醇)。 達成有效防治所需之施用率(亦即「生物有效量」) 將視諸如有待防治之無脊椎動物之物種、害蟲之生命週 期、生命階段、其尺寸、地點、季節、宿主&amp;物或動物、 攝食行為、交配行為、周圍濕度、溫度及其類似物的因 素而定。在正常情狀下,在農藝的生態系統中,使用率 約母公頃0.01至2 kg的活性成分足以控制害蟲,但少 量如0.0001 kg/公頃可能即足夠或可能需要多如8 kg/ 公頃。在非農藝應用上,所需有敦的使用率範圍從約A crushing agent (for example, crosslinked polyvinylpyrrolidone, agar, brown bath acid) and a dye or pigment. Pastes and gels also typically contain (e.g., gum arabic, alginic acid, bentonite, cellulose, sansonic, colloidal aluminum magnesium citrate) to help keep the composition in contact with the oral cavity and are not easily ejected. If the parasiticidal composition is in the form of a feed concentrate, the carrier is typically selected from the group consisting of high performance feeds, feed mites or protein concentrates. In addition to the insecticidal active ingredient, the compositions containing the feed concentrate may comprise additives which promote the health or growth of the animal, improve the meat quality of the slaughtered animal or otherwise be suitable for use in the livestock industry. Such additives may include, for example, vitamins, antibiotics, chemotherapeutic agents, bacteriostats, fungicides, coccidiostats, and hormones. The compounds of the invention may have advantageous pharmacokinetic and pharmacological properties, providing system availability from oral administration and ingestion. Thus, the compound of the invention at a concentration effective to kill the parasite in the bloodstream after ingestion by the animal to be protected protects the treated animal from blood-sucking pests such as fleas, ticks and ticks. Therefore, it is worth noting that a composition for the purpose of protecting animals from invertebrate parasitic pests for administration via 163 201204254 (i.e., in addition to the compound of the invention for killing parasitic effects) also includes - or a plurality of carriers selected from the group consisting of binders suitable for transfusion and fillers and feed concentrate carriers). Formulations for topical administration are usually in the form of a powder, a milk, a suspension, a spray, a milk, a gas, an ointment, an ointment or a gel. The topical formulation is more typically a water soluble solution which may be in the form of a concentrate which is diluted prior to use. A parasiticidal group suitable for topical administration typically comprises a compound of the invention and one or more topically suitable &amp; agents. The active ingredient migrates over the surface of the animal to cover most or all of the surface of the animal during topical application of the parasiticidal composition to the appearance of the animal in the form of a line or spot (ie, 'spot_on' treatment). Surface area. Thus, treated animals are particularly protected from invertebrate pests (such as ticks, fleas and ticks) that feed on the epidermis of animals. Thus, formulations for topical administration typically comprise at least one organic solvent which facilitates migration of the active ingredient onto the skin and/or penetration into the epidermis of the animal. Solvents generally used as carriers include: propylene glycol, diol 'paraffin, aromatics, S (such as isopropyl myristate), glycol linkages, alcohols (such as ethanol and n-propanol). The rate of application required to achieve effective control (ie, "biologically effective amount") will depend on the species of the invertebrate to be controlled, the life cycle of the pest, the stage of life, its size, location, season, host &amp; animal or animal , feeding behavior, mating behavior, ambient humidity, temperature and other similar factors. Under normal circumstances, in the agronomic ecosystem, an active ingredient of about 0.01 to 2 kg per hectare is sufficient to control pests, but a small amount such as 0.0001 kg/ha may be sufficient or may require as much as 8 kg/ha. In non-agronomic applications, the range of usage required is from about

S 164 201204254 L0至50 mg/平方公尺,但少量如〇丨mg/平方公尺可能 即足夠或可能需要多如15G mg/平方公尺。熟悉該項技 術之人士可輕易決定所需之生物有效數量,以達控制寄 生性線蟲的要求程度。 ° 一般對於獸醫學用途而言,向動物投予殺寄生蟲有 效量之式1化合物、其N_氧化物或其鹽類以使其免遭 無脊椎寄生害蟲侵害。殺寄生蟲有效量為所需之活性成 分之量,以達到減少目標無脊椎寄生害蟲之出現或活性 的可觀測效果。熟習此項技術者將瞭解殺寄生蟲有效劑 量可本發明之各種化合物及組合物、所需殺寄生蟲作 用及持績時間、目標無脊椎動物害蟲物種、有待保護之 動物、施用模式及其類似者而變化,且達到特定結果所 需之量可經由簡單實驗來確定。 對於向恆溫動物經口投予而言,本發明化合物之日 劑星通常在每公斤動物體重約〇.01 mg至約1〇〇 mg之 範圍内,更通常在每公斤動物體重約0.5 mg至約1〇〇 mg 之範圍内。對於局部(例如,經皮)投予而言,浸液及 嘴霧通常含有約〇.5 ppm至約5000 ppm、更通常約1 ppm至約3000 ppm之本發明化合物。 下列測試闡明本發明化合物對特定害蟲之控制效 力。「控制效力」表示對無脊椎動物害蟲發育之抑制(包 括死亡),因此造成攝食的顯著減少。然而,該化合物 提供之害蟲控制保護未限於這些物種。對於化合物說明 請索引表A至F。以下之縮寫係使用於索弓丨表中。化合 物No.代表化合物號碼,ph係苯基’且Py係吧咬基。 縮寫「Ex·」表示「實例」,且其後之數字意指該化合物 165 201204254 製程之實例。在(R3)n欄中的破折號(「-」)代表R3取代 基不存在。S 164 201204254 L0 to 50 mg / m ^ 2, but a small amount such as 〇丨 mg / m ^ 2 may be sufficient or may require as much as 15G mg / m ^ 2 . Those skilled in the art can easily determine the amount of bioavailable required to control the level of parasitic nematodes. ° Generally for veterinary use, a parasitic effective amount of a compound of formula 1, an N-oxide or a salt thereof is administered to an animal to protect it from invertebrate parasitic pests. The effective amount of parasiticidal is the amount of active ingredient required to achieve an observable effect of reducing the occurrence or activity of the target invertebrate parasitic pest. Those skilled in the art will appreciate that effective doses of parasiticidal agents can be various compounds and compositions of the invention, required parasiticidal effects and duration of achievement, target invertebrate pest species, animals to be protected, modes of administration, and the like. The amount required to change and achieve a particular result can be determined by simple experimentation. For oral administration to a warm-blooded animal, the daily dose of the compound of the present invention is usually in the range of from about 0.01 mg to about 1 mg per kg of animal body weight, more usually about 0.5 mg per kg of animal body weight. Within the range of about 1 〇〇mg. For topical (e.g., transdermal) administration, the infusion and mouth mist typically contain from about 0.5 ppm to about 5000 ppm, more typically from about 1 ppm to about 3000 ppm of the compound of the invention. The following tests illustrate the control efficacy of the compounds of the invention against specific pests. "Control effectiveness" means inhibition of invertebrate pest development (including death), resulting in a significant reduction in food intake. However, the pest control protection provided by this compound is not limited to these species. For compound descriptions, please index Tables A through F. The following abbreviations are used in the slings. The compound No. represents the compound number, ph is a phenyl group, and the Py system is a bite group. The abbreviation "Ex·" means "instance", and the following number means an example of the compound 165 201204254 process. A dash ("-") in the (R3)n column indicates that the R3 substituent does not exist.

索引表AIndex table A

化合物號碼 A1 A2 A3 Ri (R3)n R4 R6 m.p. (°C ) 1 (實例1) N cf3-c H-C 2-Cl-4-Py — H 4-Cl-Ph 100-102 2 (實例2) H-C C1-C Cl-C 2-Cl-4-Py - H 4-Cl-Ph * * 3 (實例3) H-C C1-C Cl-C 2-Cl-4-Py _ H 4-Cl-Ph **(註記1 ) 4 H-C H-C F3C-C 2-Cl-4-Py - H 4-Cl-Ph 本 5 H-C Cl-C H-C 2-Cl-4-Py - H 4-Cl-Ph * 6 H-C F-C H-C 2-Cl-4-Py - H 4-Cl-Ph * 7 H-C Cl-C H-C 2-CI-4-Py - Me 4-Cl-Ph * 8 H-C cf3-c H-C 2-Cl-4-Py - H 4-Cl-Ph * 9 H-C Cl-C Cl-C 2-Cl-4-Py - Me 4-Cl-Ph * 10 H-C cf3-c H-C 2-Cl-4-Py - Me 4-Cl-Ph * 11 H-C H-C F3C-C 2-Cl-4-Py - Me 4-Cl-Ph * 12 H-C F-C H-C 2-Cl-4-Py - Me 4-Cl-Ph 氺 13 N Cl-C H-C 2-Cl-4-Py - H 4-Cl-Ph * 14 N Cl-C H-C 2-Cl-4-Py - H 4-Br-Ph * 15 H-C Cl-C H-C 2-Cl-4-Py 3-Me H 4-Cl-Ph 16 (實例4) N H-C Cl-C 2-Cl-4-Py - H 4-Cl-Ph 氺本 17 (實例6) N Cl-C H-C 2-Cl-4-Py - Me 4-Cl-Ph ** 18 N H-C Cl-C 4-Py - H 4-Cl-Ph 134-136 19 N H-C Cl-C 2,6-di-Cl-4-Py — H 4-Cl-Ph 157-159Compound number A1 A2 A3 Ri (R3)n R4 R6 mp (°C ) 1 (Example 1) N cf3-c HC 2-Cl-4-Py — H 4-Cl-Ph 100-102 2 (Example 2) HC C1-C Cl-C 2-Cl-4-Py - H 4-Cl-Ph * * 3 (Example 3) HC C1-C Cl-C 2-Cl-4-Py _ H 4-Cl-Ph ** (Note 1) 4 HC HC F3C-C 2-Cl-4-Py - H 4-Cl-Ph 5 HC Cl-C HC 2-Cl-4-Py - H 4-Cl-Ph * 6 HC FC HC 2-Cl-4-Py - H 4-Cl-Ph * 7 HC Cl-C HC 2-CI-4-Py - Me 4-Cl-Ph * 8 HC cf3-c HC 2-Cl-4-Py - H 4-Cl-Ph * 9 HC Cl-C Cl-C 2-Cl-4-Py - Me 4-Cl-Ph * 10 HC cf3-c HC 2-Cl-4-Py - Me 4-Cl-Ph * 11 HC HC F3C-C 2-Cl-4-Py - Me 4-Cl-Ph * 12 HC FC HC 2-Cl-4-Py - Me 4-Cl-Ph 氺13 N Cl-C HC 2-Cl -4-Py - H 4-Cl-Ph * 14 N Cl-C HC 2-Cl-4-Py - H 4-Br-Ph * 15 HC Cl-C HC 2-Cl-4-Py 3-Me H 4-Cl-Ph 16 (Example 4) N HC Cl-C 2-Cl-4-Py - H 4-Cl-Ph 氺 Ben 17 (Example 6) N Cl-C HC 2-Cl-4-Py - Me 4-Cl-Ph ** 18 N HC Cl-C 4-Py - H 4-Cl-Ph 134-136 19 N HC Cl-C 2,6-di-Cl-4-Py — H 4-Cl-Ph 157-159

S 166 201204254 化合物號碼 A1 A2 A3 R1 (R3)n R4 R6 m.p. (°C ) 20 N C1-C Cl-C 2-Cl-4-Py - Me 4-Cl-Ph * 21 N H-C f3c-c 2-Cl-4-Py - H 4-Cl-Ph * 22 N H-C f3c-c 2-Cl-4-Py - Me 4-Cl-Ph * 23 N C1-C H-C 2-Cl-4-Py — H 3-Cl-Ph 本 24 N C1-C H-C 2-Cl-4-Py - H 2-Cl-Ph * 25 N C1-C H-C 2-Cl-4-Py — H 3-CF3-Ph * 26 N C1-C H-C 2-Cl-4-Py - H 4-F-Ph 木 81 N C1-C Cl-C 2-Cl-4-Py — H 4-Cl-Ph * 82 N Br-C Cl-C 2-Cl-4-Py - H 4-Cl-Ph * 83 N H-C Br-C 2-Cl-4-Py - H 4-Cl-Ph * 84 N H-C F-C 2-Cl-4-Py — H 4-Cl-Ph 本 85 N Cl-C F-C 2-Cl-4-Py - H 4-Cl-Ph * 86 N Cl-C Br-C 2-Cl-4-Py 一 H 4-Cl-Ph * 87 N Br-C F-C 2-Cl-4-Py — H 4-Cl-Ph 本 88 N Br-C Br-C 2-Cl-4-Py — H 4-CI-Ph 幸 89 N Br-C f3c-c 2-Cl-4-Py - H 4-Cl-Ph 本 90 N Cl-C f3c-c 2-Cl-4-Py - H 4-Cl-Ph % 91 N F-C Cl-C 2-Cl-4-Py - H 4-Cl-Ph * 92 (實例7) N h2n-c Cl-C 2-Cl-4-Py — H 4-Cl-Ph * t 93 H-C Cl-C Cl-C 2-Cl-4-Py - H 6-Cl-2-Py * 94 N f3c-c H-C 2-Cl-4-Py — H 5-Cl-2-Py 木 95 N f3c-c H-C 2-Cl-4-Py - H 6-Cl-2-Py * % (實例8) N N Cl-C 2-Cl-4-Py — H 4-Cl-Ph 本本 97 N f3c-c H-C 2-Br-4-Py - H 4-Cl-Ph * 98 N f3c-c H-C 2,F-4-Py - H 4-Cl-Ph * 99 N f3c-c H-C 3-Cl-4-Py — H 4-Cl-Ph * 100 N f3c-c H-C 2,3-di-Cl-4-Py - H 4-Cl-Ph * 101 N f3c-c H-C 2-F3C-4-Py - H 4-Cl-Ph 氺 102 N f3c-c H-C 2-Cl-3-F-4-Py - H 4-Cl-Ph * 103 N f3c-c H-C 2-Cl-4-Py 2-Me H 4-Cl-Ph * 104 H-C f3c-c N 2-Cl-4-Py - H 4-Cl-Ph 伞 105 N f3c-c H-C 4-嘧啶基 一 H 4-Cl-Ph * 106 H-C Cl-C F-C 2-Cl-4-Py — H 4-Cl-Ph * 167 201204254 化合物號碼 A1 A2 A3 R1 (R3)n R4 R6 m.p. (°C) 着 · 107 H-C Br-C F-C 2-Cl-4-Py - H 4-Cl-Ph 本 « 108 N f3c-c H-C 2-C1-5-噻唑基 — H 4-Cl-Ph * • 109 N Cl-C F-C 2-Cl-4-Py - Me 4-Cl-Ph * _ 110 N Br-C F-C 2-Cl-4-Py - Me 4-Cl-Ph * 111 N N Br-C 2-Cl-4-Py - H 4-Cl-Ph 本 註記1 :化合物2之草酸鹽。 * hNMR數據請見索引表G。 **】HNMR數據請見合成實例。S 166 201204254 Compound number A1 A2 A3 R1 (R3)n R4 R6 mp (°C ) 20 N C1-C Cl-C 2-Cl-4-Py - Me 4-Cl-Ph * 21 N HC f3c-c 2 -Cl-4-Py - H 4-Cl-Ph * 22 N HC f3c-c 2-Cl-4-Py - Me 4-Cl-Ph * 23 N C1-C HC 2-Cl-4-Py — H 3-Cl-Ph Ben 24 N C1-C HC 2-Cl-4-Py - H 2-Cl-Ph * 25 N C1-C HC 2-Cl-4-Py — H 3-CF3-Ph * 26 N C1-C HC 2-Cl-4-Py - H 4-F-Ph Wood 81 N C1-C Cl-C 2-Cl-4-Py — H 4-Cl-Ph * 82 N Br-C Cl-C 2-Cl-4-Py - H 4-Cl-Ph * 83 N HC Br-C 2-Cl-4-Py - H 4-Cl-Ph * 84 N HC FC 2-Cl-4-Py — H 4 -Cl-Ph Ben 85 N Cl-C FC 2-Cl-4-Py - H 4-Cl-Ph * 86 N Cl-C Br-C 2-Cl-4-Py-H 4-Cl-Ph * 87 N Br-C FC 2-Cl-4-Py — H 4-Cl-Ph 88 N Br-C Br-C 2-Cl-4-Py — H 4-CI-Ph Lucky 89 N Br-C f3c- c 2-Cl-4-Py - H 4-Cl-Ph 90 N Cl-C f3c-c 2-Cl-4-Py - H 4-Cl-Ph % 91 N FC Cl-C 2-Cl-4 -Py - H 4-Cl-Ph * 92 (Example 7) N h2n-c Cl-C 2-Cl-4-Py — H 4-Cl-Ph * t 93 HC Cl-C Cl-C 2-Cl- 4-Py - H 6-Cl-2-Py * 94 N f3c-c HC 2-Cl-4-Py — H 5-Cl-2-Py Wood 95 N f3c-c HC 2-Cl-4-Py - H 6-Cl-2-Py * % ( Example 8) NN Cl-C 2-Cl-4-Py — H 4-Cl-Ph Book 97 N f3c-c HC 2-Br-4-Py - H 4-Cl-Ph * 98 N f3c-c HC 2 , F-4-Py - H 4-Cl-Ph * 99 N f3c-c HC 3-Cl-4-Py — H 4-Cl-Ph * 100 N f3c-c HC 2,3-di-Cl-4 -Py - H 4-Cl-Ph * 101 N f3c-c HC 2-F3C-4-Py - H 4-Cl-Ph 氺102 N f3c-c HC 2-Cl-3-F-4-Py - H 4-Cl-Ph * 103 N f3c-c HC 2-Cl-4-Py 2-Me H 4-Cl-Ph * 104 HC f3c-c N 2-Cl-4-Py - H 4-Cl-Ph Umbrella 105 N f3c-c HC 4-pyrimidinyl-H 4-Cl-Ph * 106 HC Cl-C FC 2-Cl-4-Py — H 4-Cl-Ph * 167 201204254 Compound number A1 A2 A3 R1 (R3) n R4 R6 mp (°C) · 107 HC Br-C FC 2-Cl-4-Py - H 4-Cl-Ph This « 108 N f3c-c HC 2-C1-5-thiazolyl — H 4- Cl-Ph * • 109 N Cl-C FC 2-Cl-4-Py - Me 4-Cl-Ph * _ 110 N Br-C FC 2-Cl-4-Py - Me 4-Cl-Ph * 111 NN Br-C 2-Cl-4-Py - H 4-Cl-Ph Note 1: Compound 2 oxalate. * See the index table G for hNMR data. **] HNMR data can be found in the synthesis example.

索引表BIndex table B

NH 化合物號碼 A1 A2 A3 R1 R6 m.p. (°C) 27 H-C H-C cf3-c 2-Cl-4-Py 4-F-Ph 氺 28 H-C H-C cf3-c 2-Cl-4-Py 4-F-Ph (註記2 ) 29 H-C Cl-C Cl-C 2-Cl-4-Py 4-F-Ph 氺 30 H-C Cl-C Cl-C 2-Cl-4-Py 4-Cl-Ph 氺 31 H-C Cl-C H-C 2-Cl-4-Py 4-F-Ph 氺 32 H-C F-C H-C 2-Cl-4-Py 4-F-Ph 氺 33 H-C Cl-C H-C 2-Cl-4-Py 4-Cl-Ph * 34 H-C F-C H-C 2-Cl-4-Py 4-Cl-Ph 氺 35 N cf3-c H-C 2-Cl-4-Py 4-F-Ph 氺 36 N Cl-C Cl-C 2-Cl-4-Py 4-F-Ph 氺 37 N Br-C Cl-C 2-Cl-4-Py 4-F-Ph 氺NH Compound Number A1 A2 A3 R1 R6 mp (°C) 27 HC HC cf3-c 2-Cl-4-Py 4-F-Ph 氺28 HC HC cf3-c 2-Cl-4-Py 4-F-Ph (Note 2) 29 HC Cl-C Cl-C 2-Cl-4-Py 4-F-Ph 氺30 HC Cl-C Cl-C 2-Cl-4-Py 4-Cl-Ph 氺31 HC Cl- C HC 2-Cl-4-Py 4-F-Ph 氺32 HC FC HC 2-Cl-4-Py 4-F-Ph 氺33 HC Cl-C HC 2-Cl-4-Py 4-Cl-Ph * 34 HC FC HC 2-Cl-4-Py 4-Cl-Ph 氺35 N cf3-c HC 2-Cl-4-Py 4-F-Ph 氺36 N Cl-C Cl-C 2-Cl-4 -Py 4-F-Ph 氺37 N Br-C Cl-C 2-Cl-4-Py 4-F-Ph 氺

S 168 201204254 註記2 :化合物27之HC丨鹽。 * WNMR數據請見索引表G。 ** 1HNMR數據請見合成實例。S 168 201204254 Note 2: Compound HCl salt of Compound 27. * See the index table G for WNMR data. ** 1H NMR data can be found in the synthesis example.

索引表CIndex table C

化合物號碼 A1 A2 A3 R1 R4 R34 R6 m.p. (°C ) 38 H-C H-C f3c-c 2-Cl-4-Py H H 4-F-Ph 本 39 H-C C1-C H-C 2-Cl-4-Py H H 4-F-Ph * 40 H-C C1-C Cl-C 2-Cl-4-Py H H 4-F-Ph * 41 H-C f3c-c H-C 2-Cl-4-Py H H 4-F-Ph * 42 H-C F-C H-C 2-Cl-4-Py H H 4-F-Ph 本 43 H-C C1-C H-C 2-Cl-4-Py H H 4-Br-Ph * 44 H-C C1-C H-C 2-Cl-4-Py H H 4-Cl-Ph 本 45 H-C C1-C Cl-C 2-Cl-4-Py H H 4-Cl-Ph * 46 H-C f3c-c H-C 2_Cl_4_Py H H 4-Cl-Ph * 47 H-C H-C F3C-C 2_Cl_4_Py H H 4-Cl-Ph 木 48 H-C F-C H-C 2-Cl-4-Py H H 4-Cl-Ph * 49 H-C Cl-C H-C 2-Cl-4-Py Me H 4-F-Ph * 50 N H-C Cl-C 2-Cl-4-Py H H 4-F-Ph * 51 N Cl-C H-C 2-Cl-4-Py H H 4-F-Ph * 52 N Cl-C H-C 2-Cl-4-Py H H 4-Cl-Ph * 53 N Cl-C H-C 2-Cl-4-Py Me H 4-F-Ph * 54 H-C Cl-C H-C 2-Cl-4-Py H H 3-F-Ph 本 55 H-C Cl-C H-C 2-Cl-4-Py H H 2,4-di-F-Ph 本 56 H-C Cl-C H-C 2-Cl-4-Py H H 3,4-di-F-Ph * 169 201204254 化合物號碼 A1 A2 A3 R1 R4 R34 R6 m.p. (°C) 57 N Cl-C Cl-C 2-Cl-4-Py H H 4-F-Ph * 58 N Cl-C Cl-C 2-Cl-4-Py H H 4-Cl-Ph * 59 N f3c-c H-C 2-Cl-4-Py H H 4-F-Ph * 60 N f3c-c H-C 2-Cl-4-Py H H 4-Cl-Ph 氺 61 H-C Cl-C Cl-C 2-Cl-4-Py H H 3-F-Ph * 62 H-C Cl-C Cl-C 2-Cl-4-Py H H 2,4-di-F-Ph * 63 H-C Cl-C Cl-C 2-Cl-4-Py H H 3,4-di-F-Ph * 64 H-C Cl-C H-C 2-Cl-4-Py H H 3-Cl-Ph 本 65 H-C Cl-C H-C 2-Cl-4-Py H H 5-Cl-2-Py * 66 N f3c-c H-C 2-Cl-4-Py H H 3-F-Ph 本 67 N f3c-c H-C 2-Cl-4-Py H H 2,4-di-F-Ph * 68 N f3c-c H-C 2-Cl-4-Py H H 3,4-di-F-Ph 本 69 N f3c-c H-C 2-Cl-4-Py H H 5-Cl-2-Py * 70 H-C Cl-C Cl-C 2-Cl-4-Py H H 5-Cl-2-Py 71 N f3c-c H-C 2-Cl-4-Py H Me 4-F-Ph * 72 N Cl-C Cl-C 2-Cl-4-Py H Me 4-F-Ph * 73 N Cl-C H-C 2-Cl-4-Py H Me 4-F-Ph * 74 H-C Cl-C H-C 2-Cl-4-Py H H 2-Cl-4-F-Ph * 75 H-C Cl-C H-C 2-Cl-4-Py H H 2-F-4-Cl-Ph * 76 H-C Cl-C H-C 2-Cl-4-Py H H 2,4-di-Cl-Ph * 77 H-C Cl-C Cl-C 2-Cl-4-Py H H 2-Cl-4-F-Ph * 78 H-C Cl-C Cl-C 2-Cl-4-Py H H 2_F_4-Cl-Ph * 79 H-C Cl-C Cl-C 2-Cl-4-Py H H 2,4-di-Cl-Ph 本 80 (實例5) N Cl-C Cl-C 2-CM-Py H H 4-Br-Ph * * 112 N H-C Br-C 2-Cl-4-Py H H 4-F-Ph * 113 N H-C Br-C 2-Cl-4-Py H H 4-Cl-Ph * 114 N H-C Br-C 2-Cl-4-Py H H 4-Br-Ph * 115 N H-C Br-C 2-Cl-4-Py H H 2,4-di-F-Ph 本 116 N Cl-C H-C 2-Cl-4-Py H H 2,4-di-F-Ph 117 N Cl-C H-C 2-Cl-4-Py H H 2-Cl-4-F-Ph 本 118 N Cl-C H-C 2-Cl-4-Py H H 2-F-4_Cl-Ph * 119 N Cl-C H-C 2-Cl-4-Py H H 2,4-di-Cl-Ph * 120 N Cl-C H-C 2-Cl-4-Py H H 4-Br-Ph 幸Compound No. A1 A2 A3 R1 R4 R34 R6 mp (°C ) 38 HC HC f3c-c 2-Cl-4-Py HH 4-F-Ph This 39 HC C1-C HC 2-Cl-4-Py HH 4- F-Ph * 40 HC C1-C Cl-C 2-Cl-4-Py HH 4-F-Ph * 41 HC f3c-c HC 2-Cl-4-Py HH 4-F-Ph * 42 HC FC HC 2-Cl-4-Py HH 4-F-Ph Ben 43 HC C1-C HC 2-Cl-4-Py HH 4-Br-Ph * 44 HC C1-C HC 2-Cl-4-Py HH 4- Cl-Ph this 45 HC C1-C Cl-C 2-Cl-4-Py HH 4-Cl-Ph * 46 HC f3c-c HC 2_Cl_4_Py HH 4-Cl-Ph * 47 HC HC F3C-C 2_Cl_4_Py HH 4- Cl-Ph wood 48 HC FC HC 2-Cl-4-Py HH 4-Cl-Ph * 49 HC Cl-C HC 2-Cl-4-Py Me H 4-F-Ph * 50 N HC Cl-C 2 -Cl-4-Py HH 4-F-Ph * 51 N Cl-C HC 2-Cl-4-Py HH 4-F-Ph * 52 N Cl-C HC 2-Cl-4-Py HH 4-Cl -Ph * 53 N Cl-C HC 2-Cl-4-Py Me H 4-F-Ph * 54 HC Cl-C HC 2-Cl-4-Py HH 3-F-Ph This 55 HC Cl-C HC 2-Cl-4-Py HH 2,4-di-F-Ph 56 HC Cl-C HC 2-Cl-4-Py HH 3,4-di-F-Ph * 169 201204254 Compound number A1 A2 A3 R1 R4 R34 R6 mp (°C) 57 N Cl-C Cl-C 2-Cl-4-Py HH 4-F-Ph * 58 N Cl-C Cl-C 2-Cl-4-Py HH 4-Cl- Ph * 59 N f3c-c HC 2-Cl- 4-Py HH 4-F-Ph * 60 N f3c-c HC 2-Cl-4-Py HH 4-Cl-Ph 氺61 HC Cl-C Cl-C 2-Cl-4-Py HH 3-F- Ph * 62 HC Cl-C Cl-C 2-Cl-4-Py HH 2,4-di-F-Ph * 63 HC Cl-C Cl-C 2-Cl-4-Py HH 3,4-di- F-Ph * 64 HC Cl-C HC 2-Cl-4-Py HH 3-Cl-Ph This 65 HC Cl-C HC 2-Cl-4-Py HH 5-Cl-2-Py * 66 N f3c- c HC 2-Cl-4-Py HH 3-F-Ph This 67 N f3c-c HC 2-Cl-4-Py HH 2,4-di-F-Ph * 68 N f3c-c HC 2-Cl- 4-Py HH 3,4-di-F-Ph Ben 69 N f3c-c HC 2-Cl-4-Py HH 5-Cl-2-Py * 70 HC Cl-C Cl-C 2-Cl-4- Py HH 5-Cl-2-Py 71 N f3c-c HC 2-Cl-4-Py H Me 4-F-Ph * 72 N Cl-C Cl-C 2-Cl-4-Py H Me 4-F -Ph * 73 N Cl-C HC 2-Cl-4-Py H Me 4-F-Ph * 74 HC Cl-C HC 2-Cl-4-Py HH 2-Cl-4-F-Ph * 75 HC Cl-C HC 2-Cl-4-Py HH 2-F-4-Cl-Ph * 76 HC Cl-C HC 2-Cl-4-Py HH 2,4-di-Cl-Ph * 77 HC Cl- C Cl-C 2-Cl-4-Py HH 2-Cl-4-F-Ph * 78 HC Cl-C Cl-C 2-Cl-4-Py HH 2_F_4-Cl-Ph * 79 HC Cl-C Cl -C 2-Cl-4-Py HH 2,4-di-Cl-Ph Ben 80 (Example 5) N Cl-C Cl-C 2-CM-Py HH 4-Br-Ph * * 112 N HC Br- C 2-Cl-4-Py HH 4-F-Ph * 113 N HC Br-C 2-Cl -4-Py HH 4-Cl-Ph * 114 N HC Br-C 2-Cl-4-Py HH 4-Br-Ph * 115 N HC Br-C 2-Cl-4-Py HH 2,4-di -F-Ph Ben 116 N Cl-C HC 2-Cl-4-Py HH 2,4-di-F-Ph 117 N Cl-C HC 2-Cl-4-Py HH 2-Cl-4-F- Ph Ben 118 N Cl-C HC 2-Cl-4-Py HH 2-F-4_Cl-Ph * 119 N Cl-C HC 2-Cl-4-Py HH 2,4-di-Cl-Ph * 120 N Cl-C HC 2-Cl-4-Py HH 4-Br-Ph

S 170 201204254 化合物號碼 A1 A2 A3 R1 R4 R34 R6 m.p. (°C) 121 N f3c-c H-C 2-Cl-4-Py H H 2,4-di-Cl-Ph * 122 N f3c-c H-C 2-Cl-4-Py H H 2 冬 4-Cl-Ph * 123 N f3c-c H-C 2-Cl-4-Py H H 2-Cl-4-F-Ph 幸 124 N H-C Cl-C 2-Cl-4-Py H H 2-F-4-F-Ph * 125 N H-C Cl-C 2-Cl-4-Py H H 4-Br-Ph * 126 N H-C Cl-C 2-Cl-4-Py H H 4-Cl-Ph * 127 N Cl-C Cl-C 2-Cl-4-Py H H 2,4-di-F-Ph * 128 N H-C F-C 2-Cl-4-Py H H 4-Cl-Ph * 129 N H-C f3c-c 2-Cl-4-Py H H 2,4-di-F-Ph * 130 N H-C f3c-c 2_C1_4-Py H H 4-Br-Ph * 131 N H-C f3c-c 2-Cl-4-Py H H 4-Cl-Ph * 132 N H-C f3c-c 2-Cl-4-Py H H 4-F-Ph * 133 N H-C Br-C 2-Cl-4-Py H Me 4-F-Ph * 134 N H-C Cl-C 2-Cl-4-Py H Me 4-F-Ph * 135 N H-C F-C 2-Cl-4-Py H Me 4-F-Ph * 136 N H-C f3c-c 2-Cl-4-Py H Me 4-F-Ph * 137 N F3C-C H-C 2-Cl-4-Py H H 4-MeO-Ph 木 138 N f3c-c H-C 2-Cl-4-Py H H 4-02N-Ph * 139 N f3c-c H-C 2-Cl-4-Py H H 4-F3CO-Ph 本 140 N f3c-c H-C 2-Cl-4-Py H H 4-NC-Ph * 141 N f3c-c H-C 2-Cl-4-Py H H 4-t-Bu-Ph * 142 N f3c-c H-C 2-Cl-4-Py H H 4-F3C-Ph * 143 N H-C Cl-C 2-Cl-4-Py H Me 4-Cl-Ph * 144 N Cl-C F3C-C 2-Cl-4-Py H H 4-F-Ph * 145 N Cl-C f3c-c 2-Cl-4-Py H H 4-Cl-Ph 本 146 N Cl-C f3c-c 2-Cl-4-Py H H 4-Br-Ph 本 147 N Cl-C F-C 2-Cl-4-Py H Me 4-Cl-Ph * 148 N Cl-C F3C-C 2-Cl-4-Py H Me 4-Cl-Ph 本 149 N Cl-C Br-C 2-Cl-4-Py H Me 4-Cl-Ph 本 150 N Cl-C Br-C 2-Cl-4-Py H H 4-F-Ph * 151 N Cl-C Br-C 2-Cl-4-Py H H 4-Cl-Ph * 152 N Cl-C Br-C 2-Cl-4-Py H H 4-Br-Ph * 153 N Cl-C F-C 2-Cl-4-Py H H 4-Cl-Ph * 171 201204254 化合物號碼 A1 A2 A3 R1 R4 R34 R6 m.p. (°C) 154 N Cl-C F-C 2-Cl-4-Py H H 4-Br-Ph * 155 N Cl-C F-C 2-Cl-4_Py H H 4-F-Ph * 156 N Br-C F-C 2-Cl-4-Py H H 4-Br-Ph * 157 N Br-C F-C 2-Cl-4-Py H H 4-Cl-Ph * 158 N Br-C F-C 2-Cl-4-Py H H 4-F-Ph * 159 N Br-C F3C-C 2-Cl-4-Py H Me 4-Cl-Ph * 160 N Br-C Br-C 2-Cl-4-Py H Me 4-Cl-Ph * 161 N Br-C Cl-C 2-Cl-4-Py H Me 4-Cl-Ph * 162 N Br-C F-C 2-Cl-4-Py H Me 4-Cl-Ph * 163 N F3C-C H-C 2-Cl-4-Py H Et 4-Cl-Ph 氺 164 N Br-C Br-C 2_Cl-4-Py H H 4-Br-Ph * 165 N Br-C Br-C 2-Cl-4-Py H H 4-Cl-Ph * 166 N Br-C Br-C 2-Cl-4-Py H H 4-F-Ph * 167 N Br-C Cl-C 2-Cl-4-Py H H 4-Br-Ph * 168 N Br-C Cl-C 2-Cl-4-Py H H 4-Cl-Ph 本 169 N Br-C Cl-C 2-Cl-4-Py H H 4-F-Ph * 170 N Br-C F3C-C 2-Cl-4-Py H H 4-Cl-Ph * 171 H-C Cl-C Cl-C 2-Cl-4-Py H Me 5-Cl-2-Py * 172 N f3c-c H-C 2-Cl-4-Py H Me 5-Cl-2-Py * 173 H-C Cl-C Cl-C 2-Cl-4-Py H H 6-Br-3-Py * 174 N f3c-c H-C 2-Cl-4-Py H H 6-C1-3-。荅【口 + 井】基 氺 175 H-C Cl-C Cl-C 2-Cl-4-Py H H 6-Cl-3-Py * 176 H-C Cl-C Cl-C 2-Cl-4-Py H H 6-C1-3-嗒【口 + 井】基 * 177 N f3c-c H-C 2-Cl-4-Py H H 6-Cl-3-Py * 178 N f3c-c H-C 2_Cl-4_Py H H 6-Br-3-Py * 179 N f3c-c H-C 2-Cl-4-Py H Me 4-Cl-Ph * 180 N F-C Cl-C 2-Cl-4-Py H Me 4-Cl-Ph 本 181 N F-C Cl-C 2-Cl-4-Py H H 4-Cl-Ph * 182 H-C Cl-C Cl-C 2-Cl-4-Py H H 5-Br-2-Py * 183 N f3c-c H-C 2-Cl-4-Py H H 5-Br-2-Py 本 184 H-C Cl-C Cl-C 2-Cl-4-Py H H 2-Cl-4-Py 本 185 N f3c-c H-C 2-Cl-4-Py H H 2-Cl-4-Py 氺 s 172 201204254 化合物號碼 A1 A2 A3 R1 R4 R34 R6 m.p. (°C) 186 H-C C1-C Cl-C 2-Cl-4-Py H H 5-C1-2-嘧啶基 * 187 N f3c-c H-C 2-Cl-4-Py H H 5-C1-2-嘧啶基 * 188 N N Cl-C 2-Cl-4-Py H Me 4-Cl-Ph * 189 N f3c-c H-C 2-Br-4-Py H Me 4-Cl-Ph * 190 N f3c-c H-C 2-Br-4-Py H H 4-Cl-Ph * 191 N f3c-c H-C 2-Br-4-Py H H 4-F-Ph * 192 N f3c-c H-C 2-F-4-Py H Me 4-Cl-Ph 本 193 N f3c-c H-C 2-F-4-Py H H 4-Cl-Ph 幸 194 N f3c-c H-C 2-F-4-Py H H 4-F-Ph * 195 N f3c-c H-C 3-Cl-4-Py H Me 4-Cl-Ph * 196 N f3c-c H-C 2,3-di-Cl-4-Py H Me 4-Cl-Ph 本 197 N f3c-c H-C 2,3_di-Cl-4-Py H H 4-Cl-Ph * 198 N f3c-c H-C 2,3-di-Cl-4-Py H H 4-F-Ph * 199 N f3c-c H-C 3-Cl-4-Py H H 4-F-Ph * 200 N f3c-c H-C 3-Cl-4-Py H H 4-Cl-Ph * 201 N f3c-c H-C 2-F3C-4-Py H Me 4-Cl-Ph * 202 N f3c-c H-C 2-Cl-3-F-4-Py H Me 4-Cl-Ph 幸 203 N f3c-c H-C 2-C1-4-嘧啶基 H Me 4-Cl-Ph * 204 N f3c-c H-C 2-Cl-3-F-4-Py H H 4-Cl-Ph 本 205 H-C f3c-c N 2-Cl-4-Py H Me 4-Cl-Ph 本 206 N f3c-c H-C 4-嘯嗔基 H Me 4-Cl-Ph * 207 N f3c-c H-C 4-嘧啶基 H H 4-Cl-Ph 幸 208 H-C Cl-C Cl-C 2-Cl-4-Py H H 5-F-2-Py 本 209 N f3c-c H-C 2-Cl-4-Py H H 5-F-2-Py 本 210 H-C Cl-C F-C 2-Cl-4-Py H Me 4-Cl-Ph * 211 H-C Br-C F-C 2-Cl-4-Py H Me 4-Cl-Ph 本 212 N N Br-C 2-Cl-4-Py H Me 4-Cl-Ph * * iNMR數據請見索引表G。 ** 1HNMR數據請見合成實例。S 170 201204254 Compound number A1 A2 A3 R1 R4 R34 R6 mp (°C) 121 N f3c-c HC 2-Cl-4-Py HH 2,4-di-Cl-Ph * 122 N f3c-c HC 2-Cl -4-Py HH 2 Winter 4-Cl-Ph * 123 N f3c-c HC 2-Cl-4-Py HH 2-Cl-4-F-Ph Lucky 124 N HC Cl-C 2-Cl-4-Py HH 2-F-4-F-Ph * 125 N HC Cl-C 2-Cl-4-Py HH 4-Br-Ph * 126 N HC Cl-C 2-Cl-4-Py HH 4-Cl-Ph * 127 N Cl-C Cl-C 2-Cl-4-Py HH 2,4-di-F-Ph * 128 N HC FC 2-Cl-4-Py HH 4-Cl-Ph * 129 N HC f3c- c 2-Cl-4-Py HH 2,4-di-F-Ph * 130 N HC f3c-c 2_C1_4-Py HH 4-Br-Ph * 131 N HC f3c-c 2-Cl-4-Py HH 4 -Cl-Ph * 132 N HC f3c-c 2-Cl-4-Py HH 4-F-Ph * 133 N HC Br-C 2-Cl-4-Py H Me 4-F-Ph * 134 N HC Cl -C 2-Cl-4-Py H Me 4-F-Ph * 135 N HC FC 2-Cl-4-Py H Me 4-F-Ph * 136 N HC f3c-c 2-Cl-4-Py H Me 4-F-Ph * 137 N F3C-C HC 2-Cl-4-Py HH 4-MeO-Ph Wood 138 N f3c-c HC 2-Cl-4-Py HH 4-02N-Ph * 139 N f3c -c HC 2-Cl-4-Py HH 4-F3CO-Ph Ben 140 N f3c-c HC 2-Cl-4-Py HH 4-NC-Ph * 141 N f3c-c HC 2-Cl-4-Py HH 4-t-Bu-Ph * 142 N f3c-c HC 2-Cl-4-Py HH 4-F3C-Ph * 143 N HC Cl-C 2-Cl-4-Py H Me 4-Cl-Ph * 144 N Cl-C F3C-C 2-Cl-4-Py HH 4-F-Ph * 145 N Cl-C f3c-c 2-Cl-4-Py HH 4-Cl-Ph 146 N Cl-C f3c-c 2-Cl-4-Py HH 4-Br-Ph 147 N Cl-C FC 2-Cl-4-Py H Me 4-Cl-Ph * 148 N Cl-C F3C-C 2-Cl-4-Py H Me 4-Cl-Ph Ben 149 N Cl-C Br-C 2-Cl-4-Py H Me 4-Cl -Ph 150 N Cl-C Br-C 2-Cl-4-Py HH 4-F-Ph * 151 N Cl-C Br-C 2-Cl-4-Py HH 4-Cl-Ph * 152 N Cl -C Br-C 2-Cl-4-Py HH 4-Br-Ph * 153 N Cl-C FC 2-Cl-4-Py HH 4-Cl-Ph * 171 201204254 Compound number A1 A2 A3 R1 R4 R34 R6 Mp (°C) 154 N Cl-C FC 2-Cl-4-Py HH 4-Br-Ph * 155 N Cl-C FC 2-Cl-4_Py HH 4-F-Ph * 156 N Br-C FC 2 -Cl-4-Py HH 4-Br-Ph * 157 N Br-C FC 2-Cl-4-Py HH 4-Cl-Ph * 158 N Br-C FC 2-Cl-4-Py HH 4-F -Ph * 159 N Br-C F3C-C 2-Cl-4-Py H Me 4-Cl-Ph * 160 N Br-C Br-C 2-Cl-4-Py H Me 4-Cl-Ph * 161 N Br-C Cl-C 2-Cl-4-Py H Me 4-Cl-Ph * 162 N Br-C FC 2-Cl-4-Py H Me 4-Cl-Ph * 163 N F3C-C HC 2 -Cl-4-Py H Et 4-Cl-Ph 氺164 N Br-C Br-C 2_Cl-4-Py HH 4-Br-Ph * 165 N Br-C Br-C 2-Cl-4-Py H H 4-Cl-Ph * 166 N Br-C Br-C 2-Cl-4-Py HH 4-F-Ph * 167 N Br-C Cl-C 2-Cl-4-Py HH 4-Br-Ph * 168 N Br-C Cl-C 2-Cl-4-Py HH 4-Cl-Ph 169 N Br-C Cl-C 2-Cl-4-Py HH 4-F-Ph * 170 N Br-C F3C-C 2-Cl-4-Py HH 4-Cl-Ph * 171 HC Cl-C Cl-C 2-Cl-4-Py H Me 5-Cl-2-Py * 172 N f3c-c HC 2- Cl-4-Py H Me 5-Cl-2-Py * 173 HC Cl-C Cl-C 2-Cl-4-Py HH 6-Br-3-Py * 174 N f3c-c HC 2-Cl-4 -Py HH 6-C1-3-.荅【口+井】基氺175 HC Cl-C Cl-C 2-Cl-4-Py HH 6-Cl-3-Py * 176 HC Cl-C Cl-C 2-Cl-4-Py HH 6- C1-3-嗒[口+井]基* 177 N f3c-c HC 2-Cl-4-Py HH 6-Cl-3-Py * 178 N f3c-c HC 2_Cl-4_Py HH 6-Br-3- Py * 179 N f3c-c HC 2-Cl-4-Py H Me 4-Cl-Ph * 180 N FC Cl-C 2-Cl-4-Py H Me 4-Cl-Ph Ben 181 N FC Cl-C 2-Cl-4-Py HH 4-Cl-Ph * 182 HC Cl-C Cl-C 2-Cl-4-Py HH 5-Br-2-Py * 183 N f3c-c HC 2-Cl-4- Py HH 5-Br-2-Py Ben 184 HC Cl-C Cl-C 2-Cl-4-Py HH 2-Cl-4-Py Ben 185 N f3c-c HC 2-Cl-4-Py HH 2- Cl-4-Py 氺s 172 201204254 Compound number A1 A2 A3 R1 R4 R34 R6 mp (°C) 186 HC C1-C Cl-C 2-Cl-4-Py HH 5-C1-2-pyrimidinyl* 187 N F3c-c HC 2-Cl-4-Py HH 5-C1-2-pyrimidinyl* 188 NN Cl-C 2-Cl-4-Py H Me 4-Cl-Ph * 189 N f3c-c HC 2-Br -4-Py H Me 4-Cl-Ph * 190 N f3c-c HC 2-Br-4-Py HH 4-Cl-Ph * 191 N f3c-c HC 2-Br-4-Py HH 4-F- Ph * 192 N f3c-c HC 2-F-4-Py H Me 4-Cl-Ph 193 N f3c-c HC 2-F-4-Py HH 4-Cl-Ph 幸194 N f3c-c HC 2 -F-4-Py HH 4-F-Ph * 195 N f3c-c HC 3- Cl-4-Py H Me 4-Cl-Ph * 196 N f3c-c HC 2,3-di-Cl-4-Py H Me 4-Cl-Ph Ben 197 N f3c-c HC 2,3_di-Cl- 4-Py HH 4-Cl-Ph * 198 N f3c-c HC 2,3-di-Cl-4-Py HH 4-F-Ph * 199 N f3c-c HC 3-Cl-4-Py HH 4- F-Ph * 200 N f3c-c HC 3-Cl-4-Py HH 4-Cl-Ph * 201 N f3c-c HC 2-F3C-4-Py H Me 4-Cl-Ph * 202 N f3c-c HC 2-Cl-3-F-4-Py H Me 4-Cl-Ph 203 N f3c-c HC 2-C1-4-pyrimidinyl H Me 4-Cl-Ph * 204 N f3c-c HC 2- Cl-3-F-4-Py HH 4-Cl-Ph 205 HC f3c-c N 2-Cl-4-Py H Me 4-Cl-Ph Ben 206 N f3c-c HC 4- 嗔 嗔 H H Me 4-Cl-Ph * 207 N f3c-c HC 4-pyrimidinyl HH 4-Cl-Ph 208 HC Cl-C Cl-C 2-Cl-4-Py HH 5-F-2-Py 209 N f3c -c HC 2-Cl-4-Py HH 5-F-2-Py Ben 210 HC Cl-C FC 2-Cl-4-Py H Me 4-Cl-Ph * 211 HC Br-C FC 2-Cl- 4-Py H Me 4-Cl-Ph This 212 NN Br-C 2-Cl-4-Py H Me 4-Cl-Ph * * i NMR data can be found in index table G. ** 1H NMR data can be found in the synthesis example.

索引表D 173 201204254 ΗIndex Table D 173 201204254 Η

化合物號碼 A1 A2 A3 A4 R1 R2 T R6 m.p. (°C ) 213 H-C C1-C H-C H-C 2-Cl-4-Py H S 4-Cl-Ph * 214 N f3c-c H-C H-C 2-Cl-4-Py H NH 4-Cl-Ph * 215 N f3c-c H-C H-C 2-Cl-4-Py Me 0 4-Cl-Ph 氺 216 N Br-C H-C N 2-Cl-4-Py H 0 4-Cl-Ph * 217 N Cl-C H-C N 2-Cl-4-Py H 0 4-Cl-Ph 氺 218 N Cl-C Cl-C N 2-Cl-4-Py H 0 4-Cl-Ph * * hNMR數據請見索引表G。Compound number A1 A2 A3 A4 R1 R2 T R6 mp (°C ) 213 HC C1-C HC HC 2-Cl-4-Py HS 4-Cl-Ph * 214 N f3c-c HC HC 2-Cl-4-Py H NH 4-Cl-Ph * 215 N f3c-c HC HC 2-Cl-4-Py Me 0 4-Cl-Ph 氺216 N Br-C HC N 2-Cl-4-Py H 0 4-Cl- Ph * 217 N Cl-C HC N 2-Cl-4-Py H 0 4-Cl-Ph 氺218 N Cl-C Cl-C N 2-Cl-4-Py H 0 4-Cl-Ph * * hNMR See the index table G for data.

索引表E r34Index table Er 34

化合物 m.p 號碼 A1 A2 A3 A4 R1 R2 R34 Z R6 (°C) 219 N f3c-c H-C H-C 2-CM-Py H H NH 4-Cl-Ph 氺 220 N f3c-c H-C H-C 2-Cl-4-Py Me Me 0 4-Cl-Ph 氺 221 N f3c-c H-C H-C 2-Cl-4-Py H H NMe 4-Cl-Ph 氺 222 N f3c-c H-C H-C 2-Cl-4-Py Me H 0 4-Cl-Ph 氺 223 N Br-C H-C N 2-Cl-4-Py H Me 0 4-Cl-Ph 氺 224 N Cl-C Cl-C N 2-Cl-4-Py H Me 0 4-Cl-Ph 氺Compound mp number A1 A2 A3 A4 R1 R2 R34 Z R6 (°C) 219 N f3c-c HC HC 2-CM-Py HH NH 4-Cl-Ph 氺220 N f3c-c HC HC 2-Cl-4-Py Me Me 0 4-Cl-Ph 氺221 N f3c-c HC HC 2-Cl-4-Py HH NMe 4-Cl-Ph 氺222 N f3c-c HC HC 2-Cl-4-Py Me H 0 4- Cl-Ph 氺223 N Br-C HC N 2-Cl-4-Py H Me 0 4-Cl-Ph 氺224 N Cl-C Cl-C N 2-Cl-4-Py H Me 0 4-Cl- Ph 氺

S 174 201204254 WNMR數據請見索引表G。S 174 201204254 W NMR data can be found in index table G.

索引表FIndex table F

化合物號碼 A1 A2 A3 A1 2 R1 s t R3 4 5 m.p. (°C) 225 N f3c-c H-C H-C 2-Cl-4-Py 3 1 4-Cl-Ph 氺 226 N f3c-c H-C H-C 2-Cl-4-Py 2 2 4-Cl-Ph * 227 N f3c-c H-C H-C 2-Cl-4-Py 2 1 4-Cl-Ph * ^NMR數據請見索引表G。Compound number A1 A2 A3 A1 2 R1 st R3 4 5 mp (°C) 225 N f3c-c HC HC 2-Cl-4-Py 3 1 4-Cl-Ph 氺226 N f3c-c HC HC 2-Cl- 4-Py 2 2 4-Cl-Ph * 227 N f3c-c HC HC 2-Cl-4-Py 2 1 4-Cl-Ph * ^ NMR data can be found in index table G.

索引表G 化合物號碼 hNMR數據(除非另外說明,否則均指CDC13溶液)a 175 1 δ 8.81 (d, 1H), 8.61 (d, 1H), 8.57 (br s, 1H), 7.80 (d, 1H), 7.65 (dd, 1H), 7.37 (dd, 1H), 7.28 (s, 4H), 6.75 (d, 1H), 6.50 (d, 1H), 6.13 (dt, 1H), 4.97 (m, 1H), 3.85 (m, 1H), 3.35-3.29 (m, 4H). 2 δ 8.58 (d, 1H), 8.46 (br s, 1H), 8.41 (d, 1H), 7.79 (s, 1H), 7.64 (dd, 1H), 7.28 (s, 4H), 7.04 (dd, 1H), 6.66 (d, 1H), 6.49 (d, 1H), 6.12 (dt, 1H), 4.88 (m, 1H), 3.82 (m, 2H), 3.35-3.29 (m, 4H). 3 δ 8.58 (d, 1H), 8.40 (dd, 1H), 8.36 (br s, 1H), 7.79 (s, 1H), 7.64 (dd, 1H), 7.28 (s, 4H), 6.77 (dt, 1H), 6.50 (d, 1H), 6.43 (dd, 1H), 6.12 (dt, 1H), 4.87 (m, 1H), 3.83 (dd, 2H), 3.35-3.29 (m, 4H). 4 δ 8.59 (d, 1H), 8.44 (br s, 1H), 8.40 (d, 1H), 7.78 (d, 1H), 7.63 (dd, 1H), 7.28 (s, 4H), 7.03 (dd, 1H), 6.66 (d, 1H), 6.48 (d, 1H), 5.98 (dd, 1H), 4.83 (m, 1H), 3.80 (m, 1H), 3.74 (m, 1H), 3.27 (m, 2H), 3.01 (pentet, 1H), 1.16 (d, 3H). 5 δ 8.66 (s, 1H), 8.62 (d, 1H), 8.60 (s, 1H), 7.82 (d, 1H), 7.66 (dd, 1H), 7.35 (d, 1H), 7.28 (s, 4H), 6.89 (d, 1H), 6.50 (d, 1H), 6.13 (dt, 1H), 4.96 (m, 1H), 3.83 (m, 2H), 3.34 (m, 4H). δ 8.64 (s, 1Η), 8.60 (d, 1H), 8.47 (br s, 1H), 7.78 (s, 1H), 7.63 (dd, 1H), 7.27 (s, 4H), 6.74 (s, 1H), 6.48 (d, 1H), 5.98 (dd, 1H), 4.82 (m, 1H), 3.78 (m, 1H), 3.72 (m, 1H), 3.28 (m, 2H), 3.02 (pentet, 1H), 1.16 (d, 3H). δ 8.64 (s, 1H), 8.62-8.58 (m, 2H), 7.81 (s, 1H), 7.64 (dd, 1H), 7.34 (d, 1H), 7.28 (s, 4H), 6.88 (d, 1H), 6.48 (d, 1H), 5.98 (dd, 1H), 4.90 (m, 1H), 3.81 (m, 1H), 3.75 (m, 1H), 3.29 (m, 2H), 3.02 (pentet, 1H), 1.17 (d, 3H). δ 8.79 (s, 1H), 8.61 (d, 1H), 8.54 (br s, 1H), 7.79 (s, 1H), 7.65 (d, 1H), 7.36 (dd, 1H), 7.28 (s, 4H), 6.75 (d, 1H), 6.49 (d, 1H), 5.99 (dd, 1H), 4.92 (m, 1H), 3.85 (m, 1H), 3.78 (m, 1H), 3.28 (m, 2H), 3.03 (br s, 1H), 1.18 (d, 3H). δ 8.59 (d, 1H), 8.42-8.31 (m, 2H), 7.79 (s, 1H), 7.64 (m, 1H), 7.28 (s, 4H), 6.76 (td, 1H), 6.49 (d, 1H), 6.43 (dd, 1H), 5.99 (dd, 1H), 4.83 (m, 1H), 3.82 (m, 1H), 3.76 (m, 1H), 3.27 (m, 2H), 3.02 (br s, 1H), 1.17 (d, 3H). δ 8.67 (d, 1H), 8.60 (d, 1H), 8.32 (br s, 1H), 7.78 (d, 1H), 7.63 (dd, 1H), 7.28 (s, 4H), 7.00 (d, 1H), 6.50 (d, 1H), 6.14 (dt, 1H), 5.36 (m, 1H), 3.83 (m, 2H), 3.36-3.30 (m, 4H). δ (丙酮-d6) 9.21 (br s, 1H), 8.57-8.53 (m,2H),7.97 (s,1H), 7.94 (d, 1H), 7.48 (d, 2H), 7.27 (d, 2H), 7.06 (d, 1H), 6.74 (d, 1H), 6.18 (dt, 1H), 5.57 (m, 1H), 4.43-4.25 (m, 4H), 3.85 (d, 2H). δ 9.16 (s, 1H), 8.55 (d, 1H), 8.45 (d, 1H), 7.82 (s, 1H), 7.66 (d, 1H), 7.27 (d, 2H), 7.21 (d, 2H), 7.08 (dd, 1H), 6.74 (d, 1H), 6.40 (d, 1H), 5.95 (dt, 1H), 3.43 (d, 2H), 3.38 (d, 2H), 3.29 (d, 2H), 1.72 (s, 3H). δ 8.87 (s, 1H), 8.62 (d, 1H), 8.30 (br s, 1H), 7.77 (d, 1H), 7.63 (d, 1H), 7.28 (s, 4H), 6.48 (d, 1H), 6.00 (dd, 1H), 5.29 (m, 1H), 3.80 (m, 1H), 3.74 (m, 1H), 3.31 (m, 2H), 3.01 (br s, 1H), 1.17 (d, 3H). δ 9.0 (s, 1H), 8.62 (d, 1H), 8.41 (bs, 1H), 8.2 (s, 1H), 7.8 (s, 1H), 7.65 (d, 1H), 7.25 (s, 4H), 6.5 (dd, 1H), 6.18 (m, 1H), 5.4 (m, 1H), 3.9 (m, 2H), 3.36 (m, 4H). δ 8.66 (d, 1H), 8.61 (d, 1H), 8.31 (br s, 1H), 7.78 (d, 1H), 7.63 (dd, 1H), 7.28 (s, 4H), 7.00 (d, 1H), 6.48 (d, 1H), 6.01 (dd, 1H), 5.31 (m, 1H), 3.78 (m, 2H), 3.31 (m, 2H), 3.01 (m, 1H), 1.16 (d, 3H). 5 8.66 (d, 1H), 8.60 (d, 1H), 8.40 (br s, 1H), 7.81 (s, 1H), 7.66 (dd, 1H), 7.35 (s, 1H), 7.25-7.20 (m, 3H), 7.01 (d, 1H), 6.50 (d, 1H), 6.18 (dt, 1H), 5.39 (m, 1H), 3.86 (m, 2H), 3.43 (br s, 2H), 3.37 (d, 2H). s 176 201204254 . 24 δ 8.68 (br s, 1H), 8.63 (d, 1H), 8.59 (d, 1H), 7.88 (s, 1H), 7.76 (d, 1H), 7.52 (dd, 1H), 7.36 (dd, 1H), 7.25-7.18 (m, 2H), . 7.06-6.98 (m, 2H), 6.50 (d, 1H), 6.18 (dt, 1H), 5.39 (m, 1H), 3.86 (m, 2H), 3.43 (br s, 2H), 3.37 (d, 2H). 25 δ 8.67 (d, 1H), 8.61 (d, 1H), 8.32 (br s, 1H), 7.79 (s, 1H), 7.64 (dd, 1H), 7.60 (s, 1H), 7.53 (d, 1H), 7.49 (d, 1H), 7.43 (t, 1H), 7.01 (d, 1H), 6.58 (d, 1H), 6.25 (dt, 1H), 5.38 (m, 1H), 3.86 (m, 2H), 3.40-3.34 (m, 4H). 26 δ 8.57 (d, 1H), 8.53 (d,1H), 8.59-8.47 (br s, 1H),7.77 (s,1H), 7.63 (dd, 1H), 7.26 (m, 2H), 6.96-6.88 (m, 3H), 6.47 (d, 1H), 6.01 (dt, 1H), 5.33 (m, 1H), 3.78 (m, 2H), 3.45-3.37 (m, 2H), 3.31 (br d, 2H). 27 5 8.80 (s, 1H), 8.61 (d, 1H), 8.54 (s, 1H), 7.79 (s, 1H), 7.64 (d, 1H), 7.55-7.49 (m, 4H), 7.38-7.33 (m, 3H), 7.12 (t, 2H), 6.74 (d, 1H), 4.97 (m, 1H), 3.87 (t, 2H), 3.77 (s, 2H), 3.32 (m, 2H). 29 δ 8.65 (s, 1H), 8.60 (d, 1H), 8.45 (s, 1H), 7.78 (s, 1H), 7.62 (m, 1H), 7.56-7.48 (m, 4H), 7.34 (d, 2H), 7.12 (t, 2H), 6.74 (s, 1H), 4.88 (m, 1H), 3.83 (m, 2H), 3.76 (s, 2H), 3.31 (m, 2H). 30 5 8.65 (s, 1H), 8.60 (d, 1H), 8.44 (br s, 1H), 7.77 (s, 1H), 7.62 (d, 1H), 7.51 (dd, 4H), 7.40 (d, 2H), 7.35 (d, 2H), 6.74 (s, 1H), 4.88 (m, 1H), 3.82 (m, 2H), 3.76 (s, 2H), 3.30 (m, 2H). 31 δ 8.59 (d, 1H), 8.43 (s, 1H), 8.40 (d, 1H), 7.78 (s, 1H), 7.63 (d, 1H), 7.55-7.49 (m, 4H), 7.34 (d, 2H), 7.12 (t, 2H), 7.03 (dd, 1H), 6.66 (d, 1H), 4.89 (m, 1H), 3.84 (m, 2H), 3.76 (s, 2H), 3.30 (m, 2H). 32 δ 8.59 (d,1H), 8.39 (dd, 1H),8.34 (s,1H),7.78 (s, 1H),7.63 (d, 1H), 7.55-7.49 (m, 4H), 7.34 (d, 2H), 7.12 (t, 2H), 6.76 (ddd, 1H), 6.43 (dd, 1H), 4.88 (m, 1H), 3.85 (t, 2H), 3.76 (s, 2H), 3.30 (m, 2H). 33 δ 8.59 (d, 1H), 8.46 (s, 1H), 8.40 (d, 1H), 7.79 (s, 1H), 7.63 (d, 1H), 7.51 (dd, 4H), 7.40 (d, 2H), 7.35 (d, 2H), 7.03 (dd, 1H), 6.65 (d, 1H), 4.89 (m, 1H), 3.83 (m, 2H), 3.76 (s, 2H), 3.30 (m, 2H). 34 δ 8.58 (d, 1H), 8.39 (dd, 1H), 8.34 (s, 1H), 7.78 (s, 1H), 7.63 (d, 1H), 7.51 (dd, 4H), 7.40 (d, 2H), 7.35 (d, 2H), 6.76 (ddd, 1H), 6.43 (dd, 1H), 4.88 (m, 1H), 3.85 (t, 2H), 3.76 (s, 2H), 3.29 (m, 2H). 35 6 8.84 (d, 1H), 8.63 (d, 1H), 8.50 (br s, 1H), 7.80 (s, 1H), 7.65 (m, 1H), 7.55-7.49 (m, 4H), 7.39-7.34 (m, 3H), 7.12 (t, 2H), 5.44 (m, 1H), 3.89 (t, 2H), 3.77 (s, 2H), 3.34 (br s, 2H). 36 δ 8.87 (s, 1H), 8.62 (d, 1H), 8.33 (br s, 1H), 7.78 (s, 1H), 7.64 (d, 1H), 7.55-7.49 (m, 4H), 7.36 (d, 2H), 7.12 (t, 2H), 5.35 (m, 1H), 3.85 (m, 2H), 3.77 (s, 2H), 3.35 (br s, 2H). 177 δ 8.84 (s, 1Η), 8.62 (d, 1H), 8.31 (br s, 1H), 7.78 (s, 1H), 7.63 (d, 1H), 7.55-7.49 (m, 4H), 7.36 (d, 2H), 7.12 (t, 2H), 5.36 (m, 1H), 3.85 (m, 2H), 3.76 (s, 2H), 3.34 (br s, 2H). δ 8.80 (d, 1H), 8.61 (d, 1H), 8.58 (br s, 1H), 7.79 (d, 1H), 7.65 (dd, 1H), 7.38 (dd, 1H), 6.97 (t, 2H), 6.82 (m, 2H), 6.75 (d, 1H), 4.97 (m, 1H), 3.99 (t, 2H), 3.95 (m, 2H), 3.41 (m, 2H), 2.96 (t, 2H). δ 8.58 (d, 1H), 8.45 (br s, 1H), 8.40 (d, 1H), 7.78 (s, 1H), 7.63 (dd, 1H), 7.04 (dd, 1H), 6.97 (t, 2H), 6.82 (m, 2H), 6.66 (d, 1H), 4.89 (m, 1H), 3.98 (t, 2H), 3.92 (m, 2H), 3.40 (m, 2H), 2.95 (t, 2H). δ 8.65 (s, 1H), 8.59 (d, 1H), 8.46 (br s, 1H), 7.77 (s, 1H), 7.63 (dd, 1H), 6.96 (t, 2H), 6.82 (m, 2H), 6.74 (s, 1H), 4.88 (m, 1H), 3.98 (t, 2H), 3.91 (m, 2H), 3.41 (m, 2H), 2.96 (t, 2H). δ 8.64 (br s, 1H), 8.62-8.59 (m, 2H), 7.81 (d, 1H), 7.65 (dd, 1H), 7.35 (d, 1H), 6.96 (t, 2H), 6.88 (d, 1H), 6.82 (m, 2H), 4.96 (m, 1H), 3.99 (t, 2H), 3.94 (m, 2H), 3.43 (m, 2H), 2.96 (t, 2H). δ 8.58 (d,1H),8.39 (dd, 1H),8.36 (br s,1H),7.78 (s,1H), 7.63 (dd, 1H), 6.96 (t, 2H), 1H), 6.82 (m, 2H), 6.77 (dt, 1H), 6.43 (dd, 1H), 4.88 (m, 1H), 3.98 (t, 2H), 3.93 (m, 2H), 3.39 (m, 2H), 2.96 (t, 2H). δ 8.59 (d, 1H), 8.44 (br s, 1H), 8.40 (d, 1H), 7.78 (d, 1H), 7.63 (dd, 1H), 7.37 (d, 2H), 7.04 (dd, 1H), 6.77 (d, 2H), 6.66 (d, 1H), 4.89 (m, 1H), 3.99 (t, 2H), 3.92 (m, 2H), 3.39 (m, 2H), 2.96 (t, 2H). δ 8.58 (d, 1H), 8.44 (br s, 1H), 8.40 (d, 1H), 7.78 (d, 1H), 7.63 (dd, 1H), 7.23 (d, 2H), 7.04 (dd, 1H), 6.81 (d, 2H), 6.66 (d, 1H), 4.88 (m, 1H), 3.99 (t, 2H), 3.92 (m, 2H), 3.39 (m, 2H), 2.96 (t, 2H). δ 8.64 (s, 1H), 8.59 (d, 1H), 8.47 (br s, 1H), 7.77 (s, 1H), 7.63 (dd, 1H), 7.23 (d, 2H), 6.81 (d, 2H), 6.74 (s, 1H), 4.87 (m, 1H), 3.99 (t, 2H), 3.90 (m, 2H), 3.40 (m, 2H), 2.96 (t, 2H). δ 8.63 (br s, 1H), 8.62-8.59 (m, 2H), 7.80 (d, 1H), 7.65 (dd, 1H), 7.35 (d, 1H), 7.23 (d, 2H), 6.88 (d, 1H), 6.81 (d, 2H), 4.96 (m, 1H), 4.00 (t, 2H), 3.93 (m, 2H), 3.42 (m, 2H), 2.97 (t, 2H). δ 8.80 (d, 1H), 8.60 (d, 1H), 8.56 (br s, 1H), 7.79 (s, 1H), 7.64 (dd, 1H), 7.38 (dd, 1H), 7.23 (d, 2H), 6.81 (d, 2H), 6.74 (d, 1H), 4.97 (m, 1H), 4.00 (t, 2H), 3.95 (m, 2H), 3.41 (m, 2H), 2.97 (t, 2H). δ 8.58 (d, 1H), 8.39 (dd, 1H), 8.35 (br s, 1H), 7.78 (s, 1H), 7.63 (dd, 1H), 7.23 (d, 2H), 1H), 6.81 (d, 2H), 6.77 (dt, 1H), 6.43 (dd, 1H), 4.87 (m, 1H), 3.99 (t, 2H), 3.93 (m, 2H), 3.39 (m, 2H), 2.96 (t, 2H). s 178 201204254 * 49 δ 8.59 (d, 1Η), 8.48 (br s, 1H), 8.40 (d, 1H), 7.78 (s, 1H), 7.63 (dd, 1H), 7.04 (dd, 1H), 6.97 (t, 2H), 6.82 (m, 2H), 6.68 (d, 1H), . 4.86 (m, 1H), 3.89 (br m, 2H), 3.81 (d, 2H), 3.42 (dd, 1H), 3.35 (dd, 1H), 2.80 (m, 1H), 1.09 (d, 3H). 50 5 8.76 (d, 1H), 8.61 (d, 1H), 8.38 (br s, 1H), 7.85 (d, 1H), 7.78 (s, 1H), 7.63 (dd, 1H), 6.96 (t, 2H), 6.83 (m, 2H), 5.35 (m, 1H), 3.98 (t, 2H), 3.91 (m, 2H), 3.40 (m, 2H), 2.95 (t, 2H). 51 δ 8.66 (d, 1H), 8.60 (d, 1H), 8.34 (br s, 1H), 7.79 (s, 1H), 7.63 (dd, 1H), 7.01 (d, 1H), 6.96 (t, 2H), 6.83 (m, 2H), 5.38 (m, 1H), 3.98 (t, 2H), 3.92 (m, 2H), 3.43 (br m, 2H), 2.95 (t, 2H). 52 δ 8.66 (d,1H), 8.60 (d,1H), 8.35 (br s, 1H), 7.79 (s,1H),7.63 (dd, 1H), 7.23 (d, 2H), 7.01 (d, 1H), 6.82 (d, 2H), 5.38 (m, 1H), 3.99 (t, 2H), 3.92 (m, 2H), 3.43 (dd, 2H), 2.95 (t, 2H). 53 δ 8.66 (d, 1H), 8.61 (d, 1H), 8.34 (br s, 1H), 7.78 (s, 1H), 7.63 (dd, 1H), 7.01 (d, 1H), 6.97 (t, 2H), 6.82 (m, 2H), 5.34 (m, 1H), 3.89 (br m, 2H), 3.81 (m, 2H), 3.44 (dd, 1H), 3.38 (dd, 1H), 2.79 (m, 1H), 1.09 (d, 3H). 54 δ 8.59 (d, 1H), 8.47 (br s, 1H), 8.40 (d, 1H), 7.79 (d, 1H), 7.63 (dd, 1H), 7.22 (td, 1H), 7.04 (dd, 1H), 6.67 (m, 2H), 6.66 (d, 1H), 6.60 (dt, 1H), 4.89 (m, 1H), 4.01 (t, 2H), 3.92 (m, 2H), 3.40 (m, 2H), 2.96 (t, 2H). 55 δ 8.58 (d, 1H), 8.53 (br s, 1H), 8.40 (d, 1H), 7.80 (d, 1H), 7.64 (dd, 1H), 7.04 (dd, 1H), 6.93-6.82 (m, 2H), 6.78 (m, 1H), 6.66 (d, 1H), 4.89 (m, 1H), 4.05 (t, 2H), 3.91 (m, 2H), 3.44 (m, 2H), 2.97 (t, 2H). 56 δ 8.59 (d, 1H), 8.45 (br s, 1H), 8.40 (d, 1H), 7.79 (s, 1H), 7.64 (dd, 1H), 7.09-7.02 (m, 2H), 6.71 (m, 1H), 6.66 (d, 1H), 6.58 (m, 1H), 4.89 (m, 1H), 3.96 (t, 2H), 3.92 (m, 2H), 3.39 (m, 2H), 2.95 (t, 2H). 57 δ 8.87 (s, 1H), 8.62 (d, 1H), 8.33 (br s, 1H), 7.78 (s, 1H), 7.63 (d, 1H), 6.97 (t, 2H), 6.83 (m, 2H), 5.36 (m, 1H), 3.98 (t, 2H), 3.91 (br t, 2H), 3.43 (br s, 2H), 2.95 (t, 2H). 58 δ 8.88 (s, 1H), 8.62 (d, 1H), 8.29 (br s, 1H), 7.77 (d, 1H), 7.62 (dd, 1H), 7.23 (d, 2H), 6.82 (d, 2H), 5.35 (m, 1H), 3.99 (t, 2H), 3.91 (m, 2H), 3.42 (dd, 2H), 2.95 (t, 2H). 59 δ 8.85 (d, 1H), 8.63 (d, 1H), 8.48 (br s, 1H), 7.80 (s, 1H), 7.64 (dd, 1H), 7.38 (d, 1H), 6.96 (t, 2H), 6.83 (m, 2H), 5.43 (m, 1H), 3.98 (t, 2H), 3.95 (m, 2H), 3.42 (m, 2H), 2.95 (t, 2H). 60 6 8.85 (d, 1H), 8.63 (d, 1H), 8.49 (br s, 1H), 7.79 (s, 1H), 7.64 (dd, 1H), 7.38 (d, 1H), 7.23 (d, 2H), 6.82 (d, 2H), 5.43 (m, 1H), 3.99 (t, 2H), 3.95 (m, 2H), 3.42 (m, 2H), 2.95 (t, 2H). 179 δ 8.65 (s, 1Η), 8.59 (d, 1H), 8.46 (br s, 1H), 7.78 (d, 1H), 7.63 (dd, 1H), 7.22 (m, 1H), 6.74 (s, 1H), 6.69-6.64 (m, 2H), 6.60 (dt, 1H), 4.88 (m, 1H), 4.01 (t, 2H), 3.90 (m, 2H), 3.40 (m, 2H), 2.96 (t, 2H). δ 8.65 (s, 1H), 8.59 (d, 1H), 8.52 (br s, 1H), 7.79 (s, 1H), 7.64 (dd, 1H), 6.92-6.82 (m, 2H), 6.78 (m, 1H), 6.75 (s, 1H), 4.88 (m, 1H), 4.05 (t, 2H), 3.90 (m, 2H), 3.45 (m, 2H), 2.97 (t, 2H). δ 8.65 (s, 1H),8.60 (d,1H),8.45 (br s,1H),7.77 (s,1H), 7.63 (dd,1H),7.06 (m,1H),6.74 (s, 1H),6.70 (m, 1H), 6.58 (m, 1H), 4.88 (m, 1H), 3.96 (t, 2H), 3.90 (m, 2H), 3.39 (m, 2H), 2.95 (t, 2H). δ 8.59 (d, 1H), 8.45 (br s, 1H), 8.40 (d, 1H), 7.79 (d, 1H), 7.63 (dd, 1H), 7.19 (t, 1H), 7.04 (d, 1H), 6.94 (m, 1H), 6.89 (t, 1H), 6.78 (dd, 1H), 6.66 (d, 1H), 4.89 (m, 1H), 4.01 (t, 2H), 3.92 (m, 2H), 3.40 (m, 2H), 2.96 (t, 2H). δ 8.59 (d, 1H), 8.46 (br s, 1H), 8.40 (d, 1H), 8.07 (d, 1H), 7.78 (d, 1H), 7.63 (dd, 1H), 7.52 (dd, 1H), 7.04 (dd, 1H), 6.71 (d, 1H), 6.66 (d, 1H), 4.88 (m, 1H), 4.33 (t, 2H), 3.90 (m, 2H), 3.36 (m, 2H), 2.95 (t, 2H). δ 8.85 (d, 1H), 8.63 (d, 1H), 8.52 (br s, 1H), 7.80 (s, 1H), 7.65 (dd, 1H), 7.38 (d, 1H), 7.21 (m, 1H), 6.70 - 6.63 (m, 2H), 6.61 (dt, 1H), 5.43 (m, 1H), 4.01 (t, 2H), 3.94 (m, 2H), 3.42 (m, 2H), 2.96 (t, 2H). δ 8.84 (d, 1H), 8.63 (d, 1H), 8.58 (br s, 1H), 7.81 (s, 1H), 7.66 (dd, 1H), 7.38 (d, 1H), 6.94-6.82 (m, 2H), 6.78 (m, 1H), 5.44 (m, 1H), 4.05 (t, 2H), 3.94 (m, 2H), 3.45 (m, 2H), 2.97 (t, 2H). δ 8.85 (d, 1H), 8.63 (d, 1H), 8.49 (br s, 1H), 7.80 (s, 1H), 7.65 (dd, 1H), 7.38 (d, 1H), 7.05 (m, 1H), 6.71 (m, 1H), 6.55 (m, 1H), 5.43 (m, 1H), 3.98-3.92 (m, 4H), 3.41 (m, 2H), 2.95 (t, 2H). δ 8.84 (d, 1H), 8.63 (d, 1H), 8.47 (br s, 1H), 8.08 (d, 1H), 7.79 (s, 1H), 7.64 (dd, 1H), 7.52 (dd, 1H), 7.38 (d, 1H), 6.72 (d, 1H), 5.42 (m, 1H), 4.33 (t, 2H), 3.94 (m, 2H), 3.38 (m, 2H), 2.94 (t, 2H). 5 8.65 (s, 1H), 8.60 (d, 1H), 8.46 (br s, 1H), 8.07 (d, 1H), 7.77 (s, 1H), 7.63 (d, 1H), 7.52 (dd, 1H), 6.74 (s, 1H), 6.70 (d, 1H), 4.87 (m, 1H), 4.33 (t, 2H), 3.88 (br t, 2H), 3.37 (m, 2H), 2.95 (t, 2H). 5 8.84 (d, 1H), 8.63 (d, 1H), 8.43 (br s, 1H), 7.78 (s, 1H), 7.62 (d, 1H), 7.37 (d, 1H), 6.95 (t, 2H), 6.84 (m, 2H), 5.40 (m, 1H), 4.36 (m, 1H), 3.94 (m, 2H), 3.36 (m, 2H), 2.78 (m, 2H), 1.27 (d, 3H). δ 8.87 (s, 1H), 8.61 (d, 1H), 8.25 (br s, 1H), 7.76 (s, 1H), 7.61 (d, 1H), 6.96 (t, 2H), 6.84 (m, 2H), 5.33 (m, 1H), 4.35 (m, 1H), 3.89 (m, 2H), 3.36 (br m, 2H), 2.77 (m, 2H), 1.26 (d, 3H). 180 201204254 . 73 δ 8.65 (d, 1Η), 8.60 (d, 1H), 8.36 (br s, 1H), 7.78 (s, 1H), 7.62 (dd, 1H), 7.00 (d, 1H), 6.96 (t, 2H), 6.84 (m, 2H), 5.36 (m, 1H), # 4.35 (m, 1H), 3.88 (m, 2H), 3.38 (m, 2H), 2.77 (ddd, 2H), 1.26 * (d, 3H). 74 δ 8.58 (d, 1H), 8.51 (br s, 1H), 8.41 (d, 1H), 7.79 (d, 1H), 7.64 (dd, 1H), 7.13 (dd, 1H), 7.04 (dd, 1H), 6.92 (td, 1H), 6.83 (dd, 1H), 6.67 (d, 1H), 4.88 (m, 1H), 4.05 (t, 2H), 3.96 (m, 2H), 3.49 (m, 2H), 3.00 (t, 2H). 75 δ 8.58 (d, 1H), 8.50 (br s, 1H), 8.40 (d, 1H), 7.79 (s, 1H), 7.64 (dd, 1H), 7.10 (dd, 1H), 7.04 (m, 2H), 6.83 (t, 1H), 6.66 (d, 1H), 4.88 (m, 1H), 4.06 (t, 2H), 3.92 (m, 2H), 3.44 (m, 2H), 2.98 (t, 2H). 76 δ 8.58 (d, 1H), 8.50 (br s, 1H), 8.41 (d, 1H), 7.78 (s, 1H), 7.63 (dd, 1H), 7.37 (d, 1H), 7.18 (dd, 1H), 7.04 (dd, 1H), 6.81 (d, 1H), 6.67 (d, 1H), 4.88 (m, 1H), 4.06 (t, 2H), 3.96 (m, 2H), 3.49 (m, 2H), 3.01 (t, 2H). 77 δ 8.64 (s, 1H), 8.59 (d, 1H), 8.53 (br s, 1H), 7.78 (s, 1H), 7.63 (dd, 1H), 7.13 (dd, 1H), 6.92 (td, 1H), 6.83 (dd, 1H), 6.75 (s, 1H), 4.87 (m, 1H), 4.04 (t, 2H), 3.94 (m, 2H), 3.50 (m, 2H), 3.00 (t, 2H). 78 δ 8.65 (s, 1H), 8.59 (d, 1H), 8.51 (br s, 1H), 7.78 (s, 1H), 7.63 (dd, 1H), 7.10 (dd, 1H), 7.04 (m, 1H), 6.86 (t, 1H), 6.75 (s, 1H), 4.87 (m, 1H), 4.06 (t, 2H), 3.90 (m, 2H), 3.45 (m, 2H), 2.98 (t, 2H). 79 δ 8.65 (s, 1H), 8.59 (d, 1H), 8.52 (br s, 1H), 7.78 (d, 1H), 7.63 (dd, 1H), 7.37 (d, 1H), 7.18 (dd, 1H), 6.80 (d, 1H), 6.75 (d, 1H), 4.87 (m, 1H), 4.06 (t, 2H), 3.94 (m, 2H), 3.49 (m, 2H), 3.01 (t, 2H). 80 8.88 (s, 1H), 8.62 (d, 1H), 8.28 (br s, 1H), 7.77 (s, 1H), 7.62 (d, 1H), 7.37 (d, 2H), 6.78 (d, 2H), 5.35 (m, 1H), 3.99 (t, 2H), 3.92 (m, 2H), 3.42 (br s, 2H), 2.95 (t, 2H). 81 8.88 (s, 1H), 8.62 (d, 1H), 8.27 (br s, 1H), 7.76 (s, 1H), 7.62 (dd, 1H), 7.28 (s, 4H), 6.50 (dt, 1H), 6.14 (dt, 1H), 5.34 (m, 1H), 3.83 (m, 2H), 3.36-3.31 (m, 4H). 82 8.85 (s, 1H), 8.62 (dd, 1H), 8.25 (br s, 1H), 7.76 (m, 1H), 7.62 (dd, 1H), 7.28 (s, 4H), 6.50 (d, 1H), 6.14 (dt, 1H), 5.34 (m, 1H), 3.83 (m, 2H), 3.36-3.31 (m, 4H). 83 8.88 (d, 1H), 8.61 (d, 1H), 8.35 (br s, 1H), 7.94 (d, 1H), 7.78 (s, 1H), 7.63 (dd, 1H), 7.28 (s, 4H), 6.50 (d, 1H), 6.14 (dt, 1H), 5.34 (m, 1H), 3.83 (m, 2H), 3.36-3.31 (m, 4H). 84 8.63-8.58 (m, 2H), 8.40 (br s, 1H), 7.79 (m, 1H), 7.74 (d, 1H), 7.64 (dd, 1H), 7.28 (s, 4H), 6.50 (dt, 1H), 6.15 (dt, 1H), 5.33 (m, 1H), 3.84 (m, 2H), 3.35-3.29 (m, 4H). 181 8.71 (d, 1H), 8.62 (d, 1H), 8.31 (br s, 1H), 7.77 (s, 1H), 7.62 (dd, 1H), 7.28 (s, 4H), 6.50 (d, 1H), 6.14 (dt, 1H), 5.33 (m, 1H), 3.83 (m, 2H), 3.33-3.30 (m, 4H). 9.00 (s, 1H), 8.62 (d, 1H), 8.23 (br s, 1H), 7.76 (s, 1H), 7.61 (dd, 1H), 7.28 (s, 4H), 6.50 (d, 1H), 6.14 (dt, 1H), 5.33 (m, 1H), 3.83 (m, 2H), 3.36-3.30 (m, 4H). 8.67 (d, 1H), 8.62 (d, 1H), 8.30 (br s, 1H), 7.77 (s, 1H), 7.62 (dd, 1H), 7.28 (s, 4H), 6.50 (d, 1H), 6.14 (dt, 1H), 5.34 (m, 1H), 3.84 (m, 2H), 3.36-3.31 (m, 4H). 8.96 (s, 1H), 8.62 (d, 1H), 8.23 (br s, 1H), 7.76 (s, 1H), 7.62 (dd, 1H), 7.28 (s, 4H), 6.50 (d, 1H), 6.14 (dt, 1H), 5.33 (m, 1H), 3.83 (m, 2H), 3.36-3.31 (m, 4H). 9.05 (s, 1H), 8.60 (d, 1H), 8.30 (br s, 1H), 7.77 (s, 1H), 7.63 (dd, 1H), 7.28 (s, 4H), 6.50 (d, 1H), 6.14 (dt, 1H), 5.42 (m, 1H), 3.85 (m, 2H), 3.37 (dd, 2H), 3.34 (d, 2H). 8.62 (d, 1H), 8.39 (s, 1H), 7.83 (s, 1H), 7.70 (m, 2H), 7.26 (s, 4H), 6.47 (dt, 1H), 6.11 (dt, 1H), 5.36 (m, 1H), 3.78 (m, 2H), 3.29 (d, 2H), 3.24 (m, 2H). 8.90 (d, 1H), 8.62 (d, 1H), 8.20 (br s, 1H), 7.77 (s, 1H), 7.62 (d, 1H), 7.28 (s, 4H), 6.50 (d, 1H), 6.14 (dt, 1H), 5.29 (m, 1H), 3.83 (m, 2H), 3.38-3.31 (m, 4H). 8.65 (s, 1H), 8.61 (d, 1H), 8.49 (br s, 1H), 7.79 (s, 1H), 7.64 (dd, 1H), 7.58 (dd, 1H), 7.16 (dd, 2H), 6.75 (s, 1H), 6.70 (m, 1H), 6.58 (d, 1H), 4.87 (m, 1H), 3.82 (t, 2H), 3.39 (m, 2H), 3.36 (m, 2H). 8.85 (d, 1H), 8.64 (d, 1H), 8.50 (br s, 1H), 8.48 (d, 1H), 7.80 (s, 1H), 7.65 (dd, 1H), 7.59 (dd, 1H), 7.39 (d, 1H), 7.24 (d, 1H), 6.64 (m, 2H), 5.43 (m, 1H), 3.89 (t, 2H), 3.39 (m, 2H), 3.37 (m, 2H). 8.85 (d, 1H), 8.64 (d, 1H), 8.46 (br s, 1H), 7.80 (s, 1H), 7.64 (dd, 1H), 7.58 (dd, 1H), 7.38 (d, 1H), 7.17 (m, 2H), 6.73 (m, 1H), 6.60 (d, 2H), 5.42 (m, 1H), 3.91 (t, 2H), 3.39 (m, 2H), 3.37 (m, 2H). 8.84 (d, 1H), 8.59 (d, 1H), 8.56 (s, 1H), 7.97 (s, 1H), 7.69 (d, 1H), 7.38 (d, 1H), 7.29 (m, 4H), 6.52 (d, 1H), 6.15 (dt, 1H), 5.45 (m, 1H), 3.88 (m, 2H), 3.45 (m, 2H), 3.37 (m, 2H). 8.87 (d, 1H), 8.47 (d, 1H), 8.45 (s, 1H), 7.61 (m, 1H), 7.40 (m, 1H), 7.38 (d, 1H), 7.28 (m, 4H), 6.50 (d, 1H), 6.15 (dt, 1H), 5.42 (m, 1H), 3.87 (m, 2H), 3.35-3.31 (m, 4H). 8.93 (s, 1H), 8.89 (d, 1H), 8.78 (s, 1H), 8.71 (d, 1H), 7.79 (d, 1H), 7.37 (d, 1H), 7.28 (m, 4H), 6.49 (d, 1H), 6.14 (dt, 1H), 5.43 (m, 1H), 3.86 (m, 2H), 3.31 (m, 2H), 3.27 (m, 2H). s 182 201204254 100 8.86 (d, 1H), 8.61 (s, 1H), 8.48 (d, 1H), 7.61 (d, 1H), 7.38 (d, 1H), 7.27 (s, 4H), 6.48 (d, 1H), 6.13 (dt, 1H), 5.43 (m, 1H), 3.84 (m, 2H), 3.30 (m, 2H), 3.28 (m, 2H). 101 8.99 (d, 1H), 8.86 (d, 1H), 8.58 (s, 1H), 8.15 (s, 1H), 7.93 (d, 1H), 7.39 (d, 1H), 7.28 (s, 4H), 6.50 (d, 1H), 6.14 (dt, 1H), 5.44 (m, 1H), 3.85 (m, 2H), 3.45 (m, 2H), 3.36-3.31 (m, 4H). 102 9.14 (d, 1H), 8.88 (d, 1H), 8.44 (d, 1H), 7.96 (t, 1H), 7.37 (d, 1H), 7.29 (AB d, 4H), 6.52 (d, 1H), 6.17 (dt, 1H), 5.43 (m, 1H), 3.92 (m, 2H), 3.34 (d, 2H), 3.30 (m, 2H). 103 (major diastereomer only) 8.85 (d, 1H), 8.64 (s, 1H), 8.61 (d, 1H), 7.82 (s, 1H), 7.67 (d, 1H), 7.37 (d, 1H), 7.28 (s, 4H), 6.51 (d, 1H), 6.17 (dt, 1H), 5.54 (t, 1H), 3.70 (t, 1H), 3.62 (d, 1H), 3.46-3.38 (m, 2H), 3.23 (dd, 1H), 1.24 (d, 3H). 104 9.70 (s, 1H), 8.62 (d, 1H), 8.42 (br s, 1H), 7.81 (s, 1H), 7.67 (d, 1H), 7.28 (s, 4H), 6.96 (s, 1H), 6.51 (d, 1H), 6.12 (dt, 1H), 5.04 (m, 1H), 3.87 (m, 2H), 3.41 (m, 2H), 3.36(d, 2H). 105 10.45 (s, 1H), 9.38 (d, 1H), 9.08 (d, 1H), B.93 (d, 1H), 8.21 (dd, 1H), 7.37 (d, 1H), 7.29 (m, 4H), 6.52 (d, 1H), 6.18 (dt, 1H), 5.42 (m, 1H), 3.95 (m, 2H), 3.37-3.32 (m, 4H). 106 8.61 (br s, 1H), 8.59 (d, 1H), 8.42 (d, 1H), 7.81 (s, 1H), 7.66 (d, 1H), 7.27 (s, 4H), 6.69 (d, 1H), 6.50 (d, 1H), 6.11 (dt, 1H), 4.86 (m, 1H), 3.78 (t, 2H), 3.34 (br d, 4H). 107 8.62-8.56 (m, 2H), 8.42 (d, 1H), 7.80 (s, 1H), 7.65 (d, 1H), 7.27 (s, 4H), 6.83 (d, 1H), 6.49 (d, 1H), 6.11 (dt, 1H), 4.86 (m, 1H), 3.77 (t, 2H), 3.36-3.29 (br d, 4H). 108 8.73 (d, 1H), 8.29 (br s, 1H), 8.08 (s, 1H), 7.35 (d, 1H), 7.29 (m, 4H), 6.52 (d, 1H), 6.16 (dt, 1H), 5.42 (m, 1H), 3.87 (m, 2H), 3.37-3.27 (m, 4H). 109 8.66 (d, 1H), 8.62 (d, 1H), 8.34 (br s, 1H), 7.77 (s, 1H), 7.62 (dd, 1H), 7.28 (s, 4H), 6.48 (d, 1H), 6.00 (dd, 1H), 5.28 (m, 1H), 3.80 (t, 1H), 3.74 (t, 1H), 3.29 (m, 2H), 3.00 (m, 1H), 1.16 (d, 3H). 110 8.70 (d, 1H), 8.62 (d, 1H), 8.34 (br s, 1H), 7.77 (s, 1H), 7.62 (dd, 1H), 7.28 (s, 4H), 6.48 (d, 1H), 6.00 (dd, 1H), 5.27 (m, 1H), 3.80 (t, 1H), 3.74 (t, 1H), 3.30 (m, 2H), 3.00 (m, 1H), 1.16 (d, 3.H). 111 8.65 (d, 1H), 8.65 (s, 1H), 8.52 (br s, 1H), 7.78 (s, 1H), 7.63 (dd, 1H), 7.28 (s, 4H), 6.50 (d, 1H), 6.13 (dt, 1H), 5.54 (m, 1H), 3.86 (dd, 2H), 3.44 (m, 2H), 3.34 (d, 2H). 112 8.88 (d, 1H), 8.61 (d, 1H), 8.35 (br s, 1H), 7.94 (d, 1H), 7.78 (s, 1H), 7.63 (dd, 1H), 6.96 (t, 2H), 6.83 (m, 2H), 5.34 (m, 1H), 3.98 (t, 2H), 3.92 (m, 2H), 3.40 (dd, 2H), 2.95 (t, 2H). 1 13 8.88 (d, 1H), 8.61 (d, 1H), 8.32 (br s, 1H), 7.94 (d, 1H), 7.77 (s, 1H), 7.62 (dd, 1H), 7.22 (d, 2H), 6.82 (d, 2H), 5.34 (m, 1H), 3.99 (t, 2H), 3.91 (m, 2H), 3.39 (m, 2H), 2.95 (t, 2H). 183 201204254 114 8.88 (d, 1H), 8.61 (d, 1H), 8.32 (br s, 1H), 7.94 (d, 1H), 7.77 (s, 1H), 7.62 (dd, 1H), 7.36 (d, 2H), 6.77 (d, 2H), 5.34 (m, 1H), 3.99 (t, 2H), 3.91 (m, 2H), 3.39 (m, 2H), 2.95 (t, 2H). 115 8.88 (d, 1H), 8.61 (d, 1H), 8.37 (br s, 1H), 7.95 (d, 1H), 7.78 (s, 1H), 7.63 (dd, 1H), 6.90 (td, 1H), 6.85 (m, 1H), 6.77 (m, 1H), 5.34 (m, 1H), 4.05 (t, 2H), 3.92 (m, 2H), 3.43 (dd, 2H), 2.97 (t, 2H). 116 8.66 (d, 1H), 8.61 (d, 1H), 8.39 (br s, 1H), 7.79 (s, 1H), 7.64 (dd, 1H), 7.01 (d, 1H), 6.90 (td, 1H), 6.85 (m, 1H), 6.78 (m, 1H), 5.38 (m, 1H), 4.05 (t, 2H), 3.92 (m, 2H), 3.45 (dd, 2H), 2.97 (t, 2H). 117 8.67 (d, 1H), 8.60 (d, 1H), 8.38 (br s, 1H), 7.79 (s, 1H), 7.64 (dd, 1H), 7.13 (dd, 1H), 7.01 (d, 1H), 6.92 (m, 1H), 6.84 (dd, 1H), 5.38 (m, 1H), 4.05 (t, 2H), 3.97 (m, 2H), 3.50 (dd, 2H), 3.00 (t, 2H). 118 8.67 (d, 1H), 8.61 (d, 1H), 8.37 (br s, 1H), 7.79 (s, 1H), 7.64 (dd, 1H), 7.10 (dd, 1H), 7.04 (m, 1H), 7.01 (d, 1H), 6.87 (t, 1H), 5.38 (m, 1H), 4.05 (t, 2H), 3.92 (m, 2H), 3.45 (dd, 2H), 2.97 (t, 2H). 119 8.67 (d, 1H), 8.61 (d, 1H), 8.35 (br s, 1H), 7.78 (d, 1H), 7.63 (dd, 1H), 7.37 (d, 1H), 7.18 (dd, 1H), 7.01 (d, 1H), 6.82 (d, 1H), 5.38 (m, 1H), 4.07 (t, 2H), 3.97 (m, 2H), 3.49 (dd, 2H), 3.00 (t, 2H). 120 8.67 (d, 1H), 8.61 (d, 1H), 8.25 (br s, 1H), 7.77 (s, 1H), 7.62 (dd, 1H), 7.37 (d, 2H), 7.01 (d, 1H), 6.78 (d, 2H), 5.37 (m, 1H), 3.99 (t, 2H), 3.93 (m, 2H), 3.40 (m, 2H), 2.95 (t, 2H). 121 8.85 (d, 1H), 8.63 (d, 1H), 8.48 (br s, 1H), 7.79 (d, 1H), 7.64 (dd, 1H), 7.38 (d, 1H), 7.36 (d, 1H), 7.17 (dd, 1H), 6.82 (d, 1H), 5.42 (m, 1H), 4.07 (t, 2H), 4.01 (m, 2H), 3.49 (dd, 2H), 3.01 (t, 2H). 122 8.85 (d, 1H), 8.63 (d, 1H), 8.48 (br s, 1H), 7.80 (s, 1H), 7.64 (dd, 1H), 7.38 (d, 1H), 7.10 (dd, 1H), 7.04 (m, 1H), 6.88 (t, 1H), 5.42 (m, 1H), 4.07 (t, 2H), 3.97 (m, 2H), 3.44 (dd, 2H), 2.98 (t, 2H). 123 8.85 (d, 1H), 8.63 (d, 1H), 8.48 (br s, 1H), 7.79 (s, 1H), 7.64 (dd, 1H), 7.38 (d, 1H), 7.13 (dd, 1H), 6.92 (m, 1H), 6.84 (dd, 1H), 5.42 (m, 1H), 4.06 (t, 2H), 4.01 (m, 2H), 3.49 (dd, 2H), 3.00 (t, 2H). 124 8.76 (d, 1H), 8.62 (d, 1H), 8.38 (br s, 1H), 7.85 (d, 1H), 7.78 (s, 1H), 7.63 (dd, 1H), 6.90 (td, 1H), 6.85 (m, 1H), 6.78 (m, 1H), 5.35 (m, 1H), 4.05 (t, 2H), 3.93 (m, 2H), 3.43 (dd, 2H), 2.97 (t, 2H). 125 8.77 (d, 1H), 8.62 (d, 1H), 8.33 (br s, 1H), 7.85 (d, 1H), 7.77 (s, 1H), 7.62 (dd, 1H), 7.37 (d, 2H), 6.78 (d, 2H), 5.34 (m, 1H), 3.99 (t, 2H), 3.92 (m, 2H), 3.39 (br m, 2H), 2.95 (t, 2H). s 184 201204254 . 126 8.77 (d, 1H), 8.62 (d, 1H), 8.33 (br s, 1H), 7.85 (d, 1H), 7.77 (s, 1H), 7.63 (dd, 1H), 7.23 (d, 2H), 6.82 (d, 2H), 5.34 (m, 1H), . 3.99 (t, 2H), 3.92 (m, 2H), 3.39 (br m, 2H), 2.95 (t, 2H). 127 8.88 (s, 1H), 8.62 (d, 1H), 8.35 (br s, 1H), 7.78 (s, 1H), 7.63 (d, 1H), 6.90 (td, 1H), 6.85 (m, 1H), 6.78 (m, 1H), 5.36 (m, 1H), 4.05 (t, 2H), 3.92 (m, 2H), 3.46 (m, 2H), 2.97 (t, 2H). 128 8.63-8.58 (m, 2H), 8.41 (br s, 1H), 7.79 (m, 1H), 7.75 (d, 1H), 7.63 (dd, 1H), 7.23 (d, 2H), 6.82 (d, 2H), 5.34 (m, 1H), 3.92 (t, 2H), 3.92 (m, 2H), 3.39 (m, 2H), 2.96 (t, 2H). 129 8.98 (d, 1H), 8.63 (m, 1H), 8.53 (br s, 1H), 8.19 (m, 1H), 7.80 (m, 1H), 7.66 (m, 1H), 6.92 (td, 1H), 6.86 (m, 1H), 6.78 (m, 1H), 5.45 (m, 1H), 4.06 (t, 2H), 3.94 (m, 2H), 3.47 (dd, 2H), 2.98 (t, 2H). 130 8.98 (d, 1H), 8.63 (dd, 1H), 8.45 (br s, 1H), 8.19 (m, 1H), 7.79 (dd, 1H), 7.64 (dd, 1H), 7.37 (d, 2H), 6.78 (d, 2H), 5.43 (m, 1H), 4.00 (t, 2H), 3.94 (m, 2H), 3.43 (m, 2H), 2.96 (t, 2H). 131 8.98 (d, 1H), 8.63 (dd, 1H), 8.45 (br s, 1H), 8.19 (m, 1H), 7.79 (dd, 1H), 7.64 (dd, 1H), 7.23 (d, 2H), 6.82 (d, 2H), 5.43 (m, 1H), 4.00 (t, 2H), 3.94 (m, 2H), 3.43 (m, 2H), 2.96 (t, 2H). 132 8.98 (d, 1H), 8.63 (dd, 1H), 8.47 (br s, 1H), 8.19 (m, 1H), 7.79 (dd, 1H), 7.65 (dd, 1H), 6.97 (t, 2H), 6.83 (m, 2H), 5.44 (m, 1H), 3.99 (t, 2H), 3.94 (m, 2H), 3.44 (dd, 2H), 2.96 (t, 2H). 133 8.87 (d, 1H), 8.61 (d, 1H), 8.34 (br s, 1H), 7.93 (d, 1H), 7.77 (br s, 1H), 7.62 (dd, 1H), 6.96 (t, 2H), 6.84 (m, 2H), 5.31 (m, 1H), 4.36 (m, 1H), 3.88 (m, 2H), 3.35 (m, 2H), 2.77 (ddd, 2H), 1.26 (d, 3H). 134 8.76 (d, 1H), 8.61 (dd, 1H), 8.35 (br s, 1H), 7.84 (d, 1H), 7.77 (dd, 1H), 7.62 (dd, 1H), 6.96 (t, 2H), 6.84 (m, 2H), 5.31 (m, 1H), 4.36 (m, 1H), 3.88 (m, 2H), 3.35 (m, 2H), 2.77 (ddd, 2H), 1.26 (d, 3H). 135 8.63-8.57 (m, 2H), 8.40 (br s, 1H), 7.78 (m, 1H), 7.74 (d, 1H), 7.62 (dd, 1H), 6.96 (t, 2H), 6.84 (m, 2H), 5.31 (m, 1H), 4.36 (m, 1H), 3.89 (m, 2H), 3.34 (m, 2H), 2.78 (ddd, 2H), 1.26 (d, 3H). 136 8.97 (d, 1H), 8.62 (d, 1H), 8.45 (br s, 1H), 8.18 (m, 1H), 7.78 (dd, 1H), 7.63 (dd, 1H), 6.96 (t, 2H), 6.84 (m, 2H), 5.41 (m, 1H), 4.37 (m, 1H), 3.91 (m, 2H), 3.38 (m, 2H), 2.78 (ddd, 2H), 1.26 (d, 3H). 137 8.84 (d, 1H), 8.63 (d, 1H), 8.51 (br s, 1H), 7.80 (s, 1H), 7.64 (m, 1H), 7.38 (d, 1H), 6.83 (s, 4H), 5.43 (m, 1H), 3.98 (t, 2H), 3.94 (m, 2H), 3.76 (s, 3H), 3.42 (m, 2H), 2.94 (t, 2H). 138 8.85 (d, 1H), 8.63 (d, 1H), 8.44 (br s, 1H), 8.20 (d, 2H), 7.78 (s, 1H), 7.64 (dd, 1H), 7.39 (d, 1H), 6.96 (d, 2H), 5.43 (m, 1H), 4.12 (t, 2H), 3.99 (m, 2H), 3.43 (m, 2H), 3.01 (t, 2H). 185 8.85 (d,1H),8.63 (d,1H),8.47 (br s,1H), 7.79 (s,1H),7.64 (m, 1H), 7.38 (d, 1H), 7.14 (d, 2H), 6.88 (d, 2H), 5.43 (m, 1H), 4.01 (t, 2H), 3.96 (m, 2H), 3.42 (m, 2H), 2.96 (t, 2H). 8.85 (d, 1H), 8.63 (d, 1H), 8.45 (br s, 1H), 7.79 (s, 1H), 7.65 (m, 1H), 7.59 (d, 2H), 7.39 (d, 1H), 6.95 (d, 2H), 5.42 (m, 1H), 4.07 (t, 2H), 3.97 (m, 2H), 3.42 (m, 2H), 2.99 (t, 2H). 8.84 (d, 1H), 8.63 (d, 1H), 8.52 (br s, 1H), 7.81 (s, 1H), 7.65 (m, 1H), 7.38 (d, 1H), 7.29 (d, 2H), 6.84 (d, 2H), 5.43 (m, 1H), 4.01 (t, 2H), 3.93 (m, 2H), 3.43 (m, 2H), 2.95 (t, 2H), 1.29 (s, 9H). 8.85 (d, 1H), 8.63 (d, 1H), 8.46 (br s, 1H), 7.79 (s, 1H), 7.64 (m, 1H), 7.54 (d, 2H), 7.39 (d, 1H), 6.96 (d, 2H), 5.43 (m, 1H), 4.07 (t, 2H), 3.97 (m, 2H), 3.43 (br s, 2H), 2.99 (t, 2H). 8.76 (d, 1H), 8.61 (d, 1H), 8.30 (br s, 1H), 7.84 (d, 1H), 7.76 (s, 1H), 7.61 (dd, 1H), 7.22 (d, 2H), 6.82 (d, 2H), 5.30 (m, 1H), 4.40 (m, 1H), 3.89 (m, 2H), 3.33 (ddd, 2H), 2.77 (ddd, 2H), 1.27 (d, 3H). 8.62 (d, 1H), 8.39 (s, 1H), 7.83 (s, 1H), 7.74 (br s, 1H), 7.71 (dd, 1H), 6.95 (t, 2H), 6.81 (m, 2H), 5.37 (m, 1H), 3.95 (t, 2H), 3.86 (m, 2H), 3.32 (m, 2H), 2.91 (t, 2H). 8.62 (d, 1H), 8.39 (s, 1H), 7.83 (s, 1H), 7.74 (br s, 1H), 7.70 (dd, 1H), 7.21 (d, 2H), 6.80 (d, 2H), 5.36 (m, 1H), 3.96 (t, 2H), 3.86 (m, 2H), 3.31 (m, 2H), 2.91 (t, 2H). 8.62 (d, 1H), 8.39 (s, 1H), 7.83 (s, 1H), 7.70 (dd, 1H), 7.67 (br s, 1H), 7.35 (d, 2H), 6.75 (d, 2H), 5.36 (m, 1H), 3.95 (t, 2H), 3.86 (m, 2H), 3.30 (m, 2H), 2.91 (t, 2H). 8.70 (d, 1H), 8.62 (d, 1H), 8.30 (br s, 1H), 7.76 (s, 1H), 7.61 (dd, 1H), 7.22 (d, 2H), 6.82 (d, 2H), 5.31 (m, 1H), 4.40 (m, 1H), 3.88 (m, 2H), 3.34 (ddd, 2H), 2.77 (ddd, 2H), 1.27 (d, 3H). 8.62 (d, 1H), 8.38 (s, 1H), 7.82 (s, 1H), 7.69 (dd, 1H), 7.75-7.60 (br s, 1H), 7.20 (d, 2H), 6.80 (d, 2H), 5.32 (m, 1H), 4.37 (m, 1H), 3.82 (m, 2H), 3.26 (ddd, 2H), 2.74 (ddd, 2H), 1.24 (d, 3H). 8.99 (s, 1H), 8.62 (d, 1H), 8.24 (br s, 1H), 7.75 (s, 1H), 7.60 (dd, 1H), 7.22 (d, 2H), 6.82 (d, 2H), 5.31 (m, 1H), 4.40 (m, 1H), 3.88 (m, 2H), 3.35 (ddd, 2H), 2.77 (ddd, 2H), 1.27 (d, 3H). 8.99 (s, 1H), 8.62 (d, 1H), 8.27 (br s, 1H), 7.77 (s, 1H), 7.62 (dd, 1H), 6.96 (t, 2H), 6.83 (m, 2H), 5.35 (m, 1H), 3.98 (t, 2H), 3.92 (m, 2H), 3.43 (m, 2H), 2.95 (t, 2H). 8.99 (s, 1H), 8.62 (d, 1H), 8.28 (br s, 1H), 7.77 (s, 1H), 7.62 (dd, 1H), 7.23 (d, 2H), 6.82 (d, 2H), 5.34 (m, 1H), 3.99 (t, 2H), 3.91 (m, 2H), 3.43 (m, 2H), 2.95 (t, 2H). 8.99 (s, 1H), 8.62 (d, 1H), 8.27 (br s, 1H), 7.77 (s, 1H), 7.62 (dd, 1H), 7.37 (d, 2H), 6.77 (d, 2H), 5.35 (m, 1H), 3.99 (t, 2H), 3.91 (m, 2H), 3.42 (m, 2H), 2.95 (t, 2H). s 186 201204254 . 153 8.71 (d, 1H), 8.62 (d, 1H), 8.33 (br s, 1H), 7.78 (s, 1H), 7.63 (d, 1H), 7.23 (d, 2H), 6.82 (d, 2H), 5.35 (m, 1H), 4.00 (t, 2H), 3.92 ^ (m, 2H), 3.42 (br m, 2H), 2.95 (t, 2H). 154 8.71 (d, 1H), 8.62 (d, 1H), 8.33 (br s, 1H), 7.77 (s, 1H), 7.62 (dd, 1H), 7.37 (d, 2H), 6.78 (d, 2H), 5.34 (m, 1H), 3.99 (t, 2H), 3.92 (m, 2H), 3.41 (m, 2H), 2.95 (t, 2H). 155 8.71 (d, 1H), 8.62 (d, 1H), 8.35 (br s, 1H), 7.78 (s, 1H), 7.63 (dd, 1H), 6.97 (t, 2H), 6.83 (m, 2H), 5.35 (m, 1H), 3.99 (t, 2H), 3.92 (m, 2H), 3.43 (m, 2H), 2.95 (t, 2H). 156 8.66 (d, 1H), 8.62 (d, 1H), 8.29 (br s, 1H), 7.76 (d, 1H), 7.61 (dd, 1H), 7.37 (d, 2H), 6.78 (d, 2H), 5.34 (m, 1H), 3.99 (t, 2H), 3.92 (m, 2H), 3.40 (m, 2H), 2.95 (t, 2H). 157 8.66 (d, 1H), 8.62 (d, 1H), 8.31 (br s, 1H), 7.77 (s, 1H), 7.62 (dd, 1H), 7.23 (d, 2H), 6.82 (d, 2H), 5.35 (m, 1H), 3.99 (t, 2H), 3.93 (m, 2H), 3.41 (m, 2H), 2.95 (t, 2H). 158 8.66 (d, 1H), 8.62 (d, 1H), 8.31 (br s, 1H), 7.77 (s, 1H), 7.62 (dd, 1H), 6.97 (t, 2H), 6.83 (m, 2H), 5.35 (m, 1H), 3.98 (t, 2H), 3.93 (m, 2H), 3.41 (m, 2H), 2.95 (t, 2H). 159 8.95 (s, 1H), 8.61 (d, 1H), 8.21 (br s, 1H), 7.75 (s, 1H), 7.60 (dd, 1H), 7.22 (d, 2H), 6.82 (d, 2H), 5.31 (m, 1H), 4.40 (m, 1H), 3.89 (ddd, 2H), 3.35 (ddd, 2H), 2.77 (ddd, 2H), 1.27 (d, 3H). 160 9.03 (s, 1H), 8.62 (d, 1H), 8.27 (br s, 1H), 7.76 (s, 1H), 7.62 (dd, 1H), 7.22 (d, 2H), 6.82 (d, 2H), 5.40 (m, 1H), 4.41 (m, 1H), 3.91 (m, 2H), 3.38 (ddd, 2H), 2.78 (m, 2H), 1.27 (d, 3H). 161 8.84 (s, 1H), 8.62 (d, 1H), 8.23 (br s, 1H), 7.75 (s, 1H), 7.60 (d, 1H), 7.22 (d, 2H), 6.82 (d, 2H), 5.32 (m, 1H), 4.40 (m, 1H), 3.89 (m, 2H), 3.35 (m, 2H), 2.77 (m, 2H), 1.27 (d, 3H). 162 8.66 (d, 1H), 8.62 (d, 1H), 8.28 (br s, 1H), 7.76 (s, 1H), 7.61 (dd, 1H), 7.22 (d, 2H), 6.82 (d, 2H), 5.31 (m, 1H), 4.40 (m, 1H), 3.89 (m, 2H), 3.34 (ddd, 2H), 2.78 (ddd, 2H), 1.27 (d, 3H). 163 8.84 (d, 1H), 8.63 (d, 1H), 8.40 (br s, 1H), 7.77 (s, 1H), 7.61 (dd, 1H), 7.37 (d, 1H), 7.21 (d, 2H), 6.84 (d, 2H), 5.37 (m, 1H), 4.21 (m, 1H), 3.94 (t, 1H), 3.88 (t, 1H), 3.33 (dd, 1H), 3.28 (dd, 1H), 2.78 (m, 2H), 1.68 (m, 2H), 0.95 (t, 3H). 164 8.96 (s, 1H), 8.62 (d, 1H), 8.22 (br s, 1H), 7.75 (s, 1H), 7.61 (dd, 1H), 7.37 (d, 2H), 6.78 (d, 2H), 5.34 (m, 1H), 3.99 (t, 2H), 3.92 (m, 2H), 3.40 (m, 2H), 2.95 (t, 2H). 165 8.96 (s, 1H), 8.62 (d, 1H), 8.21 (br s, 1H), 7.75 (s, 1H), 7.61 (dd, 1H), 7.23 (d, 2H), 6.82 (d, 2H), 5.34 (m, 1H), 3.99 (t, 2H), 3.92 (m, 2H), 3.40 (dd, 2H), 2.94 (t, 2H). 166 8.96 (s, 1H), 8.62 (d, 1H), 8.22 (br s, 1H), 7.75 (s, 1H), 7.61 (dd, 1H), 6.96 (t, 2H), 6.83 (m, 2H), 5.34 (m, 1H), 3.98 (t, 2H), 3.92 (m, 2H), 3.41 (m, 2H), 2.94 (t, 2H). 187 8.85 (s, 1H), 8.62 (dd, 1H), 8.23 (br s, 1H), 7.76 (m, 1H), 7.61 (dd, 1H), 7.37 (d, 2H), 6.78 (d, 2H), 5.35 (m, 1H), 3.99 (t, 2H), 3.92 (m, 2H), 3.40 (m, 2H), 2.95 (t, 2H). 8.85 (s, 1H), 8.62 (dd, 1H), 8.24 (br s, 1H), 7.76 (m, 1H), 7.61 (dd, 1H), 7.23 (d, 2H), 6.82 (d, 2H), 5.35 (m, 1H), 3.99 (t, 2H), 3.92 (m, 2H), 3.41 (m, 2H), 2.95 (t, 2H). 8.85 (s, 1H), 8.62 (d, 1H), 8.25 (br s, 1H), 7.76 (m, 1H), 7.62 (dd, 1H), 6.97 (t, 2H), 6.83 (m, 2H), 5.35 (m, 1H), 3.98 (t, 2H), 3.92 (m, 2H), 3.41 (m, 2H), 2.95 (t, 2H). 9.04 (s, 1H), 8.63 (d, 1H), 8.28 (br s, 1H), 7.77 (s, 1H), 7.63 (dd, 1H), 7.23 (d, 2H), 6.82 (d, 2H), 5.43 (m, 1H), 4.00 (t, 2H), 3.94 (m, 2H), 3.44 (m, 2H), 2.96 (t, 2H). 8.62 (s, 1H), 8.59 (d, 1H), 8.46 (br s, 1H), 8.06(d, 1H), 7.76 (s, 1H), 7.62 (dd, 1H), 7.50 (dd, 1H), 6.72 (s, 1H), 6.65 (d, 1H), 5.23 (m, 1H), 4.83 (m, 1H), 3.84 (m, 2H), 3.36 (dd, 1H), 3.29 (dd, 1H), 2.84 (dd, 1H), 2.74 (dd, 1H), 1.29 (d, 3H). 8.84 (d, 1H), 8.63 (d, 1H), 8.48 (br s, 1H), 8.07 (d, 1H), 7.79 (s, 1H), 7.64 (d, 1H), 7.50 (dd, 1H), 7.37 (d, 1H), 6.65 (d, 1H), 5.39 (m, 1H), 5.24 (m, 1H), 3.91 (m, 2H), 3.36 (dd, 1H), 3.30 (dd, 1H), 2.84 (dd, 1H), 2.74 (dd, 1H), 1.30 (d, 3H). 8.65 (s, 1H), 8.61 (d, 1H), 8.40 (br s, 1H), 8.05 (d, 1H), 7.76 (s, 1H), 7.62 (dd, 1H), 7.37 (d, 1H), 7.10 (dd, 1H), 6.73 (s, 1H), 4.88 (m, 1H), 4.04 (m, 2H), 3.92 (m, 2H), 3.41 (m, 2H), 2.98 (dd, 2H). 8.84 (d, 1H), 8.63 (d, 1H), 8.48 (br s, 1H), 7.79 (s, 1H), 7.64 (dd, 1H), 7.38 (d, 1H), 7.36 (d, 1H), 6.99 (d, 1H), 5.43 (m, 1H), 4.55 (dd, 2H), 3.96 (m, 2H), 3.39 (m, 2H), 3.03 (dd, 2H). 8.64 (s, 1H), 8.60 (d, 1H), 8.42 (br s, 1H), 8.05 (d, 1H), 7.76 (s, 1H), 7.62 (dd, 1H), 7.23 (d, 1H), 7.18 (dd, 1H), 6.73 (s, 1H), 4.88 (m, 1H), 4.05 (m, 2H), 3.92 (m, 2H), 3.40 (m, 2H), 2.98 (dd, 2H). 8.64 (s, 1H), 8.60 (d, 1H), 8.43 (br s, 1H), 7.77 (s, 1H), 7.63 (dd, 1H), 7.37 (d, 1H), 6.98 (d, 1H), 6.73 (s, 1H), 4.88 (m, 1H), 4.55 (m, 2H), 3.92 (m, 2H), 3.38 (m, 2H), 3.02 (dd, 2H). 8.85 (d, 1H), 8.63 (d, 1H), 8.44 (br s, 1H), 8.05 (d, 1H), 7.78 (s, 1H), 7.64 (dd, 1H), 7.39 (d, 1H), 7.21 (m, 2H), 5.42 (m, 1H), 4.05 (dd, 2H), 3.96 (m, 2H), 3.41 (m, 2H), 2.98 (dd, 2H). 8.85 (d, 1H), 8.63 (d, 1H), 8.45 (br s, 1H), 8.05 (d, 1H), 7.79 (s, 1H), 7.64 (dd, 1H), 7.38 (m, 2H), 7.11 (dd, 1H), 5.42 (m, 1H), 4.05 (dd, 2H), 3.98 (m, 2H), 3.43 (m, 2H), 2.98 (dd, 2H). 8.84 (d, 1H), 8.63 (dd, 1H), 8.39 (br s, 1H), 7.77 (dd, 1H), 7.61 (dd, 1H), 7.37 (d, 1H), 7.22 (m, 2H), 6.82 (m, 2H), 5.38 (m, 1H), 4.40 (m, 1H), 3.96 (m, 1H), 3.91 (m, 1H), 3.36 (m, 1H), 3.22 (m, 1H), 2.80 (dd, 1H), 2.75 (dd, 1H), 1.28 (d, 3H). s 188 201204254 . 180 8.89 (d, 1H), 8.61 (d, 1H), 8.16 (br s, 1H), 7.75 (s, 1H), 7.60 (dd, 1H), 7.22 (m, 2H), 6.82 (m, 2H), 5.26 (m, 1H), 4.40 (m, 1H), _ 3.90 (m, 1H), 3.86 (m, 1H), 3.37 (m, 1H), 3.33 (m, 1H), 2.79 (dd, 1H), 2.74 (dd, 1H), 1.27 (d, 3H). 181 8.89 (d, 1H), 8.61 (d, 1H), 8.23 (br s, 1H), 7.77 (s, 1H), 7.62 (dd, 1H), 7.23 (d, 2H), 6.82 (d, 2H), 5.30 (m, 1H), 3.99 (t, 2H), 3.90 (m, 2H), 3.42 (m, 2H), 2.94 (t, 2H). 182 8.65 (s, 1H), 8.61 (d, 1H), 8.44 (br s, 1H), 8.16 (s, 1H), 7.77 (s, 1H), 7.63 (m, 2H), 6.74 (s, 1H), 6.66 (d, 1H),4.87 (m, 1H), 4.33 (m, 2H), 3.89 (m, 2H), 3.37 (m, 2H), 2.95 (dd, 2H). 183 8.84 (d, 1H), 8.63 (d, 1H), 8.47 (br s, 1H), 8.17( s, 1H),7.80 (s, 1H), 7.64 (m, 2H), 7.38 (d, 1H), 6.69 (d, 1H), 5.42 (m, 1H), 4.34 (t, 2H), 3.94 (m, 2H), 3.38 (m, 2H), 2.94 (t, 2H) 184 8.64 (s, 1H), 8.61 (d, 1H), 8.41 (br s, 1H), 8.19 (d, 1H), 7.76 (s, 1H), 7.63 (dd, 1H), 6.82 (d, 1H) 6.74 (m, 2H), 4.88 (m, 1H), 4.07 (dd, 2H), 3.92 (m, 2H), 3.39 (m, 2H), 2.98 (dd, 2H). 185 8.85 (d, 1H), 8.63 (d, 1H), 8.43 (br s, 1H), 8.19 (d, 1H), 7.78 (s, 1H), 7.64 (dd, 1H), 7.39 (d, 1H), 6.84 (dd, 1H), 6.75 (dd, 1H), 5.42 (m, 1H), 4.07 (dd, 2H), 3.97 (m, 2H), 3.40 (m, 2H), 2.98 (dd, 2H). 186 8.59 (m, 3H), 8.44 (s, 2H), 7.78 (s, 1H), 7.64 (dd, 1H), 6.72 (s, 1H), 4.86 (m, 1H), 4.41 (t, 2H), 3.87 (m, 2H), 3.43 (m, 2H), 2.97 (t, 2H). 187 8.83 (d, 1H), 8.63 (d, 1H), 8.56 (br s, 1H), 8.44 (s, 2H), 7.80 (s, 1H), 7.64 (dd, 1H), 7.36 (d, 1H), 5.42 (m, 1H), 4.40 (t, 2H), 3.93 (m, 2H), 3.42 (m, 2H), 2.97 (t, 2H). 188 8.65 (d, 1H), 8.52 (s, 1H), 8.48 (br s, 1H), 7.76 (s, 1H), 7.61 (dd, 1H), 7.21 (m, 2H), 6.81 (m, 2H), 5.51 (m, 1H), 4.41 (m, 1H), 3.95 (m, 1H), 3.90 (m, 1H), 3.46 (m, 1H), 3.42 (m, 1H), 2.81 (dd, 1H), 2.77 (dd, 1H), 1.27 (d, 3H). 189 8.83 (d, 1H), 8.61 (d, 1H), 8.39 (s, 1H), 7.93 (s, 1H), 7.65 (dd, 1H), 7.37 (d, 1H), 7.22 (m, 2H), 6.82 (m, 2H), 5.38 (m, 1H), 4.40 (m, 1H), 3.95 (m, 1H), 3.91 (m, 1H), 3.37 (m, 1H), 3.32 (m, 1H), 2.80 (dd, 1H), 2.75 (dd, 1H), 1.28 (d, 3H). 190 8.84 (d, 1H), 8.61 (d, 1H), 8.41 (s, 1H), 7.94 (s, 1H), 7.66 (dd, 1H), 7.38 (d, 1H), 7.23 (m, 2H), 6.82 (d, 2H), 5.42 (m, 1H), 3.99 (t, 2H), 3.96 (m, 2H), 3.40 (m, 2H), 2.95 (t, 2H). 191 8.84 (d, 1H), 8.61 (d, 1H), 8.42 (s, 1H), 7.94 (s, 1H), 7.66 (d, 1H), 7.38 (d, 1H), 6.96 (t, 2H), 6.83 (m, 2H), 5.42 (m, 1H), 4.00-3.94 (m, 4H), 3.41 (m, 2H), 2.95 (t, 2H). 192 8.86 (d, 1H), 8.46 (d, 1H), 8.43 (s, 1H), 7.59 (m, 1H), 7.40 (s, 1H), 7.38 (d, 1H), 7.22 (m, 2H), 6.82 (m, 2H), 5.39 (m, 1H), 4.40 (m, 1H), 3.95 (m, 1H), 3.91 (m, 1H), 3.36 (m, 1H), 3.32 (m, 1H), 2.80 (dd, 1H), 2.75 (dd, 1H), 1.28 (d, 3H). 189 201204254 193 8.87 (d, 1H), 8.47 (d, 1H), 8.43 (s, 1H), 7.60 (m, 1H), 7.40 (s, 1H), 7.38 (d, 1H), 7.23 (m, 2H), 6.82 (d, 2H), 5.42 (m, 1H), 3.99 (t, 2H), 3.97 (m, 2H), 3.40 (m, 2H), 2.95 (t, 2H). 194 8.87 (d, 1H), 8.47 (d, 1H), 8.44 (s, 1H), 7.61 (m, 1H), 7.40 (m, 1H), 7.38 (d, 1H), 6.96 (t, 2H), 6.83 (m, 2H), 5.42 (m, 1H), 4.00- 3.95 (m, 4H), 3.40 (m, 2H), 2.95 (t, 2H). 195 8.91 (s, 1H), 8.88 (d, 1H), 8.77 (s, 1H), 8.70 (d, 1H), 7.79 (d, 1H), 7.37 (d, 1H), 7.21 (m, 2H), 6.82 (m, 2H), 5.40 (m, 1H), 4.39 (m, 1H), 3.93 (m, 1H), 3.89 (m, 1H), 3.30 (m, 1H), 3.26 (m, 1H), 2.78 (dd, 1H), 2.73 (dd, 1H), 1.27 (d, 3H). 196 8.85 (d, 1H), 8.58 (s, 1H), 8.48 (d, 1H), 7.60 (d, 1H), 7.37 (d, 1H), 7.21 (m, 2H), 6.81 (m, 2H), 5.39 (m, 1H), 4.38 (m, 1H), 3.92 (m, 1H), 3.87 (m, 1H), 3.31 (m, 1H), 3.27 (m, 1H), 2.78 (dd, 1H), 2.72 (dd, 1H), 1.27 (d, 3H). 197 8.86 (d, 1H), 8.58 (s, 1H), 8.48 (d, 1H), 7.60 (d, 1H), 7.38 (d, 1H), 7.22 (m, 2H), 6.81 (d, 2H), 5.42 (m, 1H), 3.97 (t, 2H), 3.93 (m, 2H), 3.34 (m, 2H), 2.92 (t, 2H). 198 8.86 (d, 1H), 8.58 (s, 1H), 8.48 (d, 1H), 7.61 (d, 1H), 7.38 (d, 1H), 6.96 (t, 2H), 6.82 (m, 2H), 5.43 (m, 1H), 3.96 (t, 2H), 3.93 (m, 2H), 3.35 (m, 2H), 2.92 (t, 2H). 199 8.90 (s, 1H), 8.89 (d, 1H), 8.78 (s, 1H), 8.70 (d, 1H), 7.79 (d, 1H), 7.38 (d, 1H), 6.96 (t, 2H), 6.83 (m, 2H), 5.43 (m, 1H), 3.98-3.94 (m, 4H), 3.33 (m, 2H), 2.92 (t, 2H). 200 8.90 (s,1H),8.89 (d,1H),8.78 (s,1H),8.70 (d, 1H),7.79 (d, 1H), 7.38 (d, 1H), 7.22 (m, 2H), 6.82 (d, 2H), 5.43 (m, 1H), 4.00- 3.93 (m, 4H), 3.33 (m, 2H), 2.93 (t, 2H). 201 8.98 (d, 1H), 8.85 (d, 1H), 8.53 (s, 1H), 8.14 (s, 1H), 7.91 (d, 1H), 7.39 (d, 1H), 7.22 (m, 2H), 6.82 (m, 2H), 5.40 (m, 1H), 4.40 (m, 1H), 3.94 (m, 1H), 3.90 (m, 1H), 3.37 (m, 1H), 3.33 (m, 1H), 2.80 (dd, 1H), 2.75 (dd, 1H), 1.28 (d, 3H). 202 9.12 (d, 1H), 8.86 (d, 1H), 8.43 (d, 1H), 7.96 (t, 1H), 7.36 (d, 1H), 7.22 (m, 2H), 6.84 (m, 2H), 5.40 (m, 1H), 4.41 (m, 1H), 3.98 (m, 1H), 3.94 (m, 1H), 3.33 (m, 1H), 3.29 (m, 1H), 2.82 (dd, 1H), 2.76 (dd, 1H), 1.29 (d, 3H). 203 10.29 (s, 1H), 8.95 (d, 1H), 8.86 (d, 1H), 8.14 (d, 1H), 7.36 (d, 1H), 7.22 (m, 2H), 6.84 (m, 2H), 5.40 (m, 1H), 4.42 (m, 1H), 4.03-3.94 (m, 2H), 3.41-3.33 (m, 2H), 2.86-2.74 (m, 2H), 1.30 (d, 3H). 204 9.13 (br d, 1H), 8.87 (d, 1H), 8.44 (d, 1H), 7.96 (t, 1H), 7.38 (d, 1H), 7.23 (m, 2H), 6.84 (d, 2H), 5.43 (m, 1H), 4.04-3.98 (m, 4H), 3.36 (m, 2H), 2.97 (t, 2H). 201204254 . 205 9.70 (s, 1H),8.62 (d,1H), 8.35 (br s, 1H),7.79 (s,1H),7.64 (dd, 1H), 7.22 (m, 2H), 6.95 (s, 1Ή), 6.82 (m, 2H), 5.00 (m, 1H), 4.42 . (m, 1H), 3.94 (t, 1H), 3.90 (t, 1H), 3.44 (dd, 1H), 3.40 (dd, 1H), 2.83-2.77 (m, 2H), 1.27 (d, 3H). 206 10.42 (s, 1H), 9.38 (d, 1H), 9.08 (d, 1H), 8.92 (d, 1H), 8.21 (dd, 1H), 7.36 (d, 1H), 7.22 (m, 2H), 6.85 (m, 2H), 5.39 (m, 1H), 4.41 (m, 1H), 4.00 (m, 2H), 3.38 (dd, 1H), 3.34 (dd, 1H), 2.83 (dd, 1H), 2.77 (dd, 1H), 1.29 (d, 3H). 207 10.44 (s, 1H), 9.38 (d, 1H), 9.08 (d, 1H), 8.93 (d, 1H), 8.21 (dd, 1H), 7.37 (d, 1H), 7.23 (m, 2H), 6.84 (d, 2H), 5.43 (m, 1H), 4.04 (m, 2H), 4.01 (t, 2H), 3.41 (m, 2H), 2.98 (t, 2H). 208 8.65 (s, 1H), 8.61 (d, 1H), 8.45 (br s, 1H), 7.95 (d,lH), 7.77 (s, 1H), 7.63 (d, 1H), 7.33 (m, 1H), 6.74 (s, 1H), 6.72 (dd, 1H), 4.87 (m, 1H), 4.32 (t, 2H), 3.89 (m, 2H), 3.36 (m, 2H), 2.95 (t, 2H). 209 8.85 (d, 1H), 8.62 (d, 1H), 8.45 (br s, 1H), 7.95 (d, 1H), 7.79 (s, 1H), 7.63 (d, 1H), 7.38 (m, 1H), 7.33 (m, 1H), 6.73 (dd, 1H), 5.42 (m, 1H), 4.32 (t, 2H), 3.94 (m, 2H), 3.39 (m, 2H), 2.94 (t, 2H). 210 8.59 (d, 1H), 8.52 (br s, 1H), 8.42 (d, 1H), 7.77 (s, 1H), 7.62 (dd, 1H), 7.21 (m, 2H), 6.80 (m, 2H), 6.66 (d, 1H), 4.82 (m, 1H), 4.39 (m, 1H), 3.85 (m, 2H), 3.37 (dd, 1H), 3.32 (dd, 1H), 2.82- 2.74 (m, 2H), 1.26 (d, 3H). 211 8.59 (d, 1H), 8.51 (br s, 1H), 8.41 (d, 1H), 7.77 (s, 1H), 7.61 (dd, 1H), 7.21 (m, 2H), 6.80 (m, 3H), 6.66 (d, 1H), 4.82 (m, 1H), 4.39 (m, 1H), 3.85 (m, 2H), 3.36 (dd, 1H), 3.31 (dd, 1H), 2.82- 2.74 (m, 2H), 1.26 (d, 3H). 212 8.65 (d, 1H), 8.64 (s, 1H), 8.50 (br s, 1H), 7.76 (s, 1H), 7.61 (dd, 1H), 7.21 (m, 2H), 6.81 (m, 2H), 5.50 (m, 1H), 4.41 (m, 1H), 3.94 (m, 1H), 3.88 (m, 1H), 3.44 (m, 2H), 2.84-2.74 (m, 2H), 1.27 (d, 3H). 213 9.39 (br s, 1H), 8.59 (d, 1H), 8.48 (s, 1H), 7.87 (s, 1H), 7.72 (d, 1H), 7.49 (d, 1H), 7.40 (dd, 1H), 7.27 (d, 2H), 7.22 (d, 2H), 6.40 (d, 1H), 6.00 (dt, 1H), 3.81 (m, 1H), 3.58 (m, 2H), 3.21-3.12 (m, 4H). 214 8.58 (s, 1H), 7.91 (s, 1H), 7.85 (d, 1H), 7.76 (d, 1H), 7.27 (s, 4H), 7.06 (d, 1H), 6.48 (d, 1H), 6.09 (dt, 1H), 5.85 (br s, 1H), 4.65 (m, 1H), 3.70 (m, 2H), 3.29(d, 2H), 3.22 (m, 2H). 215 8.28 (d, 1H), 7.55 (d, 1H), 7.36 (s, 1H), 7.29 (m, 4H), 7.25 (d, 1H), 7.03 (d, 1H), 6.51 (d, 1H), 6.14 (dt, 1H), 5.21 (m, 1H), 3.83 (m, 2H), 3.39 (s, 3H), 3.30 (m, 2H), 3.2-2.8 (br m, 2H). 216 8.61 (d, 1H), 8.49 (br s, 1H), 8.15 (s, 1H), 7.80 (s, 1H), 7.66 (dd, 1H), 7.28 (s, 4H), 6.50 (d, 1H), 6.13 (dt, 1H), 5.38 (m, 1H), 3.82 (m, 2H), 3.38-3.31(m, 4H). 191 201204254 217 8.61 (d,1H),8.45 (br s,1H),8.06 (s,1H),7.79 (s,1H),7.65 (dd, 1H), 7.28 (s, 4H), 6.49 (d, 1H), 6.13 (dt, 1H), 5.37 (m, 1H), 3.81 (m, 2H), 3.36-3.30(m, 4H). 218 8.61 (d, 1H), 8.32 (br s, 1H), 7.76 (s, 1H), 7.63 (dd, 1H), 7.27 (s, 4H), 6.49 (d, 1H), 6.12 (dt, 1H), 5.34 (m, 1H), 3.81 (m, 2H), 3.31(m, 4H). 219 8.85 (d, 1H), 8.64 (d, 1H), 8.40 (br s, 1H), 7.79 (s, 1H), 7.63 (d, 1H), 7.39 (d, 1H), 7.12 (d, 2H), 6.54 (d, 2H), 5.40 (m, 1H), 3.91 (t, 2H), 3.27 (br s, 2H), 3.09 (br m, 2H), 2.81 (br m, 2H). 220 8.26 (d, 1H), 7.53 (d, 1H), 7.34 (s, 1H), 7.25 (d, 1H), 7.22 (m, 2H), 7.02 (d, 1H), 6.83 (m, 2H), 5.18 (m, 1H), 4.39 (m, 1H), 3.87 (m, 2H), 3.39 (s, 3H), 3.3-2.8 (m, 2H), 2.77 (dd, 1H), 2.72 (dd, 1H), 1.28 (d, 3H). 221 8.85 (d, 1H), 8.64 (d, 1H), 8.40 (br s, 1H), 7.78 (s, 1H), 7.62 (dd, 1H), 7.38 (d, 1H), 7.16 (d, 2H), 6.62 (d, 2H), 5.39 (m, 1H), 3.88 (m, 2H), 3.34 (t, 2H), 3.28 (m, 2H), 2.93 (s, 3H), 2.74 (t, 2H). 222 8.27 (d, 1H), 7.54 (d, 1H), 7.35 (s, 1H), 7.25 (d, 1H), 7.23 (m, 2H), 7.03 (d, 1H), 6.83 (m, 2H), 5.21 (m, 1H), 3.98 (t, 2H), 3.92 (t, 2H), 3.39 (s, 3H), 3.3-2.8 (br m, 2H), 2.92 (t, 2H). 223 8.60 (d, 1H), 8.48 (br s, 1H), 8.14 (s, 1H), 7.79 (s, 1H), 7.65 (d, 1H), 7.22 (m, 2H), 6.82 (m, 2H), 5.36 (m, 1H), 4.41 (m, 1H), 3.89 (t, 1H), 3.84 (t, 1H), 3.44-3.33 (br m, 2H), 2.83-2.73 (m, 21H), 1.26 (d, 3H). 224 8.60 (d, 1H), 8.40 (br s, 1H), 7.75 (s, 1H), 7.62 (dd, 1H), 7.21 (m, 2H), 6.80 (m, 2H), 5.30 (m, 1H), 4.39 (m, 1H), 3.85 (m, 2H), 3.36 (m, 1H), 3.31 (m, 1H), 2.79 (dd, 1H), 2.73 (m, 1H), 1.26 (d, 3H). 225 9.32 (br s, 1H), 8.81 (d, 1H), 8.59 (d, 1H), 7.83 (s, 1H), 7.69 (d, 1H), 7.35 (d, 1H), 7.26 (obscured, 2H), 7.19 (d, 2H), 6.43 (d, 1H), 6.12 (m, 1H), 5.42 (m, 1H), 3.16 (d, 2H), 2.71 (m, 2H), 2.47 (m, 1H), 1.92 (m, 2H), 1.74 (m, 1H), 1.26 (m, 2H). 226 8.84 (d, 1H), 8.63 (d, 1H), 8.51 (s, 1H), 7.76 (s, 1H), 7.62 (d, 1H), 7.35 (d, 1H), 7.30 (AB d, 4H), 6.52 (d, 1H), 6.30 (m, 1H), 5.35 (m, 1H), 3.25 (br s, 2H), 2.88 (br s, 2H), 2.51 (br s, 2H), 2.21 (br s, 2H), 1.98 (br s, 2H). 227 8.82 (d, 1H), 8.74 (br s, 1H), 8.59 (d, 1H), 7.80 (s, 1H), 7.65 (d, 1H), 7.36 (d, 1H), 7.28 (s, 4H), 6.52 (d, 1H), 6.27 (m, 1H), 5.64 (m, 1H), 3.32 (m, 2H), 3.10 (m, 2H), 2.80 (m, 1H), 2.52 (m, 1H), 2.42 (m, 1H), 2.08 (m, 1H). s 192 201204254 a H NMR數據係為偏離自四曱基矽烷的低場ppni。偶合標示為(s)_單 峰、⑷-雙峰、⑴-三峰、(m)_多峰、(dd)-雙雙峰、(dt)-雙三峰、(td)-三雙峰、(br s)·寬單峰、(br t)-寬三峰。Index Table G Compound Number hNMR data (unless otherwise stated, all refer to CDC13 solution) a 175 1 δ 8. 81 (d, 1H), 8. 61 (d, 1H), 8. 57 (br s, 1H), 7. 80 (d, 1H), 7. 65 (dd, 1H), 7. 37 (dd, 1H), 7. 28 (s, 4H), 6. 75 (d, 1H), 6. 50 (d, 1H), 6. 13 (dt, 1H), 4. 97 (m, 1H), 3. 85 (m, 1H), 3. 35-3. 29 (m, 4H).  2 δ 8. 58 (d, 1H), 8. 46 (br s, 1H), 8. 41 (d, 1H), 7. 79 (s, 1H), 7. 64 (dd, 1H), 7. 28 (s, 4H), 7. 04 (dd, 1H), 6. 66 (d, 1H), 6. 49 (d, 1H), 6. 12 (dt, 1H), 4. 88 (m, 1H), 3. 82 (m, 2H), 3. 35-3. 29 (m, 4H).  3 δ 8. 58 (d, 1H), 8. 40 (dd, 1H), 8. 36 (br s, 1H), 7. 79 (s, 1H), 7. 64 (dd, 1H), 7. 28 (s, 4H), 6. 77 (dt, 1H), 6. 50 (d, 1H), 6. 43 (dd, 1H), 6. 12 (dt, 1H), 4. 87 (m, 1H), 3. 83 (dd, 2H), 3. 35-3. 29 (m, 4H).  4 δ 8. 59 (d, 1H), 8. 44 (br s, 1H), 8. 40 (d, 1H), 7. 78 (d, 1H), 7. 63 (dd, 1H), 7. 28 (s, 4H), 7. 03 (dd, 1H), 6. 66 (d, 1H), 6. 48 (d, 1H), 5. 98 (dd, 1H), 4. 83 (m, 1H), 3. 80 (m, 1H), 3. 74 (m, 1H), 3. 27 (m, 2H), 3. 01 (pentet, 1H), 1. 16 (d, 3H).  5 δ 8. 66 (s, 1H), 8. 62 (d, 1H), 8. 60 (s, 1H), 7. 82 (d, 1H), 7. 66 (dd, 1H), 7. 35 (d, 1H), 7. 28 (s, 4H), 6. 89 (d, 1H), 6. 50 (d, 1H), 6. 13 (dt, 1H), 4. 96 (m, 1H), 3. 83 (m, 2H), 3. 34 (m, 4H).  δ 8. 64 (s, 1Η), 8. 60 (d, 1H), 8. 47 (br s, 1H), 7. 78 (s, 1H), 7. 63 (dd, 1H), 7. 27 (s, 4H), 6. 74 (s, 1H), 6. 48 (d, 1H), 5. 98 (dd, 1H), 4. 82 (m, 1H), 3. 78 (m, 1H), 3. 72 (m, 1H), 3. 28 (m, 2H), 3. 02 (pentet, 1H), 1. 16 (d, 3H).  δ 8. 64 (s, 1H), 8. 62-8. 58 (m, 2H), 7. 81 (s, 1H), 7. 64 (dd, 1H), 7. 34 (d, 1H), 7. 28 (s, 4H), 6. 88 (d, 1H), 6. 48 (d, 1H), 5. 98 (dd, 1H), 4. 90 (m, 1H), 3. 81 (m, 1H), 3. 75 (m, 1H), 3. 29 (m, 2H), 3. 02 (pentet, 1H), 1. 17 (d, 3H).  δ 8. 79 (s, 1H), 8. 61 (d, 1H), 8. 54 (br s, 1H), 7. 79 (s, 1H), 7. 65 (d, 1H), 7. 36 (dd, 1H), 7. 28 (s, 4H), 6. 75 (d, 1H), 6. 49 (d, 1H), 5. 99 (dd, 1H), 4. 92 (m, 1H), 3. 85 (m, 1H), 3. 78 (m, 1H), 3. 28 (m, 2H), 3. 03 (br s, 1H), 1. 18 (d, 3H).  δ 8. 59 (d, 1H), 8. 42-8. 31 (m, 2H), 7. 79 (s, 1H), 7. 64 (m, 1H), 7. 28 (s, 4H), 6. 76 (td, 1H), 6. 49 (d, 1H), 6. 43 (dd, 1H), 5. 99 (dd, 1H), 4. 83 (m, 1H), 3. 82 (m, 1H), 3. 76 (m, 1H), 3. 27 (m, 2H), 3. 02 (br s, 1H), 1. 17 (d, 3H).  δ 8. 67 (d, 1H), 8. 60 (d, 1H), 8. 32 (br s, 1H), 7. 78 (d, 1H), 7. 63 (dd, 1H), 7. 28 (s, 4H), 7. 00 (d, 1H), 6. 50 (d, 1H), 6. 14 (dt, 1H), 5. 36 (m, 1H), 3. 83 (m, 2H), 3. 36-3. 30 (m, 4H).  δ (acetone-d6) 9. 21 (br s, 1H), 8. 57-8. 53 (m, 2H), 7. 97 (s, 1H), 7. 94 (d, 1H), 7. 48 (d, 2H), 7. 27 (d, 2H), 7. 06 (d, 1H), 6. 74 (d, 1H), 6. 18 (dt, 1H), 5. 57 (m, 1H), 4. 43-4. 25 (m, 4H), 3. 85 (d, 2H).  δ 9. 16 (s, 1H), 8. 55 (d, 1H), 8. 45 (d, 1H), 7. 82 (s, 1H), 7. 66 (d, 1H), 7. 27 (d, 2H), 7. 21 (d, 2H), 7. 08 (dd, 1H), 6. 74 (d, 1H), 6. 40 (d, 1H), 5. 95 (dt, 1H), 3. 43 (d, 2H), 3. 38 (d, 2H), 3. 29 (d, 2H), 1. 72 (s, 3H).  δ 8. 87 (s, 1H), 8. 62 (d, 1H), 8. 30 (br s, 1H), 7. 77 (d, 1H), 7. 63 (d, 1H), 7. 28 (s, 4H), 6. 48 (d, 1H), 6. 00 (dd, 1H), 5. 29 (m, 1H), 3. 80 (m, 1H), 3. 74 (m, 1H), 3. 31 (m, 2H), 3. 01 (br s, 1H), 1. 17 (d, 3H).  δ 9. 0 (s, 1H), 8. 62 (d, 1H), 8. 41 (bs, 1H), 8. 2 (s, 1H), 7. 8 (s, 1H), 7. 65 (d, 1H), 7. 25 (s, 4H), 6. 5 (dd, 1H), 6. 18 (m, 1H), 5. 4 (m, 1H), 3. 9 (m, 2H), 3. 36 (m, 4H).  δ 8. 66 (d, 1H), 8. 61 (d, 1H), 8. 31 (br s, 1H), 7. 78 (d, 1H), 7. 63 (dd, 1H), 7. 28 (s, 4H), 7. 00 (d, 1H), 6. 48 (d, 1H), 6. 01 (dd, 1H), 5. 31 (m, 1H), 3. 78 (m, 2H), 3. 31 (m, 2H), 3. 01 (m, 1H), 1. 16 (d, 3H).  5 8. 66 (d, 1H), 8. 60 (d, 1H), 8. 40 (br s, 1H), 7. 81 (s, 1H), 7. 66 (dd, 1H), 7. 35 (s, 1H), 7. 25-7. 20 (m, 3H), 7. 01 (d, 1H), 6. 50 (d, 1H), 6. 18 (dt, 1H), 5. 39 (m, 1H), 3. 86 (m, 2H), 3. 43 (br s, 2H), 3. 37 (d, 2H).  s 176 201204254 .  24 δ 8. 68 (br s, 1H), 8. 63 (d, 1H), 8. 59 (d, 1H), 7. 88 (s, 1H), 7. 76 (d, 1H), 7. 52 (dd, 1H), 7. 36 (dd, 1H), 7. 25-7. 18 (m, 2H), .  7. 06-6. 98 (m, 2H), 6. 50 (d, 1H), 6. 18 (dt, 1H), 5. 39 (m, 1H), 3. 86 (m, 2H), 3. 43 (br s, 2H), 3. 37 (d, 2H).  25 δ 8. 67 (d, 1H), 8. 61 (d, 1H), 8. 32 (br s, 1H), 7. 79 (s, 1H), 7. 64 (dd, 1H), 7. 60 (s, 1H), 7. 53 (d, 1H), 7. 49 (d, 1H), 7. 43 (t, 1H), 7. 01 (d, 1H), 6. 58 (d, 1H), 6. 25 (dt, 1H), 5. 38 (m, 1H), 3. 86 (m, 2H), 3. 40-3. 34 (m, 4H).  26 δ 8. 57 (d, 1H), 8. 53 (d, 1H), 8. 59-8. 47 (br s, 1H), 7. 77 (s, 1H), 7. 63 (dd, 1H), 7. 26 (m, 2H), 6. 96-6. 88 (m, 3H), 6. 47 (d, 1H), 6. 01 (dt, 1H), 5. 33 (m, 1H), 3. 78 (m, 2H), 3. 45-3. 37 (m, 2H), 3. 31 (br d, 2H).  27 5 8. 80 (s, 1H), 8. 61 (d, 1H), 8. 54 (s, 1H), 7. 79 (s, 1H), 7. 64 (d, 1H), 7. 55-7. 49 (m, 4H), 7. 38-7. 33 (m, 3H), 7. 12 (t, 2H), 6. 74 (d, 1H), 4. 97 (m, 1H), 3. 87 (t, 2H), 3. 77 (s, 2H), 3. 32 (m, 2H).  29 δ 8. 65 (s, 1H), 8. 60 (d, 1H), 8. 45 (s, 1H), 7. 78 (s, 1H), 7. 62 (m, 1H), 7. 56-7. 48 (m, 4H), 7. 34 (d, 2H), 7. 12 (t, 2H), 6. 74 (s, 1H), 4. 88 (m, 1H), 3. 83 (m, 2H), 3. 76 (s, 2H), 3. 31 (m, 2H).  30 5 8. 65 (s, 1H), 8. 60 (d, 1H), 8. 44 (br s, 1H), 7. 77 (s, 1H), 7. 62 (d, 1H), 7. 51 (dd, 4H), 7. 40 (d, 2H), 7. 35 (d, 2H), 6. 74 (s, 1H), 4. 88 (m, 1H), 3. 82 (m, 2H), 3. 76 (s, 2H), 3. 30 (m, 2H).  31 δ 8. 59 (d, 1H), 8. 43 (s, 1H), 8. 40 (d, 1H), 7. 78 (s, 1H), 7. 63 (d, 1H), 7. 55-7. 49 (m, 4H), 7. 34 (d, 2H), 7. 12 (t, 2H), 7. 03 (dd, 1H), 6. 66 (d, 1H), 4. 89 (m, 1H), 3. 84 (m, 2H), 3. 76 (s, 2H), 3. 30 (m, 2H).  32 δ 8. 59 (d, 1H), 8. 39 (dd, 1H), 8. 34 (s, 1H), 7. 78 (s, 1H), 7. 63 (d, 1H), 7. 55-7. 49 (m, 4H), 7. 34 (d, 2H), 7. 12 (t, 2H), 6. 76 (ddd, 1H), 6. 43 (dd, 1H), 4. 88 (m, 1H), 3. 85 (t, 2H), 3. 76 (s, 2H), 3. 30 (m, 2H).  33 δ 8. 59 (d, 1H), 8. 46 (s, 1H), 8. 40 (d, 1H), 7. 79 (s, 1H), 7. 63 (d, 1H), 7. 51 (dd, 4H), 7. 40 (d, 2H), 7. 35 (d, 2H), 7. 03 (dd, 1H), 6. 65 (d, 1H), 4. 89 (m, 1H), 3. 83 (m, 2H), 3. 76 (s, 2H), 3. 30 (m, 2H).  34 δ 8. 58 (d, 1H), 8. 39 (dd, 1H), 8. 34 (s, 1H), 7. 78 (s, 1H), 7. 63 (d, 1H), 7. 51 (dd, 4H), 7. 40 (d, 2H), 7. 35 (d, 2H), 6. 76 (ddd, 1H), 6. 43 (dd, 1H), 4. 88 (m, 1H), 3. 85 (t, 2H), 3. 76 (s, 2H), 3. 29 (m, 2H).  35 6 8. 84 (d, 1H), 8. 63 (d, 1H), 8. 50 (br s, 1H), 7. 80 (s, 1H), 7. 65 (m, 1H), 7. 55-7. 49 (m, 4H), 7. 39-7. 34 (m, 3H), 7. 12 (t, 2H), 5. 44 (m, 1H), 3. 89 (t, 2H), 3. 77 (s, 2H), 3. 34 (br s, 2H).  36 δ 8. 87 (s, 1H), 8. 62 (d, 1H), 8. 33 (br s, 1H), 7. 78 (s, 1H), 7. 64 (d, 1H), 7. 55-7. 49 (m, 4H), 7. 36 (d, 2H), 7. 12 (t, 2H), 5. 35 (m, 1H), 3. 85 (m, 2H), 3. 77 (s, 2H), 3. 35 (br s, 2H).  177 δ 8. 84 (s, 1Η), 8. 62 (d, 1H), 8. 31 (br s, 1H), 7. 78 (s, 1H), 7. 63 (d, 1H), 7. 55-7. 49 (m, 4H), 7. 36 (d, 2H), 7. 12 (t, 2H), 5. 36 (m, 1H), 3. 85 (m, 2H), 3. 76 (s, 2H), 3. 34 (br s, 2H).  δ 8. 80 (d, 1H), 8. 61 (d, 1H), 8. 58 (br s, 1H), 7. 79 (d, 1H), 7. 65 (dd, 1H), 7. 38 (dd, 1H), 6. 97 (t, 2H), 6. 82 (m, 2H), 6. 75 (d, 1H), 4. 97 (m, 1H), 3. 99 (t, 2H), 3. 95 (m, 2H), 3. 41 (m, 2H), 2. 96 (t, 2H).  δ 8. 58 (d, 1H), 8. 45 (br s, 1H), 8. 40 (d, 1H), 7. 78 (s, 1H), 7. 63 (dd, 1H), 7. 04 (dd, 1H), 6. 97 (t, 2H), 6. 82 (m, 2H), 6. 66 (d, 1H), 4. 89 (m, 1H), 3. 98 (t, 2H), 3. 92 (m, 2H), 3. 40 (m, 2H), 2. 95 (t, 2H).  δ 8. 65 (s, 1H), 8. 59 (d, 1H), 8. 46 (br s, 1H), 7. 77 (s, 1H), 7. 63 (dd, 1H), 6. 96 (t, 2H), 6. 82 (m, 2H), 6. 74 (s, 1H), 4. 88 (m, 1H), 3. 98 (t, 2H), 3. 91 (m, 2H), 3. 41 (m, 2H), 2. 96 (t, 2H).  δ 8. 64 (br s, 1H), 8. 62-8. 59 (m, 2H), 7. 81 (d, 1H), 7. 65 (dd, 1H), 7. 35 (d, 1H), 6. 96 (t, 2H), 6. 88 (d, 1H), 6. 82 (m, 2H), 4. 96 (m, 1H), 3. 99 (t, 2H), 3. 94 (m, 2H), 3. 43 (m, 2H), 2. 96 (t, 2H).  δ 8. 58 (d, 1H), 8. 39 (dd, 1H), 8. 36 (br s,1H), 7. 78 (s, 1H), 7. 63 (dd, 1H), 6. 96 (t, 2H), 1H), 6. 82 (m, 2H), 6. 77 (dt, 1H), 6. 43 (dd, 1H), 4. 88 (m, 1H), 3. 98 (t, 2H), 3. 93 (m, 2H), 3. 39 (m, 2H), 2. 96 (t, 2H).  δ 8. 59 (d, 1H), 8. 44 (br s, 1H), 8. 40 (d, 1H), 7. 78 (d, 1H), 7. 63 (dd, 1H), 7. 37 (d, 2H), 7. 04 (dd, 1H), 6. 77 (d, 2H), 6. 66 (d, 1H), 4. 89 (m, 1H), 3. 99 (t, 2H), 3. 92 (m, 2H), 3. 39 (m, 2H), 2. 96 (t, 2H).  δ 8. 58 (d, 1H), 8. 44 (br s, 1H), 8. 40 (d, 1H), 7. 78 (d, 1H), 7. 63 (dd, 1H), 7. 23 (d, 2H), 7. 04 (dd, 1H), 6. 81 (d, 2H), 6. 66 (d, 1H), 4. 88 (m, 1H), 3. 99 (t, 2H), 3. 92 (m, 2H), 3. 39 (m, 2H), 2. 96 (t, 2H).  δ 8. 64 (s, 1H), 8. 59 (d, 1H), 8. 47 (br s, 1H), 7. 77 (s, 1H), 7. 63 (dd, 1H), 7. 23 (d, 2H), 6. 81 (d, 2H), 6. 74 (s, 1H), 4. 87 (m, 1H), 3. 99 (t, 2H), 3. 90 (m, 2H), 3. 40 (m, 2H), 2. 96 (t, 2H).  δ 8. 63 (br s, 1H), 8. 62-8. 59 (m, 2H), 7. 80 (d, 1H), 7. 65 (dd, 1H), 7. 35 (d, 1H), 7. 23 (d, 2H), 6. 88 (d, 1H), 6. 81 (d, 2H), 4. 96 (m, 1H), 4. 00 (t, 2H), 3. 93 (m, 2H), 3. 42 (m, 2H), 2. 97 (t, 2H).  δ 8. 80 (d, 1H), 8. 60 (d, 1H), 8. 56 (br s, 1H), 7. 79 (s, 1H), 7. 64 (dd, 1H), 7. 38 (dd, 1H), 7. 23 (d, 2H), 6. 81 (d, 2H), 6. 74 (d, 1H), 4. 97 (m, 1H), 4. 00 (t, 2H), 3. 95 (m, 2H), 3. 41 (m, 2H), 2. 97 (t, 2H).  δ 8. 58 (d, 1H), 8. 39 (dd, 1H), 8. 35 (br s, 1H), 7. 78 (s, 1H), 7. 63 (dd, 1H), 7. 23 (d, 2H), 1H), 6. 81 (d, 2H), 6. 77 (dt, 1H), 6. 43 (dd, 1H), 4. 87 (m, 1H), 3. 99 (t, 2H), 3. 93 (m, 2H), 3. 39 (m, 2H), 2. 96 (t, 2H).  s 178 201204254 * 49 δ 8. 59 (d, 1Η), 8. 48 (br s, 1H), 8. 40 (d, 1H), 7. 78 (s, 1H), 7. 63 (dd, 1H), 7. 04 (dd, 1H), 6. 97 (t, 2H), 6. 82 (m, 2H), 6. 68 (d, 1H), .  4. 86 (m, 1H), 3. 89 (br m, 2H), 3. 81 (d, 2H), 3. 42 (dd, 1H), 3. 35 (dd, 1H), 2. 80 (m, 1H), 1. 09 (d, 3H).  50 5 8. 76 (d, 1H), 8. 61 (d, 1H), 8. 38 (br s, 1H), 7. 85 (d, 1H), 7. 78 (s, 1H), 7. 63 (dd, 1H), 6. 96 (t, 2H), 6. 83 (m, 2H), 5. 35 (m, 1H), 3. 98 (t, 2H), 3. 91 (m, 2H), 3. 40 (m, 2H), 2. 95 (t, 2H).  51 δ 8. 66 (d, 1H), 8. 60 (d, 1H), 8. 34 (br s, 1H), 7. 79 (s, 1H), 7. 63 (dd, 1H), 7. 01 (d, 1H), 6. 96 (t, 2H), 6. 83 (m, 2H), 5. 38 (m, 1H), 3. 98 (t, 2H), 3. 92 (m, 2H), 3. 43 (br m, 2H), 2. 95 (t, 2H).  52 δ 8. 66 (d, 1H), 8. 60 (d, 1H), 8. 35 (br s, 1H), 7. 79 (s, 1H), 7. 63 (dd, 1H), 7. 23 (d, 2H), 7. 01 (d, 1H), 6. 82 (d, 2H), 5. 38 (m, 1H), 3. 99 (t, 2H), 3. 92 (m, 2H), 3. 43 (dd, 2H), 2. 95 (t, 2H).  53 δ 8. 66 (d, 1H), 8. 61 (d, 1H), 8. 34 (br s, 1H), 7. 78 (s, 1H), 7. 63 (dd, 1H), 7. 01 (d, 1H), 6. 97 (t, 2H), 6. 82 (m, 2H), 5. 34 (m, 1H), 3. 89 (br m, 2H), 3. 81 (m, 2H), 3. 44 (dd, 1H), 3. 38 (dd, 1H), 2. 79 (m, 1H), 1. 09 (d, 3H).  54 δ 8. 59 (d, 1H), 8. 47 (br s, 1H), 8. 40 (d, 1H), 7. 79 (d, 1H), 7. 63 (dd, 1H), 7. 22 (td, 1H), 7. 04 (dd, 1H), 6. 67 (m, 2H), 6. 66 (d, 1H), 6. 60 (dt, 1H), 4. 89 (m, 1H), 4. 01 (t, 2H), 3. 92 (m, 2H), 3. 40 (m, 2H), 2. 96 (t, 2H).  55 δ 8. 58 (d, 1H), 8. 53 (br s, 1H), 8. 40 (d, 1H), 7. 80 (d, 1H), 7. 64 (dd, 1H), 7. 04 (dd, 1H), 6. 93-6. 82 (m, 2H), 6. 78 (m, 1H), 6. 66 (d, 1H), 4. 89 (m, 1H), 4. 05 (t, 2H), 3. 91 (m, 2H), 3. 44 (m, 2H), 2. 97 (t, 2H).  56 δ 8. 59 (d, 1H), 8. 45 (br s, 1H), 8. 40 (d, 1H), 7. 79 (s, 1H), 7. 64 (dd, 1H), 7. 09-7. 02 (m, 2H), 6. 71 (m, 1H), 6. 66 (d, 1H), 6. 58 (m, 1H), 4. 89 (m, 1H), 3. 96 (t, 2H), 3. 92 (m, 2H), 3. 39 (m, 2H), 2. 95 (t, 2H).  57 δ 8. 87 (s, 1H), 8. 62 (d, 1H), 8. 33 (br s, 1H), 7. 78 (s, 1H), 7. 63 (d, 1H), 6. 97 (t, 2H), 6. 83 (m, 2H), 5. 36 (m, 1H), 3. 98 (t, 2H), 3. 91 (br t, 2H), 3. 43 (br s, 2H), 2. 95 (t, 2H).  58 δ 8. 88 (s, 1H), 8. 62 (d, 1H), 8. 29 (br s, 1H), 7. 77 (d, 1H), 7. 62 (dd, 1H), 7. 23 (d, 2H), 6. 82 (d, 2H), 5. 35 (m, 1H), 3. 99 (t, 2H), 3. 91 (m, 2H), 3. 42 (dd, 2H), 2. 95 (t, 2H).  59 δ 8. 85 (d, 1H), 8. 63 (d, 1H), 8. 48 (br s, 1H), 7. 80 (s, 1H), 7. 64 (dd, 1H), 7. 38 (d, 1H), 6. 96 (t, 2H), 6. 83 (m, 2H), 5. 43 (m, 1H), 3. 98 (t, 2H), 3. 95 (m, 2H), 3. 42 (m, 2H), 2. 95 (t, 2H).  60 6 8. 85 (d, 1H), 8. 63 (d, 1H), 8. 49 (br s, 1H), 7. 79 (s, 1H), 7. 64 (dd, 1H), 7. 38 (d, 1H), 7. 23 (d, 2H), 6. 82 (d, 2H), 5. 43 (m, 1H), 3. 99 (t, 2H), 3. 95 (m, 2H), 3. 42 (m, 2H), 2. 95 (t, 2H).  179 δ 8. 65 (s, 1Η), 8. 59 (d, 1H), 8. 46 (br s, 1H), 7. 78 (d, 1H), 7. 63 (dd, 1H), 7. 22 (m, 1H), 6. 74 (s, 1H), 6. 69-6. 64 (m, 2H), 6. 60 (dt, 1H), 4. 88 (m, 1H), 4. 01 (t, 2H), 3. 90 (m, 2H), 3. 40 (m, 2H), 2. 96 (t, 2H).  δ 8. 65 (s, 1H), 8. 59 (d, 1H), 8. 52 (br s, 1H), 7. 79 (s, 1H), 7. 64 (dd, 1H), 6. 92-6. 82 (m, 2H), 6. 78 (m, 1H), 6. 75 (s, 1H), 4. 88 (m, 1H), 4. 05 (t, 2H), 3. 90 (m, 2H), 3. 45 (m, 2H), 2. 97 (t, 2H).  δ 8. 65 (s, 1H), 8. 60 (d, 1H), 8. 45 (br s, 1H), 7. 77 (s, 1H), 7. 63 (dd, 1H), 7. 06 (m, 1H), 6. 74 (s, 1H), 6. 70 (m, 1H), 6. 58 (m, 1H), 4. 88 (m, 1H), 3. 96 (t, 2H), 3. 90 (m, 2H), 3. 39 (m, 2H), 2. 95 (t, 2H).  δ 8. 59 (d, 1H), 8. 45 (br s, 1H), 8. 40 (d, 1H), 7. 79 (d, 1H), 7. 63 (dd, 1H), 7. 19 (t, 1H), 7. 04 (d, 1H), 6. 94 (m, 1H), 6. 89 (t, 1H), 6. 78 (dd, 1H), 6. 66 (d, 1H), 4. 89 (m, 1H), 4. 01 (t, 2H), 3. 92 (m, 2H), 3. 40 (m, 2H), 2. 96 (t, 2H).  δ 8. 59 (d, 1H), 8. 46 (br s, 1H), 8. 40 (d, 1H), 8. 07 (d, 1H), 7. 78 (d, 1H), 7. 63 (dd, 1H), 7. 52 (dd, 1H), 7. 04 (dd, 1H), 6. 71 (d, 1H), 6. 66 (d, 1H), 4. 88 (m, 1H), 4. 33 (t, 2H), 3. 90 (m, 2H), 3. 36 (m, 2H), 2. 95 (t, 2H).  δ 8. 85 (d, 1H), 8. 63 (d, 1H), 8. 52 (br s, 1H), 7. 80 (s, 1H), 7. 65 (dd, 1H), 7. 38 (d, 1H), 7. 21 (m, 1H), 6. 70 - 6. 63 (m, 2H), 6. 61 (dt, 1H), 5. 43 (m, 1H), 4. 01 (t, 2H), 3. 94 (m, 2H), 3. 42 (m, 2H), 2. 96 (t, 2H).  δ 8. 84 (d, 1H), 8. 63 (d, 1H), 8. 58 (br s, 1H), 7. 81 (s, 1H), 7. 66 (dd, 1H), 7. 38 (d, 1H), 6. 94-6. 82 (m, 2H), 6. 78 (m, 1H), 5. 44 (m, 1H), 4. 05 (t, 2H), 3. 94 (m, 2H), 3. 45 (m, 2H), 2. 97 (t, 2H).  δ 8. 85 (d, 1H), 8. 63 (d, 1H), 8. 49 (br s, 1H), 7. 80 (s, 1H), 7. 65 (dd, 1H), 7. 38 (d, 1H), 7. 05 (m, 1H), 6. 71 (m, 1H), 6. 55 (m, 1H), 5. 43 (m, 1H), 3. 98-3. 92 (m, 4H), 3. 41 (m, 2H), 2. 95 (t, 2H).  δ 8. 84 (d, 1H), 8. 63 (d, 1H), 8. 47 (br s, 1H), 8. 08 (d, 1H), 7. 79 (s, 1H), 7. 64 (dd, 1H), 7. 52 (dd, 1H), 7. 38 (d, 1H), 6. 72 (d, 1H), 5. 42 (m, 1H), 4. 33 (t, 2H), 3. 94 (m, 2H), 3. 38 (m, 2H), 2. 94 (t, 2H).  5 8. 65 (s, 1H), 8. 60 (d, 1H), 8. 46 (br s, 1H), 8. 07 (d, 1H), 7. 77 (s, 1H), 7. 63 (d, 1H), 7. 52 (dd, 1H), 6. 74 (s, 1H), 6. 70 (d, 1H), 4. 87 (m, 1H), 4. 33 (t, 2H), 3. 88 (br t, 2H), 3. 37 (m, 2H), 2. 95 (t, 2H).  5 8. 84 (d, 1H), 8. 63 (d, 1H), 8. 43 (br s, 1H), 7. 78 (s, 1H), 7. 62 (d, 1H), 7. 37 (d, 1H), 6. 95 (t, 2H), 6. 84 (m, 2H), 5. 40 (m, 1H), 4. 36 (m, 1H), 3. 94 (m, 2H), 3. 36 (m, 2H), 2. 78 (m, 2H), 1. 27 (d, 3H).  δ 8. 87 (s, 1H), 8. 61 (d, 1H), 8. 25 (br s, 1H), 7. 76 (s, 1H), 7. 61 (d, 1H), 6. 96 (t, 2H), 6. 84 (m, 2H), 5. 33 (m, 1H), 4. 35 (m, 1H), 3. 89 (m, 2H), 3. 36 (br m, 2H), 2. 77 (m, 2H), 1. 26 (d, 3H).  180 201204254 .  73 δ 8. 65 (d, 1Η), 8. 60 (d, 1H), 8. 36 (br s, 1H), 7. 78 (s, 1H), 7. 62 (dd, 1H), 7. 00 (d, 1H), 6. 96 (t, 2H), 6. 84 (m, 2H), 5. 36 (m, 1H), # 4. 35 (m, 1H), 3. 88 (m, 2H), 3. 38 (m, 2H), 2. 77 (ddd, 2H), 1. 26 * (d, 3H).  74 δ 8. 58 (d, 1H), 8. 51 (br s, 1H), 8. 41 (d, 1H), 7. 79 (d, 1H), 7. 64 (dd, 1H), 7. 13 (dd, 1H), 7. 04 (dd, 1H), 6. 92 (td, 1H), 6. 83 (dd, 1H), 6. 67 (d, 1H), 4. 88 (m, 1H), 4. 05 (t, 2H), 3. 96 (m, 2H), 3. 49 (m, 2H), 3. 00 (t, 2H).  75 δ 8. 58 (d, 1H), 8. 50 (br s, 1H), 8. 40 (d, 1H), 7. 79 (s, 1H), 7. 64 (dd, 1H), 7. 10 (dd, 1H), 7. 04 (m, 2H), 6. 83 (t, 1H), 6. 66 (d, 1H), 4. 88 (m, 1H), 4. 06 (t, 2H), 3. 92 (m, 2H), 3. 44 (m, 2H), 2. 98 (t, 2H).  76 δ 8. 58 (d, 1H), 8. 50 (br s, 1H), 8. 41 (d, 1H), 7. 78 (s, 1H), 7. 63 (dd, 1H), 7. 37 (d, 1H), 7. 18 (dd, 1H), 7. 04 (dd, 1H), 6. 81 (d, 1H), 6. 67 (d, 1H), 4. 88 (m, 1H), 4. 06 (t, 2H), 3. 96 (m, 2H), 3. 49 (m, 2H), 3. 01 (t, 2H).  77 δ 8. 64 (s, 1H), 8. 59 (d, 1H), 8. 53 (br s, 1H), 7. 78 (s, 1H), 7. 63 (dd, 1H), 7. 13 (dd, 1H), 6. 92 (td, 1H), 6. 83 (dd, 1H), 6. 75 (s, 1H), 4. 87 (m, 1H), 4. 04 (t, 2H), 3. 94 (m, 2H), 3. 50 (m, 2H), 3. 00 (t, 2H).  78 δ 8. 65 (s, 1H), 8. 59 (d, 1H), 8. 51 (br s, 1H), 7. 78 (s, 1H), 7. 63 (dd, 1H), 7. 10 (dd, 1H), 7. 04 (m, 1H), 6. 86 (t, 1H), 6. 75 (s, 1H), 4. 87 (m, 1H), 4. 06 (t, 2H), 3. 90 (m, 2H), 3. 45 (m, 2H), 2. 98 (t, 2H).  79 δ 8. 65 (s, 1H), 8. 59 (d, 1H), 8. 52 (br s, 1H), 7. 78 (d, 1H), 7. 63 (dd, 1H), 7. 37 (d, 1H), 7. 18 (dd, 1H), 6. 80 (d, 1H), 6. 75 (d, 1H), 4. 87 (m, 1H), 4. 06 (t, 2H), 3. 94 (m, 2H), 3. 49 (m, 2H), 3. 01 (t, 2H).  80 8. 88 (s, 1H), 8. 62 (d, 1H), 8. 28 (br s, 1H), 7. 77 (s, 1H), 7. 62 (d, 1H), 7. 37 (d, 2H), 6. 78 (d, 2H), 5. 35 (m, 1H), 3. 99 (t, 2H), 3. 92 (m, 2H), 3. 42 (br s, 2H), 2. 95 (t, 2H).  81 8. 88 (s, 1H), 8. 62 (d, 1H), 8. 27 (br s, 1H), 7. 76 (s, 1H), 7. 62 (dd, 1H), 7. 28 (s, 4H), 6. 50 (dt, 1H), 6. 14 (dt, 1H), 5. 34 (m, 1H), 3. 83 (m, 2H), 3. 36-3. 31 (m, 4H).  82 8. 85 (s, 1H), 8. 62 (dd, 1H), 8. 25 (br s, 1H), 7. 76 (m, 1H), 7. 62 (dd, 1H), 7. 28 (s, 4H), 6. 50 (d, 1H), 6. 14 (dt, 1H), 5. 34 (m, 1H), 3. 83 (m, 2H), 3. 36-3. 31 (m, 4H).  83 8. 88 (d, 1H), 8. 61 (d, 1H), 8. 35 (br s, 1H), 7. 94 (d, 1H), 7. 78 (s, 1H), 7. 63 (dd, 1H), 7. 28 (s, 4H), 6. 50 (d, 1H), 6. 14 (dt, 1H), 5. 34 (m, 1H), 3. 83 (m, 2H), 3. 36-3. 31 (m, 4H).  84 8. 63-8. 58 (m, 2H), 8. 40 (br s, 1H), 7. 79 (m, 1H), 7. 74 (d, 1H), 7. 64 (dd, 1H), 7. 28 (s, 4H), 6. 50 (dt, 1H), 6. 15 (dt, 1H), 5. 33 (m, 1H), 3. 84 (m, 2H), 3. 35-3. 29 (m, 4H).  181 8. 71 (d, 1H), 8. 62 (d, 1H), 8. 31 (br s, 1H), 7. 77 (s, 1H), 7. 62 (dd, 1H), 7. 28 (s, 4H), 6. 50 (d, 1H), 6. 14 (dt, 1H), 5. 33 (m, 1H), 3. 83 (m, 2H), 3. 33-3. 30 (m, 4H).  9. 00 (s, 1H), 8. 62 (d, 1H), 8. 23 (br s, 1H), 7. 76 (s, 1H), 7. 61 (dd, 1H), 7. 28 (s, 4H), 6. 50 (d, 1H), 6. 14 (dt, 1H), 5. 33 (m, 1H), 3. 83 (m, 2H), 3. 36-3. 30 (m, 4H).  8. 67 (d, 1H), 8. 62 (d, 1H), 8. 30 (br s, 1H), 7. 77 (s, 1H), 7. 62 (dd, 1H), 7. 28 (s, 4H), 6. 50 (d, 1H), 6. 14 (dt, 1H), 5. 34 (m, 1H), 3. 84 (m, 2H), 3. 36-3. 31 (m, 4H).  8. 96 (s, 1H), 8. 62 (d, 1H), 8. 23 (br s, 1H), 7. 76 (s, 1H), 7. 62 (dd, 1H), 7. 28 (s, 4H), 6. 50 (d, 1H), 6. 14 (dt, 1H), 5. 33 (m, 1H), 3. 83 (m, 2H), 3. 36-3. 31 (m, 4H).  9. 05 (s, 1H), 8. 60 (d, 1H), 8. 30 (br s, 1H), 7. 77 (s, 1H), 7. 63 (dd, 1H), 7. 28 (s, 4H), 6. 50 (d, 1H), 6. 14 (dt, 1H), 5. 42 (m, 1H), 3. 85 (m, 2H), 3. 37 (dd, 2H), 3. 34 (d, 2H).  8. 62 (d, 1H), 8. 39 (s, 1H), 7. 83 (s, 1H), 7. 70 (m, 2H), 7. 26 (s, 4H), 6. 47 (dt, 1H), 6. 11 (dt, 1H), 5. 36 (m, 1H), 3. 78 (m, 2H), 3. 29 (d, 2H), 3. 24 (m, 2H).  8. 90 (d, 1H), 8. 62 (d, 1H), 8. 20 (br s, 1H), 7. 77 (s, 1H), 7. 62 (d, 1H), 7. 28 (s, 4H), 6. 50 (d, 1H), 6. 14 (dt, 1H), 5. 29 (m, 1H), 3. 83 (m, 2H), 3. 38-3. 31 (m, 4H).  8. 65 (s, 1H), 8. 61 (d, 1H), 8. 49 (br s, 1H), 7. 79 (s, 1H), 7. 64 (dd, 1H), 7. 58 (dd, 1H), 7. 16 (dd, 2H), 6. 75 (s, 1H), 6. 70 (m, 1H), 6. 58 (d, 1H), 4. 87 (m, 1H), 3. 82 (t, 2H), 3. 39 (m, 2H), 3. 36 (m, 2H).  8. 85 (d, 1H), 8. 64 (d, 1H), 8. 50 (br s, 1H), 8. 48 (d, 1H), 7. 80 (s, 1H), 7. 65 (dd, 1H), 7. 59 (dd, 1H), 7. 39 (d, 1H), 7. 24 (d, 1H), 6. 64 (m, 2H), 5. 43 (m, 1H), 3. 89 (t, 2H), 3. 39 (m, 2H), 3. 37 (m, 2H).  8. 85 (d, 1H), 8. 64 (d, 1H), 8. 46 (br s, 1H), 7. 80 (s, 1H), 7. 64 (dd, 1H), 7. 58 (dd, 1H), 7. 38 (d, 1H), 7. 17 (m, 2H), 6. 73 (m, 1H), 6. 60 (d, 2H), 5. 42 (m, 1H), 3. 91 (t, 2H), 3. 39 (m, 2H), 3. 37 (m, 2H).  8. 84 (d, 1H), 8. 59 (d, 1H), 8. 56 (s, 1H), 7. 97 (s, 1H), 7. 69 (d, 1H), 7. 38 (d, 1H), 7. 29 (m, 4H), 6. 52 (d, 1H), 6. 15 (dt, 1H), 5. 45 (m, 1H), 3. 88 (m, 2H), 3. 45 (m, 2H), 3. 37 (m, 2H).  8. 87 (d, 1H), 8. 47 (d, 1H), 8. 45 (s, 1H), 7. 61 (m, 1H), 7. 40 (m, 1H), 7. 38 (d, 1H), 7. 28 (m, 4H), 6. 50 (d, 1H), 6. 15 (dt, 1H), 5. 42 (m, 1H), 3. 87 (m, 2H), 3. 35-3. 31 (m, 4H).  8. 93 (s, 1H), 8. 89 (d, 1H), 8. 78 (s, 1H), 8. 71 (d, 1H), 7. 79 (d, 1H), 7. 37 (d, 1H), 7. 28 (m, 4H), 6. 49 (d, 1H), 6. 14 (dt, 1H), 5. 43 (m, 1H), 3. 86 (m, 2H), 3. 31 (m, 2H), 3. 27 (m, 2H).  s 182 201204254 100 8. 86 (d, 1H), 8. 61 (s, 1H), 8. 48 (d, 1H), 7. 61 (d, 1H), 7. 38 (d, 1H), 7. 27 (s, 4H), 6. 48 (d, 1H), 6. 13 (dt, 1H), 5. 43 (m, 1H), 3. 84 (m, 2H), 3. 30 (m, 2H), 3. 28 (m, 2H).  101 8. 99 (d, 1H), 8. 86 (d, 1H), 8. 58 (s, 1H), 8. 15 (s, 1H), 7. 93 (d, 1H), 7. 39 (d, 1H), 7. 28 (s, 4H), 6. 50 (d, 1H), 6. 14 (dt, 1H), 5. 44 (m, 1H), 3. 85 (m, 2H), 3. 45 (m, 2H), 3. 36-3. 31 (m, 4H).  102 9. 14 (d, 1H), 8. 88 (d, 1H), 8. 44 (d, 1H), 7. 96 (t, 1H), 7. 37 (d, 1H), 7. 29 (AB d, 4H), 6. 52 (d, 1H), 6. 17 (dt, 1H), 5. 43 (m, 1H), 3. 92 (m, 2H), 3. 34 (d, 2H), 3. 30 (m, 2H).  103 (major diastereomer only) 8. 85 (d, 1H), 8. 64 (s, 1H), 8. 61 (d, 1H), 7. 82 (s, 1H), 7. 67 (d, 1H), 7. 37 (d, 1H), 7. 28 (s, 4H), 6. 51 (d, 1H), 6. 17 (dt, 1H), 5. 54 (t, 1H), 3. 70 (t, 1H), 3. 62 (d, 1H), 3. 46-3. 38 (m, 2H), 3. 23 (dd, 1H), 1. 24 (d, 3H).  104 9. 70 (s, 1H), 8. 62 (d, 1H), 8. 42 (br s, 1H), 7. 81 (s, 1H), 7. 67 (d, 1H), 7. 28 (s, 4H), 6. 96 (s, 1H), 6. 51 (d, 1H), 6. 12 (dt, 1H), 5. 04 (m, 1H), 3. 87 (m, 2H), 3. 41 (m, 2H), 3. 36(d, 2H).  105 10. 45 (s, 1H), 9. 38 (d, 1H), 9. 08 (d, 1H), B. 93 (d, 1H), 8. 21 (dd, 1H), 7. 37 (d, 1H), 7. 29 (m, 4H), 6. 52 (d, 1H), 6. 18 (dt, 1H), 5. 42 (m, 1H), 3. 95 (m, 2H), 3. 37-3. 32 (m, 4H).  106 8. 61 (br s, 1H), 8. 59 (d, 1H), 8. 42 (d, 1H), 7. 81 (s, 1H), 7. 66 (d, 1H), 7. 27 (s, 4H), 6. 69 (d, 1H), 6. 50 (d, 1H), 6. 11 (dt, 1H), 4. 86 (m, 1H), 3. 78 (t, 2H), 3. 34 (br d, 4H).  107 8. 62-8. 56 (m, 2H), 8. 42 (d, 1H), 7. 80 (s, 1H), 7. 65 (d, 1H), 7. 27 (s, 4H), 6. 83 (d, 1H), 6. 49 (d, 1H), 6. 11 (dt, 1H), 4. 86 (m, 1H), 3. 77 (t, 2H), 3. 36-3. 29 (br d, 4H).  108 8. 73 (d, 1H), 8. 29 (br s, 1H), 8. 08 (s, 1H), 7. 35 (d, 1H), 7. 29 (m, 4H), 6. 52 (d, 1H), 6. 16 (dt, 1H), 5. 42 (m, 1H), 3. 87 (m, 2H), 3. 37-3. 27 (m, 4H).  109 8. 66 (d, 1H), 8. 62 (d, 1H), 8. 34 (br s, 1H), 7. 77 (s, 1H), 7. 62 (dd, 1H), 7. 28 (s, 4H), 6. 48 (d, 1H), 6. 00 (dd, 1H), 5. 28 (m, 1H), 3. 80 (t, 1H), 3. 74 (t, 1H), 3. 29 (m, 2H), 3. 00 (m, 1H), 1. 16 (d, 3H).  110 8. 70 (d, 1H), 8. 62 (d, 1H), 8. 34 (br s, 1H), 7. 77 (s, 1H), 7. 62 (dd, 1H), 7. 28 (s, 4H), 6. 48 (d, 1H), 6. 00 (dd, 1H), 5. 27 (m, 1H), 3. 80 (t, 1H), 3. 74 (t, 1H), 3. 30 (m, 2H), 3. 00 (m, 1H), 1. 16 (d, 3. H).  111 8. 65 (d, 1H), 8. 65 (s, 1H), 8. 52 (br s, 1H), 7. 78 (s, 1H), 7. 63 (dd, 1H), 7. 28 (s, 4H), 6. 50 (d, 1H), 6. 13 (dt, 1H), 5. 54 (m, 1H), 3. 86 (dd, 2H), 3. 44 (m, 2H), 3. 34 (d, 2H).  112 8. 88 (d, 1H), 8. 61 (d, 1H), 8. 35 (br s, 1H), 7. 94 (d, 1H), 7. 78 (s, 1H), 7. 63 (dd, 1H), 6. 96 (t, 2H), 6. 83 (m, 2H), 5. 34 (m, 1H), 3. 98 (t, 2H), 3. 92 (m, 2H), 3. 40 (dd, 2H), 2. 95 (t, 2H).  1 13 8. 88 (d, 1H), 8. 61 (d, 1H), 8. 32 (br s, 1H), 7. 94 (d, 1H), 7. 77 (s, 1H), 7. 62 (dd, 1H), 7. 22 (d, 2H), 6. 82 (d, 2H), 5. 34 (m, 1H), 3. 99 (t, 2H), 3. 91 (m, 2H), 3. 39 (m, 2H), 2. 95 (t, 2H).  183 201204254 114 8. 88 (d, 1H), 8. 61 (d, 1H), 8. 32 (br s, 1H), 7. 94 (d, 1H), 7. 77 (s, 1H), 7. 62 (dd, 1H), 7. 36 (d, 2H), 6. 77 (d, 2H), 5. 34 (m, 1H), 3. 99 (t, 2H), 3. 91 (m, 2H), 3. 39 (m, 2H), 2. 95 (t, 2H).  115 8. 88 (d, 1H), 8. 61 (d, 1H), 8. 37 (br s, 1H), 7. 95 (d, 1H), 7. 78 (s, 1H), 7. 63 (dd, 1H), 6. 90 (td, 1H), 6. 85 (m, 1H), 6. 77 (m, 1H), 5. 34 (m, 1H), 4. 05 (t, 2H), 3. 92 (m, 2H), 3. 43 (dd, 2H), 2. 97 (t, 2H).  116 8. 66 (d, 1H), 8. 61 (d, 1H), 8. 39 (br s, 1H), 7. 79 (s, 1H), 7. 64 (dd, 1H), 7. 01 (d, 1H), 6. 90 (td, 1H), 6. 85 (m, 1H), 6. 78 (m, 1H), 5. 38 (m, 1H), 4. 05 (t, 2H), 3. 92 (m, 2H), 3. 45 (dd, 2H), 2. 97 (t, 2H).  117 8. 67 (d, 1H), 8. 60 (d, 1H), 8. 38 (br s, 1H), 7. 79 (s, 1H), 7. 64 (dd, 1H), 7. 13 (dd, 1H), 7. 01 (d, 1H), 6. 92 (m, 1H), 6. 84 (dd, 1H), 5. 38 (m, 1H), 4. 05 (t, 2H), 3. 97 (m, 2H), 3. 50 (dd, 2H), 3. 00 (t, 2H).  118 8. 67 (d, 1H), 8. 61 (d, 1H), 8. 37 (br s, 1H), 7. 79 (s, 1H), 7. 64 (dd, 1H), 7. 10 (dd, 1H), 7. 04 (m, 1H), 7. 01 (d, 1H), 6. 87 (t, 1H), 5. 38 (m, 1H), 4. 05 (t, 2H), 3. 92 (m, 2H), 3. 45 (dd, 2H), 2. 97 (t, 2H).  119 8. 67 (d, 1H), 8. 61 (d, 1H), 8. 35 (br s, 1H), 7. 78 (d, 1H), 7. 63 (dd, 1H), 7. 37 (d, 1H), 7. 18 (dd, 1H), 7. 01 (d, 1H), 6. 82 (d, 1H), 5. 38 (m, 1H), 4. 07 (t, 2H), 3. 97 (m, 2H), 3. 49 (dd, 2H), 3. 00 (t, 2H).  120 8. 67 (d, 1H), 8. 61 (d, 1H), 8. 25 (br s, 1H), 7. 77 (s, 1H), 7. 62 (dd, 1H), 7. 37 (d, 2H), 7. 01 (d, 1H), 6. 78 (d, 2H), 5. 37 (m, 1H), 3. 99 (t, 2H), 3. 93 (m, 2H), 3. 40 (m, 2H), 2. 95 (t, 2H).  121 8. 85 (d, 1H), 8. 63 (d, 1H), 8. 48 (br s, 1H), 7. 79 (d, 1H), 7. 64 (dd, 1H), 7. 38 (d, 1H), 7. 36 (d, 1H), 7. 17 (dd, 1H), 6. 82 (d, 1H), 5. 42 (m, 1H), 4. 07 (t, 2H), 4. 01 (m, 2H), 3. 49 (dd, 2H), 3. 01 (t, 2H).  122 8. 85 (d, 1H), 8. 63 (d, 1H), 8. 48 (br s, 1H), 7. 80 (s, 1H), 7. 64 (dd, 1H), 7. 38 (d, 1H), 7. 10 (dd, 1H), 7. 04 (m, 1H), 6. 88 (t, 1H), 5. 42 (m, 1H), 4. 07 (t, 2H), 3. 97 (m, 2H), 3. 44 (dd, 2H), 2. 98 (t, 2H).  123 8. 85 (d, 1H), 8. 63 (d, 1H), 8. 48 (br s, 1H), 7. 79 (s, 1H), 7. 64 (dd, 1H), 7. 38 (d, 1H), 7. 13 (dd, 1H), 6. 92 (m, 1H), 6. 84 (dd, 1H), 5. 42 (m, 1H), 4. 06 (t, 2H), 4. 01 (m, 2H), 3. 49 (dd, 2H), 3. 00 (t, 2H).  124 8. 76 (d, 1H), 8. 62 (d, 1H), 8. 38 (br s, 1H), 7. 85 (d, 1H), 7. 78 (s, 1H), 7. 63 (dd, 1H), 6. 90 (td, 1H), 6. 85 (m, 1H), 6. 78 (m, 1H), 5. 35 (m, 1H), 4. 05 (t, 2H), 3. 93 (m, 2H), 3. 43 (dd, 2H), 2. 97 (t, 2H).  125 8. 77 (d, 1H), 8. 62 (d, 1H), 8. 33 (br s, 1H), 7. 85 (d, 1H), 7. 77 (s, 1H), 7. 62 (dd, 1H), 7. 37 (d, 2H), 6. 78 (d, 2H), 5. 34 (m, 1H), 3. 99 (t, 2H), 3. 92 (m, 2H), 3. 39 (br m, 2H), 2. 95 (t, 2H).  s 184 201204254 .  126 8. 77 (d, 1H), 8. 62 (d, 1H), 8. 33 (br s, 1H), 7. 85 (d, 1H), 7. 77 (s, 1H), 7. 63 (dd, 1H), 7. 23 (d, 2H), 6. 82 (d, 2H), 5. 34 (m, 1H), .  3. 99 (t, 2H), 3. 92 (m, 2H), 3. 39 (br m, 2H), 2. 95 (t, 2H).  127 8. 88 (s, 1H), 8. 62 (d, 1H), 8. 35 (br s, 1H), 7. 78 (s, 1H), 7. 63 (d, 1H), 6. 90 (td, 1H), 6. 85 (m, 1H), 6. 78 (m, 1H), 5. 36 (m, 1H), 4. 05 (t, 2H), 3. 92 (m, 2H), 3. 46 (m, 2H), 2. 97 (t, 2H).  128 8. 63-8. 58 (m, 2H), 8. 41 (br s, 1H), 7. 79 (m, 1H), 7. 75 (d, 1H), 7. 63 (dd, 1H), 7. 23 (d, 2H), 6. 82 (d, 2H), 5. 34 (m, 1H), 3. 92 (t, 2H), 3. 92 (m, 2H), 3. 39 (m, 2H), 2. 96 (t, 2H).  129 8. 98 (d, 1H), 8. 63 (m, 1H), 8. 53 (br s, 1H), 8. 19 (m, 1H), 7. 80 (m, 1H), 7. 66 (m, 1H), 6. 92 (td, 1H), 6. 86 (m, 1H), 6. 78 (m, 1H), 5. 45 (m, 1H), 4. 06 (t, 2H), 3. 94 (m, 2H), 3. 47 (dd, 2H), 2. 98 (t, 2H).  130 8. 98 (d, 1H), 8. 63 (dd, 1H), 8. 45 (br s, 1H), 8. 19 (m, 1H), 7. 79 (dd, 1H), 7. 64 (dd, 1H), 7. 37 (d, 2H), 6. 78 (d, 2H), 5. 43 (m, 1H), 4. 00 (t, 2H), 3. 94 (m, 2H), 3. 43 (m, 2H), 2. 96 (t, 2H).  131 8. 98 (d, 1H), 8. 63 (dd, 1H), 8. 45 (br s, 1H), 8. 19 (m, 1H), 7. 79 (dd, 1H), 7. 64 (dd, 1H), 7. 23 (d, 2H), 6. 82 (d, 2H), 5. 43 (m, 1H), 4. 00 (t, 2H), 3. 94 (m, 2H), 3. 43 (m, 2H), 2. 96 (t, 2H).  132 8. 98 (d, 1H), 8. 63 (dd, 1H), 8. 47 (br s, 1H), 8. 19 (m, 1H), 7. 79 (dd, 1H), 7. 65 (dd, 1H), 6. 97 (t, 2H), 6. 83 (m, 2H), 5. 44 (m, 1H), 3. 99 (t, 2H), 3. 94 (m, 2H), 3. 44 (dd, 2H), 2. 96 (t, 2H).  133 8. 87 (d, 1H), 8. 61 (d, 1H), 8. 34 (br s, 1H), 7. 93 (d, 1H), 7. 77 (br s, 1H), 7. 62 (dd, 1H), 6. 96 (t, 2H), 6. 84 (m, 2H), 5. 31 (m, 1H), 4. 36 (m, 1H), 3. 88 (m, 2H), 3. 35 (m, 2H), 2. 77 (ddd, 2H), 1. 26 (d, 3H).  134 8. 76 (d, 1H), 8. 61 (dd, 1H), 8. 35 (br s, 1H), 7. 84 (d, 1H), 7. 77 (dd, 1H), 7. 62 (dd, 1H), 6. 96 (t, 2H), 6. 84 (m, 2H), 5. 31 (m, 1H), 4. 36 (m, 1H), 3. 88 (m, 2H), 3. 35 (m, 2H), 2. 77 (ddd, 2H), 1. 26 (d, 3H).  135 8. 63-8. 57 (m, 2H), 8. 40 (br s, 1H), 7. 78 (m, 1H), 7. 74 (d, 1H), 7. 62 (dd, 1H), 6. 96 (t, 2H), 6. 84 (m, 2H), 5. 31 (m, 1H), 4. 36 (m, 1H), 3. 89 (m, 2H), 3. 34 (m, 2H), 2. 78 (ddd, 2H), 1. 26 (d, 3H).  136 8. 97 (d, 1H), 8. 62 (d, 1H), 8. 45 (br s, 1H), 8. 18 (m, 1H), 7. 78 (dd, 1H), 7. 63 (dd, 1H), 6. 96 (t, 2H), 6. 84 (m, 2H), 5. 41 (m, 1H), 4. 37 (m, 1H), 3. 91 (m, 2H), 3. 38 (m, 2H), 2. 78 (ddd, 2H), 1. 26 (d, 3H).  137 8. 84 (d, 1H), 8. 63 (d, 1H), 8. 51 (br s, 1H), 7. 80 (s, 1H), 7. 64 (m, 1H), 7. 38 (d, 1H), 6. 83 (s, 4H), 5. 43 (m, 1H), 3. 98 (t, 2H), 3. 94 (m, 2H), 3. 76 (s, 3H), 3. 42 (m, 2H), 2. 94 (t, 2H).  138 8. 85 (d, 1H), 8. 63 (d, 1H), 8. 44 (br s, 1H), 8. 20 (d, 2H), 7. 78 (s, 1H), 7. 64 (dd, 1H), 7. 39 (d, 1H), 6. 96 (d, 2H), 5. 43 (m, 1H), 4. 12 (t, 2H), 3. 99 (m, 2H), 3. 43 (m, 2H), 3. 01 (t, 2H).  185 8. 85 (d, 1H), 8. 63 (d, 1H), 8. 47 (br s,1H), 7. 79 (s, 1H), 7. 64 (m, 1H), 7. 38 (d, 1H), 7. 14 (d, 2H), 6. 88 (d, 2H), 5. 43 (m, 1H), 4. 01 (t, 2H), 3. 96 (m, 2H), 3. 42 (m, 2H), 2. 96 (t, 2H).  8. 85 (d, 1H), 8. 63 (d, 1H), 8. 45 (br s, 1H), 7. 79 (s, 1H), 7. 65 (m, 1H), 7. 59 (d, 2H), 7. 39 (d, 1H), 6. 95 (d, 2H), 5. 42 (m, 1H), 4. 07 (t, 2H), 3. 97 (m, 2H), 3. 42 (m, 2H), 2. 99 (t, 2H).  8. 84 (d, 1H), 8. 63 (d, 1H), 8. 52 (br s, 1H), 7. 81 (s, 1H), 7. 65 (m, 1H), 7. 38 (d, 1H), 7. 29 (d, 2H), 6. 84 (d, 2H), 5. 43 (m, 1H), 4. 01 (t, 2H), 3. 93 (m, 2H), 3. 43 (m, 2H), 2. 95 (t, 2H), 1. 29 (s, 9H).  8. 85 (d, 1H), 8. 63 (d, 1H), 8. 46 (br s, 1H), 7. 79 (s, 1H), 7. 64 (m, 1H), 7. 54 (d, 2H), 7. 39 (d, 1H), 6. 96 (d, 2H), 5. 43 (m, 1H), 4. 07 (t, 2H), 3. 97 (m, 2H), 3. 43 (br s, 2H), 2. 99 (t, 2H).  8. 76 (d, 1H), 8. 61 (d, 1H), 8. 30 (br s, 1H), 7. 84 (d, 1H), 7. 76 (s, 1H), 7. 61 (dd, 1H), 7. 22 (d, 2H), 6. 82 (d, 2H), 5. 30 (m, 1H), 4. 40 (m, 1H), 3. 89 (m, 2H), 3. 33 (ddd, 2H), 2. 77 (ddd, 2H), 1. 27 (d, 3H).  8. 62 (d, 1H), 8. 39 (s, 1H), 7. 83 (s, 1H), 7. 74 (br s, 1H), 7. 71 (dd, 1H), 6. 95 (t, 2H), 6. 81 (m, 2H), 5. 37 (m, 1H), 3. 95 (t, 2H), 3. 86 (m, 2H), 3. 32 (m, 2H), 2. 91 (t, 2H).  8. 62 (d, 1H), 8. 39 (s, 1H), 7. 83 (s, 1H), 7. 74 (br s, 1H), 7. 70 (dd, 1H), 7. 21 (d, 2H), 6. 80 (d, 2H), 5. 36 (m, 1H), 3. 96 (t, 2H), 3. 86 (m, 2H), 3. 31 (m, 2H), 2. 91 (t, 2H).  8. 62 (d, 1H), 8. 39 (s, 1H), 7. 83 (s, 1H), 7. 70 (dd, 1H), 7. 67 (br s, 1H), 7. 35 (d, 2H), 6. 75 (d, 2H), 5. 36 (m, 1H), 3. 95 (t, 2H), 3. 86 (m, 2H), 3. 30 (m, 2H), 2. 91 (t, 2H).  8. 70 (d, 1H), 8. 62 (d, 1H), 8. 30 (br s, 1H), 7. 76 (s, 1H), 7. 61 (dd, 1H), 7. 22 (d, 2H), 6. 82 (d, 2H), 5. 31 (m, 1H), 4. 40 (m, 1H), 3. 88 (m, 2H), 3. 34 (ddd, 2H), 2. 77 (ddd, 2H), 1. 27 (d, 3H).  8. 62 (d, 1H), 8. 38 (s, 1H), 7. 82 (s, 1H), 7. 69 (dd, 1H), 7. 75-7. 60 (br s, 1H), 7. 20 (d, 2H), 6. 80 (d, 2H), 5. 32 (m, 1H), 4. 37 (m, 1H), 3. 82 (m, 2H), 3. 26 (ddd, 2H), 2. 74 (ddd, 2H), 1. 24 (d, 3H).  8. 99 (s, 1H), 8. 62 (d, 1H), 8. 24 (br s, 1H), 7. 75 (s, 1H), 7. 60 (dd, 1H), 7. 22 (d, 2H), 6. 82 (d, 2H), 5. 31 (m, 1H), 4. 40 (m, 1H), 3. 88 (m, 2H), 3. 35 (ddd, 2H), 2. 77 (ddd, 2H), 1. 27 (d, 3H).  8. 99 (s, 1H), 8. 62 (d, 1H), 8. 27 (br s, 1H), 7. 77 (s, 1H), 7. 62 (dd, 1H), 6. 96 (t, 2H), 6. 83 (m, 2H), 5. 35 (m, 1H), 3. 98 (t, 2H), 3. 92 (m, 2H), 3. 43 (m, 2H), 2. 95 (t, 2H).  8. 99 (s, 1H), 8. 62 (d, 1H), 8. 28 (br s, 1H), 7. 77 (s, 1H), 7. 62 (dd, 1H), 7. 23 (d, 2H), 6. 82 (d, 2H), 5. 34 (m, 1H), 3. 99 (t, 2H), 3. 91 (m, 2H), 3. 43 (m, 2H), 2. 95 (t, 2H).  8. 99 (s, 1H), 8. 62 (d, 1H), 8. 27 (br s, 1H), 7. 77 (s, 1H), 7. 62 (dd, 1H), 7. 37 (d, 2H), 6. 77 (d, 2H), 5. 35 (m, 1H), 3. 99 (t, 2H), 3. 91 (m, 2H), 3. 42 (m, 2H), 2. 95 (t, 2H).  s 186 201204254 .  153 8. 71 (d, 1H), 8. 62 (d, 1H), 8. 33 (br s, 1H), 7. 78 (s, 1H), 7. 63 (d, 1H), 7. 23 (d, 2H), 6. 82 (d, 2H), 5. 35 (m, 1H), 4. 00 (t, 2H), 3. 92 ^ (m, 2H), 3. 42 (br m, 2H), 2. 95 (t, 2H).  154 8. 71 (d, 1H), 8. 62 (d, 1H), 8. 33 (br s, 1H), 7. 77 (s, 1H), 7. 62 (dd, 1H), 7. 37 (d, 2H), 6. 78 (d, 2H), 5. 34 (m, 1H), 3. 99 (t, 2H), 3. 92 (m, 2H), 3. 41 (m, 2H), 2. 95 (t, 2H).  155 8. 71 (d, 1H), 8. 62 (d, 1H), 8. 35 (br s, 1H), 7. 78 (s, 1H), 7. 63 (dd, 1H), 6. 97 (t, 2H), 6. 83 (m, 2H), 5. 35 (m, 1H), 3. 99 (t, 2H), 3. 92 (m, 2H), 3. 43 (m, 2H), 2. 95 (t, 2H).  156 8. 66 (d, 1H), 8. 62 (d, 1H), 8. 29 (br s, 1H), 7. 76 (d, 1H), 7. 61 (dd, 1H), 7. 37 (d, 2H), 6. 78 (d, 2H), 5. 34 (m, 1H), 3. 99 (t, 2H), 3. 92 (m, 2H), 3. 40 (m, 2H), 2. 95 (t, 2H).  157 8. 66 (d, 1H), 8. 62 (d, 1H), 8. 31 (br s, 1H), 7. 77 (s, 1H), 7. 62 (dd, 1H), 7. 23 (d, 2H), 6. 82 (d, 2H), 5. 35 (m, 1H), 3. 99 (t, 2H), 3. 93 (m, 2H), 3. 41 (m, 2H), 2. 95 (t, 2H).  158 8. 66 (d, 1H), 8. 62 (d, 1H), 8. 31 (br s, 1H), 7. 77 (s, 1H), 7. 62 (dd, 1H), 6. 97 (t, 2H), 6. 83 (m, 2H), 5. 35 (m, 1H), 3. 98 (t, 2H), 3. 93 (m, 2H), 3. 41 (m, 2H), 2. 95 (t, 2H).  159 8. 95 (s, 1H), 8. 61 (d, 1H), 8. 21 (br s, 1H), 7. 75 (s, 1H), 7. 60 (dd, 1H), 7. 22 (d, 2H), 6. 82 (d, 2H), 5. 31 (m, 1H), 4. 40 (m, 1H), 3. 89 (ddd, 2H), 3. 35 (ddd, 2H), 2. 77 (ddd, 2H), 1. 27 (d, 3H).  160 9. 03 (s, 1H), 8. 62 (d, 1H), 8. 27 (br s, 1H), 7. 76 (s, 1H), 7. 62 (dd, 1H), 7. 22 (d, 2H), 6. 82 (d, 2H), 5. 40 (m, 1H), 4. 41 (m, 1H), 3. 91 (m, 2H), 3. 38 (ddd, 2H), 2. 78 (m, 2H), 1. 27 (d, 3H).  161 8. 84 (s, 1H), 8. 62 (d, 1H), 8. 23 (br s, 1H), 7. 75 (s, 1H), 7. 60 (d, 1H), 7. 22 (d, 2H), 6. 82 (d, 2H), 5. 32 (m, 1H), 4. 40 (m, 1H), 3. 89 (m, 2H), 3. 35 (m, 2H), 2. 77 (m, 2H), 1. 27 (d, 3H).  162 8. 66 (d, 1H), 8. 62 (d, 1H), 8. 28 (br s, 1H), 7. 76 (s, 1H), 7. 61 (dd, 1H), 7. 22 (d, 2H), 6. 82 (d, 2H), 5. 31 (m, 1H), 4. 40 (m, 1H), 3. 89 (m, 2H), 3. 34 (ddd, 2H), 2. 78 (ddd, 2H), 1. 27 (d, 3H).  163 8. 84 (d, 1H), 8. 63 (d, 1H), 8. 40 (br s, 1H), 7. 77 (s, 1H), 7. 61 (dd, 1H), 7. 37 (d, 1H), 7. 21 (d, 2H), 6. 84 (d, 2H), 5. 37 (m, 1H), 4. 21 (m, 1H), 3. 94 (t, 1H), 3. 88 (t, 1H), 3. 33 (dd, 1H), 3. 28 (dd, 1H), 2. 78 (m, 2H), 1. 68 (m, 2H), 0. 95 (t, 3H).  164 8. 96 (s, 1H), 8. 62 (d, 1H), 8. 22 (br s, 1H), 7. 75 (s, 1H), 7. 61 (dd, 1H), 7. 37 (d, 2H), 6. 78 (d, 2H), 5. 34 (m, 1H), 3. 99 (t, 2H), 3. 92 (m, 2H), 3. 40 (m, 2H), 2. 95 (t, 2H).  165 8. 96 (s, 1H), 8. 62 (d, 1H), 8. 21 (br s, 1H), 7. 75 (s, 1H), 7. 61 (dd, 1H), 7. 23 (d, 2H), 6. 82 (d, 2H), 5. 34 (m, 1H), 3. 99 (t, 2H), 3. 92 (m, 2H), 3. 40 (dd, 2H), 2. 94 (t, 2H).  166 8. 96 (s, 1H), 8. 62 (d, 1H), 8. 22 (br s, 1H), 7. 75 (s, 1H), 7. 61 (dd, 1H), 6. 96 (t, 2H), 6. 83 (m, 2H), 5. 34 (m, 1H), 3. 98 (t, 2H), 3. 92 (m, 2H), 3. 41 (m, 2H), 2. 94 (t, 2H).  187 8. 85 (s, 1H), 8. 62 (dd, 1H), 8. 23 (br s, 1H), 7. 76 (m, 1H), 7. 61 (dd, 1H), 7. 37 (d, 2H), 6. 78 (d, 2H), 5. 35 (m, 1H), 3. 99 (t, 2H), 3. 92 (m, 2H), 3. 40 (m, 2H), 2. 95 (t, 2H).  8. 85 (s, 1H), 8. 62 (dd, 1H), 8. 24 (br s, 1H), 7. 76 (m, 1H), 7. 61 (dd, 1H), 7. 23 (d, 2H), 6. 82 (d, 2H), 5. 35 (m, 1H), 3. 99 (t, 2H), 3. 92 (m, 2H), 3. 41 (m, 2H), 2. 95 (t, 2H).  8. 85 (s, 1H), 8. 62 (d, 1H), 8. 25 (br s, 1H), 7. 76 (m, 1H), 7. 62 (dd, 1H), 6. 97 (t, 2H), 6. 83 (m, 2H), 5. 35 (m, 1H), 3. 98 (t, 2H), 3. 92 (m, 2H), 3. 41 (m, 2H), 2. 95 (t, 2H).  9. 04 (s, 1H), 8. 63 (d, 1H), 8. 28 (br s, 1H), 7. 77 (s, 1H), 7. 63 (dd, 1H), 7. 23 (d, 2H), 6. 82 (d, 2H), 5. 43 (m, 1H), 4. 00 (t, 2H), 3. 94 (m, 2H), 3. 44 (m, 2H), 2. 96 (t, 2H).  8. 62 (s, 1H), 8. 59 (d, 1H), 8. 46 (br s, 1H), 8. 06(d, 1H), 7. 76 (s, 1H), 7. 62 (dd, 1H), 7. 50 (dd, 1H), 6. 72 (s, 1H), 6. 65 (d, 1H), 5. 23 (m, 1H), 4. 83 (m, 1H), 3. 84 (m, 2H), 3. 36 (dd, 1H), 3. 29 (dd, 1H), 2. 84 (dd, 1H), 2. 74 (dd, 1H), 1. 29 (d, 3H).  8. 84 (d, 1H), 8. 63 (d, 1H), 8. 48 (br s, 1H), 8. 07 (d, 1H), 7. 79 (s, 1H), 7. 64 (d, 1H), 7. 50 (dd, 1H), 7. 37 (d, 1H), 6. 65 (d, 1H), 5. 39 (m, 1H), 5. 24 (m, 1H), 3. 91 (m, 2H), 3. 36 (dd, 1H), 3. 30 (dd, 1H), 2. 84 (dd, 1H), 2. 74 (dd, 1H), 1. 30 (d, 3H).  8. 65 (s, 1H), 8. 61 (d, 1H), 8. 40 (br s, 1H), 8. 05 (d, 1H), 7. 76 (s, 1H), 7. 62 (dd, 1H), 7. 37 (d, 1H), 7. 10 (dd, 1H), 6. 73 (s, 1H), 4. 88 (m, 1H), 4. 04 (m, 2H), 3. 92 (m, 2H), 3. 41 (m, 2H), 2. 98 (dd, 2H).  8. 84 (d, 1H), 8. 63 (d, 1H), 8. 48 (br s, 1H), 7. 79 (s, 1H), 7. 64 (dd, 1H), 7. 38 (d, 1H), 7. 36 (d, 1H), 6. 99 (d, 1H), 5. 43 (m, 1H), 4. 55 (dd, 2H), 3. 96 (m, 2H), 3. 39 (m, 2H), 3. 03 (dd, 2H).  8. 64 (s, 1H), 8. 60 (d, 1H), 8. 42 (br s, 1H), 8. 05 (d, 1H), 7. 76 (s, 1H), 7. 62 (dd, 1H), 7. 23 (d, 1H), 7. 18 (dd, 1H), 6. 73 (s, 1H), 4. 88 (m, 1H), 4. 05 (m, 2H), 3. 92 (m, 2H), 3. 40 (m, 2H), 2. 98 (dd, 2H).  8. 64 (s, 1H), 8. 60 (d, 1H), 8. 43 (br s, 1H), 7. 77 (s, 1H), 7. 63 (dd, 1H), 7. 37 (d, 1H), 6. 98 (d, 1H), 6. 73 (s, 1H), 4. 88 (m, 1H), 4. 55 (m, 2H), 3. 92 (m, 2H), 3. 38 (m, 2H), 3. 02 (dd, 2H).  8. 85 (d, 1H), 8. 63 (d, 1H), 8. 44 (br s, 1H), 8. 05 (d, 1H), 7. 78 (s, 1H), 7. 64 (dd, 1H), 7. 39 (d, 1H), 7. 21 (m, 2H), 5. 42 (m, 1H), 4. 05 (dd, 2H), 3. 96 (m, 2H), 3. 41 (m, 2H), 2. 98 (dd, 2H).  8. 85 (d, 1H), 8. 63 (d, 1H), 8. 45 (br s, 1H), 8. 05 (d, 1H), 7. 79 (s, 1H), 7. 64 (dd, 1H), 7. 38 (m, 2H), 7. 11 (dd, 1H), 5. 42 (m, 1H), 4. 05 (dd, 2H), 3. 98 (m, 2H), 3. 43 (m, 2H), 2. 98 (dd, 2H).  8. 84 (d, 1H), 8. 63 (dd, 1H), 8. 39 (br s, 1H), 7. 77 (dd, 1H), 7. 61 (dd, 1H), 7. 37 (d, 1H), 7. 22 (m, 2H), 6. 82 (m, 2H), 5. 38 (m, 1H), 4. 40 (m, 1H), 3. 96 (m, 1H), 3. 91 (m, 1H), 3. 36 (m, 1H), 3. 22 (m, 1H), 2. 80 (dd, 1H), 2. 75 (dd, 1H), 1. 28 (d, 3H).  s 188 201204254 .  180 8. 89 (d, 1H), 8. 61 (d, 1H), 8. 16 (br s, 1H), 7. 75 (s, 1H), 7. 60 (dd, 1H), 7. 22 (m, 2H), 6. 82 (m, 2H), 5. 26 (m, 1H), 4. 40 (m, 1H), _ 3. 90 (m, 1H), 3. 86 (m, 1H), 3. 37 (m, 1H), 3. 33 (m, 1H), 2. 79 (dd, 1H), 2. 74 (dd, 1H), 1. 27 (d, 3H).  181 8. 89 (d, 1H), 8. 61 (d, 1H), 8. 23 (br s, 1H), 7. 77 (s, 1H), 7. 62 (dd, 1H), 7. 23 (d, 2H), 6. 82 (d, 2H), 5. 30 (m, 1H), 3. 99 (t, 2H), 3. 90 (m, 2H), 3. 42 (m, 2H), 2. 94 (t, 2H).  182 8. 65 (s, 1H), 8. 61 (d, 1H), 8. 44 (br s, 1H), 8. 16 (s, 1H), 7. 77 (s, 1H), 7. 63 (m, 2H), 6. 74 (s, 1H), 6. 66 (d, 1H), 4. 87 (m, 1H), 4. 33 (m, 2H), 3. 89 (m, 2H), 3. 37 (m, 2H), 2. 95 (dd, 2H).  183 8. 84 (d, 1H), 8. 63 (d, 1H), 8. 47 (br s, 1H), 8. 17( s, 1H), 7. 80 (s, 1H), 7. 64 (m, 2H), 7. 38 (d, 1H), 6. 69 (d, 1H), 5. 42 (m, 1H), 4. 34 (t, 2H), 3. 94 (m, 2H), 3. 38 (m, 2H), 2. 94 (t, 2H) 184 8. 64 (s, 1H), 8. 61 (d, 1H), 8. 41 (br s, 1H), 8. 19 (d, 1H), 7. 76 (s, 1H), 7. 63 (dd, 1H), 6. 82 (d, 1H) 6. 74 (m, 2H), 4. 88 (m, 1H), 4. 07 (dd, 2H), 3. 92 (m, 2H), 3. 39 (m, 2H), 2. 98 (dd, 2H).  185 8. 85 (d, 1H), 8. 63 (d, 1H), 8. 43 (br s, 1H), 8. 19 (d, 1H), 7. 78 (s, 1H), 7. 64 (dd, 1H), 7. 39 (d, 1H), 6. 84 (dd, 1H), 6. 75 (dd, 1H), 5. 42 (m, 1H), 4. 07 (dd, 2H), 3. 97 (m, 2H), 3. 40 (m, 2H), 2. 98 (dd, 2H).  186 8. 59 (m, 3H), 8. 44 (s, 2H), 7. 78 (s, 1H), 7. 64 (dd, 1H), 6. 72 (s, 1H), 4. 86 (m, 1H), 4. 41 (t, 2H), 3. 87 (m, 2H), 3. 43 (m, 2H), 2. 97 (t, 2H).  187 8. 83 (d, 1H), 8. 63 (d, 1H), 8. 56 (br s, 1H), 8. 44 (s, 2H), 7. 80 (s, 1H), 7. 64 (dd, 1H), 7. 36 (d, 1H), 5. 42 (m, 1H), 4. 40 (t, 2H), 3. 93 (m, 2H), 3. 42 (m, 2H), 2. 97 (t, 2H).  188 8. 65 (d, 1H), 8. 52 (s, 1H), 8. 48 (br s, 1H), 7. 76 (s, 1H), 7. 61 (dd, 1H), 7. 21 (m, 2H), 6. 81 (m, 2H), 5. 51 (m, 1H), 4. 41 (m, 1H), 3. 95 (m, 1H), 3. 90 (m, 1H), 3. 46 (m, 1H), 3. 42 (m, 1H), 2. 81 (dd, 1H), 2. 77 (dd, 1H), 1. 27 (d, 3H).  189 8. 83 (d, 1H), 8. 61 (d, 1H), 8. 39 (s, 1H), 7. 93 (s, 1H), 7. 65 (dd, 1H), 7. 37 (d, 1H), 7. 22 (m, 2H), 6. 82 (m, 2H), 5. 38 (m, 1H), 4. 40 (m, 1H), 3. 95 (m, 1H), 3. 91 (m, 1H), 3. 37 (m, 1H), 3. 32 (m, 1H), 2. 80 (dd, 1H), 2. 75 (dd, 1H), 1. 28 (d, 3H).  190 8. 84 (d, 1H), 8. 61 (d, 1H), 8. 41 (s, 1H), 7. 94 (s, 1H), 7. 66 (dd, 1H), 7. 38 (d, 1H), 7. 23 (m, 2H), 6. 82 (d, 2H), 5. 42 (m, 1H), 3. 99 (t, 2H), 3. 96 (m, 2H), 3. 40 (m, 2H), 2. 95 (t, 2H).  191 8. 84 (d, 1H), 8. 61 (d, 1H), 8. 42 (s, 1H), 7. 94 (s, 1H), 7. 66 (d, 1H), 7. 38 (d, 1H), 6. 96 (t, 2H), 6. 83 (m, 2H), 5. 42 (m, 1H), 4. 00-3. 94 (m, 4H), 3. 41 (m, 2H), 2. 95 (t, 2H).  192 8. 86 (d, 1H), 8. 46 (d, 1H), 8. 43 (s, 1H), 7. 59 (m, 1H), 7. 40 (s, 1H), 7. 38 (d, 1H), 7. 22 (m, 2H), 6. 82 (m, 2H), 5. 39 (m, 1H), 4. 40 (m, 1H), 3. 95 (m, 1H), 3. 91 (m, 1H), 3. 36 (m, 1H), 3. 32 (m, 1H), 2. 80 (dd, 1H), 2. 75 (dd, 1H), 1. 28 (d, 3H).  189 201204254 193 8. 87 (d, 1H), 8. 47 (d, 1H), 8. 43 (s, 1H), 7. 60 (m, 1H), 7. 40 (s, 1H), 7. 38 (d, 1H), 7. 23 (m, 2H), 6. 82 (d, 2H), 5. 42 (m, 1H), 3. 99 (t, 2H), 3. 97 (m, 2H), 3. 40 (m, 2H), 2. 95 (t, 2H).  194 8. 87 (d, 1H), 8. 47 (d, 1H), 8. 44 (s, 1H), 7. 61 (m, 1H), 7. 40 (m, 1H), 7. 38 (d, 1H), 6. 96 (t, 2H), 6. 83 (m, 2H), 5. 42 (m, 1H), 4. 00- 3. 95 (m, 4H), 3. 40 (m, 2H), 2. 95 (t, 2H).  195 8. 91 (s, 1H), 8. 88 (d, 1H), 8. 77 (s, 1H), 8. 70 (d, 1H), 7. 79 (d, 1H), 7. 37 (d, 1H), 7. 21 (m, 2H), 6. 82 (m, 2H), 5. 40 (m, 1H), 4. 39 (m, 1H), 3. 93 (m, 1H), 3. 89 (m, 1H), 3. 30 (m, 1H), 3. 26 (m, 1H), 2. 78 (dd, 1H), 2. 73 (dd, 1H), 1. 27 (d, 3H).  196 8. 85 (d, 1H), 8. 58 (s, 1H), 8. 48 (d, 1H), 7. 60 (d, 1H), 7. 37 (d, 1H), 7. 21 (m, 2H), 6. 81 (m, 2H), 5. 39 (m, 1H), 4. 38 (m, 1H), 3. 92 (m, 1H), 3. 87 (m, 1H), 3. 31 (m, 1H), 3. 27 (m, 1H), 2. 78 (dd, 1H), 2. 72 (dd, 1H), 1. 27 (d, 3H).  197 8. 86 (d, 1H), 8. 58 (s, 1H), 8. 48 (d, 1H), 7. 60 (d, 1H), 7. 38 (d, 1H), 7. 22 (m, 2H), 6. 81 (d, 2H), 5. 42 (m, 1H), 3. 97 (t, 2H), 3. 93 (m, 2H), 3. 34 (m, 2H), 2. 92 (t, 2H).  198 8. 86 (d, 1H), 8. 58 (s, 1H), 8. 48 (d, 1H), 7. 61 (d, 1H), 7. 38 (d, 1H), 6. 96 (t, 2H), 6. 82 (m, 2H), 5. 43 (m, 1H), 3. 96 (t, 2H), 3. 93 (m, 2H), 3. 35 (m, 2H), 2. 92 (t, 2H).  199 8. 90 (s, 1H), 8. 89 (d, 1H), 8. 78 (s, 1H), 8. 70 (d, 1H), 7. 79 (d, 1H), 7. 38 (d, 1H), 6. 96 (t, 2H), 6. 83 (m, 2H), 5. 43 (m, 1H), 3. 98-3. 94 (m, 4H), 3. 33 (m, 2H), 2. 92 (t, 2H).  200 8. 90 (s, 1H), 8. 89 (d, 1H), 8. 78 (s, 1H), 8. 70 (d, 1H), 7. 79 (d, 1H), 7. 38 (d, 1H), 7. 22 (m, 2H), 6. 82 (d, 2H), 5. 43 (m, 1H), 4. 00- 3. 93 (m, 4H), 3. 33 (m, 2H), 2. 93 (t, 2H).  201 8. 98 (d, 1H), 8. 85 (d, 1H), 8. 53 (s, 1H), 8. 14 (s, 1H), 7. 91 (d, 1H), 7. 39 (d, 1H), 7. 22 (m, 2H), 6. 82 (m, 2H), 5. 40 (m, 1H), 4. 40 (m, 1H), 3. 94 (m, 1H), 3. 90 (m, 1H), 3. 37 (m, 1H), 3. 33 (m, 1H), 2. 80 (dd, 1H), 2. 75 (dd, 1H), 1. 28 (d, 3H).  202 9. 12 (d, 1H), 8. 86 (d, 1H), 8. 43 (d, 1H), 7. 96 (t, 1H), 7. 36 (d, 1H), 7. 22 (m, 2H), 6. 84 (m, 2H), 5. 40 (m, 1H), 4. 41 (m, 1H), 3. 98 (m, 1H), 3. 94 (m, 1H), 3. 33 (m, 1H), 3. 29 (m, 1H), 2. 82 (dd, 1H), 2. 76 (dd, 1H), 1. 29 (d, 3H).  203 10. 29 (s, 1H), 8. 95 (d, 1H), 8. 86 (d, 1H), 8. 14 (d, 1H), 7. 36 (d, 1H), 7. 22 (m, 2H), 6. 84 (m, 2H), 5. 40 (m, 1H), 4. 42 (m, 1H), 4. 03-3. 94 (m, 2H), 3. 41-3. 33 (m, 2H), 2. 86-2. 74 (m, 2H), 1. 30 (d, 3H).  204 9. 13 (br d, 1H), 8. 87 (d, 1H), 8. 44 (d, 1H), 7. 96 (t, 1H), 7. 38 (d, 1H), 7. 23 (m, 2H), 6. 84 (d, 2H), 5. 43 (m, 1H), 4. 04-3. 98 (m, 4H), 3. 36 (m, 2H), 2. 97 (t, 2H).  201204254 .  205 9. 70 (s, 1H), 8. 62 (d, 1H), 8. 35 (br s, 1H), 7. 79 (s, 1H), 7. 64 (dd, 1H), 7. 22 (m, 2H), 6. 95 (s, 1Ή), 6. 82 (m, 2H), 5. 00 (m, 1H), 4. 42 .  (m, 1H), 3. 94 (t, 1H), 3. 90 (t, 1H), 3. 44 (dd, 1H), 3. 40 (dd, 1H), 2. 83-2. 77 (m, 2H), 1. 27 (d, 3H).  206 10. 42 (s, 1H), 9. 38 (d, 1H), 9. 08 (d, 1H), 8. 92 (d, 1H), 8. 21 (dd, 1H), 7. 36 (d, 1H), 7. 22 (m, 2H), 6. 85 (m, 2H), 5. 39 (m, 1H), 4. 41 (m, 1H), 4. 00 (m, 2H), 3. 38 (dd, 1H), 3. 34 (dd, 1H), 2. 83 (dd, 1H), 2. 77 (dd, 1H), 1. 29 (d, 3H).  207 10. 44 (s, 1H), 9. 38 (d, 1H), 9. 08 (d, 1H), 8. 93 (d, 1H), 8. 21 (dd, 1H), 7. 37 (d, 1H), 7. 23 (m, 2H), 6. 84 (d, 2H), 5. 43 (m, 1H), 4. 04 (m, 2H), 4. 01 (t, 2H), 3. 41 (m, 2H), 2. 98 (t, 2H).  208 8. 65 (s, 1H), 8. 61 (d, 1H), 8. 45 (br s, 1H), 7. 95 (d,lH), 7. 77 (s, 1H), 7. 63 (d, 1H), 7. 33 (m, 1H), 6. 74 (s, 1H), 6. 72 (dd, 1H), 4. 87 (m, 1H), 4. 32 (t, 2H), 3. 89 (m, 2H), 3. 36 (m, 2H), 2. 95 (t, 2H).  209 8. 85 (d, 1H), 8. 62 (d, 1H), 8. 45 (br s, 1H), 7. 95 (d, 1H), 7. 79 (s, 1H), 7. 63 (d, 1H), 7. 38 (m, 1H), 7. 33 (m, 1H), 6. 73 (dd, 1H), 5. 42 (m, 1H), 4. 32 (t, 2H), 3. 94 (m, 2H), 3. 39 (m, 2H), 2. 94 (t, 2H).  210 8. 59 (d, 1H), 8. 52 (br s, 1H), 8. 42 (d, 1H), 7. 77 (s, 1H), 7. 62 (dd, 1H), 7. 21 (m, 2H), 6. 80 (m, 2H), 6. 66 (d, 1H), 4. 82 (m, 1H), 4. 39 (m, 1H), 3. 85 (m, 2H), 3. 37 (dd, 1H), 3. 32 (dd, 1H), 2. 82- 2. 74 (m, 2H), 1. 26 (d, 3H).  211 8. 59 (d, 1H), 8. 51 (br s, 1H), 8. 41 (d, 1H), 7. 77 (s, 1H), 7. 61 (dd, 1H), 7. 21 (m, 2H), 6. 80 (m, 3H), 6. 66 (d, 1H), 4. 82 (m, 1H), 4. 39 (m, 1H), 3. 85 (m, 2H), 3. 36 (dd, 1H), 3. 31 (dd, 1H), 2. 82- 2. 74 (m, 2H), 1. 26 (d, 3H).  212 8. 65 (d, 1H), 8. 64 (s, 1H), 8. 50 (br s, 1H), 7. 76 (s, 1H), 7. 61 (dd, 1H), 7. 21 (m, 2H), 6. 81 (m, 2H), 5. 50 (m, 1H), 4. 41 (m, 1H), 3. 94 (m, 1H), 3. 88 (m, 1H), 3. 44 (m, 2H), 2. 84-2. 74 (m, 2H), 1. 27 (d, 3H).  213 9. 39 (br s, 1H), 8. 59 (d, 1H), 8. 48 (s, 1H), 7. 87 (s, 1H), 7. 72 (d, 1H), 7. 49 (d, 1H), 7. 40 (dd, 1H), 7. 27 (d, 2H), 7. 22 (d, 2H), 6. 40 (d, 1H), 6. 00 (dt, 1H), 3. 81 (m, 1H), 3. 58 (m, 2H), 3. 21-3. 12 (m, 4H).  214 8. 58 (s, 1H), 7. 91 (s, 1H), 7. 85 (d, 1H), 7. 76 (d, 1H), 7. 27 (s, 4H), 7. 06 (d, 1H), 6. 48 (d, 1H), 6. 09 (dt, 1H), 5. 85 (br s, 1H), 4. 65 (m, 1H), 3. 70 (m, 2H), 3. 29(d, 2H), 3. 22 (m, 2H).  215 8. 28 (d, 1H), 7. 55 (d, 1H), 7. 36 (s, 1H), 7. 29 (m, 4H), 7. 25 (d, 1H), 7. 03 (d, 1H), 6. 51 (d, 1H), 6. 14 (dt, 1H), 5. 21 (m, 1H), 3. 83 (m, 2H), 3. 39 (s, 3H), 3. 30 (m, 2H), 3. 2-2. 8 (br m, 2H).  216 8. 61 (d, 1H), 8. 49 (br s, 1H), 8. 15 (s, 1H), 7. 80 (s, 1H), 7. 66 (dd, 1H), 7. 28 (s, 4H), 6. 50 (d, 1H), 6. 13 (dt, 1H), 5. 38 (m, 1H), 3. 82 (m, 2H), 3. 38-3. 31(m, 4H).  191 201204254 217 8. 61 (d, 1H), 8. 45 (br s,1H), 8. 06 (s, 1H), 7. 79 (s, 1H), 7. 65 (dd, 1H), 7. 28 (s, 4H), 6. 49 (d, 1H), 6. 13 (dt, 1H), 5. 37 (m, 1H), 3. 81 (m, 2H), 3. 36-3. 30 (m, 4H).  218 8. 61 (d, 1H), 8. 32 (br s, 1H), 7. 76 (s, 1H), 7. 63 (dd, 1H), 7. 27 (s, 4H), 6. 49 (d, 1H), 6. 12 (dt, 1H), 5. 34 (m, 1H), 3. 81 (m, 2H), 3. 31(m, 4H).  219 8. 85 (d, 1H), 8. 64 (d, 1H), 8. 40 (br s, 1H), 7. 79 (s, 1H), 7. 63 (d, 1H), 7. 39 (d, 1H), 7. 12 (d, 2H), 6. 54 (d, 2H), 5. 40 (m, 1H), 3. 91 (t, 2H), 3. 27 (br s, 2H), 3. 09 (br m, 2H), 2. 81 (br m, 2H).  220 8. 26 (d, 1H), 7. 53 (d, 1H), 7. 34 (s, 1H), 7. 25 (d, 1H), 7. 22 (m, 2H), 7. 02 (d, 1H), 6. 83 (m, 2H), 5. 18 (m, 1H), 4. 39 (m, 1H), 3. 87 (m, 2H), 3. 39 (s, 3H), 3. 3-2. 8 (m, 2H), 2. 77 (dd, 1H), 2. 72 (dd, 1H), 1. 28 (d, 3H).  221 8. 85 (d, 1H), 8. 64 (d, 1H), 8. 40 (br s, 1H), 7. 78 (s, 1H), 7. 62 (dd, 1H), 7. 38 (d, 1H), 7. 16 (d, 2H), 6. 62 (d, 2H), 5. 39 (m, 1H), 3. 88 (m, 2H), 3. 34 (t, 2H), 3. 28 (m, 2H), 2. 93 (s, 3H), 2. 74 (t, 2H).  222 8. 27 (d, 1H), 7. 54 (d, 1H), 7. 35 (s, 1H), 7. 25 (d, 1H), 7. 23 (m, 2H), 7. 03 (d, 1H), 6. 83 (m, 2H), 5. 21 (m, 1H), 3. 98 (t, 2H), 3. 92 (t, 2H), 3. 39 (s, 3H), 3. 3-2. 8 (br m, 2H), 2. 92 (t, 2H).  223 8. 60 (d, 1H), 8. 48 (br s, 1H), 8. 14 (s, 1H), 7. 79 (s, 1H), 7. 65 (d, 1H), 7. 22 (m, 2H), 6. 82 (m, 2H), 5. 36 (m, 1H), 4. 41 (m, 1H), 3. 89 (t, 1H), 3. 84 (t, 1H), 3. 44-3. 33 (br m, 2H), 2. 83-2. 73 (m, 21H), 1. 26 (d, 3H).  224 8. 60 (d, 1H), 8. 40 (br s, 1H), 7. 75 (s, 1H), 7. 62 (dd, 1H), 7. 21 (m, 2H), 6. 80 (m, 2H), 5. 30 (m, 1H), 4. 39 (m, 1H), 3. 85 (m, 2H), 3. 36 (m, 1H), 3. 31 (m, 1H), 2. 79 (dd, 1H), 2. 73 (m, 1H), 1. 26 (d, 3H).  225 9. 32 (br s, 1H), 8. 81 (d, 1H), 8. 59 (d, 1H), 7. 83 (s, 1H), 7. 69 (d, 1H), 7. 35 (d, 1H), 7. 26 (obscured, 2H), 7. 19 (d, 2H), 6. 43 (d, 1H), 6. 12 (m, 1H), 5. 42 (m, 1H), 3. 16 (d, 2H), 2. 71 (m, 2H), 2. 47 (m, 1H), 1. 92 (m, 2H), 1. 74 (m, 1H), 1. 26 (m, 2H).  226 8. 84 (d, 1H), 8. 63 (d, 1H), 8. 51 (s, 1H), 7. 76 (s, 1H), 7. 62 (d, 1H), 7. 35 (d, 1H), 7. 30 (AB d, 4H), 6. 52 (d, 1H), 6. 30 (m, 1H), 5. 35 (m, 1H), 3. 25 (br s, 2H), 2. 88 (br s, 2H), 2. 51 (br s, 2H), 2. 21 (br s, 2H), 1. 98 (br s, 2H).  227 8. 82 (d, 1H), 8. 74 (br s, 1H), 8. 59 (d, 1H), 7. 80 (s, 1H), 7. 65 (d, 1H), 7. 36 (d, 1H), 7. 28 (s, 4H), 6. 52 (d, 1H), 6. 27 (m, 1H), 5. 64 (m, 1H), 3. 32 (m, 2H), 3. 10 (m, 2H), 2. 80 (m, 1H), 2. 52 (m, 1H), 2. 42 (m, 1H), 2. 08 (m, 1H).  s 192 201204254 a H NMR data is a low field ppni deviating from tetradecyl decane. Couplings are indicated as (s)_single peak, (4)-doublet, (1)-trimodal, (m)_multimodal, (dd)-doublet, (dt)-double triplet, (td)-triplet, (br s) · wide single peak, (br t) - wide three peaks.

本發明生物實例 試驗A 為了衡量菱斑蛾(Plutella xylostella)之防治,測 試單位包含了 一小開放外殼,並有一成長12到14天之 蘿蔔於内。此測試單元由約50個新生幼蟲預侵染,該 等幼蟲經由玉米棒屑使用管道式接種器 (bazooka inoculator)分配至測試單元中。在分配進測試單元後, 該幼蟲移動至測試植物上。 使用含有10%丙酮、90%水的溶液及含有炫(芳基聚 氧乙烯、自由脂肪酸、二醇類及異丙醇的300 ppmX·77⑧Biological Example of the Invention Test A In order to measure the control of Plutella xylostella, the test unit contained a small open shell and a radish that grew for 12 to 14 days. This test unit was pre-infested with approximately 50 newborn larvae, which were distributed to the test unit via a corn bristle using a bazooka inoculator. After being dispensed into the test unit, the larva moves to the test plant. Use a solution containing 10% acetone, 90% water and 300 ppm X·778 containing aryl (aryl polyoxyethylene, free fatty acids, glycols and isopropanol)

Spreader Lo-Foam Formula 非離子界面活性劑(Loveland Industries,Inc. Greeley,Colorado, USA)配製測試化合 物。在每個測試單元頂部之上1.27 cm (0.5英吋)的位 置,透過具有1/8 JJ定製體的SUJ2霧化器喷嘴(SprayingSpreader Lo-Foam Formula Nonionic surfactant (Loveland Industries, Inc. Greeley, Colorado, USA) formulated test compounds. Above the top of each test unit at 1.27 cm (0.5 inch), through the SUJ2 nebulizer nozzle with 1/8 JJ custom body (Spraying

Systems Co· Wheaton,Illinois, USA)施用 1 mL 配製好 的化合物液體。喷灑測試化合物250及/或50 ppm,並 重複三次。喷灑完配製好的化合物之後,讓每個測試單 元乾燥1小時,然後將一黑色屏蔽蓋置於其頂部。在 25 C及70%相對濕度下將測試單元於生長腔室中保持6 天。隨後基於葉枝損耗視覺上評估植物攝食損傷。 在測試的式1化合物的測試中,以下化合物在250 ppm時提供極良好至最佳程度之防治效力或更低 193 201204254 之植物損傷及/或100%%死亡率):化合物1、2、3、4、 5、6、7、8、9、10、11、12、13、14、15、16、17、 19、20、23、24、25、26、28、29、30、31、35、38、 39、40、41、42、43、44、45、46、47、48、50、51、 5 52、53、54、55、57、58、65、66、67、68、69、70、 71、72、73、74、75、77、78、79、80、82、83、84、 112、113、114、115、116、117、118、119、120、121、 122、123、124、125、126、127、128、129、130、131、 132、133、134、135 及 214。 10 在測試的式1化合物的測試中,以下化合物在50 ppm時提供極良好至最佳程度之防治效力(40%或更低 之植物損傷及/或100%%死亡率):化合物1、2、3、4、 5、6、7、8、9、10、12、13、14、16、17、20、21、 22、23、25、26、29、31、35、38、40、43、45、47、 15 48、50、51、52、55、57、58、59、60、61、62、63、 65、66、67、68、69、70、71、72、73、74、78、80、 81、82、84、85、86、87、88、89、90、91、92、94、 95、96、97、98、99、101、103、104、106、107、109、 110、11卜 112、113、114、116、117、118、119、120、 2〇 12卜 122、123、124、125、126、127、128、129、130、 m、132、133、134、135、136、138、139、140、143、 144、145、146、147、149、150、15 卜 152、153、154、 155、156、157、158、160、16卜 162、163、164、165、 166、167、168、169、170、172、173、174、175、176、 25 177、179、180、18 卜 182、183、189、190、19 卜 192、Systems Co. Wheaton, Illinois, USA) Apply 1 mL of the formulated compound liquid. Test compound 250 and / or 50 ppm was sprayed and repeated three times. After spraying the prepared compound, each test unit was allowed to dry for 1 hour, and then a black shield cap was placed on top of it. The test unit was held in the growth chamber for 6 days at 25 C and 70% relative humidity. Plant feeding damage was then visually assessed based on leaf loss. In the tests of the compounds of formula 1 tested, the following compounds provided very good to optimal control efficacy at 250 ppm or lower 193 201204254 plant damage and/or 100%% mortality): Compounds 1, 2, 3 , 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 19, 20, 23, 24, 25, 26, 28, 29, 30, 31, 35 , 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 50, 51, 5 52, 53, 54, 55, 57, 58, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 77, 78, 79, 80, 82, 83, 84, 112, 113, 114, 115, 116, 117, 118, 119, 120, 121, 122, 123, 124, 125, 126, 127, 128, 129, 130, 131, 132, 133, 134, 135 and 214. 10 In the test of the compound of formula 1 tested, the following compounds provided extremely good to optimal control efficacy at 50 ppm (40% or less plant damage and/or 100%% mortality): Compounds 1, 2 , 3, 4, 5, 6, 7, 8, 9, 10, 12, 13, 14, 16, 17, 20, 21, 22, 23, 25, 26, 29, 31, 35, 38, 40, 43 , 45, 47, 15 48, 50, 51, 52, 55, 57, 58, 59, 60, 61, 62, 63, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 78, 80, 81, 82, 84, 85, 86, 87, 88, 89, 90, 91, 92, 94, 95, 96, 97, 98, 99, 101, 103, 104, 106, 107, 109, 110, 11 112, 113, 114, 116, 117, 118, 119, 120, 2, 12, 122, 123, 124, 125, 126, 127, 128, 129, 130, m, 132, 133, 134, 135, 136, 138, 139, 140, 143, 144, 145, 146, 147, 149, 150, 15 152, 153, 154, 155, 156, 157, 158, 160, 16 162, 163, 164, 165, 166, 167, 168, 169, 170, 172, 173, 174, 175, 176, 25 177, 179, 180, 18 182, 183, 189, 190, 19 2,

S 194 201204254 193、194、201、205、208、209、213、214、215、217、 218、219、220、221、222、223、224、226 及 227。S 194 201204254 193, 194, 201, 205, 208, 209, 213, 214, 215, 217, 218, 219, 220, 221, 222, 223, 224, 226 and 227.

試驗B 5 為了 5平估對秋季行軍蟲(Spodoptera frugiperda )的 防治,測試單元由内部有4至5天齡之玉米(玉蜀黍) 植物之小開口外殼組成。此測試單元係在一塊昆蟲餌料 上由10 — 15個1天齡之幼蟲預侵染(使用核心取樣器)。 將測試化合物如測試A所述配製且以250及/或50 ίο PPm噴灑。上述施用重複三次。喷灑之後,將測試單元 維持在25°C及70%相對濕度生長腔室中,然後如測試a 所述作視覺上的評定。 在測試的式1化合物的測試中,以下化合物在250 ppm時提供極良好至最佳程度之防治效力(4〇%或更低 15 之植物損傷及/或100%死亡率):化合物1、2、3、8、9、 10、12、13、14、16、17、20、23、24、25、26、50、 51、52、57、58、65、66、67、68、69、70、71、72、 73、77、78、79、80、82、83、84、112、113、114、 115、117、118、119、120、12卜 122、123、125、126、 2〇 127、129、130、131、132、133 及 134。 在測試的式1化合物的測試中,以下化合物在5〇 ppm時提供極良好至最佳程度之防治效力(40%或更低 之植物損傷及/或100%死亡率):化合物卜2、3、4、5、 6、7、8、9、10、12、13、14、16、17、20、2卜 22、 25 23、25、26、3卜 52、57、58、59、60、66、68、69、 7卜 72、73、8卜 82、84、85、86、87、88、89、90、 195 201204254 5 91、92、94、95 ' 96 ' 97 ' 98、99、100、101 ' 102、 103、104、106、107、109、110、111、112、113、114、 115、118、119、120、121、122、123、127、130、131、 136、137、139、143、146、147、150、15卜 152、153、 155、156、157、158、159、160、161、162、163、164、 165、166、167、168、169、170、172、178、179、180、 18卜 183、189、190、19卜 192、193、2(Π、205、209、 210、215、216、217、219、220、221、222、223、224、 226 及 227。 10Test B 5 In order to evaluate the control of the autumn army worm (Spodoptera frugiperda), the test unit consisted of a small open shell of 4 to 5 day old corn (maize) plants. This test unit was pre-infested with 10-15 day old larvae on an insect bait (using a core sampler). Test compounds were formulated as described in Test A and sprayed at 250 and/or 50 ίο PPm. The above administration was repeated three times. After spraying, the test unit was maintained in a 25 ° C and 70% relative humidity growth chamber and then visually evaluated as described in Test a. In the test of the compound of formula 1 tested, the following compounds provided extremely good to optimal control efficacy at 250 ppm (plant damage and/or 100% mortality at 4% or less): Compounds 1, 2 , 3, 8, 9, 10, 12, 13, 14, 16, 17, 20, 23, 24, 25, 26, 50, 51, 52, 57, 58, 65, 66, 67, 68, 69, 70 , 71, 72, 73, 77, 78, 79, 80, 82, 83, 84, 112, 113, 114, 115, 117, 118, 119, 120, 12, 122, 123, 125, 126, 2〇127 , 129, 130, 131, 132, 133 and 134. In the tests of the compounds of formula 1 tested, the following compounds provided extremely good to optimal control efficacy at 5 〇ppm (plant damage and/or 100% mortality at 40% or less): Compounds 2, 3 , 4, 5, 6, 7, 8, 9, 10, 12, 13, 14, 16, 17, 20, 2, 22, 25, 23, 25, 26, 3, 52, 57, 58, 59, 60, 66, 68, 69, 7 Bu 72, 73, 8 Bu 82, 84, 85, 86, 87, 88, 89, 90, 195 201204254 5 91, 92, 94, 95 ' 96 ' 97 ' 98, 99, 100 101' 102, 103, 104, 106, 107, 109, 110, 111, 112, 113, 114, 115, 118, 119, 120, 121, 122, 123, 127, 130, 131, 136, 137, 139 , 143, 146, 147, 150, 15 152, 153, 155, 156, 157, 158, 159, 160, 161, 162, 163, 164, 165, 166, 167, 168, 169, 170, 172, 178 , 179, 180, 18 183, 189, 190, 19 192, 193, 2 (Π, 205, 209, 210, 215, 216, 217, 219, 220, 221, 222, 223, 224, 226 and 227 10

試驗C 15 20 為了評估經由接觸及/或系統方式對綠桃蚜(Myzus persicae)的防治,測試單元係由内部具有12至15天 齡蘿蔔植物的小開口外殼組成。此係藉由將自培養植物 切下之葉片上的3G-4G彳晴蟲置放於測試植物之葉片 來預侵染(切葉法)。當葉片變乾時,財蟲移動至測試植 物上。在預侵染後,以-層砂覆蓋測試單元之土壤。 將測試化合物如測試A所述配製且卩25〇及/或5〇 PPm喷灑。上述施用重複三次。嘴灑完配製好的化合物 2 ’縣個測試料麟1小時,然後將-黑色屏蔽 $於其卿。在19_2心5(MQ%相龍度下將測 =元於生長腔室中保持6天。隨後視覺上評估每一測 试單元的昆轰死亡率。 在測試的41化合物的測試中,以下在25〇卯爪時 化成至少8G%死亡率:化合物丨、6、7、丨 14、16、17、20、2卜22、23、24、25、40、45、47、Test C 15 20 In order to evaluate the control of Myzus persicae via contact and/or systemic means, the test unit consisted of a small open shell with 12 to 15 day old radish plants inside. This was pre-infested by placing 3G-4G prawn on the leaves cut from the cultured plants on the leaves of the test plants (cutting method). When the leaves are dry, the insects move to the test plant. After pre-infestation, the soil of the test unit is covered with sand. Test compounds were formulated as described in Test A and sprayed at 25 〇 and/or 5 〇 PPm. The above administration was repeated three times. Sprinkle the prepared compound in the mouth 2 ' County test material Lin 1 hour, then the - black shield $ Yu Qiqing. The test was carried out for 6 days in the growth chamber at 19% of the heart 5 (MQ% phase). The Kunming mortality of each test unit was then visually evaluated. In the test of the 41 compound tested, the following 25 pawn formation into at least 8G% mortality: compound 丨, 6, 7, 丨 14, 16, 17, 20, 2, 22, 23, 24, 25, 40, 45, 47,

S 196 25 201204254 48、50、51、52、53、57、58、59、60、61、63、66、 67、68、69、70、71、72、73、79、80、85、86、88、 91、94、95、97、98、103、106、107、109、110、112、 113、114、116、118、119、120、12卜 122、123、124、 125、126、127、129、130、m、132、133、134、135、 136、 137、143、144、145、147、149、150、15卜 152、 153、155、158、160、162、163、165、166、167、168、 169、170、m、172、174、178、179、180、18 卜 182、 183、189、190、19卜 192、194、195、2(U、205、210、 219、221 及 227。 在測試的式1化合物的測試中,以下在50 ppm時 造成至少80%死亡率:化合物11、16、17、25、40、 45、50、5卜 52、58、59、60、66、67、68、69、70、 7 卜 72、85、9卜 103、112、114、116、119、120、121、 122、123、124、125、127、130、13卜 132、133、134、 137、 147、150、152、153、155、158、168、170、179、 181 及 183。S 196 25 201204254 48, 50, 51, 52, 53, 57, 58, 59, 60, 61, 63, 66, 67, 68, 69, 70, 71, 72, 73, 79, 80, 85, 86, 88, 91, 94, 95, 97, 98, 103, 106, 107, 109, 110, 112, 113, 114, 116, 118, 119, 120, 12, 122, 123, 124, 125, 126, 127, 129, 130, m, 132, 133, 134, 135, 136, 137, 143, 144, 145, 147, 149, 150, 15 152, 153, 155, 158, 160, 162, 163, 165, 166, 167, 168, 169, 170, m, 172, 174, 178, 179, 180, 18 182, 183, 189, 190, 19 192, 194, 195, 2 (U, 205, 210, 219, 221 and 227. In the test of the compound of formula 1 tested, the following caused at least 80% mortality at 50 ppm: Compound 11, 16, 17, 25, 40, 45, 50, 5, 52, 58, 59, 60, 66 , 67, 68, 69, 70, 7 Bu 72, 85, 9 Bu 103, 112, 114, 116, 119, 120, 121, 122, 123, 124, 125, 127, 130, 13 Bu 132, 133, 134 , 137, 147, 150, 152, 153, 155, 158, 168, 170, 179, 181 and 183.

試驗D 20 為了評估經由接觸及/或系統方式對西方花薊馬 (Frankliniella occidentalis)的防治,測試單元係由内 部具有5-7天齡太陽豆植物的小開口外殼組成。 如測試A所述,配製測試化合物並以250及/或50 ppm喷灑,並重複三次。喷灑完後,測試單位有1小時 25 之乾燥時間,之後放入22至27隻成熟花蓟於測試單位 ¢. 197 201204254 中並以黑;慮師蓋蓋於其上。測試單位於一生長箱,25 °C、相對濕度45-55%,保持7天。 在測試的式1化合物的測試中,以下化合物在25〇 ppm時提供極良好至最佳程度之防治效力(3〇%或更低 5 之植物損傷及/或1⑻%死亡率):化合物1、16、17、60、 69、71、85、90、91、94、95、96、97、98、101、103、 109、110、m、130、131、147、162、163、172、174、 177、179、181、183、187、189、190、191、192、193、 2(Π、209、215、220、222、224 及 227 〇 10 在測試的式1化合物的測試中,以下化合物在50 ppm時提供極良好至最佳程度之防治效力(30%或更低 之植物損傷及/或100%死亡率):化合物1及94。Test D 20 In order to evaluate the control of Frankliniella occidentalis via contact and/or systemic means, the test unit consisted of a small open shell with a 5-7 day old sun bean plant inside. Test compounds were formulated and sprayed at 250 and/or 50 ppm as described in Test A and repeated three times. After spraying, the test unit has a drying time of 1 hour and 25 hours, after which 22 to 27 mature flowers are placed in the test unit ¢. 197 201204254 and blackened; The test unit was kept in a growth chamber at 25 ° C and a relative humidity of 45-55% for 7 days. In the test of the compound of formula 1 tested, the following compounds provided extremely good to optimal control efficacy at 25 〇ppm (plant damage and/or 1 (8)% mortality at 3% or less): Compound 1, 16, 17, 60, 69, 71, 85, 90, 91, 94, 95, 96, 97, 98, 101, 103, 109, 110, m, 130, 131, 147, 162, 163, 172, 174, 177, 179, 181, 183, 187, 189, 190, 191, 192, 193, 2 (Π, 209, 215, 220, 222, 224, and 227 〇10 In the test of the compound of formula 1 tested, the following compounds were Very good to optimal control efficacy at 50 ppm (30% or less plant damage and/or 100% mortality): Compounds 1 and 94.

試驗E 15 為了評估經由接觸及/或系統方式對馬鈴薯葉蟬 (Empoasca fabae)的防治,測試單元係由内部具有5 至6天齡太陽豆(Soleil bean)植物(長出初生葉)的 小開口外殼組成。 如測試A所述,配製測試化合物並以250及/或50 2〇 ppm喷灑,並重複三次。喷麗之後,使測試單元乾燥1 小時,隨後用5個馬鈴薯葉蟬(18至21天齡之成蟲) 將其後侵染。黑濾篩蓋蓋於此圓柱上。在24°C及70% 相對濕度下將測試單元於生長腔室中保持6天。隨後視 覺上評估每一測試單元的昆蟲死亡率。Test E 15 In order to evaluate the control of potato leaf mites (Empoasca fabae) via contact and/or systemic means, the test unit consists of a small open shell with 5 to 6 day old Soleil bean plants (with nascent leaves) composition. Test compounds were formulated and sprayed at 250 and/or 50 2 〇 ppm as described in Test A and repeated three times. After the spray, the test unit was allowed to dry for 1 hour and then infested with 5 potato leafhoppers (18 to 21 day old adults). The black sieve cover is placed on the cylinder. The test unit was held in the growth chamber for 6 days at 24 ° C and 70% relative humidity. The insect mortality of each test unit was then visually assessed.

S 198 201204254 在測試的式1化合物的測試中’以下在250 ppm時 造成至少80%死亡率:化合物71、72、u〇、136、159、 163、172、179、180 及 201。 在測試的式1化合物的測試中’以下在50 ppm時 5 造成至少80%死亡率:化合物163 °S 198 201204254 In the test of the compound of formula 1 tested, the following caused at least 80% mortality at 250 ppm: compounds 71, 72, u〇, 136, 159, 163, 172, 179, 180 and 201. In the test of the compound of formula 1 tested below, at 50 ppm, 5 caused at least 80% mortality: compound 163 °

試驗F 為了評估經由接觸及/或系統方式對棉瓜财(Aphis gossypii)的防治,測試單元係由内部具有6至7天齡 ίο 棉花植物之小開口外殼組成。此係根據測試C所述之切 葉方法由30 — 40個於一片葉上之昆蟲預侵染,且以一 層砂覆蓋測試單元之土壌。如測試A所述’配製測試化 合物並以250 ppm喷灑,並重複三次。噴灑之後,將測 試單元維持在19至21°C及50至70%相對濕度生長腔 15 室中,然後如測試C所述作視覺上的評定。 在測試的式1化合物的測試中’以下在250 ppm時 造成至少80%死亡率:化合物5。Test F In order to evaluate the control of Aphis gossypii via contact and/or system, the test unit consisted of a small open shell with a 6 to 7 day old cotton plant inside. This was pre-infested by 30-40 insects on one leaf according to the cutting method described in Test C, and the soil of the test unit was covered with a layer of sand. The test compound was formulated as described in Test A and sprayed at 250 ppm and repeated three times. After spraying, the test unit was maintained in a chamber of 19 to 21 ° C and 50 to 70% relative humidity growth chamber, and then visually evaluated as described in Test C. In the test of the compound of formula 1 tested, the following caused at least 80% mortality at 250 ppm: Compound 5.

試驗G 20 為了評估經由接觸及/或系統方式對玉米飛蝨 (Peregrinus maidis)的防治’測試單元係由内部具有3 至4天齡玉米穗的小開口外殼組成。將白沙加至土壤頂 部。如測試A所述,配製測试化合物並以250 ppm喷 灑,並重複三次。喷灑之後’使測試單元乾燥1小時, 25 隨後用15至20個若蟲(18至21天齡)將其後侵染。 黑濾篩蓋蓋於此圓柱上。在24°c及70%相對濕度下將 199 201204254 測試單元於生長腔室中保持6天。隨後視覺上評估每一 測試單元的昆蟲死亡率。 在測試的式1化合物的測試中,以下在250 ppm時 造成至少80%死亡率:化合物85及132。 5 除試驗A至G之外,亦進行評估根瘤線蟲 (eloidogyne incognita)之防治的試驗,但在所測試的 投藥頻率試驗條件下,未觀察到顯著的抗此額外非脊椎 動物害蟲的活性。 ίο 【圖式簡單說明】 【主要元件符號說明】Test G 20 To evaluate the control of corn borer (Peregrinus maidis) via contact and/or systemology, the test unit consisted of a small open shell with 3 to 4 day old corn ears inside. Add white sand to the top of the soil. Test compounds were formulated and sprinkled at 250 ppm as described in Test A and repeated three times. After spraying, the test unit was allowed to dry for 1 hour, and then subsequently infested with 15 to 20 nymphs (18 to 21 days old). The black sieve cover is placed on the cylinder. The 199 201204254 test unit was maintained in the growth chamber for 6 days at 24 ° C and 70% relative humidity. The insect mortality of each test unit was then visually assessed. In the test of the compound of formula 1 tested, the following caused at least 80% mortality at 250 ppm: Compounds 85 and 132. 5 In addition to tests A to G, tests for the evaluation of the control of the root nodule nematode (eloidogyne incognita) were also carried out, but no significant activity against this additional non-vertebrate pest was observed under the test frequency of the test. Οο [Simple diagram description] [Main component symbol description]

Claims (1)

201204254 ‘ 七、申請專利範圍: . 1· 一種選自式1之化合物、其N氧化物或其鹽類,201204254 ‘ VII. Patent application scope: . 1 · A compound selected from formula 1, an N oxide thereof or a salt thereof, 、c/L—R6 r/ V 其中 10 A1 係 N 或 CR7 ; A2 係 N 或 CR8 ; A3 係 N 或 CR9 ; A4 係 N 或 CR10 ; 其限制條件為A1、A2、A3及A4之 τ 係 Ο、s(0)k 或 NR36 ; 中不多於兩個係 N; 15 L係-C(R&gt;C(R^中與R&quot;鍵結之碳原子亦與 CR R5鍵結’且與R!2鍵結之碳原子亦與尺6鍵 結;或選擇性地以至多4個獨立選自Rl;、之取代 基所取代的1,4-二伸苯基;4-C(R34)(R35)_z_,其 中與R34及R35!建結之碳原子亦與CW鍵結了 且Z係與R6鍵結; Z 係 0、S(0)m、NR37 或 CR38r39 ; R1係-選擇性地以至多5個獨立選自Rl4之取代基所 取代的苯基或5員或6員雜芳香環; 201 20 R2係Η、羥基、Cl—C6烷基、Cr_c6鹵烷基、c2_c6 烯基、C2-c6函烯基、c2-c6炔基、c3-c6鹵炔基、 C3-C7環烷基、C4-C8環燒基燒基、c厂c7環烯基、 Q-C6烷氧基、Q-Q烷氧基烷基、-CHO、 CCW^R15 . C(0)0R16,C(〇)NR17R18 ^ S(0)pR19 或 s(o)2nr2Gr21 ; 各R3係獨立為鹵素、氰基、Ci—C4烷基或C广C4烷氧 基; R4係Η或Q-C4烷基; R5係Η或Ci-c4烷基; R6係一選擇性地以至多5個獨立選自R22之取代基所 取代的苯基或5員或6員雜芳香環; R、R、R9及R10係獨立為H、_素、氮基、硝基、 〇R23、NW、c广c6 燒基、Ci—C6 ㈣基、C2—C6 稀基、c2-c6 _基、c2_c6块基、C3_C6齒快基、 C3-c7環烷基、c4—c8環烷基烷基、C5_C7環烯基、 -CHO、C(W2)R26、c(〇)〇r27、c(〇)nr28r29、 S⑼qR30、S(0)2Nr28r29 或 〇c(〇)r31 :或一苯選 擇性地以至多5個獨立選自R4。之取代基所取代 的苯基或5或6員雜芳環;或一以及r8 8 及^、或R9及f之鄰偶,與彼等偶對㈣接 之石反原子-起形成-铜合5員或6員芳環或非芳 環,其包含選自碳原子及至多3個獨立選自L 0及S之雜原子的環員; R11及R12係獨立為H、鹵素、c Γ —甘二 氧基; 圆京Cl~C2院基或Ci-ca 各R13、R14、R22及R4G係獨立為鹵素、氰基、硝基、 OR23、NR24R25、C rQ 烷基、C rC6 鹵烷基、C2-C6 烯基、C2-C6鹵烯基、C2-C6炔基、C3-C6鹵炔基、 C3-C7環烷基、C4-C8環烷基烷基、C5-C7環烯基、 -CHO、C(W2)R26、C(0)0R27、C(0)NR28R29、 S(0)qR30、S(0)2NR28R29 或 0C(0)R31 ; R15及R16係獨立為CrQ烷基、Cr-C6鹵烷基、C2-C6 烯基、C2-C6鹵烯基、C2-C6炔基、C3-C6鹵炔基、 C3-C7環烷基、C4-C8環烷基烷基或C5-C7環烯 基;或選擇性地以至多3個獨立選自_素、氰基、 硝基、OR23、NR24R25、Q-Q 烷基、C2-C4 烯基、 C2-C4炔基、CrQ鹵烷基、C2-C6烷氧基烷基、 c2-c4 鹵烯基、-CHO、C(W2)R26、C(0)0R27、 c(o)nr28r29、S(0)qR3°、s(o)2nr28r29 及 〇C(0)R31之取代基所取代的苯基; 各R17及R20係獨立為Η、Q-C6烷基、CrQ鹵烷基、 C2-C6 烯基、c2-c6 鹵烯基、c2-C6 炔基、C3-C6 鹵炔基、C3-C:7環烷基、c4-c8環烷基烷基或c5-c7 環烯基;或選擇性地以至多3個獨立選自鹵素、 氰基、硝基、OR23、NR24R25、c广c4烷基、C2-C4 烯基、&lt;:2-(:4快基、Ci-Cj i!烷基、c2_c6炫氧基 燒基、C2-C4 鹵烯基、_ch〇、C(W2)R26、 C(0)0R27、C(〇)NR28R29、S(〇)qR3。、S(〇)2NR28R29 及0C(0)R之取代基所取代的笑其. 烯基或c2-c6炔基; 201204254 各Rl9、R26、r27及R30係獨立為c「c6炫基或c「c6 鹵烷基; 各R2/及R31係獨立為H、Cl-C6烷基或C厂c6齒烷基; 各 R25、R36 及 R37 係獨立為 H、Ci_C6 烷基、c(0)R32 或 C(〇)〇R33 ; 各R28及R32係獨立為H、C广c6烷基、C广c6鹵烷基、 cr~C6 烯基、c2-C6 _ 稀基、c2_C6 快基、c3-C6 4块基、Cr~C7環烧基、c4—C8環烷基烷基或C5—C7 環烯基; 10 各R係獨立為CH:6烷基、Cl_c6鹵烷基、C2_C6 稀基、C2-C6鹵烯基、c2-c6炔基、c3—c6鹵炔基、 C3~C7環烷基、Q-Cs環烷基烷基或c5-C7環烯 基; 15 R 係 H、Cl—C4 烧基、ci-c2 i 院基、c2-c4 稀基、 CfC4炔基、c丨-c4烷氧基或氰基; R35係Η或甲基; ί =、0Η、齒素、C1-C2炫基或C1—C2院氧基; 係選自H、氰基及C广C2烧基,且當妙係識素時, 別則R 9係額外選自鹵素;或者 ’、, 20 R、R39與上述R38及R39所連接之碳原子-起代表 一羰基部份,· 衣 各W2係獨立為0或s ; k係0、1或2 ; 25 201204254 n為〇至5之整數; Ρ係0、丨或2 ; 各q係獨立為〇、1 2; S係1、2或3;且 t係1或2 ; 其限制條件為s及t之總和係2、3或4。 2.如申請專利範圍第1項所述之化合物,其中: T係〇 ; Z係〇 ; R係以1至3個獨立選自R14之取代基所取代的4_ °比咬基環’其中該取代基之一係位於該4-%嘴基 環之第2位置(2-position); R2係Η、曱基、Cr_C5烷氧基烷基或Cr_C4烷氧羰基; R係Η或燒基; R5 係 Η ; R6係選擇性地以至多5個獨立選自R22之取代基所取 代之苯環或選擇性地以至多4個獨立選自R22之 取代基所取代之°比啶環; R7、R8、R9及R10係獨立為Η、鹵素、Cr*C4烷基、 Ci-Q鹵烷基、C2-C4烯基、C2-C4鹵烯基、C2-C4 炔基、C3-C4鹵炔基、c3-c6環烷基、ch:4烧氧 基、Cr·Q鹵烷氧基、Cl—c4烷硫基、Cl_c4鹵烷 硫基或氰基,或R7及r8、或R8及R9、或R9及 R10之鄰偶,與彼等所連接之碳原子一起形成一 5 員或6員芳香麵非芳香族環,其包含選自碳原 205 201204254 子及至多3個獨立選自Ν、Ο及S之雜原子的環 員; R、R12係獨立為H、鹵素或甲基; 各R13係鹵素或甲基; 各R14係獨立為函素、Ci_C4院基、c广c4齒炫基、氰 基、C2-C4 婦基、c2-c4 i 烯基、c2-c4 快基、c3-c4 鹵炔基、Qj-C:6環烷基、Cl-C4烷氧基、Cl一c4鹵 燒氧基、Ci-C4烷硫基或Cr-Q鹵烷硫基; 各R22係獨立為鹵素、氰基、C「C6烷基、Cl—c6鹵燒 基C3-C6環烧基、c2-C6稀基、C2-C6鹵烯基、 Cr~C6炔基、Q-C6院氧基或Cr~C6鹵烧氧基; R34係Η或Cl—c2烷基; R35 係 Η ; 15 W係〇 ; η係〇 ; s係1 ;且 t係卜 •如申請專利範圍第2項所述之化合物,其中: A1 係 N 或 CR7 ; A2 係 N 或 CR8 ; A3 係 N 或 CR9 ; A4 係 CR10 ; L 係、-C(R34)(R35)〇-或未取代之聯伸 苯基; 201204254 R1係以1個選自R14之取代基所取代的4-吡啶環,其 中上述取代基係位於該4-吡啶環之第2位置 (2-position); R2 係 Η ; 5 R4係Η或甲基; R6係以1至3個獨立選自r22之取代基所取代的苯環 或°比啶環’其中一個取代基係在對位; R、R、R及R係獨立為Η、鹵素或C1-C4鹵院基; R11 與 R12係 Η ; ίο 各R14係獨立為鹵素或Cr~C4鹵烷基; 各R22係獨立為F、a、Br、氰基、CH3、CF3、環丙 基、HOC、CH30 或 CF3〇 ;以及 R34係Η或甲基。 15 4.如請求項3所述之化合物,其中: R6係在對位以一獨立選自R22之取代基所取代的苯環 或吡啶環’且選擇性地在—鄰位以一獨立選自 R22之取代基所取代; R7係Η或F ; 20 R8及R9係獨立為Η、鹵素或Ci-Q i烷基; R1Q係Η或F ; 各R14係獨立為F、a、Br或;以及 各R22係獨立為F、a、Br、CF3或Cf3〇。 25 5.如請求項4所述之化合物,其中: r6係在對位以—選自R22之取代基所取代的苯環; 207 201204254 R7 係 Η ; R8係Η、鹵素或CF3 ; R9係Η、鹵素或CF3 ; R10 係 Η ; 5 R14係Cl ;以及 R22 係 F、α、Br 或 CF3。 6.如請求項1所述之化合物,其係選自由以下所組成之群組: 2-氯-Ν-[2-[[1-[(2Ε)-3-(4-氯苯基)-2-丙烯-1-基]-3-吖 ίο 丁α定基]氧基]-6-(二乱甲基)-3-α比α定基]-4-σΗ^咬魏酉篮 胺、 2_ 氯-Ν-[4,5-二氯-2-[[1-[(2Ε)_3-(4-氯苯基)-2-丙烯 _1· 基]-3-吖丁啶基]氧基]苯基]-4-吼啶羧醯胺、 2-氯-N-[6-氣-2-[[1-[(2Ε)-3-(4-氯苯基)-2-丙烯-1-15 基]·3-α丫丁π定基]氧基]-5·氣-3-°比π定基]-4-°比咬魏酿 胺、 2-氯-Ν-[5-氣-2-[[1-[(2Ε)-3-(4-氣苯基)-2-丙烯-1-基]-3-α丫丁α定基]氧基]-6-鼠-3-°比α定基]-4-α比α定叛西篮 胺、 20 2-氯·Ν·[2-[[1-[(2Ε)·3-(4-氯苯基)·2·丙烯·1_基)-2-曱 基-3-吖丁啶基]氧基]-6-(三氟甲基)-3-。比啶基]-4-吼 啶羧醯胺,及 2-氯-N-[6-氯-2-[[l-[2-(4-氯苯氧基)丙基]-3-吖丁啶基] 氧基]-5-氟-3-°比°定基]-4-4b咬羧醯胺。 S 208 201204254 7.如請求項}所述之化合物,其係2-氣-Ν-[2-[[1-[(2Ε)-3-(4-氯苯基)-2-丙烯基]_3-吖丁啶基]氧基]-6-(三氟甲基)_3_ 吡啶基&gt;4-吡啶羧醯胺。 5 8. —種組合物,其包含請求項1所述之化合物及至少一種選 自由表面活性劑、固體稀釋劑及液體稀釋劑組成之群組的 額外組分,上述組合物選擇性地進一步包含至少一種額外 的生物活性化合物或藥劑。 ίο 9.如請求項8所述之組合物,其中該至少一種額外的生物活 性化合物或藥劑係選自由阿巴汀(abamectin )、殴殺松 (acephate)、亞酿瞒(acequinocyl)、亞滅培(acetamiprid)、 乙醯蟲腈(acetoprole)、阿納寧(acrinathrin)、磺胺蟎酯 (amidoflumet )、三亞瞒(amitraz )、阿佛菌素 15 ( avermectin )、楝素(azadirachtin )、谷速松 (azinphos-methyl )、畢芬寧(bifenthrin )、必芬蟎 (bifenazate )、雙三氟蟲腺(bistrifluron )、硼酸鹽 (borate)、布芬淨(buprofezin)、加保利(carbaryl)、加 保扶(carbofuran)、培丹(cartap)、酸酯蟎(carzol)、剋 20 安勃(chlorantraniliprole)、克凡派(chlorfenapyr)、克福 隆(chlorfluazuron)、陶斯松(chlorpyrifos)、甲基陶斯松 (chlorpyrifos-methyl)、可芬諾(chromafenozide)、克芬 蜗(clofentezin )、可尼丁( clothianidin )、氰特破 (cyantraniliprole )、赛芬蟎(cyflumetofen )、赛扶寧 25 ( cyfluthrin )、β 賽扶寧(beta-cyfluthrin )、賽洛寧 (cyhalothrin)' γ 赛洛寧(gamma-cyhalothrin)、λ 赛洛寧 201204254 (lambda-cyhalothrin)、赛滅寧(cypermethrin)、α 赛滅寧 (alpha-cypermethrin)、ζ 赛滅寧(zeta-cypermethrin)、赛 滅淨(cyromazine )、第滅寧(deltamethrin )、汰芬隆 (diafenthiuron)、大利松(diazinon)、地特靈(dieldrin)、 5 二福隆(diflubenzuron)、四氟甲醚菊酯(dimefluthrin)、 殺蟲雙(dimehypo )、大滅松(dimethoate )、達特南 (dinotefuran )、苯蟲醚(diofenolan )、因滅汀 (emamectin )、安殺番(endosulfan )、益化利 (esfenvalerate )、乙蟲清(ethiprole )、依芬寧 ίο ( etofenprox)、依殺蜗(etoxazole)、芬佈賜(fenbutatin oxide)、芬硫克(fenothiocarb)、芬諾克(fenoxycarb )、 芬普寧(fenpropathrin)、芬化利(fenvalerate )、芬普尼 (fipronil )、氟尼胺(flonicamid )、氟蟲醯胺 (flubendiamide )、護赛寧(flucythrinate )、《·密蟲胺 15 ( flufenerim )、氟芬隆(flufenoxuron )、福化利 (fluvalinate)、τ-福化利(tau-fluvalinate )、大福松 (fonophos)、覆滅蜗(formetanate)、福賽絕(fosthiazate)、 合芬隆(halofenozide)、六伏隆(hexaflumuron)、合赛多 (hexythiazox )、愛美松(hydramethylnon )、益達胺 2〇 ( imidacloprid )、因得克(indoxacarb )、殺蟲肥皂 (insecticidal soaps )、亞芬松(isofenphos )、祿芬隆 (lufenuron )、馬拉松(malathion )、美氟寧 (mepyrfluthrin )、美氟綜(metaflumizone )、滅蝸靈 (metaldehyde )、達馬松(methamidophos )、滅大松 25 ( methidathion )、滅賜克(methiodicarb )、納乃得 (methomyl )、美賜平(methoprene )、甲氧 DDT 201204254 ’ (methoxychlor )、美特寧(metofluthrin )、亞素靈 , (monocrotophos )、滅芬諾(methoxyfenozide )、烯啶蟲胺 (nitenpyram )、尼殺赛(nithiazine )、諾伐隆(novaluron )、 諾伏隆(noviflumuron )、毆殺滅(oxamyl )、巴拉松 5 ( parathion )、甲基巴拉松(parathion-methyl )、百滅寧 (permethrin)、福瑞松(phorate)、裕必松(phosalone)、 益滅松(phosmet)、福賜米松(phosphamidon)、比加普 (pirimicarb )、佈飛松(profenofos)、佈福靈(profluthrin)、 歐蜗多(propargite )、佈芬佈(protrifenbute )、派滅淨 ίο ( pymetrozine )、派福羅(pyraflupr〇ie )、除蟲菊精 (pyrethrin)、畢達本(pyridaben )、啶蟲丙醚(pyridalyl)、 彼福貴(pyrifluquinazon )、彼綠羅(pyriprole)、百利普芬 (pyriproxyfen )、魚藤精(rotenone )、魚尼丁( ryan〇dine )、 賜托拉(spinetoram )、賜諾殺(spinosad )、賜派芬 15 ( spirodiclofen )、螺甲蟎酯(spiromesifeil )、螺蟲乙酯 (spirotetramat)、氟啶蟲胺腈(sUlfoxaflor)、曱丙硫磷 (sulprofos )、得芬諾(tebufenozide )、得芬瑞 (tebufenpyrad )、得福隆(teflubenzuron )、七氟菊酯 (tefluthrin )、牦福松(terbufos )、殺蟲畏 2〇 (tetrachlorvinphos)、治滅寧(tetramethrin)、四曱基扶寧 (tetramethylfluthrin )、噻蟲啉(thiadopHd )、赛速安 (thiamethoxam )、硫敵克(thiodicarb )、殺蟲單 (thiosultap-sodium )、脫芬瑞(t〇ife叩yrad )、泰滅寧 (tralomethrin )、t»坐财威(triazamate )、三氣松 25 (trichl〇rfon )、二福隆(triflumuron )、蘇力菌(Bacillus thuringiensis)的所有品系、蟲生細菌(ent〇in〇pathogenic 211 201204254 bacteria)、核多角體病毒(Nucleo polyhydrosis viruses) 的所有品系、蟲生病毒(entomopathogenic viruses)及蟲 生真菌(entomopathogenic fungi)所組成之群組。 10.如請求項9所述之組合物,其中該至少一種額外的生物 活性化合物或藥劑係選自由阿巴汀(abamectin)、亞滅培 (acetamiprid )、阿納寧(acrinathrin )、三亞瞒(amitraz)、 阿佛菌素(avermectin)、印楝素(azadirachtin)、畢芬寧 (bifenthrin )、布芬淨(buprofezin )、加保利(carbaryl)、 培丹(cartap )、姓安勃(chlorantraniliprole )、克凡派 (chlorfenapyr )、陶斯松(chlorpyrifos )、可尼丁 (clothianidin )、氰特破(cyantraniliprole )、賽扶寧 (cyfluthrin )、β 赛扶寧(beta-cyfluthrin )、赛洛寧 (cyhalothrin)、λ 赛洛寧(lambda-cyhalothrin) γ 赛洛寧 (gamma-cyhalothrin)、赛滅寧(cypermethrin)、α 赛滅 寧(alpha-cypermethrin)、ζ 赛滅寧(zeta-Cypermethrin)、 賽滅淨(cyromazine)、第滅寧(deltamethrin)、地特靈 (dieldrin )、達特南(dinotefuran )、苯蟲醚(diofenolan)、 因滅汀(emamectin )、安殺番(end〇Sulfan )、益化利 (esfenvalerate )、乙蟲清(ethiprole )、依芬寧 (etofenprox )、依殺蟎(etoxazole )、芬硫克 (fenothiocarb )、芬諾克(fenoxycarb )、芬化利 (fenvalerate )、芬普尼(fipronii)、氟尼胺(flonicamid)、 氟蟲醯胺(flubendiamide)、氟芬隆(flufenoxuron)、福 化利(fluvalinate )、覆滅蟎(formetanate )、六伏隆 (hexaflumuron )、愛美松(hydramethylnon )、益達胺 201204254 r ( imidacloprid )、因得克(indoxacarb )、祿芬隆 • ( lufenur〇n )、美氟寧(mepyrfluthrin )、美氟综 (metaflumizone )、滅賜克(methiodicarb )、納乃得 (methomyl )、美賜平(methoprene )、滅芬諾 5 ( meth〇xyfenozide )、稀咬蟲胺(nitenpyram )、尼殺赛 (nithiazine)、諾伐隆(novaiuron )、跋殺滅(oxarnyi)、 派滅淨(pymetrozine )、除蟲菊精(pyrethrin )、畢達本 (pyridaben )、咬蟲丙鍵(pyridalyl )、百利普芬 (pyriproxyfen )、魚尼丁( ryanodine )、賜托拉 ίο ( spinetoram )、賜諾殺(spin〇sad )、賜派芬 (spirodiclofen )、螺甲蜗 g旨(Spir〇mesjfen )、螺蟲乙酉旨 (spirotetramat )、氟啶蟲胺腈(sulf〇xafl〇r )、得芬諾 (tebufenozide )、治滅寧(tetramethrin )、四甲基扶寧 (tetramethylfluthrin )、噻蟲啉(thiacl〇prid )、赛速安 15 ( thiamethoxam )、硫敵克(thiodicarb )、殺蟲單 (thiosultap-sodium )、泰滅寧(trai〇methrin )、唑蚜威 (triazamate)、三福隆(triflumuron)、蘇力菌(Bacillus thuringiensis )的所有品系及核多角體病毒(Nucieo polyhydrosis viruses )的所有品系所組成之群組。 20 11_ 一種用於保護動物免於無脊椎動物寄生害蟲侵害的組合 物,其包含一殺寄生蟲有效量的如申請專利範圍第丨項 所述之化合物及至少一載體。 213 201204254 12. — 量動物害蟲的方法,其包含‘生物* 動物害圍第1項所述之化合物接觸該::: 13.==1 述之方法,其中該無脊椎動物害蟲之環境 ’、、生物有效量崎求们所述德合物接觸。 宝I: 濩種子或由其所生長之植物免於無脊椎動物 方法,其包含以一生物有效量的請求項“斤 述之化合物接觸該種子。 15. 如j項14所述之方法,其中該種子係以調配為組合物 之明’、項1所述之化合物所塗覆,該組合物包括一成膜 劑或一黏合劑》 15 16. —種處理過的種子,其包含一量為處理前種子重量 0 0001至1%的請求項1所述之化合物。 S 214 201204254 、 四、指定代表圖: A : (一)本案指定代表圖為:第(無)圖。 ' (二)本代表圖之元件符號簡單說明: 五、本案若有化學式時,請揭示最能顯示發明特徵的化 學式:, c / L - R6 r / V where 10 A1 is N or CR7; A2 is N or CR8; A3 is N or CR9; A4 is N or CR10; and the constraints are A1, A2, A3 and A4 τ system , s(0)k or NR36; no more than two systems N; 15 L-C (R&gt;C (R^ and R&quot; bonded carbon atoms are also bonded to CR R5' and R! 2 bonded carbon atoms are also bonded to the ulnar 6; or optionally 4 or 4 diphenyl groups independently selected from R 1 ; substituents; 4-C (R34) (R35 )_z_, wherein the carbon atom established with R34 and R35! is also bonded to CW and Z is bonded to R6; Z is 0, S(0)m, NR37 or CR38r39; R1 is - selectively up to 5 phenyl or 5- or 6-membered heteroaromatic rings independently substituted with a substituent selected from R14; 201 20 R2 hydrazine, hydroxy, Cl-C6 alkyl, Cr_c6 haloalkyl, c2_c6 alkenyl, C2-c6 Alkenyl, c2-c6 alkynyl, c3-c6 haloalkynyl, C3-C7 cycloalkyl, C4-C8 cycloalkyl, c-c7 cycloalkenyl, Q-C6 alkoxy, qq alkoxy Alkyl, -CHO, CCW^R15 . C(0)0R16, C(〇)NR17R18 ^ S(0)pR19 or s(o)2nr2Gr21 ; each R3 is independently halogen, cyano, Ci-C4 Alkyl or C-C4 alkoxy; R4 is hydrazine or Q-C4 alkyl; R5 is hydrazine or Ci-c4 alkyl; R6 is optionally substituted with up to 5 substituents independently selected from R22 Phenyl or 5- or 6-membered heteroaromatic ring; R, R, R9 and R10 are independently H, _, Ni, nitro, 〇R23, NW, c-C6 alkyl, Ci-C6 (tetra), C2-C6 dilute group, c2-c6 _ group, c2_c6 block group, C3_C6 tooth fast group, C3-c7 cycloalkyl group, c4-c8 cycloalkylalkyl group, C5_C7 cycloalkenyl group, -CHO, C(W2)R26 , c(〇)〇r27, c(〇)nr28r29, S(9)qR30, S(0)2Nr28r29 or 〇c(〇)r31: or a benzene optionally substituted with up to 5 substituents independently selected from R4. Phenyl or 5- or 6-membered heteroaryl ring; or one and r8 8 and ^, or the adjacent couple of R9 and f, and their even pairs (four) connected with the stone anti-atoms - formed - copper or 5 members or 6 members a cyclic or non-aromatic ring comprising a ring member selected from the group consisting of carbon atoms and up to 3 heteroatoms independently selected from L 0 and S; R 11 and R 12 are independently H, halogen, c Γ - ganodioxy; Cl~C2, or Ci-ca, R13, R14, R22 and R4G are independently halogen, cyano, nitro, OR23, NR24R 25, C rQ alkyl, C rC6 haloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C3-C6 haloalkynyl, C3-C7 cycloalkyl, C4-C8 ring Alkylalkyl, C5-C7 cycloalkenyl, -CHO, C(W2)R26, C(0)0R27, C(0)NR28R29, S(0)qR30, S(0)2NR28R29 or 0C(0)R31 R15 and R16 are independently CrQ alkyl, Cr-C6 haloalkyl, C2-C6 alkenyl, C2-C6 haloalkenyl, C2-C6 alkynyl, C3-C6 haloalkynyl, C3-C7 cycloalkyl , C4-C8 cycloalkylalkyl or C5-C7 cycloalkenyl; or optionally up to 3 independently selected from _, cyano, nitro, OR23, NR24R25, QQ alkyl, C2-C4 alkenyl , C2-C4 alkynyl, CrQ haloalkyl, C2-C6 alkoxyalkyl, c2-c4 haloalkenyl, -CHO, C(W2)R26, C(0)0R27, c(o)nr28r29, S (0) a phenyl group substituted with a substituent of qR3°, s(o)2nr28r29 and 〇C(0)R31; each of R17 and R20 is independently Η, Q-C6 alkyl, CrQ haloalkyl, C2-C6 Alkenyl, c2-c6 haloalkenyl, c2-C6 alkynyl, C3-C6 haloalkynyl, C3-C:7 cycloalkyl, c4-c8 cycloalkylalkyl or c5-c7 cycloalkenyl; or selected Up to 3 independently selected from the group consisting of halogen, cyano, nitro, OR23, NR24R25, c-c4 , C2-C4 alkenyl, &lt;:2-(:4 fast radical, Ci-Cj i!alkyl, c2_c6 methoxyoxyalkyl, C2-C4 haloalkenyl, _ch〇, C(W2)R26, C (0) 0R27, C (〇) NR28R29, S(〇) qR3. , S(〇)2NR28R29 and the substituent of 0C(0)R are substituted. Alkenyl or c2-c6 alkynyl; 201204254 Each Rl9, R26, r27 and R30 are independently c "c6 炫 or c" C6 haloalkyl; each R2/ and R31 is independently H, Cl-C6 alkyl or C plant c6-dentate; each R25, R36 and R37 is independently H, Ci_C6 alkyl, c(0)R32 or C (〇)〇R33 ; each R28 and R32 are independently H, C widely c6 alkyl, C wide c6 haloalkyl, cr~C6 alkenyl, c2-C6 _ dilute, c2_C6 fast radical, c3-C6 4 Base, Cr~C7 cycloalkyl, c4-C8 cycloalkylalkyl or C5-C7 cycloalkenyl; 10 each R is independently CH: 6 alkyl, Cl_c6 haloalkyl, C2_C6 dilute, C2-C6 halo Alkenyl, c2-c6 alkynyl, c3-c6 haloalkynyl, C3~C7 cycloalkyl, Q-Cs cycloalkylalkyl or c5-C7 cycloalkenyl; 15 R H, Cl-C4 alkyl, Ci-c2 i hospital base, c2-c4 dilute group, CfC4 alkynyl group, c丨-c4 alkoxy group or cyano group; R35 system hydrazine or methyl group; ί =, 0 Η, dentate, C1-C2 炫 or C1 - C2 alkoxy; is selected from the group consisting of H, cyano and C-C2 alkyl, and when it is a sensation, the R 9 is additionally selected from halogen; or ',, 20 R, R39 and R above The carbon atom to which 38 and R39 are attached - represents a carbonyl moiety, and each of the W2 systems is independently 0 or s; k is 0, 1 or 2; 25 201204254 n is an integer from 〇 to 5; Ρ 0, 丨Or 2; each q series is independently 〇, 1 2; S series 1, 2 or 3; and t is 1 or 2; the limiting condition is the sum of s and t, 2, 3 or 4. 2. The compound according to Item 1, wherein: T is 〇; Z is 〇; R is a 4 ° 咬 base ring substituted with 1 to 3 substituents independently selected from R 14 wherein one of the substituents is located The second position of the 4-% mouth base ring (2-position); R2 system Η, fluorenyl group, Cr_C5 alkoxyalkyl group or Cr_C4 alkoxycarbonyl group; R system hydrazine or alkyl group; R5 system Η; R6 system selection Optionally having up to 5 phenyl rings independently substituted with a substituent selected from R22 or optionally substituted with up to 4 substituents independently selected from R22; R7, R8, R9 and R10 are independently Is hydrazine, halogen, Cr*C4 alkyl, Ci-Q haloalkyl, C2-C4 alkenyl, C2-C4 haloalkenyl, C2-C4 alkynyl, C3-C4 haloalkynyl, c3-c6 cycloalkyl , ch: 4 alkoxy, Cr·Q haloalkoxy, Cl—c4 alkylthio, Cl_c4 haloalkylthio Or a cyano group, or R7 and r8, or R8 and R9, or an adjacent couple of R9 and R10, together with the carbon atom to which they are attached, form a 5- or 6-membered aromatic non-aromatic ring comprising a carbon selected from carbon Original 205 201204254 and up to 3 ring members independently selected from the hetero atom of ruthenium, osmium and S; R, R12 are independently H, halogen or methyl; each R13 is halogen or methyl; each R14 is independent , Ci_C4, Ke C4, Cyan, C2-C4, C2-C4 i alkenyl, c2-c4, K3-C4, alkoxy, Qj-C: 6-cycloalkyl , Cl-C4 alkoxy, Cl-c4 halogen alkoxy, Ci-C4 alkylthio or Cr-Q haloalkylthio; each R22 is independently halogen, cyano, C "C6 alkyl, Cl-c6 Halogenated C3-C6 cycloalkyl, c2-C6 dilute, C2-C6 haloalkenyl, Cr~C6 alkynyl, Q-C6 alkoxy or Cr~C6 halo alkoxy; R34 hydrazine or Cl- C2 alkyl; R35 system; 15 W system; η system 〇; s system 1; and t system; as described in claim 2, wherein: A1 is N or CR7; A2 is N or CR8; A3 is N or CR9; A4 is CR10; L system, -C(R34)(R35)〇- or unsubstituted extension 201204254 R1 is a 4-pyridine ring substituted with a substituent selected from R14, wherein the above substituent is located at the second position of the 4-pyridine ring (2-position); R2 system Η; 5 R4 system Η or methyl; R6 is a benzene ring substituted with 1 to 3 substituents independently selected from r22 or a pyridine ring' wherein one of the substituents is in the para position; R, R, R and R are independently Η , halogen or C1-C4 halogen compound; R11 and R12 system Η; ίο each R14 is independently halogen or Cr~C4 haloalkyl; each R22 is independently F, a, Br, cyano, CH3, CF3, ring Propyl, HOC, CH30 or CF3 oxime; and R34 oxime or methyl. The compound according to claim 3, wherein: R6 is a benzene ring or a pyridine ring which is substituted in the para position with a substituent independently selected from R22 and is optionally independently selected from the ortho position. Substituted by a substituent of R22; R7 is hydrazine or F; 20 R8 and R9 are independently hydrazine, halogen or Ci-Q i alkyl; R1Q is hydrazine or F; each R14 is independently F, a, Br or; Each R22 is independently F, a, Br, CF3 or Cf3〇. The compound of claim 4, wherein: r6 is a benzene ring substituted in the para position with a substituent selected from R22; 207 201204254 R7 system; R8 system Η, halogen or CF3; R9 system Η , halogen or CF3; R10 system Η; 5 R14 system Cl; and R22 system F, α, Br or CF3. 6. The compound of claim 1 which is selected from the group consisting of 2-chloro-indole-[2-[[1-[(2Ε)-3-(4-chlorophenyl)-) 2-propen-1-yl]-3-吖ίο丁α定基]oxy]-6-(disorder methyl)-3-α ratio α-based]-4-σΗ^ bite Wei 酉 basket amine, 2_ chlorine -Ν-[4,5-Dichloro-2-[[1-[(2Ε)_3-(4-chlorophenyl)-2-propenyl)-yl]-3-azetidinyl]oxy]phenyl -4-Acridine Carboxamide, 2-Chloro-N-[6-Gas-2-[[1-[(2Ε)-3-(4-chlorophenyl)-2-propen-1-yl) ]·3-α丫丁 π定基]oxy]-5·gas-3-° ratio π定基]-4-° than biting weiganamine, 2-chloro-Ν-[5-gas-2-[[ 1-[(2Ε)-3-(4-Phenylphenyl)-2-propen-1-yl]-3-α丫丁α定基]oxy]-6-rat-3-° ratio α-based]- 4-α ratio α-determination of western basket amine, 20 2-chloro·Ν·[2-[[1-[(2Ε)·3-(4-chlorophenyl)·2·propylene·1_yl)-2 - Mercapto-3-azetidinyl]oxy]-6-(trifluoromethyl)-3-. Bipyridyl-4-pyridinium carboxamide, and 2-chloro-N-[6-chloro-2-[[l-[2-(4-chlorophenoxy)propyl]-3-azetidinyl ] oxy]-5-fluoro-3-° ratio °]-4-4b carboxy guanamine. S 208 201204254 7. The compound according to claim 5, which is 2-gas-Ν-[2-[[1-[(2Ε)-3-(4-chlorophenyl)-2-propenyl]_3 - azetidinyl]oxy]-6-(trifluoromethyl)_3_pyridyl&gt; 4-pyridinecarboxamide. 5. A composition comprising the compound of claim 1 and at least one additional component selected from the group consisting of a surfactant, a solid diluent, and a liquid diluent, the composition optionally further comprising At least one additional bioactive compound or agent. 9. The composition of claim 8, wherein the at least one additional biologically active compound or agent is selected from the group consisting of abamectin, acephate, acequinocyl, subculture (acetamiprid), acetoprole, acrinathrin, amidoflumet, amitraz, avermectin, azadirachtin, valsin ( Azinphos-methyl ), bifenthrin, bifenazate, bistrifluron, borate, buprofezin, carbaryl, carbofuran ), cartap, carzol, chlorantraniliprole, chlorfenapyr, chlorfluazuron, chlorpyrifos, chlorpyrifos-methyl , chromafenozide, clofentezin, clothianidin, cyantraniliprole, cyflumetofen, cyfluthrin, beta Beta-cyfluthrin, cyhalothrin' gamma-cyhalothrin, λ 赛洛宁 201204254 (lambda-cyhalothrin), cypermethrin, alpha-cypermethrin ), zeta-cypermethrin, cyromazine, deltamethrin, diafenthiuron, diazinon, dieldrin, 5 phoenix (diflubenzuron), dimefluthrin, dimehypo, dimethoate, dinotefuran, diofenolan, emamectin, ampoules Endosulfan, esfenvalerate, ethiprole, etofenprox, etoxazole, fenbutatin oxide, fenothiocarb, Fenoxycarb, fenpropathrin, fenvalerate, fipronil, flonicamid, flubendiamide, flucythrinate, · Mildewamine 15 ( flufenerim ) Flufenoxuron, fluvalinate, tau-fluvalinate, fonophos, formetanate, fosthiazate, halofenozide , hexaflumuron, hexythiazox, hydramethylnon, imidacloprid, indoxacarb, insecticidal soaps, isfenfens ), lufenuron, malathion, mepyrfluthrin, metaflumizone, metaldehyde, methamidophos, methidathion, annihilation Methiodicarb, methomyl, metoprene, methoxy DDT 201204254 ' (methoxychlor), metofluthrin, sulphate, monocrotophos, methoxyfenozide , nitenpyram, nithiazine, novaluron, noviflumuron, oxamyl, parathion, armor Parathion-methyl, permethrin, phorate, phosalone, phosmet, phosphamidon, pirimicarb, Profenofos, profluthrin, propargite, protrifenbute, pymetrozine, pyraflupr〇ie, pyrethrin ), pyripaben, pyridalyl, pyrifluquinazon, pyriprole, pyriproxyfen, rotenone, ryan 〇dine ), spinetoram, spinosad, spirodiclofen, spiromesifeil, spirotetramat, sUlfoxaflor , sulprofos, tebufenozide, tebufenpyrad, teflubenzuron, tefluthrin, terbufos, insecticidal 2〇 Tetrachlorvinphos) Rin), tetramethylfluthrin, thiadopHd, thiamethoxam, thiodicarb, thiosultap-sodium, tefife Yrad ), tralomethrin, t»triazamate, tricholson rfon, triflumuron, Bacillus thuringiensis, entomopathogenic bacteria (ent〇in〇pathogenic 211 201204254 bacteria), a group consisting of all strains of Nucleo polyhydrosis viruses, entomopathogenic viruses, and entomopathogenic fungi. 10. The composition of claim 9, wherein the at least one additional biologically active compound or agent is selected from the group consisting of abamectin, acetamiprid, acrinthrin, and amitraz. ), avermectin, azadirachtin, bifenthrin, buprofezin, carbaryl, cartap, chlorantraniliprole, kefan Chlorfenapyr, chlorpyrifos, clothianidin, cyantraniliprole, cyfluthrin, beta-cyfluthrin, cyhalothrin, λ Lamma-cyhalothrin gamma-cyhalothrin, cypermethrin, alpha-cypermethrin, zeta-Cypermethrin, cyromazine , deltamethrin, dieldrin, dinotefuran, diofenolan, emamectin, end〇Sulfan, esfenvalerate ), Ethiprole, etofenprox, etoxazole, fenothiocarb, fenoxycarb, fenvalerate, fipronii, fluoride Fluonicamid, flubendiamide, flufenoxuron, fluvalinate, formetanate, hexaflumuron, hydramethylnon, edaamine 201204254 r ( imidacloprid ), indoxacarb, lufenur〇n, mepyrfluthrin, metaflumizone, methiodicarb, methodyl ,methoprene, meth〇xyfenozide, nitenpyram, nithiazine, novaiuron, oxarnyi, 派灭净(pymetrozine), pyrethrin, pyridaben, pyridalyl, pyriproxyfen, ryanodine, spinetoram, Spin 〇s (spin〇sad), Spirodiclofen, Spir〇mesjfen, spirotetramat, sulf〇xafl〇r, tebufenozide, chlorpyrifos Tetramethrin ), tetramethylfluthrin, thiacl〇prid, thiamethoxam, thiodicarb, thiosultap-sodium, tai ning (trai) A group consisting of all strains of 〇methrin), triazamate, triflumuron, Bacillus thuringiensis, and Nucieo polyhydrosis viruses. 20 11_ A composition for protecting an animal from parasitic pests of an invertebrate comprising a parasiticidally effective amount of a compound as claimed in claim 3 and at least one carrier. 213 201204254 12. Method for measuring animal pests, which comprises the contact of the compound described in item 1 of 'Biological* Animal Diseases'::: 13.==1 The method of the invertebrate pest environment', The biologically effective amount is in contact with the German compound. Bao I: A seed or a plant grown therefrom is exempt from the invertebrate method, comprising contacting the seed with a biologically effective amount of the request "a compound of the formula." The seed is coated with a compound as described in the composition of claim 1, the composition comprising a film former or a binder. 15 16. A treated seed comprising an amount of Pre-treatment seed weight 0 0001 to 1% of the compound described in claim 1. S 214 201204254, IV. Designated representative figure: A : (1) The representative representative of the case is: (None) figure. ' (2) A brief description of the symbol of the representative figure: 5. If there is a chemical formula in this case, please disclose the chemical formula that best shows the characteristics of the invention: 55
TW100122670A 2010-07-20 2011-06-28 Pesticidal 3-(aryloxy)azacycloalkanes TW201204254A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US36592710P 2010-07-20 2010-07-20
US41810810P 2010-11-30 2010-11-30
US47692911P 2011-04-19 2011-04-19

Publications (1)

Publication Number Publication Date
TW201204254A true TW201204254A (en) 2012-02-01

Family

ID=46761203

Family Applications (1)

Application Number Title Priority Date Filing Date
TW100122670A TW201204254A (en) 2010-07-20 2011-06-28 Pesticidal 3-(aryloxy)azacycloalkanes

Country Status (1)

Country Link
TW (1) TW201204254A (en)

Similar Documents

Publication Publication Date Title
ES2381499T3 (en) 5-Aryloxisazolines to control invertebrate pests
ES2358683T3 (en) ISOXAZOLINS TO CONTROL INVERTEBRATE PESTS.
TWI652014B (en) Heterocyclic substituted bicycloazole insecticide
ES2399572T3 (en) Naxaphthalene isoxazoline compounds for the control of invertebrate pests
TWI558695B (en) Mesoionic pesticides
MX2008013307A (en) Pyrazolines for controlling invertebrate pests.
BR112012002488B1 (en) COMPOSITIONS, NON-THERAPEUTIC METHOD TO CONTROL AN INVERTEBRATE PEST, TREATED AND COMPOSED SEED
BR112017019326B1 (en) Compound, composition and method for controlling an invertebrate pest
ES2659033T3 (en) 1,3-diaryl-substituted heterocyclic pesticides
BR112019023474B1 (en) COMPOUND, COMPOSITION AND METHOD FOR CONTROLING AN INVERTEBRATE PEST
KR102389531B1 (en) 1-aryl-3-alkylpyrazole insecticides
WO2012012366A1 (en) Pesticidal 3-(aryloxy)azacycloalkanes
WO2023200911A1 (en) Novel sulfonate benzamide compounds for controlling invertebrate pests
CN117412966A (en) Condensed pyridines for combating invertebrate pests
TW201204254A (en) Pesticidal 3-(aryloxy)azacycloalkanes
WO2022271901A1 (en) Azole compounds for controlling invertebrate pests
EP4284783A1 (en) Azole compounds for controlling invertebrate pests
JP2023535958A (en) Triazolone compounds for controlling invertebrate pests
EP4168405A1 (en) Chromenone compounds for controlling invertebrate pests
EP4097094A1 (en) Pyridine compounds for controlling invertebrate pests
TW202126617A (en) Meta-diamide insecticides